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A B S T R A C T
Background
Stress urinary incontinence constitutes a significant health and economic burden to society. Traditional suburethral slings are surgical
operations used to treat women with symptoms of stress urinary incontinence.
Objectives
To assess the eIectiveness of traditional suburethral sling procedures for treating stress urinary incontinence in women; and summarise
the principal findings of relevant economic evaluations.
Search methods
We searched the Cochrane Incontinence Specialised Register, which contains trials identified from the Cochrane Central Register of
Controlled Trials (CENTRAL), as well as MEDLINE, MEDLINE In-Process, MEDLINE Epub Ahead of Print, the Cumulative Index to Nursing and
Allied Health Literature (CINAHL), ClinicalTrials.gov, and the World Health Organization International Clinical Trials Registry Platform (WHO
ICTRP); we handsearched journals and conference proceedings (searched 27 February 2017) and the reference lists of relevant articles. On
23 January 2019, we updated this search; as a result, several additional reports of studies are awaiting classification.
Selection criteria
Randomised or quasi-randomised trials that assessed traditional suburethral slings for treating stress or mixed urinary incontinence.
Data collection and analysis
At least two review authors independently extracted data from included trials and assessed risk of bias. When appropriate, a summary
statistic was calculated: risk ratio (RR) for dichotomous data, odds ratio (OR) for continence and cure rates that were expected to be high,
and mean diIerence (MD) for continuous data. We adopted the GRADE approach to assess the quality of evidence.
Main results
A total of 34 trials involving 3244 women were included. Traditional slings were compared with 10 other treatments and with each other.
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We did not identify any trials comparing suburethral slings with no treatment or sham treatment, conservative management, anterior
repair, or laparoscopic retropubic colposuspension. Most trials did not distinguish between women having surgery for primary or recurrent
incontinence. One trial compared traditional slings with bladder neck needle suspension, and another trial compared traditional slings
with single-incision slings. Both trials were too small to be informative.
Traditional suburethral sling operation versus drugs
One small trial compared traditional suburethral sling operations with oxybutynin to treat women with mixed urinary incontinence. This
trial did not report any of our GRADE-specific outcomes. It is uncertain whether surgery compared with oxybutynin leads to more women
being dry (83% vs 0%; OR 195.89, 95% confidence interval (CI) 9.91 to 3871.03) or having less urgency urinary incontinence (13% vs 43%;
RR 0.29, 95% CI 0.09 to 0.94) because the quality of this evidence is very low.
Traditional suburethral sling versus injectables
One small trial compared traditional slings with suburethral injectable treatment. The impact of surgery versus injectables is uncertain
in terms of the number of continent women (100% were dry with a traditional sling versus 71% with the injectable aEer the first year;
OR 11.57, 95% CI 0.56 to 239.74), the need for repeat surgery for urinary incontinence (RR 0.52, 95% CI 0.05 to 5.36) or the occurrence of
perioperative complications (RR 1.57, 95% CI 0.29 to 8.49), as the quality of evidence is very low.
Traditional suburethral sling versus open abdominal retropubic colposuspension
Eight trials compared slings with open abdominal retropubic colposuspension. Moderate-quality evidence shows that the traditional
suburethral sling probably leads to more continent women in the medium term (one to five years) (69% vs 59% aEer colposuspension:
OR 1.70, 95% CI 1.22 to 2.37). High-quality evidence shows that women were less likely to need repeat continence surgery aEer a
traditional sling operation than aEer colposuspension (RR 0.15, 95% CI 0.05 to 0.42). We found no evidence of a diIerence in perioperative
complications between the two groups, but the CI was very wide and the quality of evidence was very low (RR 1.24, 95% CI 0.83 to 1.86).
Traditional suburethral sling operation versus mid-urethral slings
Fourteen trials compared traditional sling operations and mid-urethral sling operations. Depending on judgements about what constitutes
a clinically important diIerence between interventions with regard to continence, traditional suburethral slings are probably no better,
and may be less eIective, than mid-urethral slings in terms of number of women continent in the medium term (one to five years) (67% vs
74%; OR 0.67, 95% CI 0.44 to 1.02; n = 458; moderate-quality evidence). One trial reported more continent women with the traditional sling
aEer 10 years (51% vs 32%: OR 2.22, 95% CI 1.07 to 4.61). Mid-urethral slings may be associated with fewer perioperative complications
(RR 1.74, 95% CI 1.16 to 2.60; low-quality evidence).
One type of traditional sling operation versus another type of traditional sling operation
Nine trials compared one type of traditional sling operation with another. The diIerent types of traditional slings, along with the number
of diIerent materials used, mean that trial results could not be pooled due to clinical heterogeneity. Complications were reported by two
trials - one comparing non-absorbable Goretex with a rectus fascia sling, and the second comparing Pelvicol with a rectus fascial sling. The
impact was uncertain due to the very low quality of evidence.
Authors' conclusions
Low-quality evidence suggests that women may be more likely to be continent in the medium term (one to five years) aEer a traditional
suburethral sling operation than aEer colposuspension. It is very uncertain whether there is a diIerence in urinary incontinence aEer
a traditional suburethral sling compared with a mid-urethral sling in the medium term. However, these findings should be interpreted
with caution, as long-term follow-up data were not available from most trials. Long-term follow-up of randomised controlled trials
(RCTs) comparing traditional slings with colposuspension and mid-urethral slings is essential. Evidence is insuIicient to suggest whether
traditional suburethral slings may be better or worse than other management techniques. This review is confined to RCTs and therefore
may not identify all of the adverse eIects that may be associated with these procedures.
A brief economic commentary (BEC) identified three eligible economic evaluations, which are not directly comparable due to diIerences
in methods, time horizons, and settings. End users of this review will need to assess the extent to which methods and results of identified
economic evaluations may be applicable (or transferable) to their own setting.
P L A I N   L A N G U A G E   S U M M A R Y
Traditional suburethral sling operations for urinary incontinence in women
Review question
How do traditional slings compare with other surgical or conservative treatments for women with stress urinary incontinence (SUI)?
Background
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A traditional suburethral sling operation is one of the surgical options for treating women with SUI. Stress urinary incontinence is loss
(leakage) of urine when coughing, laughing, sneezing, or exercising. It may be due to damage to the muscles that hold up the bladder neck
or damage to their nerves, which oEen occurs during childbirth. When stress urinary incontinence occurs together with an urge to empty
the bladder that is diIicult to defer (urgency urinary incontinence (UUI)), this is known as mixed urinary incontinence (MUI). The traditional
suburethral sling operation aims to hold up the bladder neck with a strip of material that may be biological (made from human or animal
tissue) or made of non-absorbable synthetic plastic (mesh/tape).
How up-to-date is this review?
The evidence is current to 27 February 2017. A further search on 23 January 2019 was not fully incorporated into the review.
Study characteristics
We found 34 randomised controlled trials (RCTs) involving 3244 women that compared traditional slings with drugs or other types of
surgery (colposuspension, mid-urethral slings, bladder neck needle suspension, single-incision slings (mini-slings); one type of traditional
sling with another; and traditional slings with injectables. All trials included women with SUI, but some also involved women with UUI,
who are said to have MUI.
We did not find any studies comparing suburethral slings with no treatment or sham treatment, conservative management such as pelvic
floor exercises, anterior repair, or laparoscopic colposuspension.
Study funding sources
Few trialists reported who had funded their work.
Key results
Surgery appears to work better than drugs for treating urinary incontinence. Some evidence suggests that women had less leakage with
traditional slings in the medium term (one to five years) compared with those undergoing colposuspension (a major abdominal operation),
and fewer needed repeat surgery in one trial. However, information about adverse eIects is lacking. It is not clear whether traditional
slings were better or worse than mid-urethral slings (synthetic tape) in the medium term, but one small trial showed that women who
had a traditional sling might have less leakage 10 years later. It is not clear whether traditional slings were better or worse than injectable
treatment, bladder neck needle suspension, or mini-slings. We found insuIicient information about diIerent types of slings compared
with each other, except that slings made of porcine dermis (Pelvicol) were more likely to fail than other materials. Slings made of non-
absorbable synthetic Goretex involved more complications.
Quality of the evidence
Many trials were small and used diIerent ways of measuring success, which made combining information diIicult. The quality of evidence
for most outcomes was judged to be low or very low. This means that most of our conclusions about traditional slings are uncertain.
Authors' conclusions
Some evidence suggests that women had less leakage with traditional slings in the medium term (one to five years) compared with those
undergoing colposuspension (a major abdominal operation), and fewer needed repeat surgery in one trial. Evidence on comparison of
traditional suburethral slings with other treatments is insuIicient. Three eligible economic evaluations reported similar results, but they
are not directly comparable because of diIerences in their methods. This review is confined to randomised controlled trials (RCTs) and
therefore may not identify all of the adverse eIects that may be associated with these procedures.
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S U M M A R Y   O F   F I N D I N G S
 
Summary of findings for the main comparison.   Traditional suburethral sling operation versus no treatment or sham operation
Traditional suburethral sling operation versus no treatment or sham operation
Patient or population: women with urinary incontinence 
Settings: secondary care
Intervention: sling



















Number of continent (dry) women (any definition)
in the medium term (1 to 5 years)
          Not reported
Repeat surgery for urinary incontinence           Not reported
Perioperative surgical complications           Not reported
Long-term adverse effects           Not reported
Condition-specific quality of life           Not reported
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval.
GRADE Working Group grades of evidence.
High quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.

















































































































































Summary of findings 2.   Traditional suburethral sling operation versus conservative management
Traditional suburethral sling operation versus conservative management






















Number of continent (dry) women (any definition) in
the medium term (1 to 5 years)
          Not reported
Repeat surgery for urinary incontinence           Not reported
Perioperative surgical complications           Not reported
Long-term adverse effects           Not reported
Condition-specific quality of life           Not reported
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval.
GRADE Working Group grades of evidence.
High quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.

















































































































































Summary of findings 3.   Traditional suburethral sling operation versus drugs
Traditional suburethral sling operation versus drugs




















Number of continent (dry) women (any definition) in
the medium term (1 to 5 years)
          Not reported
Repeat surgery for urinary incontinence           Not reported
Perioperative surgical complications           Not reported
Long-term adverse effects           Not reported
Condition-specific quality of life           Not reported
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval.
GRADE Working Group grades of evidence.
High quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: we are very uncertain about the estimate.
 
 
Summary of findings 4.   Traditional suburethral sling operation versus injectables



































































































































































Number of continent (dry) women
(any definition) in the medium term (1
to 5 years)








252 more women, per 1000, with tra-
ditional sling
(131 fewer to 284 more)
Repeat surgery for urinary inconti-
nence - urodynamic stress inconti-
nence (only)








44 fewer women, per 1000, with tradi-
tional sling
(86 fewer to 396 more)
Perioperative surgical complications
Urinary tract infection - stress urinary in-
continence (symptoms only)








52 more women, per 1000, with tradi-
tional sling
(65 fewer to 681 more)
Long-term adverse effects           Not reported
Condition-specific quality of life           Not reported
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; OR: odds ratio; RR: risk ratio.
GRADE Working Group grades of evidence.
High quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: we are very uncertain about the estimate.
aDowngraded one level due to serious risk of bias (unclear for sequence generation, allocation concealment, and blinding) and two levels for imprecision (95% CI very wide, 0.56















































































































































bDowngraded two levels due to very serious imprecision: single trial with small sample size.
 
 
Summary of findings 5.   Traditional suburethral sling operation versus anterior repair
Traditional suburethral sling operation versus anterior repair






















Number of continent (dry) women (any definition) in
the medium term (1 to 5 years)
          Not reported
Repeat surgery for urinary incontinence           Not reported
Perioperative surgical complications           Not reported
Long-term adverse effects           Not reported
Condition-specific quality of life           Not reported
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval.
GRADE Working Group grades of evidence.
High quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.

















































































































































Summary of findings 6.   Traditional suburethral sling operation versus bladder neck needle suspension (abdominal and vaginal)
Traditional suburethral sling operation versus bladder neck needle suspension (abdominal and vaginal)
Patient or population: women with urinary incontinence
Settings: secondary care
Intervention: sling




















Number of continent (dry) women
(any definition) in the medium term
(1 to 5 years)








200 more women, per 1000, with
traditional sling
(265 fewer to 291 more)
Repeat surgery for urinary inconti-
nence
          Not reported
Perioperative surgical complications
- urodynamic stress incontinence
(only)








700 more women, per 1000, with
traditional sling
(56 fewer to 2962 more)
Long-term adverse effects           Not reported
Condition-specific quality of life           Not reported
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; OR: odds ratio; RR: risk ratio.
GRADE Working Group grades of evidence.
High quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
















































































































































aDowngraded two levels for risk of bias (evidence comes from a single trial that was judged to be unclear for allocation concealment and blinding) and two levels for imprecision
(95% CI very wide).
 
 
Summary of findings 7.   Traditional suburethral sling operation versus open abdominal retropubic colposuspension
Traditional suburethral sling operation versus open abdominal retropubic suspension
Patient or population: women with urinary incontinence
Settings: secondary care
Intervention: sling
Comparison: open abdominal retropubic suspension
Illustrative comparative risks* (95% CI)

















Number of continent (dry) women
(any definition) in the medium term (1
to 5 years)








120 more dry women, per
1000, with traditional sling
(47 more to 186 more)
Repeat surgery for urinary inconti-
nence-stress urinary incontinence
(symptoms only)








101 fewer women having re-
peat continence surgery, per
1000, with traditional sling
(113 fewer to 69 fewer)








23 more women, per 1000,
with traditional sling
(16 fewer to 82 more)
Long-term adverse effects 
Number of women with recurrent UTIs
at > 5 years








2 more women, per 1000,
with traditional sling
(39 fewer to 75 more)
Condition-specific quality of life











Another trial reported no evi-




















































































































































(11.96 lower to 15.36
higher)
sling groups in IIQ and UDI
scores but reported no actual
numbers
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; IIQ: Incontinence Impact Questionnaire; OR: odds ratio; RCT: randomised controlled trial; RR: risk ratio; UDI: Urogenital Distress Inventory.
GRADE Working Group grades of evidence.
High quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: we are very uncertain about the estimate.
aDowngraded one level due to serious risk of bias (unclear randomisation and allocation concealment in two of the smaller trials), but the trial carrying 90% of weight in the
meta-analysis was judged to have low risk of selection bias.
bDowngraded one level for risk of bias (sequence generation was unclear in one-fourth of trials and allocation concealment was unclear in three-quarters of trials taking part in
the meta-analysis; participants were not blinded) and one level for imprecision (95% confidence interval was very wide).
cDowngraded two levels for imprecision (95% confidence interval was very wide; 0.57 to 1.82).
dDowngraded two levels for risk of bias (sequence generation and allocation concealment were judged to be "low risk"; blinding of participants was judged to be "high risk") and
two levels for imprecision (95% confidence interval was very wide; -11.96 to 15.36).
 
 
Summary of findings 8.   Traditional suburethral sling operation versus laparoscopic colposuspension
Traditional suburethral sling operation versus laparoscopic colposuspension






















Number of continent (dry) women (any definition)
in the medium term (1 to 5 years)
















































































































































Repeat surgery for urinary incontinence           Not reported
Perioperative surgical complications           Not reported
Voiding dysfunction           Not reported
Long-term adverse effects           Not reported
Condition-specific quality of life           Not reported
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval.
GRADE Working Group grades of evidence.
High quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: we are very uncertain about the estimate.
 
 
Summary of findings 9.   Traditional suburethral sling operation versus a mid-urethral sling or tape
Traditional suburethral sling operation versus a mid-urethral sling or tape
Patient or population: women with urinary incontinence
Settings: secondary care
Intervention: traditional sling
Comparison: minimally invasive sling operation
Illustrative comparative risks* (95% CI)
















Number of continent (dry)
women (any definition) in the
medium term (1 to 5 years)


























































































































































(185 fewer to 4 more)
Repeat surgery for urinary incon-
tinence - urodynamic stress in-
continence (only)
One trial reported the numbers of women having repeat continence

















143 more women, per
1000, with traditional
sling
(31 more to 309 more)
Long-term adverse effects
Release of sling required








38 more women, per
1000, with traditional
sling
(3 fewer to 157 more)
Condition-specific quality of life 
IIQ-7 - stress urinary incontinence
(symptoms only)




ity of life score in the interven-
tion groups was
0.6 higher





Eight other trials report-
ed some measure of QoL
but the data were un-
suitable for met-analy-
sis. Overall, there was no
evidence of a difference
between groups in QoL
scores
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; IIQ-7: Incontinence Impact Questionnaire Short Form; OR: odds ratio; QoL: quality of life; RCT: randomised controlled trial; RR: risk ratio.
GRADE Working Group grades of evidence.
High quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: we are very uncertain about the estimate.
1Downgraded one level due to serious risk of bias: 2/6 trials had high risk of selection bias.
2Downgraded two levels due to very serious imprecision: single study with small sample size.
3Downgraded two levels for risk of bias (sequence generation and allocation concealment were high or unclear risk in all four trials taking part in the meta-analysis).
4Downgraded two levels for risk of bias (sequence generation and allocation concealment were high or unclear risk in two of three trials taking part in the meta-analysis) and
two levels for imprecision (95% confidence interval was very wide: 0.87 to 7.35).
5Downgraded two levels for risk of bias (sequence generation was judged to be high risk, and allocation concealment was judged to be low risk; outcome data were incomplete)


















































































































































Summary of findings 10.   Traditional suburethral sling operation versus a single-incision sling (mini-sling)
Traditional suburethral sling operation versus a single-incision sling (mini-sling)
Patient or population: women with urinary incontinence
Settings: secondary care
Intervention: sling
Comparison: another type of sling
Illustrative comparative risks* (95% CI)













Number of continent (dry)
women (any definition) in
the medium term (1 to 5
years)








0 fewer women, per 1000, with
traditional sling
(245 fewer to 86 more)
Repeat surgery for urinary
incontinence






















of life score in the intervention
groups was 50.2 higher (2.23





Based on mean IIQ score, quality
of life was worse in the traditional
sling group compared with the mi-
ni-sling group
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; IIQ: Incontinence Impact Questionnaire; OR: odds ratio; RR: risk ratio.
GRADE Working Group grades of evidence.
High quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
















































































































































aDowngraded two levels due to very serious risk of bias: unclear randomisation and inadequate blinding.
bDowngraded two levels due to very serious imprecision: single trial, small sample size, wide 95% confidence intervals.
 
 
Summary of findings 11.   One type of traditional sling operation versus another traditional sling operation
One type of traditional sling operation versus another type of traditional sling operation
Patient or population: women with urinary incontinence
Settings: secondary care
Intervention: one type of traditional sling






















Number of continent (dry) women (any de-
finition) in the medium term (1 to 5 years)




Results not pooled (Analysis 11.2)
Repeat surgery for urinary incontinence at
first year
Fascial sling vs Pelvicol sling








188 fewer women, per 1000, with
fascial sling
(0 fewer to 76 fewer) (Analysis 11.4




Results not pooled (Analysis
11.14)
Long-term adverse effects
Vaginal mesh or graE exposure




Results not pooled (Analysis
11.23)
Condition-specific quality of life
ICI-Q short form UI score at 1 to 5 years




Results not pooled* (Analysis
11.25)
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; ICI-Q: International Consultation on Incontinence Questionnaire; RR: risk ratio; UI: urinary incontinence.
















































































































































High quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: we are very uncertain about the estimate.
1Downgraded two levels for imprecision (Analysis 11.2) and two levels for heterogeneity, as the trials used diIerent materials for the traditional sling procedure.
2Downgraded two levels for imprecision (Analysis 11.4)
3Downgraded one level for risk of bias (sequence generation was judged to be at low risk of bias in two of three trials and unclear in the third trial; allocation concealment was
unclear in two of three trials). Blinding (performance bias and detection bias) was judged to be unclear (two of three) or high risk (one of three). Downgraded two levels for
heterogeneity, as the trials used three diIerent materials for the traditional sling procedure, and one level for inconsistency, as 95% CIs did not overlap (Analysis 11.14).
4Downgraded two levels for heterogeneity, as the trials used four diIerent materials for the traditional sling procedure, and one level for imprecision, as the 95% CIs were very
wide (Analysis 11.23).
5Downgraded two levels for heterogeneity, as the trials used three diIerent materials for the traditional sling procedure, and one level for inconsistency, as 95% CIs did not
overlap (Analysis 11.25).
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B A C K G R O U N D
Description of the condition
Urinary incontinence (UI) in women is a distressing condition
that influences the physical, psychological, and social well-being
of aIected individuals with considerable impact on women,
carers, and health services (NICE 2013). Prevalence of urinary
incontinence varies widely in diIerent studies due to diIerences
in definition and population but ranges from 8% to 45%, with
stress urinary incontinence the most common type (Agarwal 2017).
The prevalence of urinary incontinence increases with age, parity,
smoking, and body mass index (BMI) (Amaral 2015; Lasserre 2009).
The International Continence Society defines urinary incontinence
as involuntary loss of urine (Haylen 2010). Stress (urinary)
incontinence (SUI) refers to involuntary loss of urine on eIort
or physical exertion (e.g. sporting activities), or on sneezing or
coughing (Haylen 2010). Two mechanisms for stress incontinence
are recognised: hypermobility or significant displacement of
the urethra and bladder neck during exertion, and intrinsic
urethral sphincter deficiency (Blaivas 1988). Among women, these
mechanisms may co-exist (O'Donnell 1994). Few clinical trials
have distinguished between the two conditions, probably because
no standardised and validated test is available to date (Abrams
2006; Blaivas 1988; McGuire 1993; McGuire 2004), and they are not
defined by recognised terminology (Haylen 2010). Women whose
incontinence may be due to either of these two mechanisms will be
considered together in this review.
The diagnosis of urodynamic stress incontinence (USI) requires
urodynamic investigation to exclude detrusor overactivity, in
addition to history-taking, physical examination, use of frequency/
volume charts, and urine analysis. Some study authors have
described women with only symptoms of stress incontinence
(diagnosis made on clinical evaluation without urodynamics).
Women with stress incontinence, both with and without
urodynamic investigation, will be included in this review.
Urgency urinary incontinence (UUI) is the symptom of involuntary
leakage of urine accompanied or immediately preceded by
a sudden strong desire (urgency) to void that is diIicult to
delay. The woman has a sensation of urgency because the
bladder is contracting too strongly. Detrusor overactivity (DO) is a
urodynamic diagnosis characterised by occurrence of involuntary
detrusor (bladder muscle) contractions. When a neurological cause
is known, the term neurogenic detrusor overactivity is used.
Idiopathic detrusor overactivity denotes absence of any identified
cause (Haylen 2010). Women with both these symptoms and the
urodynamic diagnosis of detrusor overactivity will be included in
the review only if they have co-existing and predominant stress
urinary incontinence (mixed urinary incontinence (MUI)).
Women with mixed incontinence included in this review will
have symptoms of stress and urgency urinary incontinence
(diagnosed clinically), or urodynamic stress incontinence and
detrusor overactivity (diagnosed via urodynamics).
Stress urinary incontinence is associated with various direct and
indirect economic costs. For example, one USA-based study found
that women about to undergo Burch or fascial sling surgery for
SUI had mean out-of-pocket costs (for supplies, laundry, and dry
cleaning) equivalent to $19 USD (SD = 30) per week in today’s terms
(2019 USD; converted from 2012 USD - Shemilt 2010 - at baseline)
(Subak 2014). The women who participated in this study had an
average (mean) age of 53 years (SD = 10) and an average (mean)
baseline frequency of urinary UI episodes of 23 per week (SD = 21);
48% had undergone prior non-surgical treatment for UI, and 16%
had undergone prior surgery for UI. Another study estimated that in
a single year (2012) in Spain alone, a national total of over 350,000
quality-adjusted life-years were lost due to UI among women 60
years of age and older (Villoro 2016).
Description of the intervention
Treatments for SUI include conservative, mechanical,
pharmacological, and surgical interventions.
• Conservative treatment centres on physical methods, including
pelvic floor muscle training, electrical stimulation, biofeedback,
and use of weighted cones.
• Mechanical devices that prevent or reduce urinary leakage are
available, such as metal plugs/patches and urethral and vaginal
inserts.
• Drug therapies, principally oestrogens and less oEen alpha-
adrenergic agents, can be used. A trial of conservative therapy is
generally undertaken before surgery is undertaken.
These interventions are the topic of separate Cochrane Reviews.
Surgical procedures to remedy stress incontinence generally aim
to liE and support the outlet of the bladder neck (urethrovesical
junction). There is disagreement, however, regarding the precise
mechanism by which continence is achieved. The choice of
procedure is oEen influenced by co-existent problems, surgeons'
and/or women's preferences, and physical features of the person
aIected.
Numerous surgical methods have been described, but essentially
they fall into nine categories.
• Open abdominal retropubic suspension (e.g. colposuspension
(Burch), Marshall-Marchetti-Krantz (MMK)) (Lapitan 2017).
• Laparoscopic retropubic suspension (Dean 2017).
• Vaginal anterior repair (anterior colporrhaphy) (Glazener 2017a).
• Traditional suburethral slings (current review).
• Mid-urethral slings (retropubic or transobturator tapes) (Ford
2017).
• Single-incision slings (mini-slings) (Nambiar 2017).
• Bladder neck needle suspensions (Glazener 2017b).
• Periurethral injections (Kirchin 2017).
• Artificial sphincters.
This review will concentrate on traditional suburethral sling
operations.
How the intervention might work
The aim of the suburethral sling operation is to restore or enhance
the patient’s urethral support during sudden movement, such as
that associated with coughing or sneezing. This is a achieved by
liEing and supporting the urethrovesical junction with autologous
or synthetic material. A traditional suburethral sling operation
requires a combined abdominal and vaginal approach. Strips of
material are tunnelled under the urethra and are attached to the
Traditional suburethral sling operations for urinary incontinence in women (Review)
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rectus muscle or to the ileopectineal ligaments. The materials used
for slings may be biological or synthetic.
Autologous biological materials include rectus fascia, fascia lata,
pubococcygeal muscle, vaginal wall, aponeurosis, and pyramidalis
fascia. Exogenous biological materials include ox fascia and porcine
dermis (Pelvicol). Synthetic materials include Teflon, Mersilene
tape in a silicon tube, lyodura, polytetrafluoroethylene (Goretex),
Marlex mesh, and Silastic.
A modification of the suburethral sling procedure is the 'minimally
invasive' mid-urethral synthetic polypropylene mesh (sling/tape)
applied via the retropubic or transobturator route. In this
operation, a tape is inserted under the mid-urethra with trocars
but without fixation of free ends of the tape. This can be done
with the patient under general or local anaesthesia (Smith 2002).
These procedures have been considered in a separate Cochrane
Review (Ford 2017). Only traditional sling operations using an open
abdominal approach and suture fixation are included in this review.
Why it is important to do this review
The wide variety of surgical treatments for urinary incontinence
suggests lack of consensus as to which procedure is best. The
most robust evidence is likely to come from consideration of all
well-designed randomised controlled trials (RCTs). Hence, an easily
accessible, periodically updated, comprehensive systematic review
of such trials is needed to identify optimal practice and to highlight
gaps in the evidence base. The findings of this review, taken in
context with the findings of other continence surgery reviews, will
provide women and their caregivers with the most robust evidence
available to enable them to make an informed decision about
whether to have surgery and, if so, what type.
O B J E C T I V E S
To assess the eIectiveness of traditional suburethral sling
procedures for treating stress urinary incontinence in women; and
summarise the principal findings of relevant economic evaluations.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised or quasi-randomised controlled trials of women with
stress incontinence (urodynamic diagnosis) or symptoms of stress
or mixed urinary incontinence (clinical diagnosis), in which at least
one trial arm involves traditional suburethral sling procedures.
Types of participants
Adult women with SUI due to hypermobility and/or intrinsic
sphincter deficiency, diagnosed clinically or with urodynamics, or
with mixed urinary incontinence. Classification of diagnoses will be
accepted as defined by the trialists.
Types of interventions
At least one arm of a study must involve traditional suburethral
sling procedures to treat stress or mixed urinary incontinence.
Comparison interventions may include other surgical techniques
and non-surgical interventions. The following comparisons were
made for traditional suburethral sling procedures (abdominal and
vaginal).
1. Traditional suburethral sling operation versus no treatment or
sham operation.
2. Traditional suburethral sling operation versus conservative
management (e.g. pelvic floor muscle training, electrical
stimulation, cones, biofeedback).
3. Traditional suburethral sling operation versus drugs.
4. Traditional suburethral sling operation versus injectables.
5. Traditional suburethral sling operation versus anterior repair.
6. Traditional suburethral sling operation versus bladder neck
needle suspension (abdominal and vaginal).
7. Traditional suburethral sling operation versus open abdominal
retropubic colposuspension.
8. Traditional suburethral sling operation versus laparoscopic
colposuspension.
9. Traditional suburethral sling operation versus a mid-urethral
sling or tape.
10.Traditional suburethral sling operation versus a single-incision
sling (mini-sling).
11.One type of traditional sling operation versus another type of
traditional sling operation.
Types of outcome measures
Outcome measures used in this review were selected on the basis
of their relevance to clinical cure or improvement in incontinence.
We regard the principal measures of eIectiveness as the proportion
of women whose incontinence was cured following surgery and the
proportion of women whose incontinence was improved.
Primary outcomes
• Urinary incontinence
* Number of continent (dry) women in the short term (less
than 12 months), medium term (one to five years), and long
term (longer than five years) as defined by women's report,
quantified measures, clinician's observations, or combined
measures (as defined by trialists; Table 1)
* Number of women who have had repeat continence surgery
Secondary outcomes
• Women's observations
* Number of women cured at one year or later (women's
observations)
* Number of women improved (cured or improved) in the short
term (less than 12 months), medium term (one to five years),
and long term (longer than five years)
* Number of women satisfied
• Quantification of symptoms
* Pad changes over 24 hours (from self-reported number of
pads used)
* Incontinent episodes over 24 hours (from self-completed
bladder chart)
* Pad test of quantified leakage (mean weight of urine loss)
• Clinician's observations
* Numbers of women with urinary incontinence (clinician's
observation) in the short term (less than 12 months), medium
term (one to five years), and long term (longer than five years)
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• Surgical outcome measures
* Duration of operation
* Length of hospital stay
* Time to return to normal activity level
* Blood loss
• Further treatment
* Number of women requiring treatment for pelvic organ
prolapse
• Adverse events
* Perioperative surgical complications
* Bladder perforation
* Urinary tract infection
* Urinary urgency symptoms, urgency urinary incontinence
* Detrusor overactivity (urodynamic overactivity)
* Voiding dysfunction (with or without urodynamic
confirmation)
* Long-term adverse eIects such as mesh exposure, pelvic
pain, dyspareunia, or release of sling
• Quality of life
* Condition-specific measures to assess quality of life (e.g.
Bristol Female Lower Urinary Tract Symptoms questionnaire
(BFLUTS)) (Jackson 1996)
* General health status measures (e.g. Short Form 36) (Ware
1993)
Main outcomes for ‘Summary of findings’ tables
We adopted the GRADE method for assessing the quality of
evidence for the following five outcomes.
• Number of continent (dry) women (any definition) in the
medium term (1 to 5 years)
• Repeat surgery for urinary incontinence.
• Perioperative surgical complications.
• Long-term adverse eIects such as mesh exposure, pain, and
dyspareunia.
• Condition-specific quality of life.
Definition of cure and urinary incontinence
AEer discussion, the review authors agreed to add another
outcome: women's report of cure of urinary incontinence. We
identified the definitions of cure and incontinence used in each
individual included trial (Table 1). However, only 14 trials used
women's report of cure or incontinence to determine cure. The
remainder used quantitative methods (such as whether pads were
wet or dry, questionnaire scores, or diaries) (seven trials), clinician-
observed or -reported urine leakage (11 trials), or a combined
definition without reporting the elements separately (10 trials).
Some trials did report incontinence in more than one way. We
therefore decided to use as our primary outcome the number of
continent (dry) women, with any method used to measure or report
urinary incontinence, but we added a further outcome of 'cure' as
reported by women at 12 months or later.
Search methods for identification of studies
We did not impose language or other restrictions on any of these
searches.
Electronic searches
Search for clinical eectiveness studies
We drew on the search strategy developed for Cochrane
Incontinence. We identified relevant trials from the Cochrane
Incontinence Specialised Register. For more details of the search
methods used to build the Specialised Register, please see the
Group's webpages, where details of the Register's development
(from inception) and of the most recent searches performed to
populate the Register can be found. To summarise, the Register
contains trials identified by searching the Cochrane Central
Register of Controlled Trials (CENTRAL), MEDLINE, MEDLINE In-
Process, MEDLINE Epub Ahead of Print, the Cumulative Index to
Nursing and Allied Health Literature (CINAHL), ClinicalTrials.gov,
and WHO ICTRP, and by handsearching journals and conference
proceedings. Many of the trials in the Cochrane Incontinence
Specialised Register are also contained in CENTRAL.
The date of the last fully incorporated search was 27 February 2017.
A further updated search was conducted on 23 January 2019, the
results of which were not fully incorporated into the review.
The terms used to search the Cochrane Incontinence Specialised
Register are given in Appendix 1.
For previous versions of this review, one of the review authors
performed extra literature searches. These are described in
Appendix 2.
Search for economic evaluations
We performed additional searches of the following databases for
the brief economic commentary (BEC).
• MEDLINE on Ovid SP (1 January 1946 to week 5 July 2018),
searched on 10 August 2018.
• Embase on Ovid SP (1 January 1980 to week 32 2018), searched
on 10 August 2018.
• National Health Service Economic Evaluation Database (NHS
EED) on Ovid SP (first quarter 2016), searched on 6 April 2017
(this database is no longer updated by the producer).
Search strategies used for the BEC are given in Appendix 3.
Searching other resources
We searched the reference lists of relevant articles for other possibly
relevant trials.
Data collection and analysis
Selection of studies
At least two review authors evaluated the appropriateness of
including reports of all possibly eligible studies without prior
consideration of the results. We retrieved the reports of potentially
eligible trials in full. We resolved any diIerences of opinion by
discussion between the review authors.
Data extraction and management
At least three review authors undertook data extraction
independently using a standard form containing pre-specified
outcomes. When data may have been collected but not reported,
we sought clarification from the trialists.
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Any diIerences of opinion related to study inclusion, data
extraction, or risk of bias assessment were resolved by discussion
among the review authors and, when necessary, were referred to a
fourth review author for arbitration. We conducted the review using
the standard Cochrane RevMan soEware.
Assessment of risk of bias in included studies
Each review author independently assessed risk of bias using
Cochrane's 'Risk of bias' tool as described in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
The following questions were assessed and reported in the 'Risk of
bias' tables.
• Was the random sequence adequately generated (selection
bias)?
• Was allocation adequately concealed (selection bias)?
• Were the participants or caregivers (performance bias) or
outcome assessors (detection bias) blinded?
• Were incomplete outcome data adequately addressed (attrition
bias)?
We judged studies to be at low risk of bias if the method of blinding
was adequate, or if lack of blinding could not have aIected the
results or could not be avoided. Each element was assessed as
having low risk, high risk, or unclear risk of bias (the latter usually
when no information was supplied).
Measures of treatment e@ect
When appropriate, we calculated a combined estimate of
treatment eIect across similar studies for each pre-specified
outcome, using risk ratios (RRs) for dichotomous data and
mean diIerences (MDs) for continuous outcomes, along with
95% confidence intervals (CIs) when possible. For categorical
(dichotomous) outcomes, the numbers reporting an outcome were
related to the numbers at risk in each group to derive a risk ratio
(RR). We have, however, used the odds ratio (OR) when reporting
the number of continent or cured women, as event rates were
expected to be high. For continuous variables, we used means
and standard deviations to derive a mean diIerence (MD). We
undertook a fixed-eIect approach to the analysis unless we noted
evidence of heterogeneity across studies.
Unit of analysis issues
We analysed studies with multiple treatment groups by treating
each pair of arms as a separate comparison, as appropriate. Studies
based on a non-standard design, such as cross-over trials and
cluster-randomised trials, would have been analysed as described
in the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011).
Dealing with missing data
We included data as they were reported. If women's subjective
reporting of (cure of) urinary incontinence was not provided, we
used the objective clinician's observations or other measures of
urine leakage as surrogate data to maximise information available
for the primary outcome - the number of continent (dry) women
(Table 1 shows data used). We did not contact authors of trials for
missing data or further details for this version of the review.
Assessment of heterogeneity
We investigated diIerences between trials when apparent from
visual inspection of the results, or when statistically significant
heterogeneity was demonstrated, by using the Chi2 test at the
10% probability level or assessment of the I2 statistic (Higgins
2003). If we found no obvious reason for the heterogeneity
(aEer consideration of populations, interventions, outcomes, and
settings of individual trials), or if heterogeneity persisted despite
removal of outlying trials, we used a random-eIects model.
Assessment of reporting biases
We would have examined publication bias through a funnel plot if
10 or more studies had been included in a meta-analysis.
Data synthesis
We sought data on the number of participants with each outcome
event by allocated treated group, irrespective of compliance and
whether or not the participant was later thought to be ineligible
or otherwise excluded from treatment or follow-up, to allow an
intention-to-treat (ITT) analysis when possible. We defined an
ITT analysis to mean that all participants were analysed in their
randomised groups whether or not they received the allocated
intervention. We used the Mantel-Haenszel statistical method for
meta-analysis. We used a fixed-eIect approach to the analysis,
unless we found evidence of heterogeneity across studies, in which
case we adopted a random-eIects model. We used a narrative
review of eligible studies when statistical synthesis of data from
than one study was not possible or was considered not appropriate.
Subgroup analysis and investigation of heterogeneity
We grouped trial data by type of incontinence: urodynamic stress
incontinence based on a urodynamic diagnosis, or stress or mixed
urinary incontinence based on symptom classification. It is unclear
whether there is a clinical diIerence between women who had SUI
alone (diagnosed by urodynamics to exclude concomitant detrusor
contractions, which might be indicative of overactive bladder or
urgency urinary incontinence) and women whose diagnosis of
SUI was based on their report of symptoms alone. Women who
have MUI (stress plus urgency) may have a worse outcome than
those with SUI alone. We wished to explore whether diIerent
interventions had a diIerential eIect among women with diIerent
types of incontinence. Quantitative synthesis was done when more
than one eligible study was identified.
We also planned to examine whether findings would vary among
women with primary versus recurrent SUI, or with presence or
absence of prolapse, but this was not possible due to lack of
information provided by the included trials.
In addition, we examined whether biological materials were
associated with diIerent outcomes compared with synthetic
materials used for traditional sling arms in a separate comparison
(comparison 11). It is biologically feasible that biological materials
might be reabsorbed by the body tissues and thus might not be as
long-lasting as non-absorbable synthetic materials.
Sensitivity analysis
We would have carried out sensitivity analysis based on eligibility
criteria, such as by including and excluding results from abstract-
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only publications or quasi-randomised trials, if we had identified
enough trials.
'Summary of findings' tables and assessing the quality of
evidence
The GRADE Working Group strongly recommends including up to
seven outcomes in 'Summary of findings' tables in a systematic
review (Guyatt 2011a; Guyatt 2011b; Guyatt 2013a; Guyatt 2013b).
We classified the primary and secondary outcomes in the Types
of outcome measures as 'critical', 'important', or 'not important'
for decision-making from the patient's perspective, and we used
this hierarchy to decide which outcomes should be included in
the 'Summary of findings' tables. We also made judgements about
which adverse events may be important to patients.
We implemented the GRADE method for assessing the quality of
evidence.
Incorporating economics evidence
Following the search outlined under Search methods for
identification of studies, we developed a brief economic
commentary (BEC) to summarise the availability and principal
findings of full economic evaluations that compare traditional
sling operations for urinary incontinence in women (Shemilt
2019). This BEC encompasses full economic evaluations (i.e.
cost-eIectiveness analyses, cost-utility analyses, and cost-benefit
analyses), conducted alongside or based upon one or more
RCTs included in the main review of intervention eIects. This
commentary focuses on the extent to which principal findings
of eligible economic evaluations indicate that an intervention
might be judged favourably or unfavourably from an economic
perspective when implemented in diIerent settings.
R E S U L T S
Description of studies
Results of the search
We screened a total of 582 records produced by the literature
search for this fourth update and retrieved 167 full-text articles
that appeared to meet the eligibility criteria for this review.
AEer assessing the full-text articles, we identified 115 reports
of 34 included studies and 50 reports of 38 excluded studies.
Additionally, we found reports of two ongoing studies (Hilton 2000;
Zhu 2014). The flow of literature through the assessment process
can be seen in Figure 1.
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Figure 1.   PRISMA study flow diagram - search for clinical e@ectiveness studies.
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Figure 1.   (Continued)
 
For this update, eight new trials were included (Abouhashem 2014;
Al-Azzawi 2014; Choe 2000; Helmy 2012; Okulu 2013; Sharifiaghdas
2015; Teleb 2011; Zargham 2013). A further four have been updated
with new information (Albo 2007; Amaro 2007; Guerrero 2008;
Wadie 2005). In total, the review now contains 34 included trials, 38
excluded trials, and two ongoing studies.
A further updated search of the Cochrane Incontinence Specialised
Register was conducted on 23 January 2019. This search was not
fully incorporated into the review. A total of 28 records retrieved
by the search were screened. Four reports of trials were eligible for
inclusion in the review - for transparency, all four eligible reports
have been added to Studies awaiting classification, and details can
be found under Characteristics of studies awaiting classification.
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In brief, the authors of Sharifiaghdas 2008 published a 10-year
update in 2017, but the data have not yet been added to the review
(Sharifiaghdas 2017). Abou Hashem 2017 served as another report
of the already included study (Abouhashem 2014); however, this
appears to be exactly the same conference abstract as the one
included study report (also a conference abstract); no new details
or data are available in this additional report. Two new ongoing
studies were also identified (Hassan 2018; Kajbafzadeh 2017), but
their data have not yet been added to the review.
Our search for economic evaluations produced a total of 465 titles
and abstracts to be screened, from which we selected four reports
of three economic evaluations for further assessment (Berman
1997; Kilonzo 2004; Kumar 2017). The flow of literature through the
assessment process is shown in Figure 2.
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Figure 2.   PRISMA study flow diagram - search for economic evaluations for the BEC.
 
Included studies
We included a total of 34 RCTs, reporting data on outcomes
of 3244 women, with sample sizes ranging from 20 to 655
participants. Three trials are quasi-randomised (Choe 2000; Kondo
2006; Zargham 2013), and two are multi-arm trials (Bai 2005;
Guerrero 2008). With the exception of Albo 2007 and Sand 2000, the
included trials were small and had short follow-up.
Participants
Inclusion criteria were not always clearly defined. Ten trials
included women (some or all) with stress-predominant MUI, both
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stress and urgency (Al-Azzawi 2014; Barbalias 1997; Basok 2008;
Kondo 2006; Okulu 2013; Osman 2003; Sand 2000; Song 2004;
Teleb 2011; Zargham 2013). Two trials involved women with
self-reported or predominant SUI (Albo 2007; Wadie 2005). All
others were restricted to women with a urodynamic diagnosis
of stress incontinence (USI, previously known as genuine stress
incontinence). Data from two trials were insuIicient, with only
abstracts available (Abouhashem 2014; Helmy 2012). All trials
included both pre-menopausal and postmenopausal women,
but none included women who were treated with hormone
replacement therapy. One study was restricted to women with
vaginal narrowing due to atrophic vaginitis or previous surgical
scars (Hilton 1989).
Previous continence surgery status
Two trials included only women without previous interventions
for incontinence (Henriksson 1978; Silva Filho 2006), and another
included only women who had recurrent incontinence aEer a
previous vaginal hysterectomy and at least one anterior repair
(Enzelsberger 1996). The others included women with both primary
and recurrent SUI but did not report outcome data separately
according to previous continence surgery.
Presence or absence of pelvic organ prolapse
This information was not routinely reported in the included trials,
and when it was, data were not reported separately.
Interventions
FiEeen materials were used for the traditional sling procedure
across 34 studies.
Autologous biological materials
• Autologous dermal graE patch (Shin 2001)
• Autologous fascia lata (Song 2004)
• Autologous rectus fascia (Abouhashem 2014; Al-Azzawi 2014;
Albo 2007; Amaro 2007; Bai 2005; Barbalias 1997; Demirci
2001; Guerrero 2008; Helmy 2012; Kondo 2006; Lucas 2000;
Maher 2005; Osman 2003; Pacetta 2005; Sharifiaghdas 2008;
Sharifiaghdas 2015; Silva Filho 2006; Tcherniakovsky 2009; Teleb
2011; Viseshsindh 2003; Wadie 2005)
• Autologous vaginal wall sling (Choe 2000; Teleb 2011;
Viseshsindh 2003; Zargham 2013)
Other biological materials
• Cadaveric fascia lata (Basok 2008; Shin 2001)
• Fortaperm (Pacetta 2005)
• Lyphohilised dura matter (Enzelsberger 1996)
• Porcine dermis, also known as Pelvicol (Arunkalaivanan 2003;
Guerrero 2008; Hilton 1989, Teixeira 2008)
Synthetic non-absorbable materials
• Goretex sling operation (Barbalias 1997)
• Polytetrafluoroethylene - PTFE (Sand 2000)
• Polytetrafluoroethylene impregnated with silver diacetate and
chlorhexidine; Antimicrobial Mycromesh (Choe 2000)
• Teflon sling (Henriksson 1978)
• Ultrapro mesh: synthetic monofilament combined mesh, non-
absorbable with absorbable coating (Okulu 2013)
• Prolene or prolene light mesh (Okulu 2013; Teleb 2011)
• Vypro mesh: semi-absorbable multi-filament mesh (Okulu 2013)
One trial, reported in abstract form, did not mention the type of
material used for the suburethral sling (Fischer 2001).
Comparators
The 34 included trials reported the following comparisons.
• One compared traditional suburethral sling operations with
oxybutynin for treating women with mixed urinary incontinence
(Osman 2003).
• One compared traditional suburethral sling operations with
suburethral injectable treatment (Maher 2005).
• One compared traditional suburethral sling operations with
bladder neck needle suspension (Hilton 1989).
• Eight compared traditional suburethral sling operations with
open abdominal retropubic colposuspension (Albo 2007; Bai
2005; Demirci 2001; Enzelsberger 1996; Fischer 2001; Helmy
2012; Henriksson 1978; Sand 2000). There were no useable data
in one of the trials identified in the updated search (Helmy 2012),
and one trial was updated with new information (Albo 2007).
• FiEeen trials compared traditional suburethral sling operations
with mid-urethral sling operations (Abouhashem 2014; Al-
Azzawi 2014; Amaro 2007; Arunkalaivanan 2003; Bai 2005; Basok
2008; Guerrero 2008; Kondo 2006; Sharifiaghdas 2008; Silva
Filho 2006; Song 2004; Tcherniakovsky 2009; Teixeira 2008;
Wadie 2005; Zargham 2013). Of these, three were added to this
comparison in this version of the review (Abouhashem 2014;
Al-Azzawi 2014; Zargham 2013), but one did not provide any
useable data (Abouhashem 2014). One trial did not provide
data aEer the first week (Al-Azzawi 2014), and further data were
identified for three trials (Amaro 2007; Guerrero 2008; Wadie
2005).
• One compared a traditional suburethral sling with a single-
incision sling (mini-sling) (Sharifiaghdas 2015).
• Nine trials compared one type of traditional suburethral sling
with another (Barbalias 1997; Choe 2000; Guerrero 2008;
Lucas 2000; Okulu 2013; Pacetta 2005; Shin 2001; Teleb 2011;
Viseshsindh 2003). Of these, three are new to this comparison for
this version of the review (Choe 2000; Okulu 2013; Teleb 2011),
and one trial was updated with further data (Guerrero 2008).
No trials compared suburethral slings with anterior repair,
laparoscopic retropubic colposuspension, or artificial sphincters.
There were seven non-traditional sling comparators across 25
studies.
• Anticholinergic (Osman 2003).
• Intravaginal slingplasty (Basok 2008).
• Mid-urethral sling (Abouhashem 2014; Al-Azzawi 2014; Amaro
2007; Arunkalaivanan 2003; Bai 2005, Guerrero 2008; Kondo
2006; Sharifiaghdas 2008; Silva Filho 2006; Song 2004;
Tcherniakovsky 2009; Teixeira 2008; Wadie 2005; Zargham 2013).
• Retropubic colposuspension: Burch colposuspension (Albo
2007; Bai 2005; Demirci 2001; Enzelsberger 1996; Fischer 2001;
Helmy 2012; Osman 2003; Sand 2000); Marshall-Marchetti-
Krantz (Henriksson 1978).
• Stamey bladder neck (needle) suspension (Hilton 1989).
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• Transurethral Macroplastique (injectable material) (Maher
2005).
• Single-incision sling (mini-sling) (Sharifiaghdas 2015).
One trial was designed to study an anticholinergic agent
(oxybutynin) in comparison with surgery (Burch or sling) for women
with MUI (Osman 2003). It was possible to extract only the data from
sling surgery in comparison with medical treatment for inclusion in
the analysis.
Outcome measures (definition of incontinence)
Outcome measures were not reported in a standardised fashion
(Table 1).
• Fourteen trials used women's self-report of cure or absence of
incontinence to define urinary incontinence.
• Seven trials used quantitative methods (such as based on wet or
dry pads, questionnaire scores, or diaries).
• Eleven trials used clinician-observed or -reported urine leakage
(such as the stress test, or at urodynamics).
• Ten trials used a combined definition without reporting the
elements separately.
The primary outcome was the number of continent (dry) women
using at least one of these definitions of urine leakage (32/34 trials).
If woman-reported leakage alone or clinician-observed leakage
was reported separately, those were also reported in separate
outcomes. Only two trials did not report any measure of urine
leakage (Al-Azzawi 2014; Teixeira 2008).
Follow-up
Trials varied in their reports of initial and long-term follow-up,
reporting data on outcomes of 3244 women at last follow-up.
• Ten trialists presented their results at three- and/or six- and/
or nine-month assessment (Bai 2005; Choe 2000; Fischer 2001;
Henriksson 1978; Osman 2003; Silva Filho 2006; Sand 2000; Song
2004; Teleb 2011; Viseshsindh 2003).
• One trial followed up women to one year and beyond but did
not provide any outcome data aEer the first week, such that cure
data were not useable (Al-Azzawi 2014).
• Eleven trials presented follow-up at around one year
(Arunkalaivanan 2003; Basok 2008; Demirci 2001; Guerrero 2008;
Lucas 2000; Maher 2005; Pacetta 2005; Sharifiaghdas 2008;
Sharifiaghdas 2015; Shin 2001; Tcherniakovsky 2009).
• Eleven trials described follow-up between one and five years
(Albo 2007; Amaro 2007; Arunkalaivanan 2003; Barbalias 1997;
Enzelsberger 1996; Hilton 1989; Kondo 2006; Okulu 2013;
Teixeira 2008; Wadie 2005; Zargham 2013).
• Three trials have now reported data on the outcomes of 892
women at the last follow-up at five years or later (Albo 2007;
Guerrero 2008; Sand 2000).
For more details about the characteristics of these trials, please see
Characteristics of included studies.
Excluded studies
In total, 38 studies were excluded. For further details, please see
Characteristics of excluded studies.
• Seventeen trials compared mid-urethral or variant sling
procedures with each other or with other operations (Amat
2007; Chong 2003; Corcos 2001; Darai 2007; Gamble 2010;
Halaska 2001; Han 2001; Kocjancic 2008; Liapis 2002; Lim 2005;
Naumann 2006; Oremus 2010; O'Sullivan 2000; Palomba 2008;
Seo 2007; Ward 2002a; Yoo 2007). Mid-urethral sling and open
colposuspension procedures are considered in other Cochrane
Reviews (Ford 2017; Lapitan 2017).
• Eleven studies were not randomised (Atherton 2000; Brandt
2009; Bruschini 2005; Debodinance 1994; Giri 2004; Giri 2006;
Hung 2001; Ishenko 1999; Kuo 2001; Obrink 1978; Schostak
2001).
• There was uncertainty regarding the population included in two
trials (Aurunkalaivanan 2001; Barrington 2003).
• Five trials included some participants who did not have SUI
(Debodinance 1993; Goldberg 2001; Kwon 2002; Meschia 2001;
Trezza 2001).
• Three trials were excluded for other reasons: Choe 2001
randomised women to having urodynamic evaluation or
not; Wang 1999 randomised women to diIerent types of
anaesthetic; Lemieux 1991 compared clamping and non-
clamping of catheters aEer incontinence surgery.
Risk of bias in included studies
Risk of bias findings for the included trials are summarised in Figure
3 and Figure 4.
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Figure 3.   Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages
across all included studies.
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Figure 4.   Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
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Figure 4.   (Continued)
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Eight trials used an adequate method of sequence generation
(Al-Azzawi 2014; Albo 2007; Amaro 2007; Barbalias 1997;
Guerrero 2008; Okulu 2013; Osman 2003; Sand 2000). Two
trials used randomisation charts to generate the randomisation
sequence without providing further information about the process
(Enzelsberger 1996; Hilton 1989). Nevertheless, these were judged
to be adequate. In one of these trials, one woman was randomised
to one arm of the study and was compared with two women
randomised to the other intervention (Barbalias 1997).
Sequence generation was inadequate in three trials, which were
therefore categorised as quasi-randomised trials. Kondo 2006 used
date of birth with even dates assigned to one group and odd dates
to the other. In two trials, women were randomised in alternate
fashion (Choe 2000; Zargham 2013).
In the remainder, women were stated to be randomised but no
other details of the process were provided.
Allocation concealment
The reported method of concealment of randomisation was secure
in seven trials (Albo 2007; Amaro 2007; Guerrero 2008; Lucas
2000; Okulu 2013; Sharifiaghdas 2015; Wadie 2005). Allocation
concealment was unknown for most of the remaining trials, as
study authors did not record it. Another trial used sealed opaque
envelopes but made no mention of numbering and thus was judged
as unclear for allocation concealment (Sharifiaghdas 2008).
Inadequate allocation concealment was noted in three quasi-
randomised trials (Kondo 2006; Choe 2000; Zargham 2013).
Blinding
Masking of women or surgeons was not reported in most trials,
but this is diIicult to achieve in surgical trials. Only two trials
attempted or reported blinding of participants or care providers
(Guerrero 2008; Wadie 2005). Third party outcome assessment was
not performed in any of the trials.
Incomplete outcome data
Most trials had complete outcome data at follow-up, or losses
were evenly distributed between randomised groups, and this was
unlikely to have a significant eIect on the final analysis. Two trials
did not account for losses at follow-up, which might potentially
have been a source of bias (Demirci 2001; Fischer 2001). One trial
had a diIerential dropout at two years' follow-up (Wadie 2005).
Other potential sources of bias
Comparability of groups at baseline
Baseline comparisons between groups were provided in 19 trials
(Albo 2007; Arunkalaivanan 2003; Bai 2005; Basok 2008; Choe
2000; Demirci 2001; Enzelsberger 1996; Hilton 1989; Kondo 2006;
Lucas 2000; Maher 2005; Okulu 2013; Sand 2000; Sharifiaghdas
2008; Song 2004; Tcherniakovsky 2009; Teleb 2011; Wadie 2005;
Zargham 2013). Henriksson 1978 stated that the two groups were
comparable without supplying data, and the remainder did not
mention baseline comparisons between groups.
Although we did not formally assess 'selective reporting' or 'other
bias' (other than comparability of groups at baseline, as above), we
had no concerns for these two domains across studies.
E@ects of interventions
See: Summary of findings for the main comparison Traditional
suburethral sling operation versus no treatment or sham operation;
Summary of findings 2 Traditional suburethral sling operation
versus conservative management; Summary of findings 3
Traditional suburethral sling operation versus drugs; Summary
of findings 4 Traditional suburethral sling operation versus
injectables; Summary of findings 5 Traditional suburethral
sling operation versus anterior repair; Summary of findings 6
Traditional suburethral sling operation versus bladder neck needle
suspension (abdominal and vaginal); Summary of findings 7
Traditional suburethral sling operation versus open abdominal
retropubic colposuspension; Summary of findings 8 Traditional
suburethral sling operation versus laparoscopic colposuspension;
Summary of findings 9 Traditional suburethral sling operation
versus a mid-urethral sling or tape; Summary of findings 10
Traditional suburethral sling operation versus a single-incision
sling (mini-sling); Summary of findings 11 One type of traditional
sling operation versus another traditional sling operation
Comparison 1. Traditional suburethral sling operation versus
no treatment or sham operation
No trials were identified.
Comparison 2. Traditional suburethral sling operation versus
conservative management
No trials were identified.
Comparison 3. Traditional suburethral sling operation versus
drugs
One trial included 75 women with MUI treated with surgery
(either Burch colposuspension (n = 24) or rectus fascia sling (n =
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26)) or oxybutynin (an anticholinergic drug treatment for urinary
incontinence, overactive bladder, and detrusor overactivity - not
for stress incontinence; n = 25)) (Osman 2003). The type of surgery
was selected according to Valsalva leak point pressure (VLPP) -
those with VLPP of less than 90 cm of water had rectus fascia
sling, and those with VLPP of more than 90 cm of water had Burch
colposuspension.
Results for the surgically managed group were similar to those for
the subgroup having slings. Due to small sample sizes, the data
were too few to be reliable, and we therefore compared only data
from oxybutynin versus sling patients in tables (Table 2).
Comparison 4. Traditional suburethral sling operation versus
injectables
Maher 2005 compared slings (n = 21) with injectable Macroplastique
(n = 22). Based on very low-quality evidence, we are uncertain about
the impact of surgery versus injectables in terms of the number of
continent women (100% were dry with a traditional sling vs 71%
with the injectable aEer the first year; odds ratio (OR) 11.57, 95%
confidence interval (CI) 0.56 to 239.74; Analysis 4.2), the need for
repeat surgery for urinary incontinence (risk ratio (RR) 0.52, 95% CI
0.05 to 5.36; Analysis 4.3), or perioperative complications such as
urinary tract infection (RR 1.57, 95% CI 0.29 to 8.49; Analysis 4.7).
Due to the small size of the trial, the data were too few to be reliable
(Summary of findings 4; Table 2).
Comparison 5. Traditional suburethral sling operation versus
anterior repair
No trials were identified.
Comparison 6. Traditional suburethral sling operation versus
bladder neck needle suspension (abdominal and vaginal)
Only one trial compared porcine dermis sling with Stamey needle
suspension (Hilton 1989). This was a small trial with only 10
women in each arm. The women were unsuitable for abdominal
colposuspension (the study author's preferred procedure) because
they had vaginal narrowing secondary to previous interventions
or atrophic vaginitis. Thus they constitute a population of women
with SUI who are not typical of the majority. All women had USI.
Groups were comparable for age, parity, previous interventions,
and hormonal status. Follow-up was reported at 3 months and at
24 months.
Due to the small size of the trial, the data were too few to be reliable
(Summary of findings 6; Table 2).
Comparison 7. Traditional suburethral sling operation versus
open abdominal retropubic colposuspension
Eight trials compared slings with open abdominal retropubic
colposuspension (Albo 2007; Bai 2005; Demirci 2001; Enzelsberger
1996; Fischer 2001; Helmy 2012; Henriksson 1978; Sand 2000).
One of these trials provided no data (Helmy 2012). The extent
to which the trials could be considered together was limited
because of diIerences in procedures compared, populations
studied, outcomes assessed, and length of follow-up. Two trials
involved a pubovaginal sling technique using autologous rectus
fascia (Albo 2007; Demirci 2001). One trial used a lyodura sling
(Enzelsberger 1996). Another trial used the Zoedler sling made of
Teflon (Henriksson 1978). Still another trial used the Gortex type
(Sand 2000). These were all biological materials except in two trials
(Henriksson 1978; Sand 2000). Fischer 2001 did not specify the sling
material used.
Only two of these trials reported follow-up for longer than five
years and presented both short-term and long-term data in two full
reports (Albo 2007; Sand 2000).
Primary outcomes
Number of continent (dry) women
Short term
Data from four trials suggested no evidence of a diIerence in the
likelihood of being continent within a year aEer treatment when
comparing slings to open abdominal colposuspension (OR 2.70,
95% CI 0.69 to 10.55; n = 147; Analysis 7.1) (Bai 2005; Fischer 2001;
Henriksson 1978; Sand 2000).
Medium term
Moderate-quality evidence from four trials show that women were
more likely to be continent between one and five years aEer surgery
with slings compared with open abdominal colposuspension (OR
1.70, 95% CI 1.22 to 2.37; n = 687; Analysis 7.2; Summary of findings
7) (Albo 2007; Bai 2005; Demirci 2001; Enzelsberger 1996).
Long term
At five years post surgery and beyond, evidence from two trials
suggests that women were more likely to be continent aEer surgery
with slings than aEer open abdominal colposuspension (OR 1.55,
95% CI 1.06 to 2.27; n = 190; Analysis 7.3) (Albo 2007; Sand 2000).
Number of women who had repeat continence surgery
High-quality evidence from one trial shows that the risk of
required repeat continence surgery was lower aEer traditional
slings compared to aEer open abdominal colposuspension (RR




Number of women cured at one year or later (women's observations)
Data from three trials suggest that women undergoing surgery
with slings were more likely to report subjective cure than women
having open abdominal colposuspension (OR 1.56, 95% CI 1.07 to
2.28; n = 221; Analysis 7.5) (Albo 2007; Demirci 2001; Sand 2000).
Number of women improved
This was not reported.
Number of women satisfied
Data from one trial indicate that more women were likely to
be satisfied with surgery with slings than with open abdominal
colposuspension (RR 1.14, 95% CI 1.02 to 1.27; n = 352; Analysis 7.6)
(Albo 2007).
Quantification of symptoms
This was not reported.
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Clinician's observations
Number of women with urinary incontinence (clinician's observations)
Short term
This was not reported.
Medium term and long term
Researchers found no evidence of a diIerence between slings and
open abdominal colposuspension in the numbers of women with
urinary incontinence at one to five years (RR 0.88, 95% CI 0.59 to
1.31; n = 626; Analysis 7.8) (Albo 2007; Demirci 2001; Enzelsberger
1996). Depending on judgements about what constitutes a
clinically important diIerence between interventions with regard
to continence, traditional suburethral slings are probably no worse,
and may be slightly more eIective, than colposuspension beyond




One trial was too small to reliably detect a diIerence in
operating times between slings (61 minutes) and open abdominal
colposuspension (55 minutes) (mean diIerence (MD) 6.02, 95%
CI -0.52 to 12.56; Analysis 7.10) (Demirci 2001). Moreover, the
diIerence in the duration of operation time observed was too small
to be of clinical importance.
Length of hospital stay/time to catheter removal
Data from three trials suggest that women undergoing surgery
with slings had longer hospital stays than women having open
abdominal colposuspension (MD 2.03 days, 95% CI 1.47 to 2.59; n
= 137; Analysis 7.11) (Demirci 2001; Enzelsberger 1996; Sand 2000).
This may have been due in part to a diIerence in the time of
catheter use aEer surgery (women in the sling group used a sling for
eight days longer (MD) aEer sling than aEer colposuspension; 95%
CI 6.84 to 9.18, n = 108; Analysis 7.12). However, it is unclear if this
was due to the procedures themselves or to diIerences in hospital
policies.
Time to return to normal activity level
This was not reported.
Blood loss
This was not reported.
Further treatment
Three trials reported that significantly more women required
treatment for a new or recurrent prolapse aEer open
colposuspension (12/282; 4.3%) compared to aEer a sling
procedure (2/277; 0.7%; RR 0.20, 95% CI 0.05 to 0.77; n =
559; Analysis 7.14) (Albo 2007; Demirci 2001; Enzelsberger 1996).
However, trial authors provided no information about subsequent
surgery for prolapse in any trial.
Adverse events
Perioperative surgical complications
Four trials reported similar numbers of perioperative complications
in the groups (47/394; 12% vs 38/398; 10%; RR 1.24, 95% CI 0.83
to 1.86; n = 792; low-quality evidence; Analysis 7.15; Summary of
findings 7) (Albo 2007; Demirci 2001; Enzelsberger 1996; Sand 2000).
Bladder perforation
One large trial reported significantly lower risk of bladder
perforation with the sling procedure (RR 0.20, 95% CI 0.04 to 0.91;
Analysis 7.16) (Albo 2007).
Urinary tract infection
Researchers reported significantly more urinary tract infections
with the sling procedure soon aEer surgery compared with
colposuspension (RR 1.50, 95% CI 1.33 to 1.70; n = 655; Analysis
7.17). However, the risk of recurrent urinary tract infection (UTI) was
not statistically diIerent at five years or later (RR 1.02, 95% CI 0.57
to 1.82; n = 453; low-quality evidence; Analysis 7.18; Summary of
findings 7) (Albo 2007).
Urinary urgency symptoms; urgency urinary incontinence
Two trials reported data on de novo urgency symptoms or
incontinence: the evidence was insuIicient to identify whether
there was a diIerence between sling and colposuspension groups
(RR 1.10, 95% CI 0.74 to 1.64; Analysis 7.19) (Albo 2007; Enzelsberger
1996).
Detrusor overactivity (urodynamic overactivity)
Evidence from four small trials was insuIicient to show whether
there was a diIerence in detrusor overactivity between sling and
colposuspension groups (RR 1.42, 95% CI 0.52 to 3.87; Analysis 7.20)
(Bai 2005; Demirci 2001; Enzelsberger 1996; Sand 2000).
Voiding dysfunction (with or without urodynamic confirmation)
Pooled data from five trials show that significantly more women
had voiding dysfunction aEer sling (13% vs 2% aEer open
colposuspension; RR 6.08, 95% CI 3.10 to 11.95; moderate-quality
evidence; Analysis 7.21) (Albo 2007; Bai 2005; Demirci 2001;
Enzelsberger 1996; Sand 2000). One trial reported long-term
voiding dysfunction at five years or later (Albo 2007). Very few
women still reported this complication (seven aEer sling vs one
aEer colposuspension).
Long-term adverse e@ects
This was not reported.
Quality of life
Data were reported in diIerent formats; thus meta-analysis was not
possible.
One trial reported quality of life scores at over five years (Albo 2007).
Women reported better quality of life aEer the sling surgery on one
scale (Urogenital Distress Inventory (UDI)) (MD -10, 95% CI -18.91
to -1.09) but no diIerence on another scale (Incontinence Impact
Questionnaire (IIQ)) (MD 1.70, 95% CI -11.96 to 15.36; very low-
quality evidence; Summary of findings 7).
One trial reported no significant diIerence in IIQ and UDI scores
between the colposuspension group and the sling group, although
actual numbers were not reported (Fischer 2001).
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Comparison 8. Traditional suburethral sling operation versus
laparoscopic colposuspension
No trials were identified.
Comparison 9. Traditional suburethral sling operation versus
mid-urethral sling or tape
FiEeen trials addressed this comparison (Abouhashem 2014; Al-
Azzawi 2014; Amaro 2007; Arunkalaivanan 2003; Bai 2005; Basok
2008; Guerrero 2008; Kondo 2006; Sharifiaghdas 2008; Silva Filho
2006; Song 2004; Tcherniakovsky 2009; Teixeira 2008; Wadie
2005; Zargham 2013). Two new trials were added in this update
(Abouhashem 2014; Zargham 2013). However, one of the new trials
did not provide any useable data (Abouhashem 2014). Three trials
were updated (Amaro 2007; Guerrero 2008; Wadie 2005).
Primary outcomes
Number of continent (dry) women
Short term
Data from 11 trials suggest there was no evidence of a diIerence
between traditional slings and mid-urethral slings in the likelihood
of being continent within one year (73% vs 75%; OR 0.94,
95% CI 0.67 to 1.32; n = 841; Analysis 9.1) (Amaro 2007;
Arunkalaivanan 2003; Bai 2005; Basok 2008; Guerrero 2008; Kondo
2006; Sharifiaghdas 2008; Song 2004; Tcherniakovsky 2009; Wadie
2005; Zargham 2013).
Medium term
Depending on judgements about what constitutes a clinically
important diIerence between interventions with regard to
continence, traditional suburethral slings are probably no better,
and may be less eIective, than mid-urethral slings in terms of
number of women continent in the medium term (one to five years).
However, the results were not statistically significant (67% vs 74%,
OR 0.67, 95% CI 0.44 to 1.02; n = 458; moderate-quality evidence);
Analysis 9.2; Summary of findings 9) (Amaro 2007; Arunkalaivanan
2003; Bai 2005; Guerrero 2008; Kondo 2006; Zargham 2013).
Long term
Data from one small trial suggest that women undergoing
traditional sling operations were nearly twice as likely to be
continent at five years aEer traditional sling surgery as women who
had received a mid-urethral sling (51% vs 32%; OR 2.22, 95% CI 1.07
to 4.61; n = 124; Analysis 9.3) (Guerrero 2008).
Number of women who had repeat continence surgery
Low-quality evidence from one trial reported the numbers of
women having repeat continence surgery; no women in either arm
required repeat surgery (traditional sling: 0/67; mid-urethral sling:
0/69; Analysis 7.4; Summary of findings 9) (Guerrero 2008). By 10
years, 2 of 63 women still being followed-up aEer a mid-urethral
sling had required repeat continence surgery compared to none in
the traditional sling group.
Secondary outcomes
Women's observations
Number of women cured aOer the first year (women's observations)
Four trials provided no evidence of a diIerence between traditional
slings and mid-urethral slings in the likelihood of cure at one year
or later (OR 1.06, 95% CI 0.65 to 1.72; n = 337; Analysis 9.5) (Amaro
2007; Arunkalaivanan 2003; Guerrero 2008; Kondo 2006).
Number of women improved or cured
Trials provided no evidence of a diIerence between traditional
slings and mid-urethral slings in the likelihood of improvement or
cure:
• within one year (OR 1.33, 95% CI 0.74 to 2.39; n = 425; Analysis
9.6) (Arunkalaivanan 2003; Basok 2008; Guerrero 2008);
• at one to five years (OR 0.76, 95% CI 0.31 to 1.87; n = 264; (Analysis
9.7) (Arunkalaivanan 2003; Guerrero 2008); or
• aEer five years (OR 1.13, 95% CI 0.51 to 2.54; n = 124; Analysis 9.8)
(Guerrero 2008).
Number of women satisfied
No evidence suggests a diIerence between traditional slings and
mid-urethral slings in the likelihood of women being satisfied (RR
1.09, 95% CI 0.89 to 1.33; n = 163; Analysis 9.9) (Amaro 2007;
Guerrero 2008).
Quantification of symptoms
Pad changes over 24 hours (from self-reported number of pads used)
This was not reported.
Incontinent episodes over 24 hours (from self-completed bladder
chart)
This was not reported.
Pad test of quantified leakage (mean weight of urine loss)
One small trial reported the mean weight of urine on a pad test
(Silva Filho 2006). Data show less incontinence in the traditional
sling group compared with the mid-urethral sling group (MD -31.00
grams, 95% CI -57.53 to -4.47; n = 20; Analysis 9.10).
Clinician's observations
Number of women with urinary incontinence
Short term
Clinician-reported incontinence within one year, defined as
complete absence of urinary leakage during a cough-stress test,
was assessed in two small trials (Kondo 2006; Sharifiaghdas 2008),
which provided no evidence of a diIerence between the two groups
(RR 1.29, 95% CI 0.45 to 3.71; Analysis 9.11).
One trial further addressed objective cure aEer the first year, but
again the evidence was insuIicient to reveal whether there was a
diIerence between groups, as the confidence interval was wide (RR
1.72, 95% CI 0.82 to 3.61; n = 44; Analysis 9.12) (Kondo 2006).
Surgical outcome measures
Duration of operation
Traditional suburethral sling operations took significantly longer
to complete (MD 57.08 minutes, 95% CI 54.67 to 59.49; Analysis
9.13). There was statistically significant heterogeneity that could
not be explained by diIerences in populations, interventions, or
settings of the individual trials. This heterogeneity persisted even
aEer sensitivity analysis was performed. This excludes the largest
trial, which showed a much longer operating time for the traditional
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sling operation than was seen in the other trials (Song 2004). It
also excludes another trial in which women also had concomitant
prolapse surgery in both arms, and in the mid-urethral sling arm,
an additional mesh kit was used to repair the prolapse (Zargham
2013). Because of heterogeneity in trials that included women
with MUI, some of whom also had concomitant prolapse surgery,
a sensitivity analysis was performed excluding the four trials (Al-
Azzawi 2014; Kondo 2006; Song 2004; Zargham 2013). The mean
diIerence in operative time was 44 minutes longer for traditional
sling surgery (95% CI 40 to 48; analysis not shown).
Length of hospital stay and duration of catheterisation
In four small trials, the length of hospital stay was longer aEer
traditional sling operations (RR 0.74 days, 95% CI 0.55 to 0.93;
Analysis 9.14) (Al-Azzawi 2014; Kondo 2006; Silva Filho 2006;
Zargham 2013). Two trials reported no evidence of a diIerence
between groups in length of time to catheter removal (MD 0.11 days,
95% -0.07 to 0.30; Analysis 9.15) (Kondo 2006; Wadie 2005).
Time to return to normal activity level
This was not reported.
Blood loss
This was not reported.
Further treatment
This was not reported.
Adverse events
Perioperative complications
Low-quality evidence from four trials was insuIicient to identify
whether risk of perioperative complications was higher aEer
traditional sling operations (49/148; 33.1% vs 28/145; 19.3% aEer
a mid-urethral sling; RR 1.74, 95% CI 1.16 to 2.60; n = 293; Analysis
9.16; Summary of findings 9) (Arunkalaivanan 2003; Kondo 2006;
Tcherniakovsky 2009; Zargham 2013).
Bladder perforation
Evidence from 10 RCTs shows that traditional slings may have
fewer bladder perforations compared with mid-urethral slings.
However, whilst there is no evidence of a statistical diIerence in the
number of bladder perforations, the confidence interval may rule
out clinically important reductions for mid-urethral slings (17/414;
4.1% vs 30/430; 6.9%; RR 0.59, 95% CI 0.34 to 1.01; n = 844; Analysis
9.17) (Al-Azzawi 2014; Arunkalaivanan 2003; Bai 2005; Guerrero
2008; Kondo 2006; Sharifiaghdas 2008; Song 2004; Tcherniakovsky
2009; Wadie 2005; Zargham 2013).
Urinary tract infection
Trials provided no evidence of a diIerence between traditional
slings and mid-urethral slings in the number of women with urinary
tract infections (RR 1.00, 95% CI 0.22 to 4.49; n = 50; Analysis 9.20)
(Zargham 2013).
Urinary urgency symptoms; urgency urinary incontinence
Combined results from four trials were insuIicient to show whether
there was a diIerence between traditional slings and mid-urethral
slings in the number of women with urinary urgency symptoms (RR
1.50, 95% CI 0.58 to 3.88; Analysis 9.22) (Guerrero 2008; Kondo 2006;
Sharifiaghdas 2008; Zargham 2013).
Detrusor overactivity (urodynamic overactivity)
Data from four trials suggest higher risk of detrusor overactivity
aEer traditional sling operations than aEer mid-urethral sling
operations (RR 2.61, 95% CI 1.17 to 5.84; n = 325; Analysis 9.23)
(Al-Azzawi 2014; Bai 2005; Basok 2008; Wadie 2005). This was
principally due to the higher weighting given to the largest trial
(Basok 2008).
Voiding dysfunction
Very low-quality evidence from eight trials suggests no diIerence
between traditional slings and mid-urethral slings in the number of
women with voiding dysfunction (RR 1.34, 95% CI 0.85 to 2.12; n =
629; Summary of findings 9) (Al-Azzawi 2014; Arunkalaivanan 2003;




Three trials reported that more women had long-term wound pain
in the traditional sling groups (17/126 vs 2/131; RR 6.40, 95% CI
1.94 to 21.12; n = 257; Analysis 9.25) (Al-Azzawi 2014; Guerrero 2008;
Wadie 2005).
Mesh exposure
Evidence from five trials was insuIicient to reveal whether there
was a diIerence in vaginal exposure (RR 0.28, 95% CI 0.05 to 1.65; n =
348; Analysis 9.26) (Al-Azzawi 2014; Guerrero 2008; Tcherniakovsky
2009; Wadie 2005; Zargham 2013). Only four cases of mesh exposure
(from 177 women) were reported in the mid-urethral sling group
compared with none among 171 women in the traditional sling
arms. The five trials all used a biological graE as traditional sling
material.
Release of sling
Very low-quality evidence from three trials suggests no diIerence
between traditional slings and mid-urethral slings in the numbers
of women requiring release of sling (11/164; 6.7% vs 4/162; 2.5%: RR
2.53, 95% CI 0.87 to 7.35; n = 326; Analysis 9.24; Summary of findings
9) (Arunkalaivanan 2003; Guerrero 2008; Kondo 2006).
Other adverse e@ects
One trial further reported urethral injury alone, which suggests no
evidence of a diIerence between groups (RR 0.36, 95% CI 0.02 to
8.39) (Kondo 2006).
Finally, one small trial reported vaginal bleeding and UTI (Analysis
9.19; Analysis 9.20) (Zargham 2013). Results show no significant
diIerence in the risk of vaginal bleeding (RR 1.67, 95% CI 0.45 to
6.24).
Quality of life
Quality of life (QoL) was assessed in nine trials (Amaro 2007;
Arunkalaivanan 2003; Basok 2008; Guerrero 2008; Kondo 2006;
Okulu 2013; Sharifiaghdas 2008; Silva Filho 2006; Wadie 2005).
Data were reported in diIerent ways; thus meta-analysis was not
possible and individual results are reported below. In this section,
results are reported qualitatively according to how trialists reported
their findings. Therefore, use of 'statistically significant' is as reported
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in the trials - not as interpreted by the review authors - and we have
not changed this.
• Amaro 2007 used the Portuguese version of King's Health
Questionnaire (KHQ), reporting no statistically significant
diIerences between groups in general health condition; impact
of incontinence; role, physical, and social limitations; personal
relationships; emotions; sleep; and severity perception of
urinary incontinence at 36 months.
• A 10-point questionnaire-based assessment was used by
Arunkalaivanan 2003. The mean score was 8.03 for mid-urethral
synthetic suburethral slings and 8.05 for traditional slings, with
a median score of 9 for both groups.
• A subjective 10-point patient satisfaction questionnaire was
used by Basok 2008, which provided no evidence of a diIerence
between groups, with satisfaction rates of 82% and 87.5% with
the traditional sling and the mid-urethral sling, respectively.
• Trialists found no significant diIerence in any domain of the
Bristol Female Lower Urinary Tract Symptom (BFLUTS) score, as
assessed in Guerrero 2008.
• Statistically significant improvement was noted postoperatively
on the IIQ Short Form (IIQ-7) and the UDI Short Form (UDI-6)
within both groups, but no significant diIerence in the degree of
improvement was evident between groups (Kondo 2006).
• One study assessed quality of life using the ICIQ-Short form
score. While there was improvement from baseline in all groups,
there were no significant diIerences between randomised
groups (Okulu 2013).
• IIQ score was also used by Sharifiaghdas 2008 to determine
subjective cure. Means were reported as 44.3 (range 35.2 to 61.5)
for the mid-urethral procedure and 48.5 (range 38.5 to 69.7) for
the sling operation (P = 0.46). A score less than 50 represents
good quality of life, between 50 and 70 moderate quality of life,
and greater than 70 poor quality of life. There was no significant
diIerence in QoL between groups; 15 (72%) in the mid-urethral
group and 20 (55%) in the sling group were satisfied with the
operation (P = 0.3, as reported by trialists).
• The KHQ was used in Silva Filho 2006 to show significantly
greater improvement in those who underwent the traditional
suburethral sling operation in the following domains: general
health perception; physical, social, and role limitations;
emotions and severity measures. There were no significant
diIerences in incontinence impact, personal relationships,
sleep, and energy domains.
• In one small trial (Wadie 2005), researchers reported UDI-6 and
IIQ-7 scores, which show no statistically significant diIerences
between trial arms (Analysis 9.27;Analysis 9.28
Comparison 10. Traditional suburethral sling operation versus
single-incision sling (mini-sling)
One small trial compared a rectus fascia pubovaginal traditional
sling with a single-incision sling (mini-sling; Ophira) and included
women with urodynamically diagnosed stress urinary incontinence
(USI) (Sharifiaghdas 2015).
Due to the small size of the trial, the data were too few to be reliable
(Table 2).
Comparison 11. One type of traditional sling operation versus
another type of traditional sling operation
Nine trials addressed this comparison (Barbalias 1997; Choe 2000;
Guerrero 2008; Lucas 2000; Okulu 2013; Pacetta 2005; Shin 2001;
Teleb 2011; Viseshsindh 2003). Three of these were newly added in
this update (Choe 2000; Okulu 2013; Teleb 2011). One was updated
(Guerrero 2008).
The traditional slings in this comparison used the following
materials to suspend the urethra.
• Autologous biological materials: rectus fascial sling (Barbalias
1997; Guerrero 2008; Lucas 2000; Teleb 2011); dermal graE patch
(Shin 2001); tissue removed from the vaginal wall (Choe 2000;
Teleb 2011; Viseshsindh 2003).
• Other biological materials: cadaveric fascia lata (Shin 2001);
Fortaperm porcine collagen matrix (Pacetta 2005); Pelvicol
(Guerrero 2008).
• Synthetic materials: Goretex (Barbalias 1997); antimicrobial
MycroMesh (Choe 2000); Vypro, Ultrapro, and Prolene (Okulu
2013); Prolene (Teleb 2011).
Some trials compared three diIerent materials: these have been
presented as pair-wise comparisons. One trial compared the same
material (autologous rectus fascia) but with diIerent lengths of the
material used (Lucas 2000). It is not possible to pool data from any
of these trials because diIerent materials were compared, and each
individual trial was too small for findings to be conclusive.
Primary outcomes
Number of continent (dry) women
Short term
Five trials reported the number of continent women within the first
year aEer surgery (Guerrero 2008; Lucas 2000; Okulu 2013; Pacetta
2005; Viseshsindh 2003). A total of 437 women studied within the
first 12 months aEer surgery showed similar incontinence rates
between traditional sling operations using biological or synthetic
materials. However, the confidence intervals were wide (Analysis
11.1).
Medium term
Seven trials reported the number of continent women from one to
five years aEer surgery (Barbalias 1997; Choe 2000; Guerrero 2008;
Lucas 2000; Okulu 2013; Shin 2001; Teleb 2011). Again, it is not
possible to pool any of these trials because diIerent materials were
compared. With one exception, none of the comparisons suggest
any evidence of a diIerence between diIerent materials. One small
trial suggests that women were more likely to be continent with
autologous fascial sling operations than with Pelvicol graE (OR 3.29,
95% 1.41 to 7.69; n = 113; Analysis 11.2.1; Summary of findings 11)
(Guerrero 2008). This eIect was evident early and led to premature
closure of the Pelvicol arm.
Long term
One trial measured continence rates at six years aEer surgery and
found no evidence of a diIerence between a standard (long) sling
and a short sling (31/73 and 35/69 continent women, respectively)
(OR 0.72, 95% CI 0.37 to 1.39, n = 142; Analysis 11.3) (Lucas 2000).
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Number of women who had repeat continence surgery
One trial reported the number of women requiring repeat
continence surgery at 1 year and at 10 years (Guerrero 2008). Only
women who received the biological material Pelvicol required any
repeat surgery (9/46; 20%; RR 0.04, 95% CI 0.00 to 0.61; Analysis
11.4; Summary of findings 11) compared to 0 of 67 women in the
rectus fascia group requiring repeat surgery 10 years later. This was
statistically significant in favour of the traditional sling with rectus




Number of women cured at one year or later (women's observations)
Three trials reported women's perception of cure of incontinence
(Guerrero 2008; Lucas 2000; Shin 2001). Only one reported any
evidence of a diIerence between groups; fascial slings were
significantly better than Pelvicol slings (OR 3.29, 95% CI 1.41 to 7.69;
Analysis 11.5.1) (Guerrero 2008).
Number of women improved
Short term
Three trials reported women’s perception of improvement within
one year (Barbalias 1997; Guerrero 2008; Pacetta 2005). Only one
reported a diIerence between groups; women having fascial slings
were more likely to perceive themselves as improved compared to
women having Pelvicol slings (69/73 vs 33/34; OR 6.27, 95% CI 1.88
to 20.94; Analysis 11.6.1) (Guerrero 2008).
Medium term
Four trials reported women’s perception of improvement aEer
one year (Barbalias 1997; Guerrero 2008; Shin 2001; Teleb 2011).
Only one reported a diIerence between groups; women having
fascial slings were more likely to perceive themselves as improved
compared to women having Pelvicol slings (60/67 vs 28/46; RR 1.47,
95% CI 1.15 to 1.88; Analysis 11.7.1) (Guerrero 2008).
Long term
This was not reported.
Number of women satisfied
Three trials reported satisfaction, but results could not be
combined and individually, numbers were too small to be
conclusive (Analysis 11.8) (Choe 2000; Guerrero 2008; Okulu 2013).
Study authors provided no evidence of a diIerence between groups
in any comparison.
Quantification of symptoms
Two trials reported data on mean weight of urine on a pad test
(Analysis 11.9) (Lucas 2000; Okulu 2013).
In the short term, trials provided no reliable evidence of a diIerence
between groups (Analysis 11.9), but aEer one year, one trial showed
that Ultrapro was better than both Vypro and Prolene light for this
outcome (Analysis 11.10) (Okulu 2013).
Clinician's observations
This was not reported.
Surgical outcome measures
Duration of operation
The duration of operation for the traditional long length sling
procedure was significantly longer in one trial, which compared
long and short lengths of autologous fascia (MD 8 minutes, 95%
CI 3 to 13; Analysis 11.7) (Lucas 2000). In another trial comparing
three materials, duration of operation was shortest for Prolene (36
minutes), intermediate for anterior vaginal wall patch (42 minutes),
and longest when rectus sheath was used as a sling (52 minutes)
(Analysis 11.11) (Teleb 2011). However, it is unclear whether these
diIerences in operating time would be enough to be clinically
important.
Length of hospital stay
Length of hospital stay was reported in one trial (Teleb 2011).
Hospital stay was longest for women having the anterior rectus
sheath sling compared to women with the other two materials
(Analysis 11.13).
Time to return to normal activity level
This was not reported.
Blood loss
Blood loss was significantly less with Prolene compared to the other
two materials (Analysis 11.12) (Teleb 2011).
• Anterior rectus sheath sling versus prolene strip: MD 32.00 mL,
95% CI 7.14 to 56.86; n = 24.
• Anterior rectus sheath sling versus anterior vaginal wall patch:
-20.00 mL, 95% CI -46.93 to 6.93; n = 20.
• Prolene strip versus anterior vaginal wall patch: MD -52.00 mL,
95% CI -77.41 to -26.59; n = 20.
However, total diIerences in volumes of blood lost were small, and
their clinical importance is uncertain.
Further treatment
This was not reported.
Adverse events
Perioperative surgical complications
The three trials that reported any perioperative complications
could not be combined because diIerent materials were compared
(Barbalias 1997; Lucas 2000; Viseshsindh 2003). More complications
were reported with the use of synthetic non-absorbable Goretex in
one trial (RR 0.05, 95% CI 0.00 to 0.80; Analysis 11.14.2) (Barbalias
1997). In the other trial, evidence was insuIicient to show whether
there was a diIerence between two biological slings (RR 1.14, 95%
CI 0.78 to 1.66; Analysis 11.14.1; Summary of findings 11) (Lucas
2000). There were no perioperative complications in the third trial
between the two groups (Viseshsindh 2003).
Bladder perforation
Three trials reported the number of bladder perforations (Guerrero
2008; Lucas 2000; Teleb 2011), showing no evidence of a diIerence
between groups in any comparison (Analysis 11.15).
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Urinary tract infection
Two trials reported the number of women with urinary tract
infection (Choe 2000; Lucas 2000), providing no evidence of a
diIerence between groups in any comparison (Analysis 11.16).
Urinary urgency symptoms; urgency urinary incontinence
Three trials reported the number of women with urgency
symptoms (Barbalias 1997; Lucas 2000; Okulu 2013), revealing
no evidence of a diIerence between groups in any comparison
(Analysis 11.20).
Detrusor overactivity (urodynamic overactivity)
One trial reported 4 of 33 women in the autologous dermal graE
patch group with de novo detrusor overactivity compared with 5 of
20 in the cadaveric fascia lata group (RR 0.48, 95% CI 0.15 to 1.60; n
= 53; Analysis 11.21) (Shin 2001).
Voiding dysfunction (with or without urodynamic confirmation)
Six trials reported the number of women with voiding dysfunction
(Choe 2000; Guerrero 2008; Lucas 2000; Okulu 2013; Teleb 2011;
Viseshsindh 2003), showing no evidence of a diIerence between
groups in any comparison (Analysis 11.19).
Long-term adverse e@ects
One trial reported the number of women with wound pain: 2 of 61
and 0 of 38 in the fascial sling and Pelvicol groups, respectively (RR
3.15, 95% CI 0.16 to 63.80; n = 99; Guerrero 2008). The same trial also
reported 2 of 61 and 1 of 38 women requiring release of sling (RR
1.25, 95% CI 0.12 to 13.28; n = 99).
Two women in one trial reported long-term scar pain aEer a rectus
fascial sling compared to none in the Pelvicol group; there were
no graE exposures in either group (Guerrero 2008). In another trial,
when participants all received a diIerent type of synthetic mesh,
five instances of mesh exposure were reported among 141 women
in the three mesh groups (Okulu 2013). One trial of a synthetic
versus a biological material reported no mesh exposures (Analysis
11.23; Summary of findings 11) (Choe 2000).
Other adverse e@ects
One trial reported 1 of 20 women with vaginal bleeding aEer
anterior wall vaginal sling compared with 0 of 20 in the biosynthetic
mesh group (RR 3.00, 95% CI 0.13 to 69.52; n = 40) (Choe 2000).
Quality of life
Data were reported in diIerent ways; thus meta-analysis was not
possible (Summary of findings 11).
• Lucas 2000 showed significant improvement in average scores
for the UDI-6 (reported P = 0.007) and the IIQ-7 (P = 0.002) when
compared with baseline. Scores between groups were similar.
• Pacetta 2005 evaluated women using the Incontinence Quality
of Life questionnaire (I-QOL), reporting improvement from 45 at
baseline to 97 at one year in the autologous fascia group, and
from 39 to 92 in the Fortaperm group.
• Okulu 2013 used the International Consultation on Incontinence
Questionnaire (ICIQ) Short Form urinary incontinence scale
to compare three synthetic meshes. Ultrapro was better than
Prolene light, which was better than Vypro, in the short term and
in the medium term (Analysis 11.24; Analysis 11.25).
D I S C U S S I O N
The main systematic review of eIects is discussed below but
we sought to supplement this review by identifying economic
evaluations that compared traditional suburethral sling operations
with any of the other main categories of surgical methods listed in
the background section. Identifed economic evaluations have been
summarised in a brief economic commentary. A supplementary
search in Ovid NHS EED, MEDLINE, and Embase identified two such
economic evaluations. Details of the search strategies are given in
Appendix 3.
Summary of main results
We included 34 trials involving 3244 women. Traditional slings were
compared with 10 other treatments and with each other; but we
did not identify any trial comparing suburethral slings with no
treatment or sham treatment, conservative management, anterior
repair, or laparoscopic retropubic colposuspension. One trial
compared traditional slings with bladder neck needle suspension
(Summary of findings 6), and another trial compared traditional
slings with single-incision slings (Summary of findings 10). Both
trials were too small to be informative.
Traditional suburethral sling operation versus drugs
One small trial comparing traditional slings with oxybutynin for
women with mixed urinary incontinence did not report any of the
outcomes used in the 'Summary of findings' tables. However, it
is uncertain whether surgery compared with oxybutynin leads to
more women being dry (83% vs 0%; odds ratio (OR) 195.89, 95%
confidence interval (CI) 9.91 to 3871.03) or having less urgency
urinary incontinence (13% vs 43%; risk ratio (RR) 0.29, 95% CI 0.09
to 0.94) (Summary of findings 3).
Traditional suburethral sling operation versus injectables
Based on very low-quality evidence from one small trial, we are
uncertain about the impact of surgery versus injectables in terms of
the numbers of continent women (100% were dry with a traditional
sling vs 71% with the injectable aEer the first year; OR 11.57,
95% CI 0.56 to 239.74) or the need for repeat surgery for urinary
incontinence (RR 0.52, 95% CI 0.05 to 5.36) or the occurrence
of perioperative complications (RR 1.57, 95% CI 0.29 to 8.49)
(Summary of findings 4).
Traditional suburethral sling operation versus open abdominal
retropubic colposuspension
Eight trials compared slings with open abdominal retropubic
colposuspension. Moderate-quality evidence shows that
traditional suburethral sling probably leads to more continent
women in the medium term (one to five years) (69% vs 59%
aEer colposuspension: OR 1.70, 95% CI 1.22 to 2.37). High-
quality evidence indicates that women were less likely to need
repeat continence surgery aEer a traditional sling than aEer
colposuspension (RR 0.15, 95% CI 0.05 to 0.42). We found no
evidence of a diIerence in perioperative complications between
the two groups, but the CI was very wide and the quality of evidence
was very low (RR 1.24, 95% CI 0.83 to 1.86; Summary of findings 7).
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Traditional suburethral sling operation versus mid-urethral
sling operation
Fourteen trials addressed the comparison between traditional
sling operations and mid-urethral sling operations. Depending
on judgements about what constitutes a clinically important
diIerence between interventions with regard to continence,
traditional suburethral slings are probably no better, and may
be less eIective, than mid-urethral slings in terms of number of
women continent in the medium term (one to five years) (67%
vs 74%; OR 0.67, 95% CI 0.44 to 1.02; n = 458; moderate-quality
evidence). One trial reported more continent women with the
traditional sling aEer 10 years (51% vs 32%; OR 2.22, 95% CI 1.07
to 4.61), but this finding needs to be replicated in other trials.
Mid-urethral slings may be associated with fewer perioperative
complications (RR 1.74, 95% CI 1.16 to 2.60; low-quality evidence;
Summary of findings 9).
One type of traditional sling operation versus another type of
traditional sling operation
Nine trials compared one type of traditional sling with another. A
number of diIerent materials were used such as porcine dermis,
lyophilised dura mater, fascia lata, vaginal wall, autologous dermis,
and rectus fascia. Study results could not be pooled due to
clinical heterogeneity, as diIerent materials or types of traditional
slings were used. Complications were reported by two trials - one
comparing non-absorbable Goretex with a rectus fascia sling, and
the second comparing Pelvicol with a rectus fascial sling. The
impact was uncertain due to the very low quality of evidence
(Summary of findings 11).
Overall completeness and applicability of evidence
Historically, traditional suburethral sling procedures were used for
women who had recurrent stress incontinence (aEer a previous
failed continence operation). However, the current review includes
both women with new and recurrent incontinence, without
reporting the results separately. These operations are designed to
restore normal urethrovesical junction support by mechanically
compressing or kinking the proximal urethra.
Evidence related to the primary outcome - urinary continence -
was available in one form or another for most trials to determine
the eIectiveness of traditional suburethral sling operations
for treatment of urinary incontinence. However, study findings
were consistent regardless of which method of ascertainment
of continence was used (urine leakage using any definition,
women's report, clinician's observation, combinations of these, or
quantification methods such as pad test weights). More long-term
data are now available, suggesting that traditional slings may be
equally as eIective or more eIective than other currently available
surgical treatments (such as colposuspension and mid-urethral
slings). However, most trials did not provide suIicient information
to adequately judge risk of bias; therefore most trials had to be
judged to be at "unclear risk of bias" due to inadequate reporting.
None of the included trials contained all relevant patient-reported
outcomes. More data on pain aEer diIerent procedures (both
postoperative and long-term) and time to return to 'normal' daily
living following surgery would have been useful. In particular,
reporting on medium- and long-term adverse eIects and the need
for repeat continence surgery in the long term is not available but
this information would be essential for informed decision-making.
This Cochrane Review is limited to randomised controlled trials
(RCTs) only. As adverse events were relatively rare and/or may not
have been reported, it is not possible to infer accurate information
about their frequency or type.
The importance of having a range of surgical options is that a
woman can choose the procedure that she is most comfortable
with, for example, trading oI eIicacy for the chance of having
fewer adverse eIects or a more minimally invasive procedure.
Traditional slings appear to be as, if not more, eIective than both
colposuspension and mid-urethral slings but without the risks
perceived to be associated with synthetic mesh.
This Cochrane Review may not be applicable to clinicians
everywhere. High-income nations have been increasingly using
mid-urethral procedures with synthetic materials as first-line
treatment for stress urinary incontinence for about 20 years but
because the safety of these operations has been called into
question, this practice may decrease in the future. Use of traditional
suburethral operations, which appear to be just as eIective, might
be reserved for countries where new technology is not available
or is too expensive. For women who wish to avoid the possible
complications of synthetic materials, biological materials such as
rectus fascia (but not porcine dermis) seem as eIective as synthetic
mid-urethral slings.
When possible, data were analysed in subgroups according to
clinical characteristics of the type of incontinence (urodynamic
stress incontinence, stress incontinence symptoms, or mixed
urinary incontinence). Study findings were similar regardless of
how incontinence was originally diagnosed. Because information
was not available on this basis, it was not possible to determine
if any type of surgery was more eIective for women who
had undergone previous failed continence surgery. Further
analysis according to clinical characteristics of women, such
as primary versus recurrent stress urinary incontinence and
presence or absence of prolapse, was not possible due to lack of
information. It might also be useful to look at possible diIerences
according to intrinsic urethral sphincter deficiency versus urethral
hypermobility (although there is no current clinical support for
the use of these terms; Abrams 2006), obesity, ethnicity, vaginal
delivery versus C-section, or experience of the surgeon. These
might make the findings of this review more generalisable.
However, most trials have not reported these characteristics.
Quality of life, emotional well-being, and social implications were
poorly reported, or they were assessed by a variety of instruments,
thus precluding meta-analysis. These outcomes are of great
importance to women and to decision-makers.
Two searches have been conducted since the last fully incorporated
search (9 October 2017 and 23 January 2019). Four studies
are awaiting classification: Abou Hashem 2017; Hassan 2018;
Kajbafzadeh 2017; Sharifiaghdas 2017. Of these, two are ongoing
trials (Hassan 2018; Kajbafzadeh 2017), one is a second but identical
publication of an included trial with no useable data (Abou Hashem
2017; Abouhashem 2014, respectively), and one is a 10-year update
of an already included trial (Sharifiaghdas 2017; Sharifiaghdas
2008, respectively).
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Quality of the evidence
Quality of evidence plays a crucial role in our confidence in the
estimate of eIect. Most GRADE-specific outcomes were judged to
be of "low" or "very low" quality. This indicates that when more
evidence becomes available, the estimate of eIect is likely to be
changed, or that any estimate of eIect is very uncertain. In this
systematic review, we assessed the methodological flaws of the
included trials using trial reports. Therefore, our judgement of risk
of bias and quality of evidence was influenced by reporting.
Although trial authors stated that their trials were randomised,
most reports did not give suIicient detail about the method
of sequence generation or concealment of allocation. Ten trials
used an adequate randomisation method. Blinding of surgeons or
women was generally not possible, but only two trials reported that
outcomes were assessed by a nurse who was blinded to allocation.
The total number of women enrolled was 3244, but some trials
recruited only 10 women per arm. In addition, several types of
slings were compared with diIerent interventions, meaning that
diIerent materials had to be grouped together for comparison.
Thus the numbers in each comparison were small, and the
confidence intervals were wide; therefore several outcomes were
downgraded due to imprecision.
Study populations varied, including women with and without
previous surgery, and one study included only women who were
deemed not suitable for another procedure (Hilton 1989). Although
most study participants had urodynamic stress incontinence, some
trials included women with mixed urinary incontinence. Baseline
comparability of groups was not reported in all trials. Several trials
assessed diIerent types of sling in comparison with autologous
rectus fascia, suggesting that the latter was considered as the
'standard' comparator.
Although eight trials used open abdominal retropubic
colposuspension as the comparator, each used a diIerent type
of sling, and three followed up on women for only six months.
Fourteen trials used a mid-urethral sling as the comparator as this
has arguably become the gold standard procedure for continence
surgery in many countries.
In general, most trials reported diIerent outcome measures, oEen
poorly. The principal measure of eIectiveness used in most studies
was the proportion of women with incontinence following surgery.
Few researchers have considered other outcomes, such as activities
of daily living and quality of life. Few have addressed general health
status, repeat incontinence surgery, later prolapse surgery, or time
to return to normal activity level. Satisfaction with and acceptability
of the treatment were also seldom addressed but are important
factors for choice of management.
Potential biases in the review process
All relevant databases were searched and no language restriction
was imposed during the search process, which enabled as many
potentially eligible trials as possible to be included. Some reports of
trials may not be published; therefore the full extent of the data may
not have been captured. To account for any potential bias in the
review process, data extraction and risk of bias assessment were
performed by at least two independent review authors.
Although most trials reported the outcomes that they mentioned
in their methods sections, none reported all outcomes of interest
for this review, including, in many cases, the primary outcomes of
urinary incontinence and repeat continence surgery (Figure 4).
The review sought to use rigorous methods of synthesis throughout
and has sought to identify statistical evidence of diIerences
between interventions. For some comparisons, no statistical
evidence of a diIerence was identified but examination of the
confidence intervals produced indicate that clinically important
diIerences may be unlikely. Such conclusions require judgements
about the magnitude of the minimum (clinically) important
diIerence. Such judgements might be contested.
Agreements and disagreements with other studies or
reviews
No other comparable systematic reviews of RCTs have addressed
the specific use of traditional slings for treating women with stress
urinary incontinence.
Brief economic commentary
To supplement the main systematic review, we looked for economic
evaluations that compared traditional suburethral slings with a
variety of surgical interventions for treating women with stress
urinary incontinence.
Three studies, selected from a search carried out on 10 August
2018, provided a cost analysis (Berman 1997), a cost-utility analysis
(Kilonzo 2004), and another cost-utility analysis (Kumar 2017).
The comparative cost analysis by Berman 1997 used data from
a retrospective observational study carried out in the United
States, which compared traditional suburethral retropubic sling
procedures with transurethral collagen injections in women with
stress urinary incontinence. This study included a total of 14
women across both arms, each of whom had had stress urinary
incontinence and had undergone an average of 1.1 procedures
between December 1993 and October 1995. The retrospective
analysis found that the traditional sling had an average operating
room time of 186 minutes and required an average hospital stay of
2.9 days. The total cost per patient was on average $16,229 (in 2019
International Dollars; $10,381 in 1995 USD). The collagen treatment
was on average less costly (P < 0.001) with an average cost in
2019 International Dollars of $7810 (or $4996 in 1995 USD). Average
procedure time for the collagen injections was 57 minutes, and no
time was spent as a hospital inpatient. A high percentage of costs
for the traditional sling study arm involved those for the physician
(33%) and operating room (36%), and costs for the collagen arm
included collagen (40%) and physician fees (22%). Postoperative
care for the traditional sling cost $1927 2019 International Dollars
($1,233 1995 USD), which was almost twice the cost of the collagen
injection - $980 in 2019 International Dollars ($627 in 1995 USD).
Before the procedure, there was no evidence of a diIerence in the
occurrence of incontinence between groups. However, the average
number of pads decreased aEer the procedure from 4.7 to 1.4
and from 5.2 to 2.3 for traditional sling and collagen injection,
respectively (P = 0.049).
Women were followed up for 15 months post surgery, and 71.4%
of those in the traditional sling arm were symptom-free compared
with 26.7% in the collagen injection arm (P = 0.05), with 85% from
the traditional sling arm having minimal or no incontinence (using
one pad or no pads daily).
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Despite lower costs associated with the collagen injection, the
traditional sling arm showed better overall improvement and had
lower reoperation rates. The study author concluded that the
traditional sling might be more cost-eIective when compared with
collagen injection.
A cost-utility analysis using a Markov model compared
the mid-urethral sling with open abdominal retropubic
colposuspension, laparoscopic colposuspension, the traditional
suburethral retropubic sling, and injectables (Kilonzo 2004). This
study provides a summary of work presented in the technology
assessment review conducted for the UK’s National Institute for
Clinical Excellence (NICE) (Cody 2003). Study authors utilised
clinical data from a systematic review of RCTs conducted up to
mid-2003 (Lapitan 2003; Moehrer 2002; Ward 2002b), and these
results were based on economic modelling for a time horizon of up
to 10 years; all costs were originally reported in UK pounds for 2001
and were adjusted to international dollars for 2019.
This study assumed, based upon the findings of Cody 2003, that the
traditional sling and open abdominal retropubic colposuspension
had equivalent eIectiveness. This contrasts with evidence from the
current review showing that traditional slings are more eIective
(Summary of findings 7).
The cost for traditional slings was $2756 per woman (2019
International Dollars; £1340 2001 GBP), with operation time
of 46 minutes and average hospital stay of 7.2 days. Mid-
urethral slings cost $2176 (2019 International Dollars; £1058
2001 GBP) per woman, with an average hospital stay of 2.9
days and operation time of 30 minutes, but these costs were
excluded. Open colposuspension cost $2676 per woman (2019
International Dollars; £1301 2001 GBP), with an operation time of
52 minutes and average hospital stay of 7.1 days, and laparoscopic
colposuspension cost $2709 (2019 International Dollars; £1317
2001 GBP), with an operation time of 60 minutes and an
average hospital stay of 4.6 days. A formal comparison of the
cost-eIectiveness of traditional slings versus any of the other
interventions was not performed. However, Kilonzo 2004 estimated
that there was an 86% probability that mid-urethral slings
were cost-eIective compared to open colposuspension, if society
was willing to pay approximately $62,000 (2019 International
Dollars; £30,000 2001 GBP) per quality-adjusted life-year (QALY)
gained. Given the model assumptions (traditional slings being
more costly and as eIective as open colposuspension), by
implication traditional slings would not in this evaluation be
considered cost-eIective compared with mid-urethral slings or
open colposuspension.
A cost-utility analysis (Markov model) by Kumar 2017 compared the
eIectiveness of the traditional sling with Burch colposuspension.
This study utilised data from published RCTs that included women
60 years of age and older with stress urinary incontinence, which
compared the two procedures (Albo 2007; Bai 2005; Culligan 2003;
Sand 2000). Follow-up from these studies varied from three months
to 73 months. However, the model extrapolated follow-up of
women for a time horizon of 16 years. The cost perspective was
not explicitly stated but appears to be that of the US patient and
healthcare provider based on captured costs (procedure costs and
costs of caring for the patient with treatment failure for a year).
These costs were originally reported in USD for 2015 and were
converted to 2019 International Dollars.
Literature describing this cost-utility analysis shows that the cure
rate for Burch colposuspension at 3 months, 12 months, 36 months,
and 73 months was 90%, 87%, 49%, and 84.6%, respectively,
and that for the traditional sling was 100% at 3 months and 73
months, 87.8% at 12 months, and 66% at 36 months. Studies
reported that the overall cost of the traditional sling per woman
was $8186 (2019 International Dollars; $7619 2015 USD) less than
the overall cost of Burch colposuspension. The cost-utility analysis
concluded that the traditional sling was more eIective than
Burch colposuspension based on the QALY gained. Women in the
traditional sling arm (11.18 QALYs) had 0.99 QALYs more compared
with those in the Burch colposuspension arm (10.19 QALYs), with
an incremental cost per QALY of $8251 (2019 International Dollars;
$7696 2015 USD). Kumar 2017 stated that it would be important
to have published data from large-scale trials before a definitive
recommendation could be provided.
Eligible economic evaluations were not directly comparable due
to diIerences in methods, time horizons, and settings. We have
not sought to determine the potential reasons why results diIer
between studies, nor have we conducted any critical appraisal.
Consequently, we do not attempt to draw any firm or general
conclusions regarding the relative costs or eIiciency of traditional
suburethral retropubic slings for surgical management of stress
urinary incontinence compared with current alternatives.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
Traditional sling procedures appeared to result in less urinary
incontinence or need for repeat surgery for incontinence or
prolapse and greater satisfaction in comparison to open retropubic
colposuspension in the medium and long term. However, the long-
term adverse event profile is still unclear. Traditional slings may
be slightly less eIective than mid-urethral slings in the medium
term but may be more eIective in the long term (based on only
one trial). However, they had higher rates of adverse eIects. This
should be interpreted with some caution, as the quality of evidence
in included studies was variable, follow-up was most oEen short,
and randomised trials have inherent limitations in identifying
complication rates.
The data were too scarce to address whether the types of
suburethral slings tested were as eIective as other sling materials,
injectables, drugs, needle suspension, or single-incision slings.
Limited evidence from one small trial suggests that slings made of
non-absorbable synthetic Goretex led to more complications than
slings made of biological rectus fascia. However, slings made of
porcine dermis (Pelvicol) were less eIective than rectus fascia or a
mid-urethral sling in another trial.
The broader eIects of suburethral slings could not be established
because most trials did not include appropriate outcome
measures, such as general health status and time to return to
normal activity level, and follow-up was short in the majority of
trials.
Evidence to clarify whether traditional suburethral slings may be
better or worse than surgical or conservative management options,
other than those reported in this review, is lacking.
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Implications for research
The methods used by trials and their appropriate reporting must
be addressed in future research. Some evidence was limited by the
poor quality and small numbers of included randomised trials. The
CONSORT guidelines should be used to ensure adequate reporting.
In the absence of RCTs that compare each method of continence
surgery with other types, a network meta-analysis of all available
RCTs would enable interventions to be compared indirectly with
each other.
There is a need for additional trials of adequate power and better
quality and reporting standards to assess the eIectiveness of
suburethral slings in comparison with other surgical techniques
and diIerent types of slings, and in specific situations, such
as among women who have already had previous continence
surgery, or those with concomitant prolapse. Long-term follow-up
is paramount.
Future research on incontinence treatments should incorporate
standardised, validated, and simple outcome measures - both
woman-reported and clinician-observed. Outcomes should be
relevant to women who have incontinence and are seeking
treatment, taking their preferences into account, and policy
makers should commission treatment to allow comparison
between treatments. In particular, quality of life and psychological
and economic outcomes should be incorporated. Surgical trials
related to urinary incontinence should systematically address
surgical morbidity outcomes, such as adverse perioperative and
postoperative events, length of hospital stay, time to return to
normal activities, development of urgency symptoms or detrusor
overactivity, and especially the need for repeat surgery or
alternative interventions.
To assess the eIicacy and safety of these operations in the longer
term, it is essential that trialists carry out and report their long-term
follow-up data for proper evaluation of treatment for incontinence.
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Characteristics of included studies [ordered by study ID]
 
Methods Design: RCT
Participants 56 consecutive women with SUI. Patients followed up for 5 years; 48/56 completed evaluation
Interventions A: TVT
B: rectus sheath sling
Outcomes Cure defined as no leakage of urine during stress test and urodynamic testing (clinician-reported)
A: 88.5%
B: 84.6%
Denominators for individual groups not provided
Notes Abstract only; no useable data
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk No information
Allocation concealment
(selection bias)
Unclear risk No information
Blinding (performance
bias and detection bias) 
All outcomes
Unclear risk No information
Abouhashem 2014 
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Setting: hospital in Iraq
Participants N = 80
Women with main complaint of SUI (mixed group); BMI < 30 kg/m2
Exclusion: mild UI (defined as 0 to 1 pad per day; a few drops of urine leaked on stress); cystocoele (an-
terior prolapse) > grade 1; active vaginal infection or UTI; neurogenic voiding dysfunction; significant
postvoid residual urine volume (PVR); other bladder or urethral pathology or fistula
Recruitment: December 4 to July 12
Follow-up: 1 week; 1, 3, 6, and 12 months; yearly thereafter
Interventions A (40): autologous rectus fascia sling
B (40): transobturator mid-urethral sling (TOT), synthetic polypropylene tape
Cystoscopy at time of surgery to exclude other pathology before surgery and to check for injury after in-
sertion of sling or tape
Outcomes Cure of SUI defined as significant dryness as perceived by the patient, no more use of pads, negative
stress test, and acceptable voiding stream (combined primary outcome)
Cure at 1 week: A: 39/40; B: 38/40
No further data provided for cure at later follow-up, but trialists state, "there were no significant
changes in the continence achieved throughout the follow-up period"
Operation time (mean minutes (SD) N): A: 80 (11.11) 40, B: 20 (4.44) 40
Hospital stay (mean days (SD) N): A: 2.8 (1.33) 40, B: 1.2 (0.44) 40
Adverse effects:
Intraoperative visceral injury (bladder perforation): A: 0/40, B: 0/40
Vaginal or urethral erosion: A: 0/40, B: 0/40
De novo detrusor overactivity: A: 2/40, B: 2/40
Other adverse effects:
Abdominal wound problems, pain, ooze, haematoma, infection: A: 8, B: 0
Foot drop: A: 1, B: 0
Groin and upper thigh pain: A: 0, B: 5
Voiding difficulty: A: 0, B: 1
Vaginal bleeding: A: 0, B: 1
Late PVR (postvoid residual): A: 3, B: 2
Al-Azzawi 2014 
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Total other adverse effects: A: 12/40, B: 9/40
All complications described as "marginal, treated conservatively and comparable with other studies"
Further treatment required for urinary urgency with anti-muscarinic drugs: A: 3/40, B: 3/40
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)




Unclear risk "were assigned randomly" – too little detail for assessment
Blinding (performance
bias and detection bias) 
All outcomes








Methods Design: RCT by electronic treatment assignment; 2 arms; unblinded.
Setting: multi-centre; tertiary referral centres; USA
Follow-up at 24 months; analysis with intention-to-treat
SISTER trial
Participants N = 655
4 ineligible after randomisation (3 Burch, 1 sling); 1 did not undergo allocated treatment. Only 520 as-
sessed at end of trial (255 Burch, 265 sling)
Symptom-based diagnosis of SUI, confirmed by standard stress test. A few women had DO at baseline
as well (A: 16/243, B: 25/239) (MUI), but we have classified the trial as in women with predominant SUI
Inclusion: documented pure or predominant symptom of SUI for ≥ 3 months, positive standardised uri-
nary stress test
Exclusion: age < 21 years, non-ambulatory status, pregnancy, current cancer chemotherapy or radio-
therapy, systemic disease affecting bladder function, urethral diverticulum, prior augmentation cysto-
plasty or artificial urethral sphincter, recent pelvic surgery
Groups similar in age, ethnic group, marital status, BMI, vaginal deliveries, hormone treatment, smok-
ing, mixed UI, POP, UDS, concomitant surgery
Interventions A (326): sling
B (329): Burch
Burch as modified by Tanagho
Sling procedure using autologous rectus fascia at level of the bladder neck and proximal urethra
Albo 2007 
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Interventions standardised across centres
Outcomes Number with overall success, number with SUI-specific success, pad test, number of incontinence
episodes in a 3-day voiding diary, POP, adverse events, voiding dysfunction (use of a catheter), postop-
erative UUI
Overall success defined as no self-reported symptoms of UI, no incontinence on 3-day diary, negative
stress test, no re-treatment
SUI-specific success defined as no symptoms, negative stress test, and no re-treatment for SUI (com-
bined outcome)
All outcomes reported at 2 years' follow-up
Failure (composite symptoms, self-report of UI or on diary, or surgical re-treatment) at 24 months: A:
101/265, B: 130/255 (used as surrogate for subjective UI)
Failure (pad test, objective) at 24 months: A: 37/265, B: 38/255
Complications at 24 months:
Number of women with any complications: A: 206/326, B: 156/329
Number of women with serious adverse events: A: 42/326, B: 32/329
Number of women with bleeding: A: 8/326, B: 5/329
Number of women with any voiding dysfunction: A: 46/326, B: 7/329
Number of women with voiding dysfunction requiring surgical revision: A: 20/326, B: 0/329
Postoperative cystitis (UTI): A: 247/326, B: 166/329
Bladder perforation: A: 2/326, B: 10/329
5-year outcomes (Brubaker 2012):
Enrolled 482 women: A: 243, B: 239
5-year FU completed by A: 183, B: 174, but data from more women reported for different outcomes
Failure (self-reported UI) at 5 years: A: 130/224, B: 158/229 (woman-reported)
Composite failure rate (self-report of UI or on diary, or surgical re-treatment): A: 153/221, B: 161/212
Surgical re-treatment for UI: A: 4/223, B: 27/227
Prolapse treatment: A: 1/224, B: 5/229
Not satisfied: A: 31/182, B: 46/170
UDI score (mean (SD) N): A: 40.2 (45.8) 224, B: 50.2 (50.9) 229
IIQ score (mean (SD) N): A: 44.8 (79.6) 224, B: 43.1 (68.2) 229
Adverse events (number): A: 37/224, B: 38/229
Adverse events (number of women): A: 22/224, B: 23/229
Number of women with UTI (included in AE above): A: 21/224, B: 21/229
Urgency urinary incontinence (new or persistent): A: 36/224, B: 36/229
Voiding dysfunction: A: 7/224, B: 1/229
Notes Full text with several other reports in full text and abstract form
Albo 2007  (Continued)
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5-year data published in 2012
For some outcomes, denominator assumed to be those who supplied subjective information about
continence status
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)




Low risk Randomisation was performed in the operating room after anaesthesia induc-
tion
Blinding (performance
bias and detection bias) 
All outcomes
High risk Patients were aware of study group assignments postoperatively. Independent
data and safety monitoring board oversaw progress, interim results, and safe-




Low risk 135 women were lost to follow-up at 2 years: 61 from the sling group and 74
from Burch failed to attend clinic. At 5 years, 243 and 239 women were fol-
lowed up





Methods Design: RCT of autologous fascial sling with TVT; single-blind
Follow-up assessment carried out at 1, 6, 12, and 36 months
Participants Women with involuntary detrusor contractions or pre-existing bladder outlet obstruction (BOO) during
urodynamic study were excluded (USI)
Interventions A (21): autologous fascial sling
B (20): TVT
Outcomes Cure rates (defined as complete dryness with no usage of pads (woman-reported)), operative room
time, postoperative analgesia, complications, time of hospital stay, postoperative catheterisation, time
to return to normal activities. 60-minute pad test was used and QoL was evaluated with a validated
Portuguese version of King's Health Questionnaire
Incontinent at 6 months: A: 9/21, B: 6/20
Incontinent at 12 months: A: 9/21, B: 7/20
Mean operative time (minutes): A: 70, B: 33
Mean dosage of analgesia (milligrams): A: 142, B: 85
Bladder injuries: A: 1, B: 2
Mean hospital stay (hours): A: 24, B: 24
Mean postoperative catheterisation (hours): A: 24, B: 24
Time to return to normal activity (days): A: 30, B: 30
Amaro 2007 
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36-month outcomes:
1 patient died in each group: A: 1/21, B: 1/20
Satisfaction rates at 36 months: dissatisfied: A: 4/20, B: 8/19
QoL on King’s Health Questionnaire at 36 months:
Domain of KHQ (median)
General health score: A: 50, B: 50
Incontinence impact score: A: 33.34, B: 0
Role limitation score: A: 0, B: 0
Physical limitation score: A: 0, B: 0
Social limitation score: A: 5.56, B: 0
Personal relationship score: A: 0, B: 0
Emotions score: A: 0, B: 0
Sleep score: A: 25, B: 0
Severity perception of UI: A: 16.67, B: 26.57
De novo urgency at 36 months: A: 8/20, B: 8/19
Notes Abstract and poster, 36-month outcome paper
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomisation followed a blind raffle where procedures (TVT and sling) were




Low risk The box was opened just before surgery, when the medical team found out
which procedure would be performed
Blinding (performance
bias and detection bias) 
All outcomes








Methods Design: RCT; randomisation method unclear. Patient demographics were well reported. Procedures
were standardised
Follow-up at 2 to 6 months, 12 months, and 24 months (median 12 months)
Participants 142 women with urodynamically proven SUI were recruited. Women with detrusor instability were ex-
cluded. Groups were comparable
Arunkalaivanan 2003 
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Interventions A (74): Pelvicol
B (68): TVT
Outcomes Outcome measures: cure of incontinence was defined as quality of life (QoL) improvement of 90% and/
or patient-determined continent status as dry (woman-reported) (subjective, questionnaire-based; pad
used - not weighed), levels of morbidity and impact on quality of life, and symptom severity
Failure at 12 months (incontinence): A: 8/74, B: 10/68
Not improved at 12 months: A: 6/74, B: 4/68
Failure at 36 months (incontinence): A: 12/68, B: 7/60
Not improved at 36 months: A: 5/68, B: 4/60
Complications: any complications: A: 17/74, B: 13/68; any voiding dysfunction: A: 8/74, B: 6/68; reten-
tion up to 6 weeks A: 6/74, B: 1/68; release of sling required A: 5/74, B: 2/68; bladder perforations: A:
0/74, B: 0/68
Notes Surgery was offered only after conservative therapy had proved unsuccessful
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not mentioned
Allocation concealment
(selection bias)
Unclear risk Not mentioned
Blinding (performance
bias and detection bias) 
All outcomes




Low risk No patients lost to follow-up at 12 months. All outcome data assessed. At 36
months, in the Pelvicol arm, 2 patients died and 4 were lost to follow-up; in the





Methods Design: RCT. Method not described; 3 arms; blinding not mentioned
Setting: Ob&Gyne; South Korea
Unclear if intention-to-treat
Follow-up at 1 year with assessments at 3, 6, and 9 months
Participants Urodynamics confirmed; no mixed incontinence
Groups comparable as to age, parity, BMI, menopausal status, MUCP, VLPP, functional urethral length,
and peak flow rates at baseline
Inclusion: USI grades 1 and 2
Bai 2005 
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Exclusion: grade III incontinence, detrusor overactivity, UTI, ISD, POP > grade II
Interventions A (28): sling
B (33): Burch
C (31): TVT
Sling procedure used a pubovaginal sling with autologous rectus muscle fascia
Outcomes Number cured (3, 6, 12 months); complication rate (number with idiopathic detrusor overactivity, hesi-
tancy, urinary retention)
Cure defined as absence of subjective complaints of leakage and absence of urinary leakage on stress
test
Not cured (6 months): A: 2/28, B: 3/33, C: 2/31
Not cured (12 months): A: 2/28, B: 4/33, C: 4/31
De novo detrusor overactivity: A: 0/28, B: 3/33, C: 0/31
Voiding dysfunction: A: 2/28, B: 1/33, C: 4/31
Notes TVT technique according to Ulmsten
All procedures performed by 1 surgeon
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not mentioned
Allocation concealment
(selection bias)
Unclear risk Not mentioned.
Blinding (performance
bias and detection bias) 
All outcomes









Follow-up at 6 months and 30 months; all women available at follow-up
Women allocated to 1 of 2 interventions by a computer-generated random numbers table at a 2:1 ratio
Participants 48 consecutive women. Inclusion and exclusion criteria not clearly stated, but some patients with
mixed incontinence
Interventions A (32): rectus fascia sling
B (16): Goretex sling operation
Barbalias 1997 
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Outcomes Cure defined as complete freedom from SUI (clinician-assessed) or improved (persistence or recur-
rence of SUI, but at lesser intensity)
Failure rates at 6 months: A: 6/32, B: 2/16
Failure rates at 30 months: A:11/32, B: 2/16
Complications: B: 2 cases of erosion of sling and 3 other cases of recurrent UTI
Notes Pre-operative characteristics reported but no comparisons between groups made; statistical analysis
reported for urodynamic parameters before and after operation. No other statistical comparison be-
tween groups reported. Some patients with mixed incontinence, but results not stratified by group or
by type of incontinence
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-randomised numbers, assigning 2 successive numbers to the fascial
group and the following number to the Goretex group
Allocation concealment
(selection bias)
Unclear risk Not mentioned
Blinding (performance
bias and detection bias) 
All outcomes








Methods Design: RCT.  Details of randomisation not given; 2 arms 
Follow-up: 12 months
Participants 139 women randomised. Baseline comparisons made: number of patients, mean age (years), mean dai-
ly pad usage, mean parturition, mean BMI, mixed urinary incontinence. No statistical differences  
Inclusion criteria: stress urinary incontinence due to urethral hypermobility
Exclusion criteria: patients with ISD, uterine prolapsed, rectocoele, enterocoele, grade III or IV cysto-
coele
Concomitant urgency urinary incontinence was present in some women; mixed urinary incontinence
was present in 49 patients (73%) in the fascia lata sling group and in 44 patients (61%) in the intravagi-
nal slingplasty group
Interventions A (67): cadaveric fascia lata
B (72): intravaginal slingplasty
Outcomes Objective cure rate was evaluated by the pad test, and patient satisfaction rate was assessed by a sub-
jective questionnaire. Cure and improvement were defined as a totally dry patient and 1 pad/d, respec-
tively. Usage of more than 1 pad/d was accepted as surgical failure. The sum of cure and improvement
rates was conceded as a total success rate
Basok 2008 
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Other outcomes measured were mean operating time, bladder perforation, urinary retention, erosion,
sling revision, haematoma, persistent urgency urinary incontinence, defective vaginal wall, de novo de-
trusor overactivity
Total success: A: 79.0%, B: 70.8%
Satisfaction at 12 months: A: 82.0%, B: 87.5%
Incontinence at 12 months: A: 32/67, B: 38/72
Not improved at 12 months: A: 14/67, B: 21/72
Daily mean pad usage (SD): A: 4.1 (3.5), B: 2.9 (1.7)
Operative time: A: 50 minutes, B: 25 minutes
Adverse events: de novo detrusor overactivity: A: 15/67, B: 5/72; bladder perforation: A: 3/67, B: 8/72;
urinary retention: A: 8/67, B: 8/72; vaginal erosion: A: 0/67, B: 0/72; sling revision: A: 2/67, B: 0/72
Notes Pre-operative evaluation of all patients included urogynaecological history, previous pelvic surgery,
voiding diary, parturition, and daily pad usage
Abstract indicated that QoL was significantly improved in the study; full article showed that measure-
ment was carried out by patient satisfaction questionnaire. No comment was made on validity or relia-
bility of this questionnaire
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not mentioned
Allocation concealment
(selection bias)
Unclear risk Not mentioned
Blinding (performance
bias and detection bias) 
All outcomes








Methods Design: quasi-RCT. Patients randomised in alternate fashion to mesh or vaginal wall group
Mean follow-up: 22 months (12 to 27 months)
Participants 40 women with stress or mixed urinary incontinence and vaginal prolapse underwent implantation of
transvaginal sling and vaginal reconstruction from 1997 to 1998
Pre-operative investigations included urodynamic studies, cystoscopy, cough-stress test, cotton swab
test, and detailed pelvic examination with patients supine and standing
Groups were not significantly different with respect to mean age, parity, weight, and pre-operative pad
use, although the biosynthetic mesh group was younger and heavier. Of the entire cohort, 65% of mesh
and 86% of vaginal graE groups had undergone previous vaginal operations (P > 0.05)
Choe 2000 
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Concomitant prolapse: A: 14/20 (70%), B: 18/20 (90%)
Interventions A (20): antimicrobial MycroMesh (1-mm polytetrafluoroethylene mesh patch impregnated with silver
diacetate and chlorhexidine (biosynthetic mesh); average patch size 3.5 × 1.5 cm
B (20): autologous vaginal wall sling using a free patch of vaginal skin (biological graE) soaked in antibi-
otic until ready for use
Single transverse suprapubic abdominal incision and polytetrafluoroethylene sutures attached to
mesh or graE edges and secured abdominally by tying down across midline anterior to the rectus fascia
Concomitant surgery:
None: A: 6/20, B: 2/20
Cystocoele repair: A: 6/20, B: 8/20
Cystocoele and rectocoele repair: A: 3/20, B: 6/20
Cystocoele and rectocoele repair + enterocoele or sacrospinous fixation: A: 3/20, B: 2/20
Hysterectomy: A: 2/20, B: 2/20
Outcomes Routine follow-up with cough-stress test, cotton swab test, and voiding trial was performed on postop-
erative day 7
Urine loss during cough-stress test was defined as persistent (objective) stress incontinence: clini-
cian-reported
Additional follow-up was done at 1, 3, and every 6 months. At each follow-up visit, cough-stress test
and cotton swab test were performed at speculum examination to detect recurrent stress incontinence
and vaginal wall prolapse
Stress incontinence was considered cured if objective loss of urine was not demonstrated and patients
did not report involuntary loss of urine during physical activity (combined outcome)
Mean time to suprapubic tube removal, days (range): A: 9 (1 to 21); B: 10 (1 to 35)
Mean postvoid residual volume, millilitres (range): A: 13 (0 to 60); B: 14 (0 to 50)
Mean time to resumption of normal activity in weeks (range): both groups 3.5 weeks (2 to 4 weeks)
Postoperative early complications:
Blocked suprapubic tube: A: 3/20; B: 0/20
Abdominal wound infection: A: 4/20, B: 2/20
Urinary tract infection: A: 1/20, B: 0/20
Bleeding (intraoperative blood transfusion): A: 0/20, B: 1/20
Vaginitis: A: 1/20, B: 1/20
Transient de novo urgency incontinence resolved after 3 months: A: 1/8, B: 1/7
Late complications:
Urethral erosion: A: 0/20, B: 0/20
Voiding dysfunction (‘urethral obstruction’): A: 0/20, B: 0/20
Resolution of pre-operative urgency incontinence: A: 8/12, B: 7/13
Recurrent stress incontinence: A: 1/20, B: 6/20
Choe 2000  (Continued)
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Postoperative satisfaction:




Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
High risk Randomised in alternate fashion
Allocation concealment
(selection bias)
High risk Randomised in alternate fashion
Blinding (performance
bias and detection bias) 
All outcomes
High risk Women in the mesh arm (A) signed a consent form stating that they were re-








Methods Design: RCT. No details of allocation method given
Follow-up at 12 months. Not all women available for follow-up
Participants 46 women recruited, 23 in each arm of the study. 34 women available for follow-up; reasons for loss to
follow-up not reported. Inclusion and exclusion criteria well defined
Interventions A (23): rectus fascia sling
B (23): Burch colposuspension
Outcomes Cure defined as dry, symptom-free (subjective based on history and objective on ultrasonography to
assess bladder neck mobility)
Failure rate (‘surgical’ – assume objective clinician-reported at 1 year): A: 0/17, B: 1/17
Dry (symptom-free patients at 1 year; assume woman-reported): A: 16/17, B: 15/17
Operating time (mean minutes (SD) N): A: 60.66 (8.63) 15, B: 54.64 (9.29) 14 (women having concomi-
tant hysterectomy excluded)
Length of hospital stay (mean days (SD) N): A: 5.93 (1.38) 15, B: 5.42 (1.28) 14 (women having concomi-
tant hysterectomy excluded)
UTI: A: 1/15, B: 2/14
Late complications (1-year follow-up):
A: 1 detrusor instability, 3 suprapubic pain, 1 dyspareunia
B: 1 detrusor instability, 2 dyspareunia, 2 genital prolapse (1 cystocoele, 1 enterocoele)
Demirci 2001 
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Notes Ultrasonography for measurement of bladder neck mobility was tested in both groups pre-operatively
and postoperatively, showing significant improvement but no significant differences between groups
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not mentioned
Allocation concealment
(selection bias)
Unclear risk Not mentioned
Blinding (performance
bias and detection bias) 
All outcomes




High risk 12 women missing and lost to follow-up; reason not reported. No mention of




Methods Design: RCT. Women allocated to 1 of 2 interventions by open random numbers chart
Follow-up at 32 to 48 months; all women available for follow-up
Participants 72 women recruited, 36 in each arm of the study
Inclusion criteria: all patients with GSI (urodynamic and sonographic diagnosis) had a vaginal hysterec-
tomy and at least 1 previous anterior repair; 57 were postmenopausal without hormone replacement
therapy
Exclusion criteria: urinary tract infection, unstable bladder, voiding difficulty and severe cystocoele
and/or rectocoele. Groups were comparable for age, weight, parity, menopausal status, previous
surgery, and time of follow-up
Interventions A (36) group II: lyophilised dura mater sling operation
B (36) group I: modified Burch colposuspension (2 pairs of sutures instead of 3)
Outcomes Cure defined as dry, symptom-free without objective urine loss during stress with bladder filled to 300
mL or positive urethral closure pressure during stress provocation
Failure rate at follow-up at 32 to 48 months: A: 3/36, B: 5/36
Urodynamic results reported before and at follow-up: reported longer hospital stay and suprapubic
catheter permanence for A. Equal frequency pyrexia and bladder laceration
Late complications:
Enterocoele or rectocoele: A: 1/36, B: 5/36
Voiding difficulty A: 5/36, B: 1/36; both differences statistically significant
Other problems not statistically significant: urgency urinary incontinence (A: 6/36, B: 3/36)
Enzelsberger 1996 
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Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random number chart: even numbers underwent colposuspension; odd num-
bers underwent sling procedure
Allocation concealment
(selection bias)
Unclear risk Not mentioned
Blinding (performance
bias and detection bias) 
All outcomes








Methods Design: RCT. Details not given
Follow-up at 6 months
Participants 22 women with intrinsic sphincter deficiency, 11 in each arm
Interventions A (11): suburethral sling
B (11): Burch retropubic urethropexy
Outcomes Subjective cure assessed using comparison between pre-operative and postoperative Incontinence Im-
pact Questionnaire (IIQ), Urinary Distress Inventory (UDI) (measured)
Objective cure by stress test; voiding dysfunction by urodynamic assessment if incontinence seen (clin-
ician-assessed)
Success rate reported as follows: A: 100% (11/11), B: 77.8% (7/9), P = 1
Mean postoperative IIQ and UDI scores not significantly different
Notes Abstract only
Aim to evaluate prognostic value of urethral electrodiagnosis
Two patients in the Burch group were found to have recurrent UVJ hypermobility or displacement and
were not included in the final analysis
A high proportion of excluded women were found to have end-stage urethral neuropathy
Risk of bias
Bias Authors' judgement Support for judgement
Fischer 2001 
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Random sequence genera-
tion (selection bias)
Unclear risk Not mentioned
Allocation concealment
(selection bias)
Unclear risk Not mentioned
Blinding (performance
bias and detection bias) 
All outcomes




High risk Two patients in the Burch group were found to have recurrent UVJ hypermo-
bility, were considered surgical failures, and were excluded from final analysis.




Methods Design: RCT (3 arms). Computer-generated randomisation schedule used for each centre and for each
individual surgeon. Remote telephone randomisation undertaken by independent CRU; type of sling
faxed on the morning of the operation. Patients were not told which sling they had, although they
could not be blinded to Pfannenstiel incision; research nurses collecting data were not told what proce-
dure the women had undergone
Setting: 4 centres
Follow-up at 6 months and 1 year; 85% available for follow-up at 1 year
Participants 201 women randomised (mean age 52 years) to Pelvicol-50, TVT-72, autologous sling-79
Inclusion criteria: women requiring primary surgical treatment for urodynamic USI following failed con-
servative treatment
Exclusion criteria: previous surgery for SUI, neurological disease, pelvic organ prolapse > stage 2, detru-
sor overactivity, or bladder hypocompliance on urodynamic assessment
Interventions A (79): autologous fascial sling from rectus (sling-on-a-string)
B (50): Pelvicol (randomisation to this arm halted half way through the trial) 12 × 2 cm Pelvicol graE
C (72): TVT (Gynecare)
Dropout at 12 months: A: 12; B: 4; C: 3; no explanation for differential dropout from group A
Outcomes Success and improvement rates described but method of assessment not defined
Other outcome measures included operative details, complications, dry/improved rates, quality of life
assessment, catheterisation, and re-operation rates
Theatre time, minutes, mean (range): A: 54 (25 to 140); B: 36 (17 to 70); C: 35 (14 to 120)
Length postop stay, days, median (range): A: 4 (1 to 22), B: 4 (1 to 12), C: 2 (1 to 10)
Incontinent at 6 months: A: 38/73, B: 25/45, C: 35/71
Incontinent at 12 months: A: 35/67, B: 36/46, C: 31/69
Not improved at 6 months: A: 4/73, B: 12/45, C: 6/71
Not improved at 12 months: A: 7/67, B: 18/46, C: 5/69
Re-operation rate: A: 0/67, B: 9/46, C: 0/69
Guerrero 2008 
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Self-catheterisation at 12 months: A: 0/67, B: 0/46, C: 0/69
Adverse effects:
Bladder injury: A: 2/79, B: 1/50, C: 4/72
Urethrolysis (release of tape): A: 1/67, B: 0/46, C: 1/69
10-year follow-up:
162 women available at 10 years (A: 61, B: 38, C: 63)
Incontinence at 10 years: A: 30/61, B: 32/38, C: 43/63
Not improved at 10 years: A: 15/61, B: 16/38, C: 17/63
Satisfaction: A: 43/61, B: 20/38, C: 44/63
Recommend to a friend: A: 46/61, B: 25/38, C: 53/63
Reoperation rate for SUI at 10 years: A: 0/61, B: 5/38, C: 2/63
Other gynaecological surgery: A 7/61, B 4/38, C 5/63
De novo urgency: A: 0/61, B: 0/38, C: 1/63
Self-catheterisation: A: 4/61, B: 0/38, C: 3/63
Sling release: A: 2/61, B: 1/38, C: 2/63
(long-term voiding dysfunction at 10 years: A: 6/61, B: 1/38, C: 5/63)
Tape/graE exposure: A: 0/61, B: 0/38, C: 1/63
Scar pain: A: 2/61, B: 0/38, C: 0/63
Notes High re-operation rates (1 in 5) in Pelvicol group (group B), so arm closed. Study closed at 6 years be-
fore target number reached. Interim analysis after first 50 patients in each group
Although there was no mention of how success rate was assessed in the abstract, on contacting a listed
author, we were informed that figures were patient-reported
Interim analysis showed that women randomised to Pelvicol (group B) had significantly poorer out-
comes; therefore this arm was dropped and the trial was continued as a 2-arm RCT
Study closed after 6 years due to failure to recruit target numbers and high re-operation rate
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)




Low risk Remote telephone randomisation undertaken by the independent CRU; type
of sling faxed on the morning of the operation
Blinding (performance
bias and detection bias) 
All outcomes
Low risk Patients were not told which sling they had, although they could not be blind-
ed to Pfannenstiel incision; research nurses collecting data were not told what
procedure the women had undergone
Incomplete outcome data
(attrition bias) 
Low risk No differential dropout (although group B was stopped early due to poor out-
comes)
Guerrero 2008  (Continued)
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Methods Design: RCT; randomised prospective study
Participants 482 women with urinary incontinence
Inclusion and exclusion criteria not defined
Interventions A: fascial sling
B: Burch urethropexy
Outcomes Continence rates: defined as no urinary leakage in a 3-day voiding diary, no self-reported stress inconti-
nence symptoms, and no stress incontinence surgical treatment (combined outcome)
Continence rates:
3 years: A: 30.8%, B: 24.1%
Satisfaction rates:
5 years: A: 83%, B: 73%
Adverse event rates (follow-up period not specified):
A: 9%, B: 10%
Number of women with adverse events: A: 22; B: 23
Notes Abstract only; no useable data
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk No information available
Allocation concealment
(selection bias)
Unclear risk No information available
Blinding (performance
bias and detection bias) 
All outcomes








Methods Design: RCT. Details not given
Follow-up at 4 to 6 months
Henriksson 1978 
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Participants 30 women randomised, 15 in each arm of the study, all with genuine stress incontinence. All age groups
of patients given but menopausal status not reported
Exclusion criteria: cystocoele, uterine prolapse, urgency urinary incontinence, neurogenic bladder, uri-
nary tract infection
Interventions A (15): Teflon sling (Zoedler urethroplasty)
B (15): MMK urethrocystopexy
Outcomes Cure defined as complete freedom from SUI (subjective and objective demonstrations) (combined out-
come). All patients in both groups cured. Complications not reported. Main differences observed in
stress closing pressure of urethra, which became positive after surgery in both groups
Notes Groups stated similar, but no comparisons made at baseline. Short follow-up
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not mentioned
Allocation concealment
(selection bias)
Unclear risk Not mentioned
Blinding (performance
bias and detection bias) 
All outcomes








Methods Design: RCT. Women allocated to 1 of 2 interventions by random tables
Follow-up at 2, 3, 12, and 24 months. All women available at follow-up
Participants 20 women recruited, 10 in each arm of the study
Inclusion criteria: GSI (urodynamic diagnosis), vaginal narrowing, postsurgical scar, unsuitable for col-
posuspension
Groups comparable for age, parity, and number of previous surgical incontinence procedures.
Menopausal status not reported
Exclusion criteria: not stated
Interventions A (10): porcine dermis sling operation
B (10): Stamey bladder neck (needle) suspension
Outcomes Cure stated as objective (urodynamic diagnosis, pad test (clinician-reported)) at 3 months' and as sub-
jective (woman-reported) at 24 months' follow-up
Failure rates at 3 months: A: 1/10, B: 2/10
Hilton 1989 
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Failure rates at 24 months: A: 1/10, B: 3/10
Differences not statistically significant at 3 and 24 months
Postoperative complications: A: 9/10, B: 2/10 (operative blood loss, pyrexia, infective complications,
suprapubic catheter permanence)
Hospital stay: A: 20 (12.9), B: 7 (0.3)
Late complications not reported
Voiding problems at 3 months: A: 4/10, B:2/10
Detrusor instability: A: 2/10, B: 1/10
Urgency urinary incontinence: A: 5/10, B: 3/10
No difference in frequency of uninhibited detrusor contractions, residual volume, and maximum void-
ing pressure
Peak flow significantly reduced for A, although higher than 15 mL/s
Notes Pad test at 12 and 24 months stated but not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random numbers chart
Allocation concealment
(selection bias)
Unclear risk Not mentioned
Blinding (performance
bias and detection bias) 
All outcomes








Methods Design: quasi-RCT. Randomisation by date of birth method;  2 arms. Odd days assigned to TVT arm,
even days to PVS
Follow-up: 3, 12, and 24 months
Participants 63 women who complained of SUI were recruited: 3 eventually declined to undergo surgery; therefore a
total of 60 women (29 PVS, 31 TVT) with urodynamic stress or mixed incontinence were included
Diagnosis was made by a cough-stress test, a 60-minute pad-weighing test, and urodynamic studies
Interventions A (29): PVS
B (31): TVT
Outcomes Primary outcome measure was cure of SUI. Subjective cure was consistent with complete dryness or a
few drops of water with strong exercises (assumed to be woman-reported)
Kondo 2006 
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Objective cure was defined as complete absence of leakage during cough-stress test with 250 or 300 mL
of water in the bladder (clinician-reported)
Other outcome measures (6-parameter analysis) were operation time, numbers of analgesics required
in a perioperative period, changes in haematocrit, length of a Foley catheter, and length of stay
Not cured at 24 months (subjective): A: 7/21, B: 4/23
Not cured at 24 months (objective): A: 11/21, B: 7/23
Operative time, mean minutes (SD) N: A: 87.1 (13.3) 21, B: 43.9 (17.3) 23
Length of hospital stay, mean (SD): A: 9.2 (0.9), B: 9.2 (0.6) days
Time to catheter removal, mean (SD): A: 1.4 (0.5), B: 1.3 (0.1) days
Complications:
All complications: A: 11/29, B: 9/31
Bladder perforation: A: 7/29, B: 7/31
Urethral injury: A: 0/29, B: 1/31
Subcutaneous haematoma: A: 0/29, B: 1/31
Voiding dysfunction: A: 4/29, B: 0/31
Release of sling surgery: A: 4/29, B: 0/31
De novo detrusor urgency: A: 3/29, B: 2/31
Notes Follow-up at 24 months. Women who underwent concomitant surgery (5 PVS, 8 TVT) and/or had revi-
sion surgery were excluded from the 6-parameter analysis because extra interventions made compar-
ison difficult. Subjects for assessment were reduced to 23 women in the TVT group and 21 in the PVS
group
Data updated from new publication
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
High risk Date of birth method
Allocation concealment
(selection bias)
High risk Date of birth
Blinding (performance
bias and detection bias) 
All outcomes









Traditional suburethral sling operations for urinary incontinence in women (Review)









Cochrane Database of Systematic Reviews
Methods Design: RCT. Women allocated to each arm by a central telephone randomisation system. Not blinded -
operation obvious to all medical and nursing personnel
Setting: 3 hospitals
Follow-up at 3, 6, and 12 months
Participants 165 women randomly assigned to 2 groups. Baseline demographics and symptoms were similar: age,
height, weight, symptom years, previous surgery, number and type of concurrent problems between
groups
Inclusion criteria: patients older than 18 years; urodynamically proven SUI
Exclusion criteria: evidence of neurological disease; urodynamic evidence of detrusor instability and
hypocompliance
Interventions A (81): standard sling insertion (long)
B (84): sling on a string (short)
Outcomes Primary outcome was to compare QoL scores in both groups over time. Success rate was measured by
recurrence of stress leakage as reported on patient questionnaire (woman-reported)
Secondary outcomes were measured by patient quality of life, clinical indicators (such as immediate
postoperative complications, time to first void, pad tests), administrative indicators, pain scores, and
patient satisfaction
Patient satisfaction at 12 months: A: 57/73, B: 62/82
Stress leakage at 12 months: A: 14/72, B: 16/72
Stress leakage at 3 years: A: 35/75, B: 30/70
Stress leakage at 6 years: A: 42/73, B: 34/69
De novo urgency: A: 6/81, B: 2/84
Pad test volumes (mL): A: 7.71, B: 4.61, P = 0.56
Mean operative time, minutes (range): A: 62 (38 to 135), B: 54 (25 to 140), P = 0.001 (P used to calculate
SD: 15.33 in each group)
Mean blood loss (mL): A: 274 (50 to 800), B: 230 (50 to 700), P = 0.07
Length of stay (days): A: 6.48, B: 6.73
Voiding dysfunction 12 months: A: 19/81, B: 17/84
Re-admission within 3 months: A: 19/79, B: 9/83
Surgery to release sling: A: 1/81, B: 4/84
Further continence surgery: A: 2/56, B: 5/69
Pain at 3 months: A: 52/78, B: 42/82
Adverse effects:
Perioperative surgical complications: A: 34/81, B: 31/84
Bladder perforation: A: 2/81, B: 3/84
UTI: A: 10/81, B: 6/84
Lucas 2000 
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Notes Detailed outcome measures at 3, 6, and 12 months were provided. Both groups showed improvement
in quality of life with no significant statistical differences between allocated operations
46 patients had previously undergone 1 or more forms of incontinence surgery
Data were updated from new publication
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated randomisation schedule
Allocation concealment
(selection bias)
Low risk Remote telephone randomisation
Blinding (performance
bias and detection bias) 
All outcomes
High risk Not blinded; operation performed obvious to all medical and nursing person-




Low risk Ouctome data analysed according to randomised group, per protocol, and
best possible. Twenty-one women lost to follow-up by 12 months, 23 lost by 3
years. Similar losses from each arm unlikely to affect the final analysis. Actual




Methods Design: RCT of pubovaginal sling vs Macroplastique
Intention-to-treat analysis performed
Follow-up: 6 months, 1 year
Participants 45 women randomised. 1 from each arm lost to follow-up by 1 year
Inclusion criteria: women with USI and ISD diagnosed by MUCP ≤ 20 cm H2O who failed to respond to
conservative treatment
Exclusion criteria: required prolapse surgery, had undergone a sling procedure, were unsuitable for
general anaesthesia
Baseline comparison included age (years), BMI (kg/m2), menopause status, parity, previous surgery
(abdominal hysterectomy, vaginal hysterectomy/repair, retropubic continence surgery, needle suspen-
sion)
Interventions A (22): pubovaginal sling
B (23): transurethral Macroplastique
Outcomes Subjective success: no or occasional (less than once a week) stress incontinence (woman-reported)
Objective success: no leakage due to SUI on repeat urodynamic study (clinician-reported)
Other outcome measures included voiding dysfunction, patient satisfaction, operating time, blood
loss, inpatient days, duration of catheterisation, time to resume normal activities
Incontinent within 1 year: A: 2/21, B: 5/22, P = 0.41
Maher 2005 
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Incontinent after 1 year: A: 0/13, B: 4/14, P = 0.1
Incontinent within 1 year (objective): A: 4/21, B: 20/22, P ≤ 0.0001
Patient satisfaction (self-reported at 6 months): A: 7/21, B: 13/22, P = 0.41
Patient satisfaction (self-reported at 5 years): A: 9/13, B: 4/14, P = 0.057
Operative time, minutes (range): A: 60 (25 to 105), B: 22 (10 to 41), P ≤ 0.0001
Length of hospital stay, days (range): A: 4 (3 to 81), B: 1 (1 to 2), P ≤ 0.0001
Time to normal activity, weeks (range): A: 4 (0 to 42), B: 28 (0 to 35), P ≤ 0.0001
Time to catheter removal, days (range): A: 5 (2 to 42), B: 1 (0 to 7), P ≤ 0.0001
Further continence surgery: A: 1/21, B: 2/22
Complications:
UTI: A: 3/21, B: 2/22
De novo detrusor overactivity: A: 1/21, B: 0/22
Voiding dysfunction: A: 4/21, B: 1/22
Notes Tertiary referral centres
Macroplastique (uroplasty, Minneapolis, Minnesota, USA) is a vulcanised silicone microimplant (poly-
diamethylsiloxane) suspended in a povidone gel designed to provide urethral bulking for treatment of
SUI
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Computer randomisation software; no description given
Allocation concealment
(selection bias)
Unclear risk Not mentioned
Blinding (performance
bias and detection bias) 
All outcomes




Low risk Ouctome data analysed according to randomised group. One woman in each





Methods Design: RCT: randomised prospective study
Participants 144 women
Inclusion criteria: incontinence, clinical and/or urodynamic diagnosis of SUI, positive stress test
Okulu 2013 
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Exclusion criteria: urodynamic MUI, detrusor overactivity, > 200 mL postvoid residual urine, contraindi-
cation to anaesthesia, pelvic organ prolapse, pregnancy, neurogenic bladder, bladder outlet obstruc-
tion, urinary fistula, active UTI, vaginal infection
Some women had failed previous continence surgery, hysterectomy; some were post menopause
Interventions A (48): broad-based double-forced sling using Vypro mesh (semi-absorbable multi-filament)
B (48): broad-based double-forced sling using Ultrapro mesh (synthetic combined mesh, non-ab-
sorbable with absorbable coating, monofilament)
C (48): broad-based double-forced sling with Prolene light mesh (non-absorbable, monofilament)
Meshes fixed with 2 polypropylene sutures to fascia of the rectus muscle
Outcomes Cure defined as no pad use (measured):
6 months: A: 40/46, B: 44/48, C: 41/47
12 months: A: 41/46, B: 45/48, C: 41/47
48 months: A: 39/46, B: 44/48, C: 40/47
Incontinence rate: A: 6/46
ICIQ-SF score (higher is worse), mean (SD) N:
At 6 months: A: 3.1 (0.9) 46, B: 2.1 (0.8) 48, C: 2.7 (0.8) 47
At 12 months: A: 2 (0.7) 46, B: 1.2 (0.6) 48, C: 1.7 (0.4) 47
At 48 months: A: 2.1 (0.5) 46, B: 0.8 (0.5) 48, C: 1.5 (0.3) 47
24-hour pad test (grams), mean (SD) N:
6 months: A: 4.2 (6.4) 46, B: 2.7 (6.2) 48, C: 3.03 (5.8) 47
12 months: A: 2.1 (1.4) 46, B: 2 (1.1) 48, C: 2.4 (3.8) 47
48 months: A: 2.3 (1.1) 46, B: 1.3 (0.8) 48, C: 2.4 (1.1) 47
Number of pads used mean (SD) N:
At 6 months: A: 0.93 (0.5) 46, B: 0.83 (0.5) 48, C: 1.1 (0.8) 47
At 12 months: A: 0.62 (0.4) 46, B: 0.33 (0.2) 48, C: 0.94 (0.6) 47
At 48 months: A: 0.65 (0.3) 46, B: 0.2 (0.15) 48, C: 0.83 (0.54) 47
Voiding or storage symptoms: A: 9/46; B: 4/48; C: 7/47
Dissatisfaction rate: A: 9/46; B: 7/48; C: 9/47
Complications at 48 months:
Vaginal erosion: A: 2/46, B: 1/48, C: 2/47
Urethral erosion: A: 1/46, B: 0/48, C: 1/47
Suture granuloma: A: 3/46, B: 1/48, C: 3/47
Urine retention: A: 2/46, B: 2/48, C: 2/47
De novo urgency: A: 5/46, B: 2/48, C: 4/47
Notes  
Okulu 2013  (Continued)
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Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)




Low risk ‘randomly allocated into three groups by centralised computerised system
(1:1:1)’
Blinding (performance
bias and detection bias) 
All outcomes








Methods Design: RCT (block randomisation technique). Selection criteria well reported
Follow-up reported at 6 months
Participants 75 women with mixed incontinence symptoms and a negative cystometrogram for motor detrusor
overactivity. All had proven stress urinary incontinence. No details on demographic data were reported
21 patients (anticholinergic) and 24 (sling) were available for follow-up
Interventions A (50): surgery (Ai (24) Burch colposuspension, Aii (26) rectus fascia sling)
B (25): anticholinergic treatment
Outcomes Patients were evaluated by SEAPI score (subjective and objective) and underwent urodynamic exami-
nation before and after treatment (combined outcome)
Cure for urge symptoms: Aii: 88%, B: 57%
Cure for SUI: Aii: 83%, B: 0
Notes Study was designed to investigate anticholinergic therapy in comparison with surgery. Patients allocat-
ed to surgery had a sling procedure if Valsalva leak point pressure was < 90 cm H2O. We extracted only
data on sling in comparison with anticholinergics
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Block randomisation
Allocation concealment
(selection bias)
Unclear risk Not mentioned
Blinding (performance
bias and detection bias) 
Unclear risk Not mentioned
Osman 2003 
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Low risk Of 75 women randomised, 68 evaluated after 6 months. Four in anticholinergic
arm and 3 in surgical arm lost. Insufficient information to determine whether




Methods Design: RCT. Abstract. Randomisation 2:1. Two arms 
Follow-up: 1 year
Participants 34 women randomised. No mention of baseline comparison
Inclusion criteria: women 30 to 77 years old with SUI due to hypermobility or ISD underwent surgical
correction
Interventions A (10): autologous fascia
B (24): Fortaperm
Outcomes Subjective patient evaluations included QoL questionnaire, incontinence diary, pain, and global out-
come assessments (measured)
Objective outcome assessment was urine loss with a provocative pad test (clinician-reported)
Biopsies were taken at 1 year from FP implant sites adjacent to urethra for histology
Objective incontinence within first year: A: 1/10, B: 5/24
Not improved within first year (subjective): A: 0/10, B: 2/24
Notes Fortaperm is absorbable biomaterial composed of laminated sheets of purified porcine collagen matrix
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not mentioned
Allocation concealment
(selection bias)
Unclear risk Not mentioned
Blinding (performance
bias and detection bias) 
All outcomes








Methods Design: RCT by random numbers table
Sand 2000 
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Follow-up at 3 months and at 72.6 months (mean)
Participants 36 women with genuine stress incontinence and maximum urethral closure pressure ≤ 20 cm H2O.
Groups comparable in terms of age, parity, and urodynamic variables, except for detrusor instability (>
Burch vs sling) and residual volume (> Burch vs sling)
Interventions A (17): PTFE sling operation
B (19): modified (overcorrection) Burch colposuspension
Outcomes Cure defined as objective (urodynamic: clinician-reported separately) and subjective (history: woman-
reported)
Number of continent women (short-term): A: 17/17, B: 17/19
Objective cure (long-term): A: 100%, 13/13, B: 86%, 13/15
Subjective cure (long-term): A: 84%, 11/13, B: 93%, 14/15
There were no statistically significant differences in outcome measures
Notes First publication (2000) reported short-term follow-up and was considered the primary reference. Last
publication (2003) reported long-term results
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random numbers table
Allocation concealment
(selection bias)
Unclear risk Not mentioned
Blinding (performance
bias and detection bias) 
All outcomes








Methods Design: RCT of tension-free vaginal tape with autologous rectus fascia sling. Randomisation by sealed
opaque envelopes 
Follow-up: 1, 3, 6, and 12 months
Participants 100 women randomised into 2 groups. However, only 61 followed up to 1 year. 16 lost due to distance
and expense of travel - 12 were age-related and 11 occurred because of dissatisfaction with surgical re-
sult (6 sling, 5 TVT)
Inclusion criteria: history of USI, 1-hour pad test (> 2 grams of leakage), objective positive cough (effort
or exertion), induced stress test, normal cystourethroscopy and urodynamic confirmation of SI, ure-
thral hypermobility, competent bladder neck
Sharifiaghdas 2008 
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Exclusion criteria: history of more than 3 episodes of UTI in past 2 years, other gynaecological problems
such as high-grade uterine prolapse, high-grade rectocoele and enterocoele, cystocoele ≥ grade 2, ab-
normal filling phase of urodynamic study, low flow rates (< 15 mL/s), residual urine of more than 100
mL, trabeculated bladder mucosa on cystourethroscopy, history of major pelvic trauma, fracture that
might negatively affect urethral function
Women with mixed incontinence symptoms were included provided urodynamics showed normal ca-
pacity, normal compliance, and stable bladder
The 2 groups had similar characteristics with respect to age, parity, hysterectomy, previous inconti-
nence surgery, sensory urgency incontinence, pre-operative IIQ score
Interventions A (52): pubovaginal sling
B (48): TVT
Outcomes Objective cure defined as negative cough-induced stress test with full bladder (at least 250 mL filled) in
the lithotomy and standing positions (clinician-reported) and a 1-hour pad test ≤ 2 grams (measured)
Subjective cure defined by mean IIQ score in each group
Also assessed were type of anaesthesia, operative time, estimated blood loss, bladder penetration, and
satisfaction with procedure
Incontinent within 1 year (stress test): A: 6/36, B: 3/25, P = 0.9
Incontinent within 1 year (1-hour pad test): A: 10/36, B: 6/25, P = 0.83
Patient satisfaction at 12 months: A: 20/36, B: 15/25
Operative time (minutes): A: 80 (50 to 180), B: 45 (30 to 70), P = 0.01
Length of hospital stay (days): A: 5 (3 to 7), B: 2 (1 to 5), P = 0.001
Time to catheter removal, days (range): A: 4.6 (3 to 6), B: 1.3 (1 to 5), P = 0.001
Complications:
De novo urgency symptoms: A: 8/36, B: 1/25
Voiding dysfunction: A: 11/36, B: 5/25
Bladder perforation: A: 2/36, B: 6/25, P = 0.05
Bleeding (> 250 mL): A: 1/36, B: 1/25, P = 1.00
Suprapubic incisional hernia after 8 months: A: 1/36, B: 1/25
Notes Procedures were performed by single surgeon
All patients were pre-operatively evaluated by physical examination, plain abdominal X-ray, urinary
tract ultrasound, cystourethroscopy, and urodynamic study
Physical examination assessed degree of prolapse and basal lab tests (FBC, renal and liver function
tests, serum electrolytes, urine analysis, culture)
Assumption was made that t-test was used for operative time, catheterisation, and hospital stay
10-year follow-up was published (Sharifiaghdas 2017), but data were not added to the review
Risk of bias
Bias Authors' judgement Support for judgement
Sharifiaghdas 2008  (Continued)
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Random sequence genera-
tion (selection bias)
Unclear risk Not mentioned.
Allocation concealment
(selection bias)
Unclear risk Sealed opaque envelopes; no mention of numbering
Blinding (performance
bias and detection bias) 
All outcomes




Low risk All outcomes assessed in randomised groups. 39 patients lost to follow-up.





Setting: Shahid Labbafinejad Medical Centre, Iran
Follow-up: mean 13.8 months (SD 4.4), range 12 to 20
Follow-up at hospital visits at 1 week; 1, 3, 6, and 12 months after surgery
Participants 72 women with main complaint of SUI unresponsive to conservative treatment, urethral hypermobility,
positive cough-stress test; urodynamics in all women and DO excluded - therefore classes and USI
Exclusion criteria: persistent UTI, active UTI at surgery, urogynaecological malignancy, cystocoele (pro-
lapse) ≥ grade 3, neurogenic bladder, abnormal filling or voiding, detrusor overactivity, low flow rate,
residual urine > 100 mL, abnormal cystourethroscopy findings
Interventions A (35): autologous rectus fascia pubovaginal sling
B (35): mini-sling (Ophira)
Outcomes Cure defined as woman report of some degree of SUI at 1 year after surgery
Cure: A: 31/35, B: 31/35
Number of women satisfied: A: 25/35, B: 28/35
Number of women with UI: A: 4/35, B: 4/35
Objective UI (positive cough-stress test): A: 4/35, B: 4/35
IIQ score, mean (SD) N: A: 50.2 (11.1) 35, B: 42.7 (11.4) 35
Adverse effects:
Surgery for tape exposure: A: 0/35, B: 2/35
Adverse effects (dyspareunia, bladder perforation, urethral erosion, vaginal erosion/wound
haematoma and/or infection: A: 21.6%, B: 2.9% (all treated conservatively with antibiotics, local care,
or dressings)
Haematoma and/or infection: A: 8/35, B: 1/35
Dyspareunia: A: 3/35, B: 4/35
Bladder perforation: A: 1/35, B: 0/35
Sharifiaghdas 2015 
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Vaginal erosion: A: 1/35, B: 2/35
Urgency incontinence: A: 5/35, B: 1/35
Obstructive voiding symptoms: A: 6/35, B: 1/35 (1 woman required urethral dilatation, but group is un-
known)
UTI: A: 0, B: 0
Notes Groups were comparable at baseline, although sling group was younger
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Randomly assigned by envelope sealed cards
Allocation concealment
(selection bias)
Low risk Randomly assigned by envelope sealed cards
Blinding (performance
bias and detection bias) 
All outcomes








Methods Design: RCT stated. Details not given in abstract of the trial
Follow-up after first year reported
Participants 57 women with various types of SUI. Patient characteristics not reported
Interventions A (33): autologous dermal graE patch
B (24): cadaveric fascia lata
Outcomes Outcome measures reported were success rate (dry/improved) (method unspecified: assumed woman-
reported), de novo detrusor instability
Success rate (dry or improved): A: 30/33 (91.6%), B: 22/24 (93.2%)
Dry: A: 25/33, B: 19/24
Improved (only): A: 5/33, B: 3/27
De novo detrusor instability: A: 4/33, B: 5/20
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Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Insufficient information
Allocation concealment
(selection bias)
Unclear risk Not mentioned
Blinding (performance
bias and detection bias) 
All outcomes








Methods Design: RCT of SAFYRE TOT with autologous pubovaginal sling. Randomisation method unclear 
Follow-up: 6 months
Participants 20 women (average age 52.5 ± 11.8 years) with both USI and SUI but without detrusor overactivity
The 2 groups had similar characteristics with respect to age, parity, BMI, menopausal status, presence
of pelvic floor defects, and mean Valsalva leak point pressure in pre-operative UDS
Interventions A (10): pubovaginal sling
B (10): SAFYRE TOT
Outcomes Cure rates and intraoperative and postoperative morbidity. Women were declared objectively cured
when they had a postoperative pad test ≤ 8 grams
All patients were pre-operatively evaluated by history, physical examination, quality of life question-
naire (King's Health Questionnaire), 24-hour pad weight test, 2-day voiding diary, and multi-chan-
nel urodynamic study that included uroflowmetry, postvoid residual volume measured by urethral
catheter, and cystometrogram. Objective quantification of the severity of incontinence was done by
mean stress leaking point pressure in the urodynamic study. Pre-operative measurements included
type of anaesthesia, duration of surgery, intraoperative complications, occurrence of combined proce-
dures, and hospital stay
At 6-month follow-up, aforementioned measurements were carried out excluding UDS
Postoperative pad test, mean (SD): A: 8.4 (16.44), B: 39.4 (39.53) grams, P = 0.01
Operative time, mean (SD): A: 69.5 (23.7), B: 21.1 (3.8) minutes, P < 0.001
Length of hospital stay, mean (SD): A: 44.4 (5.8), B: 28.8 (8.4) hours, P < 0.001
Notes SAFYRE consists of a monofilament polypropylene mesh between 2 silicone columns made of multiple
cone-shaped soE tissue anchors. The 2 columns are fixed to the obturator muscle. Pubovaginal sling
uses rectus fascia
Risk of bias
Bias Authors' judgement Support for judgement
Silva Filho 2006 
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Random sequence genera-
tion (selection bias)
Unclear risk Not mentioned
Allocation concealment
(selection bias)
Unclear risk Not mentioned
Blinding (performance
bias and detection bias) 
All outcomes








Methods Design: RCT of TVT compared with autologous fascia lata pubovaginal sling
Setting: single centre
Participants 67 women with SUI were randomised. Basline comparisons of age, menopausal status, parity, SUI,
mixed incontinence, and intrinsic sphincter dysfunction were made
Inclusion criteria: type II to IV SUI, mixed SUI, intrinsic sphincter dysfunction, failed previous operations
Mixed incontinence was included in this study
Interventions A (19): autologous fascia lata pubovaginal sling
B (48): TVT
Outcomes Cure rates and operative morbidity
Damage to bladder, urinary retention, difficulty voiding
Incontinent at 3 months: A: 1/19, B: 3/48
Not improved at 3 months A: 0/19, B: 0/48
Operative time (SD): A: 125 (13), B: 27 (5) minutes
Mean length of hospital stay: A: 7.2, B: 1.8 days
Mean time to catheter removal: A: 5.3, B: 1 days
Complications:
Voiding dysfunction: A: 3/19, B: 3/48
Urinary retention: A: 2/19, B: 0/48
Bladder injury: A: 0/19, B: 2/48
Detrusor overactivity: A: 1/19, B: 3/48
Notes Follow-up on average was between 20 and 37 months. Cure rates were assessed at 3 months
Full text was translated from Chinese
Song 2004 
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Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not mentioned
Allocation concealment
(selection bias)
Unclear risk Divided into 2 groups randomly (no details given, but numbers in groups un-
equal)
Blinding (performance
bias and detection bias) 
All outcomes









Follow-up at 12 months
Participants 41 women randomly distributed into 2 groups. Patients had similar baseline characteristics (age,
BMI, parity, vaginal births, postmenopausal conditions, hormone replacement therapy, previous SUI
surgery, genital prolapse, previous surgery/previous hysterectomy, disease duration)
Inclusion criteria: USI, confirmed through medical history, physical exam, and urodynamic investiga-
tion
Interventions A (20): retropubic sling (aponeurotic sling)
B (21): SAFYRE TOT (synthetic transobturator)
Outcomes Cure was defined as the reported absence of SUI and no urinary loss during effort manoeuvres (com-
bined outcome) during 12-month follow-up re-evaluation
Failure at 12 months: A: 1/20, B: 2/21
Operative time, mean (SD): A: 59.7 (10.3), B: 12.8 (2.4) minutes
Time to catheter removal: A: 2, B: 1 day
Complications:
All complications: A: 12/20, B: 3/21
UTI: A: 2/20 B: 0/21
Bladder perforation: A: 1/20, B: 0/21
Urinary retention: A: 2/21, B: 3/20
Vaginal mesh erosion (isolated): A: 0/20, B: 1/21
Notes Physical exam specifically evaluated urinary loss through Valsalva maneuver and presence of other
concurrent dystopia of pelvic floor (anterior, posterior, and apical), using POP-Q classification
Tcherniakovsky 2009 
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VLPP standardised in this study at 200 mL of vesical repletion
Urodynamic study performed on every patient included
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Patients "randomly distributed". No details provided
Allocation concealment
(selection bias)
Unclear risk Not mentioned
Blinding (performance
bias and detection bias) 
All outcomes








Methods Design: RCT. Details not given in abstract 
Follow-up: 24 hours and 90 days
Participants 42 patients were randomised (porcine collagen 21, polypropylene tapes 21)
Inclusion criteria: stress urinary incontinence
Interventions A (21): porcine collagen
B (21): polypropylene tapes
Outcomes No outcome measure relevant to this review
C-reactive protein and white blood count measured previous day and at 24 hours after surgery
Biopsy at 90 days post operation for local inflammatory markers (polymorphonuclear cells, mononu-
clear cells, giant cells, and neovascularisation) and collagen reaction (collagen amount, composition,
and organisation)
Notes Trial assessing systemic and local inflammatory responses with different sling materials
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk No details provided
Allocation concealment
(selection bias)
Unclear risk "blindly randomised" - no details provided
Blinding (performance
bias and detection bias) 
Unclear risk Not mentioned
Teixeira 2008 
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Unclear risk 2 patients with missing outcome data. No details provided on whether losses




Methods Design: prospective randomised study
All operations were performed by the same surgical team
Participants 32 women with main complaint of SUI established by history, examination, and urodynamic evaluation
Exclusion criteria: neurological disease, overactive bladder, other causes and forms of incontinence
(overflow or pure urge), recurrent SUI (after anti-incontinence procedure), any form of prolapse requir-
ing surgery (only cases with grade 1 asymptomatic cysto-urethrocoele included)
Interventions Transvaginal tension-free mid-urethral slings were used under the mid-urethra via a retropubic route
A (12): anterior rectus sheath sling harvested via 7-cm Pfannenstiel incision and with 0 Prolene suture
placed at each end to be pulled up
B (12): 7 × 1.5-cm tailored Prolene strip with 0 Prolene sutures placed at each end to be used as a sling
C (8): rectangular anterior vaginal wall patch 5 × 1.5 cm harvested and placed under mid-urethra with
Prolene sutures in the same manner
Outcomes Cured defined as no leakage reported by patient or noticed at examination (at ˜ 18 months): A: 8/12, B:
9/12, C: 6/8
Improved defined as leakage occurring only with severe exertion unlike before surgery (at 3 months): A:
3/12, B: 2/12, C: 1/8
Failure: A: 1/12, B: 1/12, C: 1/8
Operative blood loss, mean (SD; range): A: 181.2 (33.1; 130 to 230), B: 149.2 (28.8; 100 to 200), C: 200.8
(28.1; 160 to 360)
Duration minutes, mean (SD; range): A 52.1 (4.4; 45 to 60), B 35.7 (3.4; 30 to 40), C 42.2 (4.5; 35 to 50)
Hospital stay (hours), mean (SD; range): A: 58 (12.3; 48 to 72), B: 33 (9; 24 to 48), C 36 (9.1; 24 to 48)
Adverse outcome: bladder perforation: A: 0/12, B:1/12, C: 1/8
Urinary retention: managed by urethral dilators: A: 0/12, B: 1/12, C: 0/8
Notes Mean follow-up was 18, 18.5, and 18 months in Groups A, B, and C. 11 patients completed 36 months of
follow-up (A: 4, B: 4, C: 3)
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk No information
Allocation concealment
(selection bias)
Unclear risk No information
Teleb 2011 
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Blinding (performance
bias and detection bias) 
All outcomes




Low risk No differential dropout was reported at 18 months. Only 11/32 patients com-




Methods Design: RCT. Method not clarified
Only short-term follow-up reported
Participants 26 women with stress urinary incontinence
Interventions A (15): fascial sling
B (11): vaginal wall sling
Outcomes Measures of outcomes included SEAPI-QMN questionnaire, presence of SUI at postoperative period,
urinary symptoms and hospital stay at 3 months (median follow-up 7 months):
SEAPI scores: decreased from 6.1 to 0.9 for B, from 6.3 to 0.8 for A
Persistent SUI: A: 1/15, B: 0/11
Urgency incontinence: A: 2/15, B: 1/11
Serious postoperative complications: A: 0/15, B: 0/11
Permanent urinary retention (voiding disorder): A: 0/15, B: 0/11
Notes All procedures performed by the same surgeon
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Insufficient information
Allocation concealment
(selection bias)
Unclear risk Not mentioned
Blinding (performance
bias and detection bias) 
All outcomes
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Methods Design: RCT. Randomisation by closed envelope delivered to surgeon by a third party. Procedures per-
formed by 1 surgeon
Follow-up: 6 months
Participants 63 women (mean age 47.8 years) with SUI were randomised; all had similar background characteristics
(age, BMI, parity, grade of associated cystocoele)
Inclusion criteria: age > 21 years, predominant symptom of SUI, willing to give informed consent, life
expectancy > 1 year, normal upper urinary tract, normal manual dexterity
Exclusion criteria: pelvic or vaginal surgery within 6 months, urgency urinary incontinence as predom-
inant symptom, > grade 2 cystocoele, associated urethral pathology (e.g. diverticulum), associated
bladder pathology (e.g. fistula, culture-proven, active UTI)
12 lost to follow-up; no information about which group
Interventions A (25): autologous fascial sling (harvested from rectus sheath)
B (28): TVT
Concomitant surgery: grade 2 or 3 cystocoele or rectocoele (27)
Median follow-up: 54 (± 21.9) (range 24 to 102 months)
Outcomes Cure defined as complete dryness with no usage of pad and negative cough-stress test
Not cured at 6 months: A: 2/25, B: 2/28
Operative time, mean (SD) N: A: 68 (23) 25, B: 48 (25) 28 minutes
Time to catheter removal, mean (SD) N: A: 6.6 (5.3) 25, B: 4.3 (2.6) 28 days
Complications:
Bladder perforation: A: 1/25, B: 2/28
De novo detrusor overactivity at 6 months: A: 1/23, B: 0/24
Stitch sinus at 1 week: A: 0/25, B: 1/28
Vaginal erosion: A: 0/25, B: 0/28
Wound pain at 6 months: A: 7/25, B: 2/28
Voiding dysfunction: A: 7/25, B: 3/28
2-year results:
NB: denominators reported at 2 years were different from those reported at 6 months
Quality of life/condition-specific score:
UDI-6, mean (SD) N: A: 31.7 (16.9) 39; B: 24.4 (19.1) 24 (higher is worse)
IIQ-7, mean (SD) N: A: 24.4 (20.5) 39; B: 23.8 (21.6) 24 (higher is worse)
Female sexual function Index (FSFI): no reference to score cited; SD not given
Data on pain, satisfaction, lubrication, desire, arousal, and orgasm also provided but not used due to
uncertainty about the instrument
Notes  
Wadie 2005 
Traditional suburethral sling operations for urinary incontinence in women (Review)









Cochrane Database of Systematic Reviews
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not mentioned
Allocation concealment
(selection bias)
Low risk Closed opaque envelopes held by a non-involved third party who revealed the
allocation after patient was anaesthetised just before start of surgery
Blinding (performance
bias and detection bias) 
All outcomes








Methods Design: quasi-randomised clinical trial
Setting: Isfahan University of Medical Sciences, Iran
Follow-up: 3 days and 18 days; 1, 6, 12, and 18 months
Participants Inclusion criteria: 56 women with severe SUI or mixed urinary incontinence with predominant stress
component and anterior vaginal wall prolapse (grade 1 to 3 prolapse based on half-way classification
system)
Severity of SUI was diagnosed by ICIQ-SF or a positive 1-hour pad test (> 10 grams urine loss with a full
bladder)
Exclusion criteria: active urinary tract infection; urolithiasis; neurogenic bladder; urogenital malignan-
cy; high-grade rectocoele, enterocoele, or cystocoele; > POP stage 3
28 women (56%) had previous surgery: vaginal POP A: 12, B: 16; incontinence surgery A: 18, B: 21
Age, mean, years: A: 54.1, B: 55.9
Interventions A (26): anterior colporrhaphy (Kelly placation) and sling placement with a strip of anterior vaginal wall
tied over rectus fascia and placed tension-free under the mid-urethra
B (30): TVT (craniocaudal, top-to-bottom, SPARC) with transvaginal tension-free self-fixing sling
for mesh correction of anterior vaginal wall prolapse with a T-sling mesh kit (Herniamesh Compa-
ny Polypropylene, Italy). Monofilament non-woven polypropylene with central portion of mesh ab-
sorbable - used for both SUI and cystocoele repair
Outcomes Objective assessment via 48-hour frequency volume chart, 48-hour pad test, and standardised stress
test
Surgery was considered successful when there was no postoperative SUI (patient was dry and stress
test was negative) and postoperative cystocoele was less than grade 2
Objective and subjective cure rates were evaluated between 3 and 18 days, and 1, 6, 12, and 18 months
after surgery (data extracted from graphs)
Cure at 18 months (from abstract): A: 54%, B: 72%
Zargham 2013 
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Subjective cure (graph 1):
12 months: A: 14/25, B: 19/25
18 months: A: 13/25, B: 18/25
Objective cure (graph 1):
12 months: A: 13/25, B: 20/25
18 months: A: 13/25, B: 20/25
Mean duration of operation, minutes (SD): A: 42 (20), B: 56 (24)
Mean duration of hospital stay, days (SD): A: 2.88 (0.94), B: 2.07 (0.92)
Any complications (from abstract): A: 9/25, B: 3/25
Short-term complications:
Vaginal bleeding: A: 5/25, B: 3/25
Haematoma: A: 0/25, B: 2/25
Bladder injury: A: 1/25, B: 2/25
Long-term complications (> 1 month):
Cystitis: A: 3/25, B: 3/25
Vaginal erosion: A: 0/25, B: 2/25
De novo urgency: A: 0/25, B: 2/25
Recurrence of SUI: A: 8/25, B: 1/25
Chronic urinary retention: A: 0/25, B: 4/25
Notes Denominators in the table are different from those in the text
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
High risk File number (assumed to be alternation by record number)
Allocation concealment
(selection bias)
Unclear risk Randomised into 2 groups
Blinding (performance
bias and detection bias) 
All outcomes




Low risk Only 1 patient reported as lost to follow-up, but data reported for 25 in each
group (actual loss of 4 and 5)
Zargham 2013  (Continued)
BMI: body mass index.
ISD: intrinsic sphincter dysfunction.
MMK: Marshall-Marchetti-Krantz.
PVR: postvoid residual.
RCT: randomised controlled trial.
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SUI: stress urinary incontinence.
UDS: urodynamics.
USI: urodynamic stress incontinence.
 
Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
Amat 2007 RCT. One mid-urethral sling vs another
Atherton 2000 Not an RCT: non-randomised
Aurunkalaivanan 2001 We are not sure about the population studied; it could be the same population as Barrington 2003
and Arunkalaivanan 2003 (included in the review). We have written to study authors to clarify this
point
Barrington 2003 We are not sure about the population studied; it could be the same population as Arunkalaivanan
2001 and Arunkalaivanan 2003 (included in the review). We have written to study authors to clarify
this point
Brandt 2009 Not an RCT: prospective longitudinal study
Bruschini 2005 Not an RCT: no comparator group
Choe 2001 All participants were randomised to undergo or not undergo pre-operative urodynamic evaluation.
They then had implantation of sub-urethral Mycromesh sling. Therefore this study analyses the im-
pact on effectiveness of a sling if the diagnosis of SUI is made with or without urodynamic evalua-
tion
Chong 2003 All participants had a TVT operation and were randomised to division/no division of tape
Corcos 2001 Participants were randomised to surgery or collagen injection, but those in the surgery arm were
selected to sling by patient option. Three types of operations could be chosen in the surgery group:
Burch, sling, or bladder neck suspension. Results were reported in terms of collagen vs surgery
Darai 2007 RCT; comparators not of interest
One mid-urethral sling vs another
Debodinance 1993 Not all participants had stress incontinence. Debodinance 2000 is a 10-year follow-up of the first
published study. This is a comparative study between Bologna (a sling made of strips of vaginal
wall) and Ingelman-Sundberg procedures (anterior colporrhaphy with pubococcygeum muscle)
Debodinance 1994 Not clear how participants were allocated. Paper in French; needs translation
Gamble 2010 RCT in women with low-pressure urethra but of TVT vs TOT (TOT described as 'bladder neck sling')
Giri 2004 We are not sure about the population studied; it could be the same population as Giri 2006, which
has been excluded as it was a non-randomised study. We have made attempts to contact study au-
thors
Giri 2006 Not an RCT; non-randomised
Goldberg 2001 Prolapse surgery rather than incontinence surgery
Halaska 2001 Study comparing transvaginal tape vs colposuspension
Han 2001 Study comparing transvaginal tape vs colposuspension
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Study Reason for exclusion
Hung 2001 Not clear how patients were allocated; we have written to study authors
Ishenko 1999 Randomisation process and groups unclear ('randomised by age'). Excluded as attempts to contact
study authors were unsuccessful and insufficient information was given in the abstract Interven-
tions: vaginal hysterectomy, modified Pereyra procedure, anterior and posterior repair vs vaginal
hysterectomy, sling procedure with Mersilene mesh, anterior and posterior repair
Kocjancic 2008 Study comparing transvaginal tape procedures; will be included in a separate review on self-fixing
slings
Kuo 2001 Comparison between rectus fascia and polypropylene mesh
Kwon 2002 Not all patients had stress incontinence; all patients were treated for prolapse, but 1 group re-
ceived concomitant transvaginal sling (processed fascia lata), 1 group received an alternate
surgery for SUI, and the last group did not have SUI and received only treatment for prolapse
Lemieux 1991 Interventions were for clamping vs non-clamping of catheters post anti-incontinence surgery
Liapis 2002 Study comparing transvaginal tape vs colposuspension
Lim 2005 Study comparing mid-urethral sling procedures
Meschia 2001 Surgery for prolapse rather than incontinence
Naumann 2006 This study is comparing tape procedures
O'Sullivan 2000 Patients randomised to colposuspension or transvaginal tape. Reported outcome measures (colla-
gen metabolism) not included in this review
Obrink 1978 Not clear how patients were allocated. Request sent to study author October 2001 but no reply re-
ceived
Oremus 2010 RCT of injectables vs 3 types of surgery; not reported separately
Palomba 2008 RCT of 3 different materials to carry out TOT; http://clinicaltrials.gov/show/NCT00744198
Schostak 2001 Unclear how patients were allocated. Bone anchoring used
Seo 2007 One mid-urethral sling vs another
Trezza 2001 Occult incontinence treated at the same time as prolapse repair performed
Wang 1999 Randomised to different types of anaesthetic
Ward 2002a Study comparing transvaginal tape vs colposuspension
Yoo 2007 This study is comparing tape procedures
RCT: randomised controlled trial.
SUI: stress urinary incontinence.
TOT: transobturator tape.
TVT: tension-free vaginal tape.
 
Characteristics of studies awaiting assessment [ordered by study ID]
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Methods Please see Abouhashem 2014
Participants Please see Abouhashem 2014
Interventions Please see Abouhashem 2014
Outcomes Please see Abouhashem 2014
Notes Please note: this appears to be exactly the same abstract as the only report (a conference abstract)
of the already included Abouhashem 2014. This study report was identified by the search conduct-








Notes Ongoing trial. This study report was identified by the search conducted 23 January 2019, which has




Methods RCT. Single-blind trial. 'Randomly (computer-based) categorized into two groups'
Participants 40 women aged 30 to 50 with proven pure type 3 SUI (USI)
Interventions Acellular skin graE using tension-free vaginal tape (TVT) vs placement of synthetic mesh
Outcomes Mean number of postsurgical problems and improvement in SUI
Notes Ongoing trial
Start date: 08.12.2016 to 01.06.2018
Contact information: kajbafzd@sina.tums.ac.ir
This study report was identified by the search conducted 23 January 2019, which has not been fully
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Outcomes  
Notes This is a report at 10 years of the already included Sharifiaghdas 2008 study. This study report was
identified by the search conducted 23 January 2019, which has not been fully incorporated into this
review
Sharifiaghdas 2017  (Continued)
RCT: randomised controlled trial.
SUI: stress urinary incontinence.
TVT: tension-free vaginal tape.
USI: urodynamic stress incontinence.
 
Characteristics of ongoing studies [ordered by study ID]
 
Trial name or title A prospective randomised comparative trial of a tension-free vaginal tape (TVT) and fas-
cial sling procedure for 'secondary' genuine stress incontinence
Methods  
Participants 146 planned recruitment








Trial name or title A multi-center, randomized, controlled clinical trial of the safety and efficacy of Regen sling treat-
ment for female patients with stress urinary incontinence
Methods Multi-centre, randomised, single-blind, positive parallel controlled, non-inferiority validation clin-
ical trial: 'allocate random number to the patients in chronological order (random number alloca-
tion method: small to large'
Participants Female patients with stress urinary incontinence
Interventions Regen sling (high-biocompatibility polyvinylidene fluoride (PVDF)) vs transobturator sling TVT-O™
(Gynecare™, USA)
Outcomes Anti-urinary incontinence effect; sexual life situation; vaginal tape erosion; improvement in pa-
tients' symptoms
Starting date December 2014 to December 2015
Contact information tianquan@medprin.com; Professor Zhu Lan
Notes  
Zhu 2014 
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D A T A   A N D   A N A L Y S E S
 
Comparison 3.   Traditional suburethral sling operation versus drugs





Statistical method Effect size
1 Number of continent women within
1 year (any definition)
1   Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 urodynamic stress incontinence
(only)
0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 stress urinary incontinence
(symptoms only)
0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 mixed incontinence 1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Urge urinary symptoms, urgency
urinary incontinence
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 urodynamic stress incontinence
(only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 mixed incontinence 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 
 
Analysis 3.1.   Comparison 3 Traditional suburethral sling operation versus
drugs, Outcome 1 Number of continent women within 1 year (any definition).
Study or subgroup Sling Anticholinergic drug Odds Ratio Odds Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
3.1.1 urodynamic stress incontinence (only)  
   
3.1.2 stress urinary incontinence (symptoms only)  
   
3.1.3 mixed incontinence  
Osman 2003 20/24 0/21 195.89[9.91,3871.03]
Favours anticholinergic 10000.001 100.1 1 Favours sling
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Analysis 3.2.   Comparison 3 Traditional suburethral sling operation versus
drugs, Outcome 2 Urge urinary symptoms, urgency urinary incontinence.
Study or subgroup Sling Anticholinergic drug Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
3.2.1 urodynamic stress incontinence (only)  
   
3.2.2 stress urinary incontinence (symptoms only)  
   
3.2.3 mixed incontinence  
Osman 2003 3/24 9/21 0.29[0.09,0.94]
Favours sling 100.1 50.2 20.5 1 Favours anticholinergic
 
 
Comparison 4.   Traditional suburethral sling operation versus injectables





Statistical method Effect size
1 Number of continent women with-
in 1 year (any definition)
1   Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 urodynamic stress incontinence
(only)
1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 stress urinary incontinence
(symptoms only)
0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 mixed urinary incontinence 0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Number of continent women at 1
to 5 years (any definition)
1   Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 urodynamic stress incontinence
(only)
1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 stress urinary incontinence
(symptoms only)
0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 mixed urinary incontinence 0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Repeat surgery for urinary inconti-
nence
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3.1 urodynamic stress incontinence
(only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 mixed urinary incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Number of women cured after first
year (women's observations)
1   Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
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Statistical method Effect size
4.1 urodynamic stress incontinence
(only)
1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 stress urinary incontinence
(symptoms only)
0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.3 mixed urinary incontinence 0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Number of women satisfied
(women's observations)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
5.1 urodynamic stress incontinence
(only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Number of women with urinary in-
continence within first year (clini-
cian's observations)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
6.1 urodynamic stress incontinence
(only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 mixed urinary incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Urinary tract infection 1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
7.1 urodynamic stress incontinence
(only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.3 mixed urinary incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8 De novo detrusor overactivity
(urodynamic diagnosis)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
8.1 urodynamic stress incontinence
(only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.3 mixed urinary incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9 Voiding dysfunction 1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
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Statistical method Effect size
9.1 urodynamic stress incontinence
(only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.3 mixed urinary incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 
 
Analysis 4.1.   Comparison 4 Traditional suburethral sling operation versus
injectables, Outcome 1 Number of continent women within 1 year (any definition).
Study or subgroup Traditional sling Injectable Odds Ratio Odds Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
4.1.1 urodynamic stress incontinence (only)  
Maher 2005 19/21 17/22 2.79[0.48,16.33]
   
4.1.2 stress urinary incontinence (symptoms only)  
   
4.1.3 mixed urinary incontinence  
Favours injectable 500.02 100.1 1 Favours traditional sling
 
 
Analysis 4.2.   Comparison 4 Traditional suburethral sling operation versus
injectables, Outcome 2 Number of continent women at 1 to 5 years (any definition).
Study or subgroup Traditional sling Injectable Odds Ratio Odds Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
4.2.1 urodynamic stress incontinence (only)  
Maher 2005 13/13 10/14 11.57[0.56,239.74]
   
4.2.2 stress urinary incontinence (symptoms only)  
   
4.2.3 mixed urinary incontinence  
Favours injectable 5000.002 100.1 1 Favours traditional sling
 
 
Analysis 4.3.   Comparison 4 Traditional suburethral sling operation
versus injectables, Outcome 3 Repeat surgery for urinary incontinence.
Study or subgroup Traditional sling Injectable Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
4.3.1 urodynamic stress incontinence (only)  
Maher 2005 1/21 2/22 0.52[0.05,5.36]
   
4.3.2 stress urinary incontinence (symptoms only)  
Favours traditional sling 5000.002 100.1 1 Favours injectable
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Study or subgroup Traditional sling Injectable Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
   
4.3.3 mixed urinary incontinence  
Favours traditional sling 5000.002 100.1 1 Favours injectable
 
 
Analysis 4.4.   Comparison 4 Traditional suburethral sling operation versus injectables,
Outcome 4 Number of women cured aOer first year (women's observations).
Study or subgroup Traditional sling Injectable Odds Ratio Odds Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
4.4.1 urodynamic stress incontinence (only)  
Maher 2005 13/13 10/14 11.57[0.56,239.74]
   
4.4.2 stress urinary incontinence (symptoms only)  
   
4.4.3 mixed urinary incontinence  
Favours injectable 10000.001 100.1 1 Favours traditional sling
 
 
Analysis 4.5.   Comparison 4 Traditional suburethral sling operation versus
injectables, Outcome 5 Number of women satisfied (women's observations).
Study or subgroup Traditional sling Injectable Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
4.5.1 urodynamic stress incontinence (only)  
Maher 2005 9/13 4/14 2.42[0.98,5.98]
   
4.5.2 stress urinary incontinence (symptoms only)  
   
4.5.3 mixed incontinence  
Favours injectable 50.2 20.5 1 Favours traditional sling
 
 
Analysis 4.6.   Comparison 4 Traditional suburethral sling operation versus injectables, Outcome
6 Number of women with urinary incontinence within first year (clinician's observations).
Study or subgroup Traditional sling Injectable Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
4.6.1 urodynamic stress incontinence (only)  
Maher 2005 4/21 20/22 0.21[0.09,0.51]
   
4.6.2 stress urinary incontinence (symptoms only)  
   
4.6.3 mixed urinary incontinence  
Favours traditional sling 100.1 50.2 20.5 1 Favours injectable
 
 
Traditional suburethral sling operations for urinary incontinence in women (Review)









Cochrane Database of Systematic Reviews
Analysis 4.7.   Comparison 4 Traditional suburethral sling
operation versus injectables, Outcome 7 Urinary tract infection.
Study or subgroup Traditional sling Injectable Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
4.7.1 urodynamic stress incontinence (only)  
Maher 2005 3/21 2/22 1.57[0.29,8.49]
   
4.7.2 stress urinary incontinence (symptoms only)  
   
4.7.3 mixed urinary incontinence  
Favours traditional sling 100.1 50.2 20.5 1 Favours injectable
 
 
Analysis 4.8.   Comparison 4 Traditional suburethral sling operation versus
injectables, Outcome 8 De novo detrusor overactivity (urodynamic diagnosis).
Study or subgroup Traditional sling Injectable Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
4.8.1 urodynamic stress incontinence (only)  
Maher 2005 1/21 0/22 3.14[0.13,72.96]
   
4.8.2 stress urinary incontinence (symptoms only)  
   
4.8.3 mixed urinary incontinence  
Favours traditional sling 10000.001 100.1 1 Favours injectable
 
 
Analysis 4.9.   Comparison 4 Traditional suburethral sling
operation versus injectables, Outcome 9 Voiding dysfunction.
Study or subgroup Traditional sling Injectable Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
4.9.1 urodynamic stress incontinence (only)  
Maher 2005 4/21 1/22 4.19[0.51,34.5]
   
4.9.2 stress urinary incontinence (symptoms only)  
   
4.9.3 mixed urinary incontinence  
Favours traditional sling 500.02 100.1 1 Favours injectable
 
 
Comparison 6.   Traditional suburethral sling operation versus bladder neck needle suspension (abdominal and
vaginal)





Statistical method Effect size
1 Number of continent women
within 1 year (any definition)
1   Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
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Statistical method Effect size
1.1 urodynamic stress inconti-
nence (only)
1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 stress urinary incontinence
(symptoms only)
0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 mixed incontinence 0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Number of continent women at
1 to 5 years (any definition)
1   Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 urodynamic stress inconti-
nence (only)
1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 stress urinary incontinence
(symptoms only)
0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 mixed incontinence 0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 CURE: number of women cured
after first year (women's observa-
tions)
1   Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
3.1 urodynamic stress inconti-
nence (only)
1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 stress urinary incontinence
(symptoms only)
0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 mixed incontinence 0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Length of hospital stay (hours) 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.1 urodynamic stress inconti-
nence (only)
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 stress urinary incontinence
(symptoms only)
0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.3 mixed incontinence 0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Perioperative surgical compli-
cations
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
5.1 urodynamic stress inconti-
nence (only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Urinary urgency symptoms, ur-
gency urinary incontinence
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
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Statistical method Effect size
6.1 urodynamic stress inconti-
nence (only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Detrusor overactivity (urody-
namic diagnosis)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
7.1 urodynamic stress inconti-
nence (only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8 Voiding dysfunction after 3
months
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
8.1 urodynamic stress inconti-
nence (only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 
 
Analysis 6.1.   Comparison 6 Traditional suburethral sling operation versus bladder neck needle suspension
(abdominal and vaginal), Outcome 1 Number of continent women within 1 year (any definition).
Study or subgroup Traditional sling Needle suspension Odds Ratio Odds Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
6.1.1 urodynamic stress incontinence (only)  
Hilton 1989 9/10 8/10 2.25[0.17,29.77]
   
6.1.2 stress urinary incontinence (symptoms only)  
   
6.1.3 mixed incontinence  
Favours needle suspension 200.05 50.2 1 Favours traditional sling
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Analysis 6.2.   Comparison 6 Traditional suburethral sling operation versus bladder neck needle suspension
(abdominal and vaginal), Outcome 2 Number of continent women at 1 to 5 years (any definition).
Study or subgroup Traditional sling Needle suspension Odds Ratio Odds Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
6.2.1 urodynamic stress incontinence (only)  
Hilton 1989 9/10 7/10 3.86[0.33,45.57]
   
6.2.2 stress urinary incontinence (symptoms only)  
   
6.2.3 mixed incontinence  
Favours needle suspension 2000.005 100.1 1 Favours traditional sling
 
 
Analysis 6.3.   Comparison 6 Traditional suburethral sling operation versus bladder neck needle suspension
(abdominal and vaginal), Outcome 3 CURE: number of women cured aOer first year (women's observations).
Study or subgroup Traditional sling Needle suspension Odds Ratio Odds Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
6.3.1 urodynamic stress incontinence (only)  
Hilton 1989 9/10 7/10 3.86[0.33,45.57]
   
6.3.2 stress urinary incontinence (symptoms only)  
   
6.3.3 mixed incontinence  
Favours needle suspension 2000.005 100.1 1 Favours traditional sling
 
 
Analysis 6.4.   Comparison 6 Traditional suburethral sling operation versus bladder neck
needle suspension (abdominal and vaginal), Outcome 4 Length of hospital stay (hours).
Study or subgroup Traditional sling Needle suspension Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
6.4.1 urodynamic stress incontinence (only)  
Hilton 1989 10 20 (12.9) 10 7 (0.3) 13[5,21]
   
6.4.2 stress urinary incontinence (symptoms only)  
   
6.4.3 mixed incontinence  




Analysis 6.5.   Comparison 6 Traditional suburethral sling operation versus bladder neck
needle suspension (abdominal and vaginal), Outcome 5 Perioperative surgical complications.
Study or subgroup Traditional sling Needle suspension Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
6.5.1 urodynamic stress incontinence (only)  
Hilton 1989 9/10 2/10 4.5[1.28,15.81]
   
Favours traditional sling 200.05 50.2 1 Favours needle suspen-
sion
Traditional suburethral sling operations for urinary incontinence in women (Review)
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Study or subgroup Traditional sling Needle suspension Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
6.5.2 stress urinary incontinence (symptoms only)  
   
6.5.3 mixed incontinence  




Analysis 6.6.   Comparison 6 Traditional suburethral sling operation versus bladder neck needle suspension
(abdominal and vaginal), Outcome 6 Urinary urgency symptoms, urgency urinary incontinence.
Study or subgroup Traditional sling Needle suspension Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
6.6.1 urodynamic stress incontinence (only)  
Hilton 1989 5/10 3/10 1.67[0.54,5.17]
   
6.6.2 stress urinary incontinence (symptoms only)  
   
6.6.3 mixed incontinence  




Analysis 6.7.   Comparison 6 Traditional suburethral sling operation versus bladder neck needle
suspension (abdominal and vaginal), Outcome 7 Detrusor overactivity (urodynamic diagnosis).
Study or subgroup Traditional sling Needle suspension Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
6.7.1 urodynamic stress incontinence (only)  
Hilton 1989 2/10 1/10 2[0.21,18.69]
   
6.7.2 stress urinary incontinence (symptoms only)  
   
6.7.3 mixed incontinence  




Analysis 6.8.   Comparison 6 Traditional suburethral sling operation versus bladder neck
needle suspension (abdominal and vaginal), Outcome 8 Voiding dysfunction aOer 3 months.
Study or subgroup Traditional sling Needle suspension Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
6.8.1 urodynamic stress incontinence (only)  
Hilton 1989 4/10 2/10 2[0.47,8.56]
   
6.8.2 stress urinary incontinence (symptoms only)  
   
6.8.3 mixed incontinence  
Favours traditional sling 200.05 50.2 1 Favours needle suspen-
sion
 
Traditional suburethral sling operations for urinary incontinence in women (Review)
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Comparison 7.   Traditional suburethral sling operation versus open abdominal retropubic colposuspension





Statistical method Effect size
1 Number of continent women
within 1 year (any definition)
4 147 Odds Ratio (M-H, Fixed, 95% CI) 2.70 [0.69, 10.55]
1.1 urodynamic stress inconti-
nence (only)
4 147 Odds Ratio (M-H, Fixed, 95% CI) 2.70 [0.69, 10.55]
1.2 stress urinary incontinence
(symptoms only)
0 0 Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 mixed incontinence 0 0 Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Number of continent women at 1
to 5 years (any definition)
4 687 Odds Ratio (M-H, Fixed, 95% CI) 1.70 [1.22, 2.37]
2.1 urodynamic stress inconti-
nence (only)
3 167 Odds Ratio (M-H, Fixed, 95% CI) 1.84 [0.65, 5.24]
2.2 stress urinary incontinence
(symptoms only)
1 520 Odds Ratio (M-H, Fixed, 95% CI) 1.69 [1.19, 2.39]
2.3 mixed incontinence 0 0 Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Number of continent women af-
ter 5 years (any definition)
2 481 Odds Ratio (M-H, Fixed, 95% CI) 1.55 [1.06, 2.27]
3.1 urodynamic stress inconti-
nence (only)
1 28 Odds Ratio (M-H, Fixed, 95% CI) 0.39 [0.03, 4.92]
3.2 stress urinary incontinence
(symptoms only)
1 453 Odds Ratio (M-H, Fixed, 95% CI) 1.61 [1.09, 2.37]
3.3 mixed incontinence 0 0 Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Repeat surgery for urinary incon-
tinence
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
4.1 urodynamic stress inconti-
nence (only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 stress urinary incontinence
(symptoms only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Number of women cured after
first year (women's observations)
3 515 Odds Ratio (M-H, Fixed, 95% CI) 1.56 [1.07, 2.28]
5.1 urodynamic stress inconti-
nence (only)
2 62 Odds Ratio (M-H, Fixed, 95% CI) 0.93 [0.18, 4.89]
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Statistical method Effect size
5.2 stress urinary incontinence
(symptoms only)
1 453 Odds Ratio (M-H, Fixed, 95% CI) 1.61 [1.09, 2.37]
5.3 mixed incontinence 0 0 Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Number of women satisfied
(women's observations)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
6.1 urodynamic stress inconti-
nence (only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 stress urinary incontinence
(symptoms only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Number of women with urinary
incontinence within first year (clin-
ician's observations)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.1 urodynamic stress inconti-
nence (only)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.2 stress urinary incontinence
(symptoms only)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.3 mixed incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8 Number of women with urinary
incontinence at 1 to 5 years (clini-
cian's observations)
3 626 Risk Ratio (M-H, Fixed, 95% CI) 0.88 [0.59, 1.31]
8.1 urodynamic stress inconti-
nence (only)
2 106 Risk Ratio (M-H, Fixed, 95% CI) 0.54 [0.16, 1.86]
8.2 stress urinary incontinence
(symptoms only)
1 520 Risk Ratio (M-H, Fixed, 95% CI) 0.94 [0.62, 1.42]
8.3 mixed incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9 Number of women with urinary
incontinence after 5 years (clini-
cian's observations)
2 461 Risk Ratio (M-H, Fixed, 95% CI) 0.90 [0.80, 1.01]
9.1 urodynamic stress inconti-
nence (only)
1 28 Risk Ratio (M-H, Fixed, 95% CI) 0.23 [0.01, 4.37]
9.2 stress urinary incontinence
(symptoms only)
1 433 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.81, 1.02]
9.3 mixed incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
10 Duration of operation (minutes) 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
Traditional suburethral sling operations for urinary incontinence in women (Review)
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Statistical method Effect size
10.1 urodynamic stress inconti-
nence (only)
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
10.2 stress urinary incontinence
(symptoms only)
0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
10.3 mixed incontinence 0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
11 Length of hospital stay (days) 3 137 Mean Difference (IV, Fixed, 95% CI) 2.03 [1.47, 2.59]
11.1 urodynamic stress inconti-
nence (only)
3 137 Mean Difference (IV, Fixed, 95% CI) 2.03 [1.47, 2.59]
11.2 stress urinary incontinence
(symptoms only)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
11.3 mixed incontinence 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
12 Time to catheter removal (days) 2 108 Mean Difference (IV, Fixed, 95% CI) 8.01 [6.84, 9.18]
12.1 urodynamic stress inconti-
nence (only)
2 108 Mean Difference (IV, Fixed, 95% CI) 8.01 [6.84, 9.18]
12.2 stress urinary incontinence
(symptoms only)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
12.3 mixed incontinence 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
13 Time to return to normal activi-
ty level
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
13.1 urodynamic stress inconti-
nence (only)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
13.2 stress urinary incontinence
(symptoms only)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
13.3 mixed incontinence 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
14 Number of women requiring
treatment for pelvic organ pro-
lapse
3 559 Risk Ratio (M-H, Fixed, 95% CI) 0.20 [0.05, 0.77]
14.1 urodynamic stress inconti-
nence (only)
2 106 Risk Ratio (M-H, Fixed, 95% CI) 0.2 [0.04, 1.11]
14.2 stress urinary incontinence
(symptoms only)
1 453 Risk Ratio (M-H, Fixed, 95% CI) 0.20 [0.02, 1.74]
14.3 mixed incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
15 Perioperative surgical compli-
cations
4 792 Risk Ratio (M-H, Fixed, 95% CI) 1.24 [0.83, 1.86]
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Statistical method Effect size
15.1 urodynamic stress inconti-
nence (only)
3 137 Risk Ratio (M-H, Fixed, 95% CI) 0.85 [0.28, 2.52]
15.2 stress urinary incontinence
(symptoms only)
1 655 Risk Ratio (M-H, Fixed, 95% CI) 1.32 [0.86, 2.04]
15.3 mixed incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
16 Bladder perforation 1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
16.1 urodynamic stress inconti-
nence (only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
16.2 stress urinary incontinence
(symptoms only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
16.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
17 Urinary tract infection 1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
17.1 urodynamic stress inconti-
nence (only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
17.2 stress urinary incontinence
(symptoms only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
17.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
18 Number of women with recur-
rent UTIs at > 5 years
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
18.1 urodynamic stress inconti-
nence (only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.2 stress urinary incontinence
(symptoms only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19 Urinary urgency symptoms, ur-
gency urinary incontinence
2 525 Risk Ratio (M-H, Fixed, 95% CI) 1.10 [0.74, 1.64]
19.1 urodynamic stress inconti-
nence (only)
1 72 Risk Ratio (M-H, Fixed, 95% CI) 2.0 [0.54, 7.39]
19.2 stress urinary incontinence
(symptoms only)
1 453 Risk Ratio (M-H, Fixed, 95% CI) 1.02 [0.67, 1.56]
19.3 mixed incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
20 Detrusor overactivity (urody-
namic diagnosis)
4 203 Risk Ratio (M-H, Fixed, 95% CI) 1.42 [0.52, 3.87]
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Statistical method Effect size
20.1 urodynamic stress inconti-
nence (only)
4 203 Risk Ratio (M-H, Fixed, 95% CI) 1.42 [0.52, 3.87]
20.2 stress urinary incontinence
(symptoms only)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
20.3 mixed incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
21 Voiding dysfunction after 3
months
5 853 Risk Ratio (M-H, Fixed, 95% CI) 6.08 [3.10, 11.95]
21.1 urodynamic stress inconti-
nence (only)
4 198 Risk Ratio (M-H, Fixed, 95% CI) 4.48 [1.16, 17.36]
21.2 stress urinary incontinence
(symptoms only)
1 655 Risk Ratio (M-H, Fixed, 95% CI) 6.63 [3.04, 14.47]
21.3 mixed incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
22 Long-term voiding dysfunction
> 5 years
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
22.1 urodynamic stress inconti-
nence (only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
22.2 stress urinary incontinence
(symptoms only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
22.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
23 Condition-specific measures to
assess quality of life
1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
23.1 Urinary Distress Index (UDI) 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
23.2 Incontinence Impact Ques-
tionnaire (IIQ)
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
 
 
Analysis 7.1.   Comparison 7 Traditional suburethral sling operation versus open abdominal
retropubic colposuspension, Outcome 1 Number of continent women within 1 year (any definition).




Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
7.1.1 urodynamic stress incontinence (only)  
Bai 2005 26/28 30/33 71.05% 1.3[0.2,8.39]
Fischer 2001 11/11 7/9 12.31% 7.67[0.32,183.01]
Henriksson 1978 15/15 15/15   Not estimable
Sand 2000 17/17 17/19 16.63% 5[0.22,111.86]
Subtotal (95% CI) 71 76 100% 2.7[0.69,10.55]
Favours colposuspension 2000.005 100.1 1 Favours sling
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Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Total events: 69 (Traditional sling), 69 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=1.16, df=2(P=0.56); I2=0%  
Test for overall effect: Z=1.43(P=0.15)  
   
7.1.2 stress urinary incontinence (symptoms only)  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
7.1.3 mixed incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total (95% CI) 71 76 100% 2.7[0.69,10.55]
Total events: 69 (Traditional sling), 69 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=1.16, df=2(P=0.56); I2=0%  
Test for overall effect: Z=1.43(P=0.15)  
Test for subgroup differences: Not applicable  
Favours colposuspension 2000.005 100.1 1 Favours sling
 
 
Analysis 7.2.   Comparison 7 Traditional suburethral sling operation versus open abdominal
retropubic colposuspension, Outcome 2 Number of continent women at 1 to 5 years (any definition).




Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
7.2.1 urodynamic stress incontinence (only)  
Bai 2005 26/28 29/33 3.53% 1.79[0.3,10.61]
Demirci 2001 16/17 15/17 1.64% 2.13[0.17,26.03]
Enzelsberger 1996 33/36 31/36 4.79% 1.77[0.39,8.06]
Subtotal (95% CI) 81 86 9.95% 1.84[0.65,5.24]
Total events: 75 (Traditional sling), 75 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0.02, df=2(P=0.99); I2=0%  
Test for overall effect: Z=1.14(P=0.25)  
   
7.2.2 stress urinary incontinence (symptoms only)  
Albo 2007 164/265 125/255 90.05% 1.69[1.19,2.39]
Subtotal (95% CI) 265 255 90.05% 1.69[1.19,2.39]
Total events: 164 (Traditional sling), 125 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.94(P=0)  
   
7.2.3 mixed incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Heterogeneity: Not applicable  
Favours colposuspension 1000.01 100.1 1 Favours sling
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Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Test for overall effect: Not applicable  
   
Total (95% CI) 346 341 100% 1.7[1.22,2.37]
Total events: 239 (Traditional sling), 200 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0.04, df=3(P=1); I2=0%  
Test for overall effect: Z=3.16(P=0)  
Test for subgroup differences: Chi2=0.02, df=1 (P=0.88), I2=0%  
Favours colposuspension 1000.01 100.1 1 Favours sling
 
 
Analysis 7.3.   Comparison 7 Traditional suburethral sling operation versus open abdominal
retropubic colposuspension, Outcome 3 Number of continent women aOer 5 years (any definition).




Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
7.3.1 urodynamic stress incontinence (only)  
Sand 2000 11/13 14/15 4.68% 0.39[0.03,4.92]
Subtotal (95% CI) 13 15 4.68% 0.39[0.03,4.92]
Total events: 11 (Traditional sling), 14 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.72(P=0.47)  
   
7.3.2 stress urinary incontinence (symptoms only)  
Albo 2007 94/224 71/229 95.32% 1.61[1.09,2.37]
Subtotal (95% CI) 224 229 95.32% 1.61[1.09,2.37]
Total events: 94 (Traditional sling), 71 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.42(P=0.02)  
   
7.3.3 mixed incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total (95% CI) 237 244 100% 1.55[1.06,2.27]
Total events: 105 (Traditional sling), 85 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=1.17, df=1(P=0.28); I2=14.46%  
Test for overall effect: Z=2.27(P=0.02)  
Test for subgroup differences: Chi2=1.17, df=1 (P=0.28), I2=14.43%  
Favours colposuspension 1000.01 100.1 1 Favours sling
 
 
Traditional suburethral sling operations for urinary incontinence in women (Review)









Cochrane Database of Systematic Reviews
Analysis 7.4.   Comparison 7 Traditional suburethral sling operation versus open abdominal
retropubic colposuspension, Outcome 4 Repeat surgery for urinary incontinence.
Study or subgroup Traditional sling Colposuspension Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
7.4.1 urodynamic stress incontinence (only)  
   
7.4.2 stress urinary incontinence (symptoms only)  
Albo 2007 4/223 27/227 0.15[0.05,0.42]
   
7.4.3 mixed incontinence  




Analysis 7.5.   Comparison 7 Traditional suburethral sling operation versus open abdominal retropubic
colposuspension, Outcome 5 Number of women cured aOer first year (women's observations).




Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
7.5.1 urodynamic stress incontinence (only)  
Demirci 2001 16/17 15/17 2.02% 2.13[0.17,26.03]
Sand 2000 11/13 14/15 4.58% 0.39[0.03,4.92]
Subtotal (95% CI) 30 32 6.61% 0.93[0.18,4.89]
Total events: 27 (Traditional sling), 29 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0.87, df=1(P=0.35); I2=0%  
Test for overall effect: Z=0.09(P=0.93)  
   
7.5.2 stress urinary incontinence (symptoms only)  
Albo 2007 94/224 71/229 93.39% 1.61[1.09,2.37]
Subtotal (95% CI) 224 229 93.39% 1.61[1.09,2.37]
Total events: 94 (Traditional sling), 71 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.42(P=0.02)  
   
7.5.3 mixed incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total (95% CI) 254 261 100% 1.56[1.07,2.28]
Total events: 121 (Traditional sling), 100 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=1.23, df=2(P=0.54); I2=0%  
Test for overall effect: Z=2.33(P=0.02)  
Test for subgroup differences: Chi2=0.4, df=1 (P=0.53), I2=0%  
Favours colposuspension 500.02 100.1 1 Favours sling
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Analysis 7.6.   Comparison 7 Traditional suburethral sling operation versus open abdominal
retropubic colposuspension, Outcome 6 Number of women satisfied (women's observations).
Study or subgroup Traditional sling Colposuspension Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
7.6.1 urodynamic stress incontinence (only)  
   
7.6.2 stress urinary incontinence (symptoms only)  
Albo 2007 151/182 124/170 1.14[1.02,1.27]
   
7.6.3 mixed incontinence  
Favours colposuspension 1 Favours sling
 
 
Analysis 7.8.   Comparison 7 Traditional suburethral sling operation versus open abdominal retropubic
colposuspension, Outcome 8 Number of women with urinary incontinence at 1 to 5 years (clinician's observations).




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
7.8.1 urodynamic stress incontinence (only)  
Demirci 2001 0/17 1/17 3.32% 0.33[0.01,7.65]
Enzelsberger 1996 3/36 5/36 11.05% 0.6[0.15,2.33]
Subtotal (95% CI) 53 53 14.37% 0.54[0.16,1.86]
Total events: 3 (Traditional sling), 6 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0.11, df=1(P=0.74); I2=0%  
Test for overall effect: Z=0.98(P=0.33)  
   
7.8.2 stress urinary incontinence (symptoms only)  
Albo 2007 37/265 38/255 85.63% 0.94[0.62,1.42]
Subtotal (95% CI) 265 255 85.63% 0.94[0.62,1.42]
Total events: 37 (Traditional sling), 38 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=0.3(P=0.76)  
   
7.8.3 mixed incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total (95% CI) 318 308 100% 0.88[0.59,1.31]
Total events: 40 (Traditional sling), 44 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0.76, df=2(P=0.68); I2=0%  
Test for overall effect: Z=0.64(P=0.53)  
Test for subgroup differences: Chi2=0.69, df=1 (P=0.41), I2=0%  
Favours sling 1000.01 100.1 1 Favours colposuspension
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Analysis 7.9.   Comparison 7 Traditional suburethral sling operation versus open abdominal retropubic
colposuspension, Outcome 9 Number of women with urinary incontinence aOer 5 years (clinician's observations).




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
7.9.1 urodynamic stress incontinence (only)  
Sand 2000 0/13 2/15 1.4% 0.23[0.01,4.37]
Subtotal (95% CI) 13 15 1.4% 0.23[0.01,4.37]
Total events: 0 (Traditional sling), 2 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.98(P=0.33)  
   
7.9.2 stress urinary incontinence (symptoms only)  
Albo 2007 153/221 161/212 98.6% 0.91[0.81,1.02]
Subtotal (95% CI) 221 212 98.6% 0.91[0.81,1.02]
Total events: 153 (Traditional sling), 161 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=1.56(P=0.12)  
   
7.9.3 mixed incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total (95% CI) 234 227 100% 0.9[0.8,1.01]
Total events: 153 (Traditional sling), 163 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0.86, df=1(P=0.35); I2=0%  
Test for overall effect: Z=1.73(P=0.08)  
Test for subgroup differences: Chi2=0.84, df=1 (P=0.36), I2=0%  
Favours sling 1000.01 100.1 1 Favours colposuspension
 
 
Analysis 7.10.   Comparison 7 Traditional suburethral sling operation versus open
abdominal retropubic colposuspension, Outcome 10 Duration of operation (minutes).
Study or subgroup Traditional sling Colposuspension Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
7.10.1 urodynamic stress incontinence (only)  
Demirci 2001 15 60.7 (8.6) 14 54.6 (9.3) 6.02[-0.52,12.56]
   
7.10.2 stress urinary incontinence (symptoms only)  
   
7.10.3 mixed incontinence  
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Analysis 7.11.   Comparison 7 Traditional suburethral sling operation versus open
abdominal retropubic colposuspension, Outcome 11 Length of hospital stay (days).
Study or subgroup Traditional sling Colposuspension Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
7.11.1 urodynamic stress incontinence (only)  
Demirci 2001 15 5.9 (1.4) 14 5.4 (1.3) 33.62% 0.51[-0.46,1.48]
Enzelsberger 1996 36 16 (3) 36 8 (2) 22.72% 8[6.82,9.18]
Sand 2000 17 5.1 (1.2) 19 5 (1.4) 43.66% 0.1[-0.75,0.95]
Subtotal *** 68   69   100% 2.03[1.47,2.59]
Heterogeneity: Tau2=0; Chi2=127.99, df=2(P<0.0001); I2=98.44%  
Test for overall effect: Z=7.1(P<0.0001)  
   
7.11.2 stress urinary incontinence (symptoms only)  
Subtotal *** 0   0   Not estimable
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
7.11.3 mixed incontinence  
Subtotal *** 0   0   Not estimable
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total *** 68   69   100% 2.03[1.47,2.59]
Heterogeneity: Tau2=0; Chi2=127.99, df=2(P<0.0001); I2=98.44%  
Test for overall effect: Z=7.1(P<0.0001)  
Test for subgroup differences: Not applicable  
Favours sling 105-10 -5 0 Favours colposuspension
 
 
Analysis 7.12.   Comparison 7 Traditional suburethral sling operation versus open
abdominal retropubic colposuspension, Outcome 12 Time to catheter removal (days).
Study or subgroup Traditional sling Colposuspension Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
7.12.1 urodynamic stress incontinence (only)  
Enzelsberger 1996 36 15 (3) 36 7 (2) 99.27% 8[6.82,9.18]
Sand 2000 17 23.3 (24.4) 19 13.8 (16.5) 0.73% 9.5[-4.27,23.27]
Subtotal *** 53   55   100% 8.01[6.84,9.18]
Heterogeneity: Tau2=0; Chi2=0.05, df=1(P=0.83); I2=0%  
Test for overall effect: Z=13.38(P<0.0001)  
   
7.12.2 stress urinary incontinence (symptoms only)  
Subtotal *** 0   0   Not estimable
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
7.12.3 mixed incontinence  
Subtotal *** 0   0   Not estimable
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total *** 53   55   100% 8.01[6.84,9.18]
Favours sling 2010-20 -10 0 Favours colposuspension
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Study or subgroup Traditional sling Colposuspension Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
Heterogeneity: Tau2=0; Chi2=0.05, df=1(P=0.83); I2=0%  
Test for overall effect: Z=13.38(P<0.0001)  
Test for subgroup differences: Not applicable  
Favours sling 2010-20 -10 0 Favours colposuspension
 
 
Analysis 7.14.   Comparison 7 Traditional suburethral sling operation versus open abdominal retropubic
colposuspension, Outcome 14 Number of women requiring treatment for pelvic organ prolapse.




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
7.14.1 urodynamic stress incontinence (only)  
Demirci 2001 0/17 2/17 20.09% 0.2[0.01,3.88]
Enzelsberger 1996 1/36 5/36 40.18% 0.2[0.02,1.63]
Subtotal (95% CI) 53 53 60.27% 0.2[0.04,1.11]
Total events: 1 (Traditional sling), 7 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0, df=1(P=1); I2=0%  
Test for overall effect: Z=1.84(P=0.07)  
   
7.14.2 stress urinary incontinence (symptoms only)  
Albo 2007 1/224 5/229 39.73% 0.2[0.02,1.74]
Subtotal (95% CI) 224 229 39.73% 0.2[0.02,1.74]
Total events: 1 (Traditional sling), 5 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.45(P=0.15)  
   
7.14.3 mixed incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total (95% CI) 277 282 100% 0.2[0.05,0.77]
Total events: 2 (Traditional sling), 12 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0, df=2(P=1); I2=0%  
Test for overall effect: Z=2.35(P=0.02)  
Test for subgroup differences: Chi2=0, df=1 (P=0.99), I2=0%  
Favours sling 5000.002 100.1 1 Favours colposuspension
 
 
Analysis 7.15.   Comparison 7 Traditional suburethral sling operation versus open
abdominal retropubic colposuspension, Outcome 15 Perioperative surgical complications.




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
7.15.1 urodynamic stress incontinence (only)  
Demirci 2001 2/15 1/14 2.7% 1.87[0.19,18.38]
Favours sling 1000.01 100.1 1 Favours colposuspension
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Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Enzelsberger 1996 3/36 4/36 10.44% 0.75[0.18,3.11]
Sand 2000 0/17 1/19 3.71% 0.37[0.02,8.53]
Subtotal (95% CI) 68 69 16.85% 0.85[0.28,2.52]
Total events: 5 (Traditional sling), 6 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0.75, df=2(P=0.69); I2=0%  
Test for overall effect: Z=0.3(P=0.76)  
   
7.15.2 stress urinary incontinence (symptoms only)  
Albo 2007 42/326 32/329 83.15% 1.32[0.86,2.04]
Subtotal (95% CI) 326 329 83.15% 1.32[0.86,2.04]
Total events: 42 (Traditional sling), 32 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.27(P=0.2)  
   
7.15.3 mixed incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total (95% CI) 394 398 100% 1.24[0.83,1.86]
Total events: 47 (Traditional sling), 38 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=1.26, df=3(P=0.74); I2=0%  
Test for overall effect: Z=1.06(P=0.29)  
Test for subgroup differences: Chi2=0.56, df=1 (P=0.45), I2=0%  
Favours sling 1000.01 100.1 1 Favours colposuspension
 
 
Analysis 7.16.   Comparison 7 Traditional suburethral sling operation versus
open abdominal retropubic colposuspension, Outcome 16 Bladder perforation.
Study or subgroup Traditional sling Colposuspension Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
7.16.1 urodynamic stress incontinence (only)  
   
7.16.2 stress urinary incontinence (symptoms only)  
Albo 2007 2/326 10/329 0.2[0.04,0.91]
   
7.16.3 mixed incontinence  




Analysis 7.17.   Comparison 7 Traditional suburethral sling operation versus open
abdominal retropubic colposuspension, Outcome 17 Urinary tract infection.
Study or subgroup Traditional sling Colposuspension Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
7.17.1 urodynamic stress incontinence (only)  
Favours sling 20.5 1.50.7 1 Favours colposuspen-
sion
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Study or subgroup Traditional sling Colposuspension Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
   
7.17.2 stress urinary incontinence (symptoms only)  
Albo 2007 247/326 166/329 1.5[1.33,1.7]
   
7.17.3 mixed incontinence  




Analysis 7.18.   Comparison 7 Traditional suburethral sling operation versus open abdominal
retropubic colposuspension, Outcome 18 Number of women with recurrent UTIs at > 5 years.
Study or subgroup Traditional sling Colposuspension Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
7.18.1 urodynamic stress incontinence (only)  
   
7.18.2 stress urinary incontinence (symptoms only)  
Albo 2007 21/224 21/229 1.02[0.57,1.82]
   
7.18.3 mixed incontinence  




Analysis 7.19.   Comparison 7 Traditional suburethral sling operation versus open abdominal
retropubic colposuspension, Outcome 19 Urinary urgency symptoms, urgency urinary incontinence.




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
7.19.1 urodynamic stress incontinence (only)  
Enzelsberger 1996 6/36 3/36 7.77% 2[0.54,7.39]
Subtotal (95% CI) 36 36 7.77% 2[0.54,7.39]
Total events: 6 (Traditional sling), 3 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.04(P=0.3)  
   
7.19.2 stress urinary incontinence (symptoms only)  
Albo 2007 36/224 36/229 92.23% 1.02[0.67,1.56]
Subtotal (95% CI) 224 229 92.23% 1.02[0.67,1.56]
Total events: 36 (Traditional sling), 36 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.1(P=0.92)  
   
7.19.3 mixed incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total (95% CI) 260 265 100% 1.1[0.74,1.64]
Favours sling 200.05 50.2 1 Favours colposuspension
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Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Total events: 42 (Traditional sling), 39 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0.92, df=1(P=0.34); I2=0%  
Test for overall effect: Z=0.46(P=0.65)  
Test for subgroup differences: Chi2=0.92, df=1 (P=0.34), I2=0%  
Favours sling 200.05 50.2 1 Favours colposuspension
 
 
Analysis 7.20.   Comparison 7 Traditional suburethral sling operation versus open abdominal
retropubic colposuspension, Outcome 20 Detrusor overactivity (urodynamic diagnosis).




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
7.20.1 urodynamic stress incontinence (only)  
Bai 2005 0/28 3/33 52.25% 0.17[0.01,3.11]
Demirci 2001 1/17 1/17 16.22% 1[0.07,14.72]
Enzelsberger 1996 3/36 1/36 16.22% 3[0.33,27.5]
Sand 2000 4/17 1/19 15.32% 4.47[0.55,36.19]
Subtotal (95% CI) 98 105 100% 1.42[0.52,3.87]
Total events: 8 (Traditional sling), 6 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=3.71, df=3(P=0.29); I2=19.23%  
Test for overall effect: Z=0.69(P=0.49)  
   
7.20.2 stress urinary incontinence (symptoms only)  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
7.20.3 mixed incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total (95% CI) 98 105 100% 1.42[0.52,3.87]
Total events: 8 (Traditional sling), 6 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=3.71, df=3(P=0.29); I2=19.23%  
Test for overall effect: Z=0.69(P=0.49)  
Test for subgroup differences: Not applicable  
Favours sling 5000.002 100.1 1 Favours colposuspension
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Analysis 7.21.   Comparison 7 Traditional suburethral sling operation versus open
abdominal retropubic colposuspension, Outcome 21 Voiding dysfunction aOer 3 months.




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
7.21.1 urodynamic stress incontinence (only)  
Bai 2005 2/28 1/33 9.8% 2.36[0.23,24.64]
Demirci 2001 0/17 0/17   Not estimable
Enzelsberger 1996 5/36 1/36 10.67% 5[0.61,40.7]
Sand 2000 3/15 0/16 5.17% 7.44[0.42,132.95]
Subtotal (95% CI) 96 102 25.64% 4.48[1.16,17.36]
Total events: 10 (Traditional sling), 2 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0.42, df=2(P=0.81); I2=0%  
Test for overall effect: Z=2.17(P=0.03)  
   
7.21.2 stress urinary incontinence (symptoms only)  
Albo 2007 46/326 7/329 74.36% 6.63[3.04,14.47]
Subtotal (95% CI) 326 329 74.36% 6.63[3.04,14.47]
Total events: 46 (Traditional sling), 7 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=4.75(P<0.0001)  
   
7.21.3 mixed incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total (95% CI) 422 431 100% 6.08[3.1,11.95]
Total events: 56 (Traditional sling), 9 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0.73, df=3(P=0.87); I2=0%  
Test for overall effect: Z=5.24(P<0.0001)  
Test for subgroup differences: Chi2=0.24, df=1 (P=0.62), I2=0%  
Favours sling 10000.001 100.1 1 Favours colposuspension
 
 
Analysis 7.22.   Comparison 7 Traditional suburethral sling operation versus open abdominal
retropubic colposuspension, Outcome 22 Long-term voiding dysfunction > 5 years.
Study or subgroup Traditional sling Colposuspension Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
7.22.1 urodynamic stress incontinence (only)  
   
7.22.2 stress urinary incontinence (symptoms only)  
Albo 2007 7/224 1/229 7.16[0.89,57.69]
   
7.22.3 mixed incontinence  
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Analysis 7.23.   Comparison 7 Traditional suburethral sling operation versus open abdominal
retropubic colposuspension, Outcome 23 Condition-specific measures to assess quality of life.
Study or subgroup Traditional sling Colposuspension Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
7.23.1 Urinary Distress Index (UDI)  
Albo 2007 224 40.2 (45.8) 229 50.2 (50.9) -10[-18.91,-1.09]
   
7.23.2 Incontinence Impact Questionnaire (IIQ)  
Albo 2007 224 44.8 (79.6) 229 43.1 (68.2) 1.7[-11.96,15.36]




Comparison 9.   Traditional suburethral sling operation versus mid-urethral sling or tape





Statistical method Effect size
1 Number of continent women with-
in 1 year (any definition)
11 841 Odds Ratio (M-H, Fixed, 95% CI) 0.94 [0.67, 1.32]
1.1 urodynamic stress incontinence
(only)
5 427 Odds Ratio (M-H, Fixed, 95% CI) 0.97 [0.60, 1.56]
1.2 stress urinary incontinence
(symptoms only)
1 53 Odds Ratio (M-H, Fixed, 95% CI) 0.88 [0.12, 6.79]
1.3 mixed urinary incontinence 5 361 Odds Ratio (M-H, Fixed, 95% CI) 0.91 [0.55, 1.51]
2 Number of continent women at 1
to 5 years (any definition)
6 458 Odds Ratio (M-H, Fixed, 95% CI) 0.67 [0.44, 1.02]
2.1 urodynamic stress incontinence
(only)
4 364 Odds Ratio (M-H, Fixed, 95% CI) 0.77 [0.47, 1.25]
2.2 stress urinary incontinence
(symptoms only)
0 0 Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 mixed urinary incontinence 2 94 Odds Ratio (M-H, Fixed, 95% CI) 0.42 [0.17, 1.04]
3 Number of continent women after
5 years (any definition)
1   Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
3.1 urodynamic stress incontinence
(only)
1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 stress urinary incontinence
(symptoms only)
0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 mixed urinary incontinence 0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Repeat surgery for urinary inconti-
nence
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
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Statistical method Effect size
4.1 urodynamic stress incontinence
(only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 stress urinary incontinence
(symptoms only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Number of women cured after first
year (women's observations)
4 337 Odds Ratio (M-H, Fixed, 95% CI) 1.06 [0.65, 1.72]
5.1 urodynamic stress incontinence
(only)
3 293 Odds Ratio (M-H, Fixed, 95% CI) 1.21 [0.72, 2.03]
5.2 stress urinary incontinence
(symptoms only)
0 0 Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.3 mixed urinary incontinence 1 44 Odds Ratio (M-H, Fixed, 95% CI) 0.42 [0.10, 1.72]
6 Number of women improved or
cured within 1 year (women's obser-
vations)
3 425 Odds Ratio (M-H, Fixed, 95% CI) 1.33 [0.74, 2.39]
6.1 urodynamic stress incontinence
(only)
2 286 Odds Ratio (M-H, Fixed, 95% CI) 1.06 [0.43, 2.64]
6.2 stress urinary incontinence
(symptoms only)
0 0 Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 mixed urinary incontinence 1 139 Odds Ratio (M-H, Fixed, 95% CI) 1.56 [0.72, 3.39]
7 Number of women improved or
cured at 1 to 5 years (women's ob-
servations)
2 264 Odds Ratio (M-H, Fixed, 95% CI) 0.76 [0.31, 1.87]
7.1 urodynamic stress incontinence
(only)
2 264 Odds Ratio (M-H, Fixed, 95% CI) 0.76 [0.31, 1.87]
7.2 stress urinary incontinence
(symptoms only)
0 0 Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.3 mixed urinary incontinence 0 0 Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8 Number of women improved or
cured after 5 years (women's obser-
vations)
1   Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
8.1 urodynamic stress incontinence
(only)
1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.2 stress urinary incontinence
(symptoms only)
0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.3 mixed urinary incontinence 0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Statistical method Effect size
9 Number of women satisfied
(women's observations)
2   Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
9.1 urodynamic stress incontinence
(only)
2 163 Risk Ratio (M-H, Fixed, 95% CI) 1.09 [0.89, 1.33]
9.2 stress urinary incontinence
(symptoms only)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.3 mixed urinary incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
10 Pad test of quantified leakage
(mean weight of urine lost)
1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
10.1 urodynamic stress inconti-
nence (only)
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
10.2 stress urinary incontinence
(symptoms only)
0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
10.3 mixed urinary incontinence 0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
11 Number of women with urinary
incontinence within first year (clini-
cian's observations)
2 105 Risk Ratio (M-H, Fixed, 95% CI) 1.29 [0.45, 3.71]
11.1 urodynamic stress inconti-
nence (only)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
11.2 stress urinary incontinence
(symptoms only)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
11.3 mixed urinary incontinence 2 105 Risk Ratio (M-H, Fixed, 95% CI) 1.29 [0.45, 3.71]
12 Number of women with urinary
incontinence at 1 to 5 years (any de-
finition) (clinician's observations)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
12.1 urodynamic stress inconti-
nence (only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
12.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
12.3 mixed urinary incontinence 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
13 Duration of operation (minutes) 7 355 Mean Difference (IV, Fixed, 95% CI) 57.08 [54.67, 59.49]
13.1 urodynamic stress inconti-
nence (only)
2 61 Mean Difference (IV, Fixed, 95% CI) 46.91 [42.31, 51.52]
13.2 stress urinary incontinence
(symptoms only)
1 53 Mean Difference (IV, Fixed, 95% CI) 20.0 [7.08, 32.92]
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Statistical method Effect size
13.3 mixed urinary incontinence 4 241 Mean Difference (IV, Fixed, 95% CI) 62.96 [60.07, 65.86]
14 Length of hospital stay (days) 4 194 Mean Difference (IV, Fixed, 95% CI) 0.74 [0.55, 0.93]
14.1 urodynamic stress inconti-
nence (only)
1 20 Mean Difference (IV, Fixed, 95% CI) 0.65 [0.39, 0.91]
14.2 stress urinary incontinence
(symptoms only)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
14.3 mixed urinary incontinence 3 174 Mean Difference (IV, Fixed, 95% CI) 0.83 [0.56, 1.10]
15 Time to catheter removal (days) 2 113 Mean Difference (IV, Fixed, 95% CI) 0.11 [-0.07, 0.30]
15.1 urodynamic stress inconti-
nence (only)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
15.2 stress urinary incontinence
(symptoms only)
1 53 Mean Difference (IV, Fixed, 95% CI) 2.3 [0.01, 4.59]
15.3 mixed urinary incontinence 1 60 Mean Difference (IV, Fixed, 95% CI) 0.10 [-0.09, 0.29]
16 Perioperative surgical complica-
tions
4 293 Risk Ratio (M-H, Fixed, 95% CI) 1.74 [1.16, 2.60]
16.1 urodynamic stress inconti-
nence (only)
2 183 Risk Ratio (M-H, Fixed, 95% CI) 1.73 [1.01, 2.96]
16.2 stress urinary incontinence
(symptoms only)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
16.3 mixed urinary incontinence 2 110 Risk Ratio (M-H, Fixed, 95% CI) 1.74 [0.94, 3.21]
17 Bladder perforations 10 844 Risk Ratio (M-H, Fixed, 95% CI) 0.59 [0.34, 1.01]
17.1 urodynamic stress inconti-
nence (only)
3 334 Risk Ratio (M-H, Fixed, 95% CI) 0.74 [0.19, 2.86]
17.2 stress urinary incontinence
(symptoms only)
1 53 Risk Ratio (M-H, Fixed, 95% CI) 0.56 [0.05, 5.81]
17.3 mixed urinary incontinence 6 457 Risk Ratio (M-H, Fixed, 95% CI) 0.56 [0.30, 1.03]
18 Urethral injury 1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
18.1 urodynamic stress inconti-
nence (only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.3 mixed urinary incontinence 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19 Vaginal bleeding 1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
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Statistical method Effect size
19.1 urodynamic stress inconti-
nence (only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19.3 mixed urinary incontinence 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
20 Urinary tract infection 1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
20.1 urodynamic stress inconti-
nence (only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
20.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
20.3 mixed urinary incontinence 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
21 Voiding dysfunction 8 629 Risk Ratio (M-H, Fixed, 95% CI) 1.34 [0.85, 2.12]
21.1 urodynamic stress inconti-
nence (only)
3 325 Risk Ratio (M-H, Fixed, 95% CI) 1.22 [0.60, 2.46]
21.2 stress urinary incontinence
(symptoms only)
1 53 Risk Ratio (M-H, Fixed, 95% CI) 2.61 [0.76, 9.03]
21.3 mixed urinary incontinence 4 251 Risk Ratio (M-H, Fixed, 95% CI) 1.18 [0.58, 2.40]
22 Urinary urgency symptoms, ur-
gency urinary incontinence
4 295 Risk Ratio (M-H, Fixed, 95% CI) 1.50 [0.58, 3.88]
22.1 urodynamic stress inconti-
nence (only)
1 124 Risk Ratio (M-H, Fixed, 95% CI) 0.34 [0.01, 8.29]
22.2 stress urinary incontinence
(symptoms only)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
22.3 mixed urinary incontinence 3 171 Risk Ratio (M-H, Fixed, 95% CI) 1.81 [0.65, 5.06]
23 De novo detrusor overactivity
(urodynamic diagnosis)
4 325 Risk Ratio (M-H, Fixed, 95% CI) 2.61 [1.17, 5.84]
23.1 urodynamic stress inconti-
nence (only)
1 59 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
23.2 stress urinary incontinence
(symptoms only)
1 47 Risk Ratio (M-H, Fixed, 95% CI) 3.13 [0.13, 73.01]
23.3 mixed urinary incontinence 2 219 Risk Ratio (M-H, Fixed, 95% CI) 2.57 [1.12, 5.92]
24 Long-term adverse effects (re-
lease of sling required)
3 326 Risk Ratio (M-H, Fixed, 95% CI) 2.53 [0.87, 7.35]
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Statistical method Effect size
24.1 urodynamic stress inconti-
nence (only)
2 266 Risk Ratio (M-H, Fixed, 95% CI) 1.68 [0.50, 5.66]
24.2 stress urinary incontinence
(symptoms only)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
24.3 mixed urinary incontinence 1 60 Risk Ratio (M-H, Fixed, 95% CI) 9.6 [0.54, 170.84]
25 Long-term adverse effects
(wound pain at 6 months)
3 257 Risk Ratio (M-H, Fixed, 95% CI) 6.40 [1.94, 21.12]
25.1 urodynamic stress inconti-
nence (only)
1 124 Risk Ratio (M-H, Fixed, 95% CI) 5.16 [0.25, 105.36]
25.2 stress urinary incontinence
(symptoms only)
1 53 Risk Ratio (M-H, Fixed, 95% CI) 3.92 [0.90, 17.15]
25.3 mixed urinary incontinence 1 80 Risk Ratio (M-H, Fixed, 95% CI) 17.0 [1.01, 284.96]
26 Long-term adverse effects (vagi-
nal mesh or graE exposure)
5 348 Risk Ratio (M-H, Fixed, 95% CI) 0.28 [0.05, 1.65]
26.1 urodynamic stress inconti-
nence (only)
2 165 Risk Ratio (M-H, Fixed, 95% CI) 0.35 [0.04, 3.24]
26.2 stress urinary incontinence
(symptoms only)
1 53 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
26.3 mixed urinary incontinence 2 130 Risk Ratio (M-H, Fixed, 95% CI) 0.2 [0.01, 3.97]
27 Condition-specific measures to
assess quality of life: UDI-6
1 63 Mean Difference (IV, Fixed, 95% CI) 7.30 [-2.00, 16.60]
27.1 urodynamic stress inconti-
nence (only)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
27.2 stress urinary incontinence
(symptoms only)
1 63 Mean Difference (IV, Fixed, 95% CI) 7.30 [-2.00, 16.60]
27.3 mixed urinary incontinence 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
28 Condition-specific measures to
assess quality of life: IIQ-7
1 63 Mean Difference (IV, Fixed, 95% CI) 0.60 [-10.17, 11.37]
28.1 urodynamic stress inconti-
nence (only)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
28.2 stress urinary incontinence
(symptoms only)
1 63 Mean Difference (IV, Fixed, 95% CI) 0.60 [-10.17, 11.37]
28.3 mixed urinary incontinence 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Analysis 9.1.   Comparison 9 Traditional suburethral sling operation versus mid-urethral
sling or tape, Outcome 1 Number of continent women within 1 year (any definition).




Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
9.1.1 urodynamic stress incontinence (only)  
Amaro 2007 12/21 14/20 9.02% 0.57[0.16,2.07]
Arunkalaivanan 2003 66/74 58/68 9.59% 1.42[0.53,3.84]
Bai 2005 26/28 29/31 2.89% 0.9[0.12,6.83]
Guerrero 2008 35/73 36/71 27.89% 0.9[0.47,1.72]
Tcherniakovsky 2009 19/20 19/21 1.36% 2[0.17,23.96]
Subtotal (95% CI) 216 211 50.75% 0.97[0.6,1.56]
Total events: 158 (Traditional sling), 156 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=1.61, df=4(P=0.81); I2=0%  
Test for overall effect: Z=0.14(P=0.89)  
   
9.1.2 stress urinary incontinence (symptoms only)  
Wadie 2005 23/25 26/28 2.88% 0.88[0.12,6.79]
Subtotal (95% CI) 25 28 2.88% 0.88[0.12,6.79]
Total events: 23 (Traditional sling), 26 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.12(P=0.91)  
   
9.1.3 mixed urinary incontinence  
Basok 2008 35/67 34/72 22.98% 1.22[0.63,2.38]
Kondo 2006 19/21 21/23 2.8% 0.9[0.12,7.07]
Sharifiaghdas 2008 30/36 22/25 6.35% 0.68[0.15,3.03]
Song 2004 18/19 45/48 1.97% 1.2[0.12,12.31]
Zargham 2013 14/25 19/25 12.27% 0.4[0.12,1.35]
Subtotal (95% CI) 168 193 46.37% 0.91[0.55,1.51]
Total events: 116 (Traditional sling), 141 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=2.7, df=4(P=0.61); I2=0%  
Test for overall effect: Z=0.36(P=0.72)  
   
Total (95% CI) 409 432 100% 0.94[0.67,1.32]
Total events: 297 (Traditional sling), 323 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=4.33, df=10(P=0.93); I2=0%  
Test for overall effect: Z=0.36(P=0.72)  
Test for subgroup differences: Chi2=0.03, df=1 (P=0.98), I2=0%  
Favours mid-urethral 500.02 100.1 1 Favours traditional
 
 
Analysis 9.2.   Comparison 9 Traditional suburethral sling operation versus mid-urethral
sling or tape, Outcome 2 Number of continent women at 1 to 5 years (any definition).




Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
9.2.1 urodynamic stress incontinence (only)  
Amaro 2007 12/21 13/20 11.04% 0.72[0.2,2.53]
Arunkalaivanan 2003 56/68 53/60 19.21% 0.62[0.23,1.68]
Bai 2005 26/28 27/31 3.54% 1.93[0.32,11.43]
Favours mid-urethral 500.02 100.1 1 Favours traditional
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Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Guerrero 2008 32/67 38/69 37.82% 0.75[0.38,1.46]
Subtotal (95% CI) 184 180 71.61% 0.77[0.47,1.25]
Total events: 126 (Traditional sling), 131 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=1.23, df=3(P=0.75); I2=0%  
Test for overall effect: Z=1.08(P=0.28)  
   
9.2.2 stress urinary incontinence (symptoms only)  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
9.2.3 mixed urinary incontinence  
Kondo 2006 14/21 19/23 11.69% 0.42[0.1,1.72]
Zargham 2013 13/25 18/25 16.71% 0.42[0.13,1.36]
Subtotal (95% CI) 46 48 28.39% 0.42[0.17,1.04]
Total events: 27 (Traditional sling), 37 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=0, df=1(P=1); I2=0%  
Test for overall effect: Z=1.88(P=0.06)  
   
Total (95% CI) 230 228 100% 0.67[0.44,1.02]
Total events: 153 (Traditional sling), 168 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=2.5, df=5(P=0.78); I2=0%  
Test for overall effect: Z=1.85(P=0.06)  
Test for subgroup differences: Chi2=1.3, df=1 (P=0.25), I2=23.22%  
Favours mid-urethral 500.02 100.1 1 Favours traditional
 
 
Analysis 9.3.   Comparison 9 Traditional suburethral sling operation versus mid-urethral
sling or tape, Outcome 3 Number of continent women aOer 5 years (any definition).
Study or subgroup Traditional sling Mid-urethral sling Odds Ratio Odds Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
9.3.1 urodynamic stress incontinence (only)  
Guerrero 2008 31/61 20/63 2.22[1.07,4.61]
   
9.3.2 stress urinary incontinence (symptoms only)  
   
9.3.3 mixed urinary incontinence  
Favours mid-urethral 200.05 50.2 1 Favours traditional
 
 
Analysis 9.4.   Comparison 9 Traditional suburethral sling operation versus mid-
urethral sling or tape, Outcome 4 Repeat surgery for urinary incontinence.
Study or subgroup Traditional sling Mid-urethral sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
9.4.1 urodynamic stress incontinence (only)  
Favours traditional 2000.005 100.1 1 Favours mid-urethral
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Study or subgroup Traditional sling Mid-urethral sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
Guerrero 2008 0/67 0/69 Not estimable
   
9.4.2 stress urinary incontinence (symptoms only)  
Guerrero 2008 0/61 2/63 0.21[0.01,4.21]
   
9.4.3 mixed incontinence  
Favours traditional 2000.005 100.1 1 Favours mid-urethral
 
 
Analysis 9.5.   Comparison 9 Traditional suburethral sling operation versus mid-urethral
sling or tape, Outcome 5 Number of women cured aOer first year (women's observations).




Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
9.5.1 urodynamic stress incontinence (only)  
Amaro 2007 12/21 14/20 19.32% 0.57[0.16,2.07]
Arunkalaivanan 2003 56/68 53/60 31.24% 0.62[0.23,1.68]
Guerrero 2008 31/61 20/63 30.43% 2.22[1.07,4.61]
Subtotal (95% CI) 150 143 80.99% 1.21[0.72,2.03]
Total events: 99 (Traditional sling), 87 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=5.69, df=2(P=0.06); I2=64.86%  
Test for overall effect: Z=0.71(P=0.48)  
   
9.5.2 stress urinary incontinence (symptoms only)  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
9.5.3 mixed urinary incontinence  
Kondo 2006 14/21 19/23 19.01% 0.42[0.1,1.72]
Subtotal (95% CI) 21 23 19.01% 0.42[0.1,1.72]
Total events: 14 (Traditional sling), 19 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.2(P=0.23)  
   
Total (95% CI) 171 166 100% 1.06[0.65,1.72]
Total events: 113 (Traditional sling), 106 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=7.59, df=3(P=0.06); I2=60.49%  
Test for overall effect: Z=0.23(P=0.82)  
Test for subgroup differences: Chi2=1.89, df=1 (P=0.17), I2=47.18%  
Favours mid-urethral 200.05 50.2 1 Favours traditional
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Analysis 9.6.   Comparison 9 Traditional suburethral sling operation versus mid-urethral sling or
tape, Outcome 6 Number of women improved or cured within 1 year (women's observations).




Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
9.6.1 urodynamic stress incontinence (only)  
Arunkalaivanan 2003 68/74 64/68 28.03% 0.71[0.19,2.63]
Guerrero 2008 69/73 65/71 18.72% 1.59[0.43,5.9]
Subtotal (95% CI) 147 139 46.75% 1.06[0.43,2.64]
Total events: 137 (Traditional sling), 129 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=0.73, df=1(P=0.39); I2=0%  
Test for overall effect: Z=0.13(P=0.9)  
   
9.6.2 stress urinary incontinence (symptoms only)  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
9.6.3 mixed urinary incontinence  
Basok 2008 53/67 51/72 53.25% 1.56[0.72,3.39]
Subtotal (95% CI) 67 72 53.25% 1.56[0.72,3.39]
Total events: 53 (Traditional sling), 51 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=1.12(P=0.26)  
   
Total (95% CI) 214 211 100% 1.33[0.74,2.39]
Total events: 190 (Traditional sling), 180 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=1.12, df=2(P=0.57); I2=0%  
Test for overall effect: Z=0.94(P=0.35)  
Test for subgroup differences: Chi2=0.39, df=1 (P=0.53), I2=0%  
Favours mid-urethral 100.1 50.2 20.5 1 Favours traditional
 
 
Analysis 9.7.   Comparison 9 Traditional suburethral sling operation versus mid-urethral sling or
tape, Outcome 7 Number of women improved or cured at 1 to 5 years (women's observations).




Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
9.7.1 urodynamic stress incontinence (only)  
Arunkalaivanan 2003 63/68 56/60 39.91% 0.9[0.23,3.52]
Guerrero 2008 60/67 64/69 60.09% 0.67[0.2,2.22]
Subtotal (95% CI) 135 129 100% 0.76[0.31,1.87]
Total events: 123 (Traditional sling), 120 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=0.1, df=1(P=0.75); I2=0%  
Test for overall effect: Z=0.59(P=0.55)  
   
9.7.2 stress urinary incontinence (symptoms only)  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Favours mid-urethral 100.1 50.2 20.5 1 Favours traditional
Traditional suburethral sling operations for urinary incontinence in women (Review)
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Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Test for overall effect: Not applicable  
   
9.7.3 mixed urinary incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total (95% CI) 135 129 100% 0.76[0.31,1.87]
Total events: 123 (Traditional sling), 120 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=0.1, df=1(P=0.75); I2=0%  
Test for overall effect: Z=0.59(P=0.55)  
Test for subgroup differences: Not applicable  
Favours mid-urethral 100.1 50.2 20.5 1 Favours traditional
 
 
Analysis 9.8.   Comparison 9 Traditional suburethral sling operation versus mid-urethral sling
or tape, Outcome 8 Number of women improved or cured aOer 5 years (women's observations).
Study or subgroup Traditional sling Mid-urethral sling Odds Ratio Odds Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
9.8.1 urodynamic stress incontinence (only)  
Guerrero 2008 46/61 46/63 1.13[0.51,2.54]
   
9.8.2 stress urinary incontinence (symptoms only)  
   
9.8.3 mixed urinary incontinence  
Favours mid-urethral 200.05 50.2 1 Favours traditional
 
 
Analysis 9.9.   Comparison 9 Traditional suburethral sling operation versus mid-
urethral sling or tape, Outcome 9 Number of women satisfied (women's observations).




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
9.9.1 urodynamic stress incontinence (only)  
Amaro 2007 16/20 11/19 20.67% 1.38[0.89,2.15]
Guerrero 2008 43/61 44/63 79.33% 1.01[0.8,1.27]
Subtotal (95% CI) 81 82 100% 1.09[0.89,1.33]
Total events: 59 (Traditional sling), 55 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=1.53, df=1(P=0.22); I2=34.82%  
Test for overall effect: Z=0.8(P=0.43)  
   
9.9.2 stress urinary incontinence (symptoms only)  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Favours mid-urethral 2000.005 100.1 1 Favours traditional
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Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Test for overall effect: Not applicable  
   
9.9.3 mixed urinary incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours mid-urethral 2000.005 100.1 1 Favours traditional
 
 
Analysis 9.10.   Comparison 9 Traditional suburethral sling operation versus mid-urethral
sling or tape, Outcome 10 Pad test of quantified leakage (mean weight of urine lost).
Study or subgroup Traditional sling Mid-urethral sling Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
9.10.1 urodynamic stress incontinence (only)  
Silva Filho 2006 10 8.4 (16.4) 10 39.4 (39.5) -31[-57.53,-4.47]
   
9.10.2 stress urinary incontinence (symptoms only)  
   
9.10.3 mixed urinary incontinence  
Favours traditional 5025-50 -25 0 Favours mid-urethral
 
 
Analysis 9.11.   Comparison 9 Traditional suburethral sling operation versus mid-urethral sling or tape,
Outcome 11 Number of women with urinary incontinence within first year (clinician's observations).




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
9.11.1 urodynamic stress incontinence (only)  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
9.11.2 stress urinary incontinence (symptoms only)  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
9.11.3 mixed urinary incontinence  
Kondo 2006 2/21 2/23 35.03% 1.1[0.17,7.1]
Sharifiaghdas 2008 6/36 3/25 64.97% 1.39[0.38,5.04]
Subtotal (95% CI) 57 48 100% 1.29[0.45,3.71]
Total events: 8 (Traditional sling), 5 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=0.04, df=1(P=0.84); I2=0%  
Favours traditional 100.1 50.2 20.5 1 Favours mid-urethral
Traditional suburethral sling operations for urinary incontinence in women (Review)
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Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Test for overall effect: Z=0.47(P=0.64)  
   
Total (95% CI) 57 48 100% 1.29[0.45,3.71]
Total events: 8 (Traditional sling), 5 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=0.04, df=1(P=0.84); I2=0%  
Test for overall effect: Z=0.47(P=0.64)  
Test for subgroup differences: Not applicable  
Favours traditional 100.1 50.2 20.5 1 Favours mid-urethral
 
 
Analysis 9.12.   Comparison 9 Traditional suburethral sling operation versus mid-urethral sling or tape, Outcome
12 Number of women with urinary incontinence at 1 to 5 years (any definition) (clinician's observations).
Study or subgroup Traditional sling Mid-urethral sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
9.12.1 urodynamic stress incontinence (only)  
   
9.12.2 stress urinary incontinence (symptoms only)  
   
9.12.3 mixed urinary incontinence  
Kondo 2006 11/21 7/23 1.72[0.82,3.61]
Favours traditional 100.1 50.2 20.5 1 Favours mid-urethral
 
 
Analysis 9.13.   Comparison 9 Traditional suburethral sling operation versus
mid-urethral sling or tape, Outcome 13 Duration of operation (minutes).
Study or subgroup Traditional sling Mid-urethral sling Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
9.13.1 urodynamic stress incontinence (only)  
Silva Filho 2006 10 69.5 (74.9) 10 21.1 (12) 0.26% 48.4[1.39,95.41]
Tcherniakovsky 2009 20 59.7 (10.3) 21 12.8 (2.4) 27.08% 46.9[42.27,51.53]
Subtotal *** 30   31   27.34% 46.91[42.31,51.52]
Heterogeneity: Tau2=0; Chi2=0, df=1(P=0.95); I2=0%  
Test for overall effect: Z=19.96(P<0.0001)  
   
9.13.2 stress urinary incontinence (symptoms only)  
Wadie 2005 25 68 (23) 28 48 (25) 3.47% 20[7.08,32.92]
Subtotal *** 25   28   3.47% 20[7.08,32.92]
Heterogeneity: Not applicable  
Test for overall effect: Z=3.03(P=0)  
   
9.13.3 mixed urinary incontinence  
Al-Azzawi 2014 40 80 (11.1) 40 20 (4.4) 42.22% 60[56.29,63.71]
Kondo 2006 21 87.1 (13.3) 23 43.9 (17.3) 7.05% 43.2[34.13,52.27]
Song 2004 19 125 (13) 48 27 (5) 16.05% 98[91.99,104.01]
Zargham 2013 25 42 (20) 25 56 (24) 3.87% -14[-26.25,-1.75]
Subtotal *** 105   136   69.18% 62.96[60.07,65.86]
Favours traditional 10050-100 -50 0 Favours mid-urethral
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Study or subgroup Traditional sling Mid-urethral sling Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
Heterogeneity: Tau2=0; Chi2=302.78, df=3(P<0.0001); I2=99.01%  
Test for overall effect: Z=42.61(P<0.0001)  
   
Total *** 160   195   100% 57.08[54.67,59.49]
Heterogeneity: Tau2=0; Chi2=368.95, df=6(P<0.0001); I2=98.37%  
Test for overall effect: Z=46.44(P<0.0001)  
Test for subgroup differences: Chi2=66.17, df=1 (P<0.0001), I2=96.98%  
Favours traditional 10050-100 -50 0 Favours mid-urethral
 
 
Analysis 9.14.   Comparison 9 Traditional suburethral sling operation versus
mid-urethral sling or tape, Outcome 14 Length of hospital stay (days).
Study or subgroup Traditional sling Mid-urethral sling Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
9.14.1 urodynamic stress incontinence (only)  
Silva Filho 2006 10 1.9 (0.2) 10 1.2 (0.4) 51.03% 0.65[0.39,0.91]
Subtotal *** 10   10   51.03% 0.65[0.39,0.91]
Heterogeneity: Not applicable  
Test for overall effect: Z=4.84(P<0.0001)  
   
9.14.2 stress urinary incontinence (symptoms only)  
Subtotal *** 0   0   Not estimable
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
9.14.3 mixed urinary incontinence  
Al-Azzawi 2014 40 2.8 (1.3) 40 1.2 (0.4) 18.73% 1.6[1.17,2.03]
Kondo 2006 21 9.2 (0.9) 23 9.2 (0.6) 16.95% 0[-0.46,0.46]
Zargham 2013 25 2.9 (0.9) 25 2.1 (0.9) 13.28% 0.81[0.29,1.33]
Subtotal *** 86   88   48.97% 0.83[0.56,1.1]
Heterogeneity: Tau2=0; Chi2=24.79, df=2(P<0.0001); I2=91.93%  
Test for overall effect: Z=6.07(P<0.0001)  
   
Total *** 96   98   100% 0.74[0.55,0.93]
Heterogeneity: Tau2=0; Chi2=25.69, df=3(P<0.0001); I2=88.32%  
Test for overall effect: Z=7.71(P<0.0001)  
Test for subgroup differences: Chi2=0.9, df=1 (P=0.34), I2=0%  
Favours traditional 21-2 -1 0 Favours mid-urethral
 
 
Analysis 9.15.   Comparison 9 Traditional suburethral sling operation versus
mid-urethral sling or tape, Outcome 15 Time to catheter removal (days).
Study or subgroup Traditional sling Mid-urethral sling Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
9.15.1 urodynamic stress incontinence (only)  
Subtotal *** 0   0   Not estimable
Heterogeneity: Not applicable  
Favours traditional 42-4 -2 0 Favours mid-urethral
Traditional suburethral sling operations for urinary incontinence in women (Review)
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Study or subgroup Traditional sling Mid-urethral sling Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
Test for overall effect: Not applicable  
   
9.15.2 stress urinary incontinence (symptoms only)  
Wadie 2005 25 6.6 (5.3) 28 4.3 (2.6) 0.65% 2.3[0.01,4.59]
Subtotal *** 25   28   0.65% 2.3[0.01,4.59]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.97(P=0.05)  
   
9.15.3 mixed urinary incontinence  
Kondo 2006 29 1.4 (0.5) 31 1.3 (0.1) 99.35% 0.1[-0.09,0.29]
Subtotal *** 29   31   99.35% 0.1[-0.09,0.29]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.06(P=0.29)  
   
Total *** 54   59   100% 0.11[-0.07,0.3]
Heterogeneity: Tau2=0; Chi2=3.52, df=1(P=0.06); I2=71.61%  
Test for overall effect: Z=1.21(P=0.23)  
Test for subgroup differences: Chi2=3.52, df=1 (P=0.06), I2=71.61%  
Favours traditional 42-4 -2 0 Favours mid-urethral
 
 
Analysis 9.16.   Comparison 9 Traditional suburethral sling operation versus
mid-urethral sling or tape, Outcome 16 Perioperative surgical complications.




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
9.16.1 urodynamic stress incontinence (only)  
Arunkalaivanan 2003 17/74 13/68 48.09% 1.2[0.63,2.29]
Tcherniakovsky 2009 12/20 3/21 10.39% 4.2[1.39,12.71]
Subtotal (95% CI) 94 89 58.48% 1.73[1.01,2.96]
Total events: 29 (Traditional sling), 16 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=3.7, df=1(P=0.05); I2=73%  
Test for overall effect: Z=2.01(P=0.04)  
   
9.16.2 stress urinary incontinence (symptoms only)  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
9.16.3 mixed urinary incontinence  
Kondo 2006 11/29 9/31 30.88% 1.31[0.64,2.69]
Zargham 2013 9/25 3/25 10.65% 3[0.92,9.79]
Subtotal (95% CI) 54 56 41.52% 1.74[0.94,3.21]
Total events: 20 (Traditional sling), 12 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=1.42, df=1(P=0.23); I2=29.66%  
Test for overall effect: Z=1.78(P=0.08)  
   
Total (95% CI) 148 145 100% 1.74[1.16,2.6]
Favours traditional 2000.005 100.1 1 Favours mid-urethral
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Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Total events: 49 (Traditional sling), 28 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=5.12, df=3(P=0.16); I2=41.46%  
Test for overall effect: Z=2.68(P=0.01)  
Test for subgroup differences: Chi2=0, df=1 (P=0.99), I2=0%  
Favours traditional 2000.005 100.1 1 Favours mid-urethral
 
 
Analysis 9.17.   Comparison 9 Traditional suburethral sling operation
versus mid-urethral sling or tape, Outcome 17 Bladder perforations.




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
9.17.1 urodynamic stress incontinence (only)  
Arunkalaivanan 2003 0/74 0/68   Not estimable
Guerrero 2008 2/79 4/72 13.51% 0.46[0.09,2.41]
Tcherniakovsky 2009 1/20 0/21 1.58% 3.14[0.14,72.92]
Subtotal (95% CI) 173 161 15.08% 0.74[0.19,2.86]
Total events: 3 (Traditional sling), 4 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=1.14, df=1(P=0.29); I2=12.02%  
Test for overall effect: Z=0.44(P=0.66)  
   
9.17.2 stress urinary incontinence (symptoms only)  
Wadie 2005 1/25 2/28 6.09% 0.56[0.05,5.81]
Subtotal (95% CI) 25 28 6.09% 0.56[0.05,5.81]
Total events: 1 (Traditional sling), 2 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.49(P=0.63)  
   
9.17.3 mixed urinary incontinence  
Al-Azzawi 2014 0/40 0/40   Not estimable
Basok 2008 3/67 8/72 24.89% 0.4[0.11,1.46]
Kondo 2006 7/29 7/31 21.83% 1.07[0.43,2.67]
Sharifiaghdas 2008 2/36 6/25 22.85% 0.23[0.05,1.05]
Song 2004 0/19 1/48 2.81% 0.82[0.03,19.21]
Zargham 2013 1/25 2/25 6.45% 0.5[0.05,5.17]
Subtotal (95% CI) 216 241 78.83% 0.56[0.3,1.03]
Total events: 13 (Traditional sling), 24 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=3.53, df=4(P=0.47); I2=0%  
Test for overall effect: Z=1.86(P=0.06)  
   
Total (95% CI) 414 430 100% 0.59[0.34,1.01]
Total events: 17 (Traditional sling), 30 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=4.66, df=7(P=0.7); I2=0%  
Test for overall effect: Z=1.93(P=0.05)  
Test for subgroup differences: Chi2=0.13, df=1 (P=0.94), I2=0%  
Favours traditional 1000.01 100.1 1 Favours mid-urethral
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Analysis 9.18.   Comparison 9 Traditional suburethral sling operation
versus mid-urethral sling or tape, Outcome 18 Urethral injury.
Study or subgroup Traditional sling Mid-urethral sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
9.18.1 urodynamic stress incontinence (only)  
   
9.18.2 stress urinary incontinence (symptoms only)  
   
9.18.3 mixed urinary incontinence  
Kondo 2006 0/29 1/31 0.36[0.02,8.39]
Favours traditional 5000.002 100.1 1 Favours mid-urethral
 
 
Analysis 9.19.   Comparison 9 Traditional suburethral sling operation
versus mid-urethral sling or tape, Outcome 19 Vaginal bleeding.
Study or subgroup Traditional sling Mid-urethral sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
9.19.1 urodynamic stress incontinence (only)  
   
9.19.2 stress urinary incontinence (symptoms only)  
   
9.19.3 mixed urinary incontinence  
Zargham 2013 5/25 3/25 1.67[0.45,6.24]
Favours traditional 5000.002 100.1 1 Favours mid-urethral
 
 
Analysis 9.20.   Comparison 9 Traditional suburethral sling operation
versus mid-urethral sling or tape, Outcome 20 Urinary tract infection.
Study or subgroup Traditional sling Mid-urethral sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
9.20.1 urodynamic stress incontinence (only)  
   
9.20.2 stress urinary incontinence (symptoms only)  
   
9.20.3 mixed urinary incontinence  
Zargham 2013 3/25 3/25 1[0.22,4.49]
Favours traditional 5000.002 100.1 1 Favours mid-urethral
 
 
Analysis 9.21.   Comparison 9 Traditional suburethral sling operation
versus mid-urethral sling or tape, Outcome 21 Voiding dysfunction.




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
9.21.1 urodynamic stress incontinence (only)  
Arunkalaivanan 2003 8/74 6/68 22.16% 1.23[0.45,3.35]
Favours traditional 10000.001 100.1 1 Favours mid-urethral
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Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Bai 2005 2/28 4/31 13.45% 0.55[0.11,2.79]
Guerrero 2008 6/61 3/63 10.46% 2.07[0.54,7.89]
Subtotal (95% CI) 163 162 46.08% 1.22[0.6,2.46]
Total events: 16 (Traditional sling), 13 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=1.51, df=2(P=0.47); I2=0%  
Test for overall effect: Z=0.55(P=0.58)  
   
9.21.2 stress urinary incontinence (symptoms only)  
Wadie 2005 7/25 3/28 10.03% 2.61[0.76,9.03]
Subtotal (95% CI) 25 28 10.03% 2.61[0.76,9.03]
Total events: 7 (Traditional sling), 3 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.52(P=0.13)  
   
9.21.3 mixed urinary incontinence  
Al-Azzawi 2014 0/40 1/40 5.32% 0.33[0.01,7.95]
Kondo 2006 4/29 0/31 1.71% 9.6[0.54,170.84]
Sharifiaghdas 2008 11/36 5/25 20.91% 1.53[0.61,3.86]
Zargham 2013 0/25 4/25 15.95% 0.11[0.01,1.96]
Subtotal (95% CI) 130 121 43.89% 1.18[0.58,2.4]
Total events: 15 (Traditional sling), 10 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=5.54, df=3(P=0.14); I2=45.9%  
Test for overall effect: Z=0.47(P=0.64)  
   
Total (95% CI) 318 311 100% 1.34[0.85,2.12]
Total events: 38 (Traditional sling), 26 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=8.19, df=7(P=0.32); I2=14.53%  
Test for overall effect: Z=1.27(P=0.21)  
Test for subgroup differences: Chi2=1.3, df=1 (P=0.52), I2=0%  
Favours traditional 10000.001 100.1 1 Favours mid-urethral
 
 
Analysis 9.22.   Comparison 9 Traditional suburethral sling operation versus mid-urethral
sling or tape, Outcome 22 Urinary urgency symptoms, urgency urinary incontinence.




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
9.22.1 urodynamic stress incontinence (only)  
Guerrero 2008 0/61 1/63 20.82% 0.34[0.01,8.29]
Subtotal (95% CI) 61 63 20.82% 0.34[0.01,8.29]
Total events: 0 (Traditional sling), 1 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.66(P=0.51)  
   
9.22.2 stress urinary incontinence (symptoms only)  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours traditional 5000.002 100.1 1 Favours mid-urethral
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Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
   
9.22.3 mixed urinary incontinence  
Kondo 2006 3/29 2/31 27.27% 1.6[0.29,8.92]
Sharifiaghdas 2008 8/36 1/25 16.65% 5.56[0.74,41.68]
Zargham 2013 0/25 2/25 35.26% 0.2[0.01,3.97]
Subtotal (95% CI) 90 81 79.18% 1.81[0.65,5.06]
Total events: 11 (Traditional sling), 5 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=3.3, df=2(P=0.19); I2=39.35%  
Test for overall effect: Z=1.13(P=0.26)  
   
Total (95% CI) 151 144 100% 1.5[0.58,3.88]
Total events: 11 (Traditional sling), 6 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=4.2, df=3(P=0.24); I2=28.54%  
Test for overall effect: Z=0.85(P=0.4)  
Test for subgroup differences: Chi2=0.95, df=1 (P=0.33), I2=0%  
Favours traditional 5000.002 100.1 1 Favours mid-urethral
 
 
Analysis 9.23.   Comparison 9 Traditional suburethral sling operation versus mid-
urethral sling or tape, Outcome 23 De novo detrusor overactivity (urodynamic diagnosis).




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
9.23.1 urodynamic stress incontinence (only)  
Bai 2005 0/28 0/31   Not estimable
Subtotal (95% CI) 28 31 Not estimable
Total events: 0 (Traditional sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
9.23.2 stress urinary incontinence (symptoms only)  
Wadie 2005 1/23 0/24 6.7% 3.13[0.13,73.01]
Subtotal (95% CI) 23 24 6.7% 3.13[0.13,73.01]
Total events: 1 (Traditional sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.71(P=0.48)  
   
9.23.3 mixed urinary incontinence  
Al-Azzawi 2014 2/40 2/40 27.36% 1[0.15,6.76]
Basok 2008 15/67 5/72 65.94% 3.22[1.24,8.39]
Subtotal (95% CI) 107 112 93.3% 2.57[1.12,5.92]
Total events: 17 (Traditional sling), 7 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=1.15, df=1(P=0.28); I2=13.34%  
Test for overall effect: Z=2.22(P=0.03)  
   
Total (95% CI) 158 167 100% 2.61[1.17,5.84]
Total events: 18 (Traditional sling), 7 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=1.17, df=2(P=0.56); I2=0%  
Test for overall effect: Z=2.33(P=0.02)  
Favours traditional 1000.01 100.1 1 Favours mid-urethral
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Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Test for subgroup differences: Chi2=0.01, df=1 (P=0.91), I2=0%  
Favours traditional 1000.01 100.1 1 Favours mid-urethral
 
 
Analysis 9.24.   Comparison 9 Traditional suburethral sling operation versus mid-
urethral sling or tape, Outcome 24 Long-term adverse e@ects (release of sling required).




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
9.24.1 urodynamic stress incontinence (only)  
Arunkalaivanan 2003 5/74 2/68 45.95% 2.3[0.46,11.45]
Guerrero 2008 2/61 2/63 43.38% 1.03[0.15,7.1]
Subtotal (95% CI) 135 131 89.33% 1.68[0.5,5.66]
Total events: 7 (Traditional sling), 4 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=0.39, df=1(P=0.53); I2=0%  
Test for overall effect: Z=0.84(P=0.4)  
   
9.24.2 stress urinary incontinence (symptoms only)  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
9.24.3 mixed urinary incontinence  
Kondo 2006 4/29 0/31 10.67% 9.6[0.54,170.84]
Subtotal (95% CI) 29 31 10.67% 9.6[0.54,170.84]
Total events: 4 (Traditional sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.54(P=0.12)  
   
Total (95% CI) 164 162 100% 2.53[0.87,7.35]
Total events: 11 (Traditional sling), 4 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=1.67, df=2(P=0.43); I2=0%  
Test for overall effect: Z=1.7(P=0.09)  
Test for subgroup differences: Chi2=1.19, df=1 (P=0.27), I2=16.2%  
Favours traditional 2000.005 100.1 1 Favours mid-urethral
 
 
Analysis 9.25.   Comparison 9 Traditional suburethral sling operation versus mid-
urethral sling or tape, Outcome 25 Long-term adverse e@ects (wound pain at 6 months).




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
9.25.1 urodynamic stress incontinence (only)  
Guerrero 2008 2/61 0/63 17.09% 5.16[0.25,105.36]
Subtotal (95% CI) 61 63 17.09% 5.16[0.25,105.36]
Favours traditional 2000.005 100.1 1 Favours mid-urethral
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Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Total events: 2 (Traditional sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.07(P=0.29)  
   
9.25.2 stress urinary incontinence (symptoms only)  
Wadie 2005 7/25 2/28 65.54% 3.92[0.9,17.15]
Subtotal (95% CI) 25 28 65.54% 3.92[0.9,17.15]
Total events: 7 (Traditional sling), 2 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.81(P=0.07)  
   
9.25.3 mixed urinary incontinence  
Al-Azzawi 2014 8/40 0/40 17.37% 17[1.01,284.96]
Subtotal (95% CI) 40 40 17.37% 17[1.01,284.96]
Total events: 8 (Traditional sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.97(P=0.05)  
   
Total (95% CI) 126 131 100% 6.4[1.94,21.12]
Total events: 17 (Traditional sling), 2 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=0.91, df=2(P=0.64); I2=0%  
Test for overall effect: Z=3.05(P=0)  
Test for subgroup differences: Chi2=0.82, df=1 (P=0.66), I2=0%  
Favours traditional 2000.005 100.1 1 Favours mid-urethral
 
 
Analysis 9.26.   Comparison 9 Traditional suburethral sling operation versus mid-urethral
sling or tape, Outcome 26 Long-term adverse e@ects (vaginal mesh or graO exposure).




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
9.26.1 urodynamic stress incontinence (only)  
Guerrero 2008 0/61 1/63 27.13% 0.34[0.01,8.29]
Tcherniakovsky 2009 0/20 1/21 26.93% 0.35[0.02,8.1]
Subtotal (95% CI) 81 84 54.06% 0.35[0.04,3.24]
Total events: 0 (Traditional sling), 2 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=0, df=1(P=0.99); I2=0%  
Test for overall effect: Z=0.93(P=0.35)  
   
9.26.2 stress urinary incontinence (symptoms only)  
Wadie 2005 0/25 0/28   Not estimable
Subtotal (95% CI) 25 28 Not estimable
Total events: 0 (Traditional sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
9.26.3 mixed urinary incontinence  
Al-Azzawi 2014 0/40 0/40   Not estimable
Zargham 2013 0/25 2/25 45.94% 0.2[0.01,3.97]
Favours traditional 5000.002 100.1 1 Favours mid-urethral
Traditional suburethral sling operations for urinary incontinence in women (Review)









Cochrane Database of Systematic Reviews




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Subtotal (95% CI) 65 65 45.94% 0.2[0.01,3.97]
Total events: 0 (Traditional sling), 2 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.06(P=0.29)  
   
Total (95% CI) 171 177 100% 0.28[0.05,1.65]
Total events: 0 (Traditional sling), 4 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=0.08, df=2(P=0.96); I2=0%  
Test for overall effect: Z=1.41(P=0.16)  
Test for subgroup differences: Chi2=0.08, df=1 (P=0.77), I2=0%  
Favours traditional 5000.002 100.1 1 Favours mid-urethral
 
 
Analysis 9.27.   Comparison 9 Traditional suburethral sling operation versus mid-urethral
sling or tape, Outcome 27 Condition-specific measures to assess quality of life: UDI-6.
Study or subgroup Traditional sling Mid-urethral sling Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
9.27.1 urodynamic stress incontinence (only)  
Subtotal *** 0   0   Not estimable
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
9.27.2 stress urinary incontinence (symptoms only)  
Wadie 2005 39 31.7 (16.9) 24 24.4 (19.1) 100% 7.3[-2,16.6]
Subtotal *** 39   24   100% 7.3[-2,16.6]
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=1.54(P=0.12)  
   
9.27.3 mixed urinary incontinence  
Subtotal *** 0   0   Not estimable
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total *** 39   24   100% 7.3[-2,16.6]
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=1.54(P=0.12)  
Test for subgroup differences: Not applicable  
Favours traditional 10050-100 -50 0 Favours mid-urethral
 
 
Analysis 9.28.   Comparison 9 Traditional suburethral sling operation versus mid-urethral
sling or tape, Outcome 28 Condition-specific measures to assess quality of life: IIQ-7.
Study or subgroup Traditional sling Mid-urethral sling Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
9.28.1 urodynamic stress incontinence (only)  
Subtotal *** 0   0   Not estimable
Favours traditional 10050-100 -50 0 Favours mid-urethral
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Study or subgroup Traditional sling Mid-urethral sling Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
9.28.2 stress urinary incontinence (symptoms only)  
Wadie 2005 39 24.4 (20.5) 24 23.8 (21.6) 100% 0.6[-10.17,11.37]
Subtotal *** 39   24   100% 0.6[-10.17,11.37]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.11(P=0.91)  
   
9.28.3 mixed urinary incontinence  
Subtotal *** 0   0   Not estimable
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total *** 39   24   100% 0.6[-10.17,11.37]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.11(P=0.91)  
Test for subgroup differences: Not applicable  
Favours traditional 10050-100 -50 0 Favours mid-urethral
 
 
Comparison 10.   Traditional suburethral sling operation versus a single-incision sling (mini-sling)





Statistical method Effect size
1 Number of continent women at 1
to 5 years (any definition)
1   Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 urodynamic stress inconti-
nence (only)
1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 stress urinary incontinence
(symptoms only)
0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 mixed incontinence 0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Number of women cured after
first year (women's observations)
1   Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 urodynamic stress inconti-
nence (only)
1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 stress urinary incontinence
(symptoms only)
0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 mixed incontinence 0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Number of women satisfied
(women's observations)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
Traditional suburethral sling operations for urinary incontinence in women (Review)
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Statistical method Effect size
3.1 urodynamic stress inconti-
nence (only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Number of women with urinary
incontinence (clinician's observa-
tions) within first year
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
4.1 urodynamic stress inconti-
nence (only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Bladder perforation 1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
5.1 urodynamic stress inconti-
nence (only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Urinary urgency symptoms, ur-
gency urinary incontinence
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
6.1 urodynamic stress inconti-
nence (only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Pain with intercourse (dyspareu-
nia)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
7.1 urodynamic stress inconti-
nence (only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8 Long-term adverse effects (vagi-
nal mesh or graE exposure)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
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Statistical method Effect size
8.1 urodynamic stress inconti-
nence (only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9 Condition-specific measures to
assess quality of life: IIQ score
1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
9.1 urodynamic stress inconti-
nence (only)
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.2 stress urinary incontinence
(symptoms only)
0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.3 mixed urinary incontinence 0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
 
 
Analysis 10.1.   Comparison 10 Traditional suburethral sling operation versus a single-incision
sling (mini-sling), Outcome 1 Number of continent women at 1 to 5 years (any definition).
Study or subgroup Traditional sling Mini-sling Odds Ratio Odds Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
10.1.1 urodynamic stress incontinence (only)  
Sharifiaghdas 2015 31/35 31/35 1[0.23,4.36]
   
10.1.2 stress urinary incontinence (symptoms only)  
   
10.1.3 mixed incontinence  
Favours mini-sling 1000.01 100.1 1 Favours traditional sling
 
 
Analysis 10.2.   Comparison 10 Traditional suburethral sling operation versus a single-incision
sling (mini-sling), Outcome 2 Number of women cured aOer first year (women's observations).
Study or subgroup Traditional sling Mini-sling Odds Ratio Odds Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
10.2.1 urodynamic stress incontinence (only)  
Sharifiaghdas 2015 31/35 31/35 1[0.23,4.36]
   
10.2.2 stress urinary incontinence (symptoms only)  
   
10.2.3 mixed incontinence  
Favours mini-sling 1000.01 100.1 1 Favours traditional sling
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Analysis 10.3.   Comparison 10 Traditional suburethral sling operation versus a single-
incision sling (mini-sling), Outcome 3 Number of women satisfied (women's observations).
Study or subgroup Traditional sling Mini-sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
10.3.1 urodynamic stress incontinence (only)  
Sharifiaghdas 2015 25/35 28/35 0.89[0.68,1.17]
   
10.3.2 stress urinary incontinence (symptoms only)  
   
10.3.3 mixed incontinence  
Favours mini-sling 20.5 1.50.7 1 Favours traditional sling
 
 
Analysis 10.4.   Comparison 10 Traditional suburethral sling operation versus a single-incision sling (mini-
sling), Outcome 4 Number of women with urinary incontinence (clinician's observations) within first year.
Study or subgroup Traditional sling Mini-sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
10.4.1 urodynamic stress incontinence (only)  
Sharifiaghdas 2015 4/35 4/35 1[0.27,3.69]
   
10.4.2 stress urinary incontinence (symptoms only)  
   
10.4.3 mixed incontinence  
Favours traditional sling 10000.001 100.1 1 Favours mini-sling
 
 
Analysis 10.5.   Comparison 10 Traditional suburethral sling operation
versus a single-incision sling (mini-sling), Outcome 5 Bladder perforation.
Study or subgroup Traditional sling Mini-sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
10.5.1 urodynamic stress incontinence (only)  
Sharifiaghdas 2015 1/35 0/35 3[0.13,71.22]
   
10.5.2 stress urinary incontinence (symptoms only)  
   
10.5.3 mixed incontinence  
Favours traditional sling 10000.001 100.1 1 Favours mini-sling
 
 
Analysis 10.6.   Comparison 10 Traditional suburethral sling operation versus a single-incision
sling (mini-sling), Outcome 6 Urinary urgency symptoms, urgency urinary incontinence.
Study or subgroup Traditional sling Mini-sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
10.6.1 urodynamic stress incontinence (only)  
Sharifiaghdas 2015 5/35 1/35 5[0.62,40.64]
   
Favours traditional sling 1000.01 100.1 1 Favours mini-sling
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Study or subgroup Traditional sling Mini-sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
10.6.2 stress urinary incontinence (symptoms only)  
   
10.6.3 mixed incontinence  
Favours traditional sling 1000.01 100.1 1 Favours mini-sling
 
 
Analysis 10.7.   Comparison 10 Traditional suburethral sling operation versus a
single-incision sling (mini-sling), Outcome 7 Pain with intercourse (dyspareunia).
Study or subgroup Traditional sling Mini-sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
10.7.1 urodynamic stress incontinence (only)  
Sharifiaghdas 2015 3/35 4/35 0.75[0.18,3.11]
   
10.7.2 stress urinary incontinence (symptoms only)  
   
10.7.3 mixed incontinence  
Favours traditional sling 10000.001 100.1 1 Favours mini-sling
 
 
Analysis 10.8.   Comparison 10 Traditional suburethral sling operation versus a single-incision
sling (mini-sling), Outcome 8 Long-term adverse e@ects (vaginal mesh or graO exposure).
Study or subgroup Traditional sling Mini-sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
10.8.1 urodynamic stress incontinence (only)  
Sharifiaghdas 2015 1/35 2/35 0.5[0.05,5.27]
   
10.8.2 stress urinary incontinence (symptoms only)  
   
10.8.3 mixed incontinence  
Favours traditional sling 10000.001 100.1 1 Favours mini-sling
 
 
Analysis 10.9.   Comparison 10 Traditional suburethral sling operation versus a single-incision
sling (mini-sling), Outcome 9 Condition-specific measures to assess quality of life: IIQ score.
Study or subgroup Traditional sling Mini-sling Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
10.9.1 urodynamic stress incontinence (only)  
Sharifiaghdas 2015 35 50.2 (11.1) 35 42.7 (11.4) 7.5[2.23,12.77]
   
10.9.2 stress urinary incontinence (symptoms only)  
   
10.9.3 mixed urinary incontinence  
Favours traditional sling 5025-50 -25 0 Favours mini-sling
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Comparison 11.   One type of traditional sling operation versus another type of traditional sling operation





Statistical method Effect size
1 Number of continent women
within 1 year (any definition)
5   Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 fascial sling vs Pelvicol sling 1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 standard sling vs short sling 1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 autologous fascial sling vs Fort-
aperm sling
1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.4 Vypro vs Ultrapro 1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.5 Vypro vs Prolene light 1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.6 Ultrapro vs Prolene light 1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.7 fascial sling vs vaginal wall
sling
1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Number of continent women at 1
to 5 years (any definition)
7   Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 fascial sling vs Pelvicol sling 1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 standard sling vs short sling 1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 autologous dermal graE patch
vs cadaveric fascia lata
1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.4 rectus fascia sling vs Goretex
sling
1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.5 Vypro vs Ultrapro 1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.6 Vypro vs Prolene light 1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.7 Ultrapro vs Prolene light 1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.8 anterior vaginal wall sling vs
biosynthetic mesh sling
1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.9 anterior rectus sheath sling vs
Prolene strip
1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.10 anterior rectus sheath sling vs
anterior vaginal wall patch
1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.11 Prolene strip vs anterior vagi-
nal wall patch
1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Statistical method Effect size
3 Number of continent women af-
ter 5 years (any definition)
1   Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
3.1 standard sling vs short sling 1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Repeat surgery for urinary incon-
tinence
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
4.1 fascial sling vs Pelvicol sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Number of women cured after
first year (women's observations)
3   Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
5.1 fascial sling vs Pelvicol sling 1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 standard sling vs short sling 1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.3 autologous dermal graE patch
vs cadaveric fascia lata
1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Number of women improved or
cured within first year (women's
observations)
3   Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
6.1 fascial sling vs Pelvicol sling 1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 autologous fascial sling vs Fort-
aperm sling
1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 rectus fascia sling vs Goretex
sling
1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Number of women improved or
cured at 1 to 5 years (women's ob-
servations)
4   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
7.1 fascial sling vs Pelvicol sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.2 autologous dermal graE patch
vs cadaveric fascia lata
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.3 rectus fascia sling vs Goretex
sling
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.4 anterior rectus sheath sling vs
Prolene strip
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.5 anterior rectus sheath sling vs
anterior vaginal wall patch
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.6 Prolene strip vs anterior vagi-
nal wall patch
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Statistical method Effect size
8 Number of women satisfied
(women's observations)
3   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
8.1 fascial sling vs Pelvicol sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.2 Vypro vs Ultrapro 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.3 Vypro vs Prolene light 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.4 Ultrapro vs Prolene light 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.5 anterior vaginal wall sling vs
biosynthetic mesh sling
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9 Pad test of quantified leakage
(mean weight of urine lost) within
1 year
2   Mean Difference (IV, Fixed, 95% CI) Totals not selected
9.1 standard sling vs short sling 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.2 Vypro vs Ultrapro 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.3 Vypro vs Prolene light 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.4 Ultrapro vs Prolene light 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
10 Pad test of quantified leakage
(mean weight of urine lost) at 1 to
5 years
1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
10.1 Vypro vs Ultrapro 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
10.2 Vypro vs Prolene light 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
10.3 Ultrapro vs Prolene light 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
11 Duration of operation (minutes) 2   Mean Difference (IV, Fixed, 95% CI) Totals not selected
11.1 standard sling vs short sling 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
11.2 anterior rectus sheath sling vs
Prolene strip
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
11.3 anterior rectus sheath sling vs
anterior vaginal wall patch
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
11.4 Prolene strip vs anterior vagi-
nal wall patch
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
12 Blood loss (mL) 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
12.1 anterior rectus sheath sling vs
Prolene strip
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Statistical method Effect size
12.2 anterior rectus sheath sling vs
anterior vaginal wall patch
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
12.3 Prolene strip vs anterior vagi-
nal wall patch
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
13 Length of hospital stay (days) 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
13.1 anterior rectus sheath sling vs
Prolene strip
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
13.2 anterior rectus sheath sling vs
anterior vaginal wall patch
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
13.3 Prolene strip vs anterior vagi-
nal wall patch
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
14 Perioperative surgical compli-
cations
3   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
14.1 standard sling vs short sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
14.2 rectus fascia sling vs Goretex
sling
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
14.3 fascial sling vs vaginal wall
sling
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
15 Bladder perforation 3   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
15.1 standard sling vs short sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
15.2 fascial sling vs Pelvicol sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
15.3 anterior rectus sheath sling vs
Prolene strip
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
15.4 anterior rectus sheath sling vs
anterior vaginal wall patch
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
15.5 Prolene strip vs anterior vagi-
nal wall patch
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
16 Urinary tract infection 2   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
16.1 standard sling vs short sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
16.2 anterior vaginal wall sling vs
biosynthetic mesh sling
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
17 Vaginal bleeding 1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
17.1 anterior vaginal wall sling vs
biosynthetic mesh sling
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Statistical method Effect size
18 Long-term adverse effects
(wound pain)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
18.1 fascial sling vs Pelvicol sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19 Voiding dysfunction 6   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
19.1 fascial sling vs Pelvicol sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19.2 standard sling vs short sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19.3 Vypro vs Ultrapro 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19.4 Vypro vs Prolene light 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19.5 Ultrapro vs Prolene light 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19.6 anterior vaginal wall sling vs
biosynthetic mesh sling
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19.7 anterior rectus sheath sling vs
Prolene strip
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19.8 anterior rectus sheath sling vs
anterior vaginal wall patch
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19.9 Prolene strip vs anterior vagi-
nal wall patch
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19.10 fascial sling vs vaginal wall
sling
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
20 Urinary urgency symptoms, ur-
gency urinary incontinence
3   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
20.1 standard sling vs short sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
20.2 Vypro vs Ultrapro 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
20.3 Vypro vs Prolene light 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
20.4 Ultrapro vs Prolene light 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
20.5 rectus fascia sling vs Goretex
sling
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
21 Detrusor overactivity (urody-
namic overactivity)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
21.1 autologous dermal graE patch
vs cadaveric fascia lata
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
22 Long-term adverse effects (re-
lease of sling required)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
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Statistical method Effect size
22.1 fascial sling vs Pelvicol sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
23 Long-term adverse effects (vagi-
nal mesh or graE exposure)
3   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
23.1 fascial sling vs Pelvicol sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
23.2 Vypro vs Ultrapro 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
23.3 Vypro vs Prolene light 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
23.4 Ultrapro vs Prolene light 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
23.5 anterior vaginal wall sling vs
biosynthetic mesh sling
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
24 Condition-specific measures to
assess quality of life (ICI-Q short
form UI score at 1 year)
1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
24.1 Vypro vs Ultrapro 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
24.2 Vypro vs Prolene light 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
24.3 Ultrapro vs Prolene light 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
25 Condition-specific measures to
assess quality of life (ICI-Q short
form UI score at 1 to 5 years)
1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
25.1 Vypro vs Ultrapro 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
25.2 Vypro vs Prolene light 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
25.3 Ultrapro vs Prolene light 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
 
 
Analysis 11.1.   Comparison 11 One type of traditional sling operation versus another type of
traditional sling operation, Outcome 1 Number of continent women within 1 year (any definition).
Study or subgroup Sling type A Sling type B Odds Ratio Odds Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
11.1.1 fascial sling vs Pelvicol sling  
Guerrero 2008 38/73 25/45 0.87[0.41,1.83]
   
11.1.2 standard sling vs short sling  
Lucas 2000 58/72 56/72 1.18[0.53,2.65]
   
11.1.3 autologous fascial sling vs Fortaperm sling  
Pacetta 2005 9/10 19/24 2.37[0.24,23.36]
Favours sling B 1000.01 100.1 1 Favours sling A
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Study or subgroup Sling type A Sling type B Odds Ratio Odds Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
   
11.1.4 Vypro vs Ultrapro  
Okulu 2013 41/46 45/48 0.55[0.12,2.43]
   
11.1.5 Vypro vs Prolene light  
Okulu 2013 41/46 41/47 1.2[0.34,4.24]
   
11.1.6 Ultrapro vs Prolene light  
Okulu 2013 45/48 41/47 2.2[0.52,9.35]
   
11.1.7 fascial sling vs vaginal wall sling  
Viseshsindh 2003 14/15 11/11 0.42[0.02,11.31]
Favours sling B 1000.01 100.1 1 Favours sling A
 
 
Analysis 11.2.   Comparison 11 One type of traditional sling operation versus another type of
traditional sling operation, Outcome 2 Number of continent women at 1 to 5 years (any definition).
Study or subgroup Sling type A Sling type B Odds Ratio Odds Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
11.2.1 fascial sling vs Pelvicol sling  
Guerrero 2008 32/67 10/46 3.29[1.41,7.69]
   
11.2.2 standard sling vs short sling  
Lucas 2000 40/75 40/70 0.86[0.44,1.65]
   
11.2.3 autologous dermal graO patch vs cadaveric fascia lata  
Shin 2001 25/33 19/24 0.82[0.23,2.92]
   
11.2.4 rectus fascia sling vs Goretex sling  
Barbalias 1997 21/32 14/16 0.27[0.05,1.42]
   
11.2.5 Vypro vs Ultrapro  
Okulu 2013 39/46 44/48 0.51[0.14,1.86]
   
11.2.6 Vypro vs Prolene light  
Okulu 2013 39/46 40/47 0.98[0.31,3.04]
   
11.2.7 Ultrapro vs Prolene light  
Okulu 2013 44/48 40/47 1.93[0.52,7.07]
   
11.2.8 anterior vaginal wall sling vs biosynthetic mesh sling  
Choe 2000 14/20 19/20 0.12[0.01,1.14]
   
11.2.9 anterior rectus sheath sling vs Prolene strip  
Teleb 2011 8/12 9/12 0.67[0.11,3.93]
   
11.2.10 anterior rectus sheath sling vs anterior vaginal wall patch  
Teleb 2011 4/12 6/8 0.17[0.02,1.23]
   
Favours sling B 2000.005 100.1 1 Favours sling A
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Study or subgroup Sling type A Sling type B Odds Ratio Odds Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
11.2.11 Prolene strip vs anterior vaginal wall patch  
Teleb 2011 9/12 6/8 1[0.13,7.89]
Favours sling B 2000.005 100.1 1 Favours sling A
 
 
Analysis 11.3.   Comparison 11 One type of traditional sling operation versus another type of
traditional sling operation, Outcome 3 Number of continent women aOer 5 years (any definition).
Study or subgroup Sling type A Sling type B Odds Ratio Odds Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
11.3.1 standard sling vs short sling  
Lucas 2000 31/73 35/69 0.72[0.37,1.39]
Favours sling B 50.2 20.5 1 Favours sling A
 
 
Analysis 11.4.   Comparison 11 One type of traditional sling operation versus another
type of traditional sling operation, Outcome 4 Repeat surgery for urinary incontinence.
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
11.4.1 fascial sling vs Pelvicol sling  
Guerrero 2008 0/67 9/46 0.04[0,0.61]
Favours sling A 10000.001 100.1 1 Favours sling B
 
 
Analysis 11.5.   Comparison 11 One type of traditional sling operation versus another type of traditional
sling operation, Outcome 5 Number of women cured aOer first year (women's observations).
Study or subgroup Sling type A Sling type B Odds Ratio Odds Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
11.5.1 fascial sling vs Pelvicol sling  
Guerrero 2008 32/67 10/46 3.29[1.41,7.69]
   
11.5.2 standard sling vs short sling  
Lucas 2000 31/73 35/69 0.72[0.37,1.39]
   
11.5.3 autologous dermal graO patch vs cadaveric fascia lata  
Shin 2001 19/24 25/33 1.22[0.34,4.32]
Favours sling B 500.02 100.1 1 Favours sling A
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Analysis 11.6.   Comparison 11 One type of traditional sling operation versus another type of traditional
sling operation, Outcome 6 Number of women improved or cured within first year (women's observations).
Study or subgroup Sling type A Sling type B Odds Ratio Odds Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
11.6.1 fascial sling vs Pelvicol sling  
Guerrero 2008 69/73 33/45 6.27[1.88,20.94]
   
11.6.2 autologous fascial sling vs Fortaperm sling  
Pacetta 2005 10/10 22/24 2.33[0.1,53.03]
   
11.6.3 rectus fascia sling vs Goretex sling  
Barbalias 1997 26/32 14/16 0.62[0.11,3.48]
Favours sling B 5000.002 100.1 1 Favours sling A
 
 
Analysis 11.7.   Comparison 11 One type of traditional sling operation versus another type of traditional
sling operation, Outcome 7 Number of women improved or cured at 1 to 5 years (women's observations).
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
11.7.1 fascial sling vs Pelvicol sling  
Guerrero 2008 60/67 28/46 1.47[1.15,1.88]
   
11.7.2 autologous dermal graO patch vs cadaveric fascia lata  
Shin 2001 30/33 22/24 0.99[0.84,1.17]
   
11.7.3 rectus fascia sling vs Goretex sling  
Barbalias 1997 32/32 16/16 1[0.91,1.1]
   
11.7.4 anterior rectus sheath sling vs Prolene strip  
Teleb 2011 11/12 11/12 1[0.79,1.27]
   
11.7.5 anterior rectus sheath sling vs anterior vaginal wall patch  
Teleb 2011 11/12 7/8 1.05[0.77,1.43]
   
11.7.6 Prolene strip vs anterior vaginal wall patch  
Teleb 2011 11/12 7/8 1.05[0.77,1.43]
Favours sling A 500.02 100.1 1 Favours sling B
 
 
Analysis 11.8.   Comparison 11 One type of traditional sling operation versus another type of
traditional sling operation, Outcome 8 Number of women satisfied (women's observations).
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
11.8.1 fascial sling vs Pelvicol sling  
Guerrero 2008 43/61 20/38 1.34[0.95,1.89]
   
11.8.2 Vypro vs Ultrapro  
Okulu 2013 37/46 41/48 0.94[0.78,1.13]
Favours sling B 100.1 50.2 20.5 1 Favours sling A
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Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
   
11.8.3 Vypro vs Prolene light  
Okulu 2013 37/46 38/47 0.99[0.82,1.21]
   
11.8.4 Ultrapro vs Prolene light  
Okulu 2013 41/48 38/47 1.06[0.88,1.27]
   
11.8.5 anterior vaginal wall sling vs biosynthetic mesh sling  
Choe 2000 16/20 20/20 0.8[0.64,1.02]
Favours sling B 100.1 50.2 20.5 1 Favours sling A
 
 
Analysis 11.9.   Comparison 11 One type of traditional sling operation versus another type of traditional
sling operation, Outcome 9 Pad test of quantified leakage (mean weight of urine lost) within 1 year.
Study or subgroup Sling type A Sling type B Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
11.9.1 standard sling vs short sling  
Lucas 2000 81 7.7 (34.1) 84 4.6 (34.1) 3.1[-7.3,13.5]
   
11.9.2 Vypro vs Ultrapro  
Okulu 2013 46 2.1 (1.4) 48 2 (1.1) 0.1[-0.41,0.61]
   
11.9.3 Vypro vs Prolene light  
Okulu 2013 46 2.1 (1.4) 47 2.4 (3.8) -0.3[-1.46,0.86]
   
11.9.4 Ultrapro vs Prolene light  
Okulu 2013 48 2 (1.1) 47 2.4 (3.8) -0.4[-1.53,0.73]
Favours sling A 105-10 -5 0 Favours sling B
 
 
Analysis 11.10.   Comparison 11 One type of traditional sling operation versus another type of traditional
sling operation, Outcome 10 Pad test of quantified leakage (mean weight of urine lost) at 1 to 5 years.
Study or subgroup Sling type A Sling type B Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
11.10.1 Vypro vs Ultrapro  
Okulu 2013 46 0.7 (0.3) 48 0.2 (0.2) 0.45[0.35,0.55]
   
11.10.2 Vypro vs Prolene light  
Okulu 2013 46 0.7 (0.3) 47 0.8 (0.5) -0.18[-0.36,-0]
   
11.10.3 Ultrapro vs Prolene light  
Okulu 2013 48 0.2 (0.2) 47 0.8 (0.5) -0.63[-0.79,-0.47]
Favours sling A 21-2 -1 0 Favours sling B
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Analysis 11.11.   Comparison 11 One type of traditional sling operation versus another
type of traditional sling operation, Outcome 11 Duration of operation (minutes).
Study or subgroup Sling type A Sling type B Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
11.11.1 standard sling vs short sling  
Lucas 2000 81 62 (15.3) 84 54 (15.3) 8[3.32,12.68]
   
11.11.2 anterior rectus sheath sling vs Prolene strip  
Teleb 2011 12 52.1 (4.4) 12 35.7 (3.4) 16.4[13.25,19.55]
   
11.11.3 anterior rectus sheath sling vs anterior vaginal wall patch  
Teleb 2011 12 52.1 (4.4) 8 42.2 (4.5) 9.9[5.91,13.89]
   
11.11.4 Prolene strip vs anterior vaginal wall patch  
Teleb 2011 12 35.7 (3.4) 8 42.2 (4.5) -6.5[-10.16,-2.84]
Favours sling A 2010-20 -10 0 Favours sling B
 
 
Analysis 11.12.   Comparison 11 One type of traditional sling operation versus
another type of traditional sling operation, Outcome 12 Blood loss (mL).
Study or subgroup Sling type A Sling type B Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
11.12.1 anterior rectus sheath sling vs Prolene strip  
Teleb 2011 12 181 (33) 12 149 (29) 32[7.14,56.86]
   
11.12.2 anterior rectus sheath sling vs anterior vaginal wall patch  
Teleb 2011 12 181 (33) 8 201 (28) -20[-46.93,6.93]
   
11.12.3 Prolene strip vs anterior vaginal wall patch  
Teleb 2011 12 149 (29) 8 201 (28) -52[-77.41,-26.59]
Favours sling A 10050-100 -50 0 Favours sling B
 
 
Analysis 11.13.   Comparison 11 One type of traditional sling operation versus another
type of traditional sling operation, Outcome 13 Length of hospital stay (days).
Study or subgroup Sling type A Sling type B Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
11.13.1 anterior rectus sheath sling vs Prolene strip  
Teleb 2011 12 2.4 (0.5) 12 1.4 (0.4) 1.04[0.68,1.4]
   
11.13.2 anterior rectus sheath sling vs anterior vaginal wall patch  
Teleb 2011 12 2.4 (0.5) 8 1.5 (0.4) 0.92[0.53,1.31]
   
11.13.3 Prolene strip vs anterior vaginal wall patch  
Teleb 2011 12 1.4 (0.4) 8 1.5 (0.4) -0.12[-0.46,0.22]
Favours sling A 52.5-5 -2.5 0 Favours sling B
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Analysis 11.14.   Comparison 11 One type of traditional sling operation versus another
type of traditional sling operation, Outcome 14 Perioperative surgical complications.
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
11.14.1 standard sling vs short sling  
Lucas 2000 34/81 31/84 1.14[0.78,1.66]
   
11.14.2 rectus fascia sling vs Goretex sling  
Barbalias 1997 0/32 5/16 0.05[0,0.8]
   
11.14.3 fascial sling vs vaginal wall sling  
Viseshsindh 2003 0/15 0/11 Not estimable
Favours sling A 5000.002 100.1 1 Favours sling B
 
 
Analysis 11.15.   Comparison 11 One type of traditional sling operation versus
another type of traditional sling operation, Outcome 15 Bladder perforation.
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
11.15.1 standard sling vs short sling  
Lucas 2000 2/81 3/84 0.69[0.12,4.03]
   
11.15.2 fascial sling vs Pelvicol sling  
Guerrero 2008 2/79 1/50 1.27[0.12,13.6]
   
11.15.3 anterior rectus sheath sling vs Prolene strip  
Teleb 2011 0/12 1/12 0.33[0.01,7.45]
   
11.15.4 anterior rectus sheath sling vs anterior vaginal wall patch  
Teleb 2011 0/12 1/8 0.23[0.01,5.05]
   
11.15.5 Prolene strip vs anterior vaginal wall patch  
Teleb 2011 1/12 1/8 0.67[0.05,9.19]
Favours sling A 2000.005 100.1 1 Favours sling B
 
 
Analysis 11.16.   Comparison 11 One type of traditional sling operation versus
another type of traditional sling operation, Outcome 16 Urinary tract infection.
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
11.16.1 standard sling vs short sling  
Lucas 2000 10/81 6/84 1.73[0.66,4.54]
   
11.16.2 anterior vaginal wall sling vs biosynthetic mesh sling  
Choe 2000 0/20 1/20 0.33[0.01,7.72]
Favours sling A 1000.01 100.1 1 Favours sling B
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Analysis 11.17.   Comparison 11 One type of traditional sling operation versus
another type of traditional sling operation, Outcome 17 Vaginal bleeding.
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
11.17.1 anterior vaginal wall sling vs biosynthetic mesh sling  
Choe 2000 1/20 0/20 3[0.13,69.52]
Favours sling A 1000.01 100.1 1 Favours sling B
 
 
Analysis 11.18.   Comparison 11 One type of traditional sling operation versus another
type of traditional sling operation, Outcome 18 Long-term adverse e@ects (wound pain).
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
11.18.1 fascial sling vs Pelvicol sling  
Guerrero 2008 2/61 0/38 3.15[0.16,63.8]
Favours sling A 5000.002 100.1 1 Favours sling B
 
 
Analysis 11.19.   Comparison 11 One type of traditional sling operation versus
another type of traditional sling operation, Outcome 19 Voiding dysfunction.
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
11.19.1 fascial sling vs Pelvicol sling  
Guerrero 2008 4/61 0/38 5.66[0.31,102.29]
   
11.19.2 standard sling vs short sling  
Lucas 2000 19/81 17/84 1.16[0.65,2.07]
   
11.19.3 Vypro vs Ultrapro  
Okulu 2013 2/46 2/48 1.04[0.15,7.1]
   
11.19.4 Vypro vs Prolene light  
Okulu 2013 2/46 2/47 1.02[0.15,6.95]
   
11.19.5 Ultrapro vs Prolene light  
Okulu 2013 2/48 2/47 0.98[0.14,6.67]
   
11.19.6 anterior vaginal wall sling vs biosynthetic mesh sling  
Choe 2000 0/20 0/20 Not estimable
   
11.19.7 anterior rectus sheath sling vs Prolene strip  
Teleb 2011 0/12 1/12 0.33[0.01,7.45]
   
11.19.8 anterior rectus sheath sling vs anterior vaginal wall patch  
Teleb 2011 0/12 0/8 Not estimable
   
11.19.9 Prolene strip vs anterior vaginal wall patch  
Teleb 2011 1/12 0/8 2.08[0.09,45.45]
Favours sling A 5000.002 100.1 1 Favours sling B
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Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
   
11.19.10 fascial sling vs vaginal wall sling  
Viseshsindh 2003 0/15 0/11 Not estimable
Favours sling A 5000.002 100.1 1 Favours sling B
 
 
Analysis 11.20.   Comparison 11 One type of traditional sling operation versus another type of
traditional sling operation, Outcome 20 Urinary urgency symptoms, urgency urinary incontinence.
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
11.20.1 standard sling vs short sling  
Lucas 2000 6/81 2/84 3.11[0.65,14.97]
   
11.20.2 Vypro vs Ultrapro  
Okulu 2013 5/46 2/48 2.61[0.53,12.78]
   
11.20.3 Vypro vs Prolene light  
Okulu 2013 5/46 4/47 1.28[0.37,4.46]
   
11.20.4 Ultrapro vs Prolene light  
Okulu 2013 2/48 4/47 0.49[0.09,2.55]
   
11.20.5 rectus fascia sling vs Goretex sling  
Barbalias 1997 4/32 3/16 0.67[0.17,2.63]
Favours sling A 100.1 50.2 20.5 1 Favours sling B
 
 
Analysis 11.21.   Comparison 11 One type of traditional sling operation versus another type
of traditional sling operation, Outcome 21 Detrusor overactivity (urodynamic overactivity).
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
11.21.1 autologous dermal graO patch vs cadaveric fascia lata  
Shin 2001 4/33 5/20 0.48[0.15,1.6]
Favours sling A 100.1 50.2 20.5 1 Favours sling B
 
 
Analysis 11.22.   Comparison 11 One type of traditional sling operation versus another type of
traditional sling operation, Outcome 22 Long-term adverse e@ects (release of sling required).
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
11.22.1 fascial sling vs Pelvicol sling  
Guerrero 2008 2/61 1/38 1.25[0.12,13.28]
Favours sling A 10000.001 100.1 1 Favours sling B
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Analysis 11.23.   Comparison 11 One type of traditional sling operation versus another type of
traditional sling operation, Outcome 23 Long-term adverse e@ects (vaginal mesh or graO exposure).
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
11.23.1 fascial sling vs Pelvicol sling  
Guerrero 2008 0/61 0/38 Not estimable
   
11.23.2 Vypro vs Ultrapro  
Okulu 2013 2/46 1/48 2.09[0.2,22.24]
   
11.23.3 Vypro vs Prolene light  
Okulu 2013 2/46 2/47 1.02[0.15,6.95]
   
11.23.4 Ultrapro vs Prolene light  
Okulu 2013 1/48 2/47 0.49[0.05,5.22]
   
11.23.5 anterior vaginal wall sling vs biosynthetic mesh sling  
Choe 2000 0/20 0/20 Not estimable
Favours sling A 5000.002 100.1 1 Favours sling B
 
 
Analysis 11.24.   Comparison 11 One type of traditional sling operation versus another type of traditional sling
operation, Outcome 24 Condition-specific measures to assess quality of life (ICI-Q short form UI score at 1 year).
Study or subgroup Sling type A Sling type B Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
11.24.1 Vypro vs Ultrapro  
Okulu 2013 46 2 (0.7) 48 1.2 (0.6) 0.8[0.54,1.06]
   
11.24.2 Vypro vs Prolene light  
Okulu 2013 46 2 (0.7) 47 1.7 (0.4) 0.3[0.07,0.53]
   
11.24.3 Ultrapro vs Prolene light  
Okulu 2013 48 1.2 (0.6) 47 1.7 (0.4) -0.5[-0.7,-0.3]
Favours sling A 52.5-5 -2.5 0 Favours sling B
 
 
Analysis 11.25.   Comparison 11 One type of traditional sling operation versus
another type of traditional sling operation, Outcome 25 Condition-specific
measures to assess quality of life (ICI-Q short form UI score at 1 to 5 years).
Study or subgroup Sling type A Sling type B Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
11.25.1 Vypro vs Ultrapro  
Okulu 2013 46 2.1 (0.5) 48 0.8 (0.5) 1.3[1.1,1.5]
   
11.25.2 Vypro vs Prolene light  
Okulu 2013 46 2.1 (0.5) 47 1.5 (0.3) 0.6[0.43,0.77]
   
Favours sling A 52.5-5 -2.5 0 Favours sling B
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Study or subgroup Sling type A Sling type B Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
11.25.3 Ultrapro vs Prolene light  
Okulu 2013 48 0.8 (0.5) 47 1.5 (0.3) -0.7[-0.87,-0.53]
Favours sling A 52.5-5 -2.5 0 Favours sling B
 
 
Comparison 12.   Traditional suburethral sling operation versus drugs





Statistical method Effect size
1 Number of women with urinary inconti-
nence (worse, unchanged, or improved)
within first year (women's observations)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
1.1 urodynamic stress incontinence (only) 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 stress urinary incontinence (symp-
toms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 mixed incontinence 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Urge urinary symptoms, urgency uri-
nary incontinence
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
2.1 urodynamic stress incontinence (only) 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 stress urinary incontinence (symp-
toms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 mixed incontinence 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 
 
Analysis 12.1.   Comparison 12 Traditional suburethral sling operation versus drugs, Outcome 1 Number of
women with urinary incontinence (worse, unchanged, or improved) within first year (women's observations).
Study or subgroup sling anticholinergic Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
12.1.1 urodynamic stress incontinence (only)  
   
12.1.2 stress urinary incontinence (symptoms only)  
   
12.1.3 mixed incontinence  
Osman 2003 4/24 21/21 0.18[0.08,0.43]
Favours sling 10000.001 100.1 1 Favours anticholinergic
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Analysis 12.2.   Comparison 12 Traditional suburethral sling operation versus
drugs, Outcome 2 Urge urinary symptoms, urgency urinary incontinence.
Study or subgroup sling anticholinergic Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
12.2.1 urodynamic stress incontinence (only)  
   
12.2.2 stress urinary incontinence (symptoms only)  
   
12.2.3 mixed incontinence  
Osman 2003 3/24 9/21 0.29[0.09,0.94]
Favours sling 100.1 50.2 20.5 1 Favours anticholinergic
 
 
Comparison 13.   Traditional suburethral sling operation versus injectables





Statistical method Effect size
1 Number of women with urinary in-
continence (worse, unchanged, or im-
proved) within first year (women's ob-
servations)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
1.1 urodynamic stress incontinence
(only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 stress urinary incontinence (symp-
toms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 mixed urinary incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Number of women with urinary in-
continence (worse, unchanged, or im-
proved) after first year (women's ob-
servations)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
2.1 urodynamic stress incontinence
(only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 stress urinary incontinence (symp-
toms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 mixed urinary incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Number of women with urinary in-
continence (clinician's observations)
within first year
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
3.1 urodynamic stress incontinence
(only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 stress urinary incontinence (symp-
toms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Statistical method Effect size
3.3 mixed urinary incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 CURE: number of women cured after
first year (women's observations)
1   Odds Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
4.1 urodynamic stress incontinence
(only)
1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 stress urinary incontinence (symp-
toms only)
0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.3 mixed urinary incontinence 0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Voiding dysfunction 1   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
5.1 urodynamic stress incontinence
(only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 stress urinary incontinence (symp-
toms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.3 mixed urinary incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 De novo detrusor overactivity (urody-
namic diagnosis)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
6.1 urodynamic stress incontinence
(only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 stress urinary incontinence (symp-
toms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 mixed urinary incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Urinary tract infection 1   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
7.1 urodynamic stress incontinence
(only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.2 stress urinary incontinence (symp-
toms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.3 mixed urinary incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8 Repeat surgery for urinary inconti-
nence
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
8.1 urodynamic stress incontinence
(only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.2 stress urinary incontinence (symp-
toms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
Traditional suburethral sling operations for urinary incontinence in women (Review)









Cochrane Database of Systematic Reviews





Statistical method Effect size
8.3 mixed urinary incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 
 
Analysis 13.1.   Comparison 13 Traditional suburethral sling operation versus injectables, Outcome 1 Number of
women with urinary incontinence (worse, unchanged, or improved) within first year (women's observations).
Study or subgroup Traditional Sling Injectable Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
13.1.1 urodynamic stress incontinence (only)  
Maher 2005 2/21 5/22 0.42[0.09,1.93]
   
13.1.2 stress urinary incontinence (symptoms only)  
   
13.1.3 mixed urinary incontinence  
Favours traditional sling 200.05 50.2 1 Favours injectable
 
 
Analysis 13.2.   Comparison 13 Traditional suburethral sling operation versus injectables, Outcome 2 Number
of women with urinary incontinence (worse, unchanged, or improved) aOer first year (women's observations).
Study or subgroup Traditional Sling Injectable Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
13.2.1 urodynamic stress incontinence (only)  
Maher 2005 0/13 4/14 0.12[0.01,2.02]
   
13.2.2 stress urinary incontinence (symptoms only)  
   
13.2.3 mixed urinary incontinence  
Favours traditional sling 5000.002 100.1 1 Favours injectable
 
 
Analysis 13.3.   Comparison 13 Traditional suburethral sling operation versus injectables, Outcome
3 Number of women with urinary incontinence (clinician's observations) within first year.
Study or subgroup Traditional Sling Injectable Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
13.3.1 urodynamic stress incontinence (only)  
Maher 2005 4/21 20/22 0.21[0.09,0.51]
   
13.3.2 stress urinary incontinence (symptoms only)  
   
13.3.3 mixed urinary incontinence  
Favours traditional sling 100.1 50.2 20.5 1 Favours injectable
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Analysis 13.4.   Comparison 13 Traditional suburethral sling operation versus injectables,
Outcome 4 CURE: number of women cured aOer first year (women's observations).
Study or subgroup Traditional Sling Injectable Odds Ratio Odds Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
13.4.1 urodynamic stress incontinence (only)  
Maher 2005 13/13 10/14 11.57[0.56,239.74]
   
13.4.2 stress urinary incontinence (symptoms only)  
   
13.4.3 mixed urinary incontinence  
Favours injectable 5000.002 100.1 1 Favours traditional sling
 
 
Analysis 13.5.   Comparison 13 Traditional suburethral sling
operation versus injectables, Outcome 5 Voiding dysfunction.
Study or subgroup Traditional Sling Injectable Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
13.5.1 urodynamic stress incontinence (only)  
Maher 2005 4/21 1/22 4.19[0.51,34.5]
   
13.5.2 stress urinary incontinence (symptoms only)  
   
13.5.3 mixed urinary incontinence  
Favours traditional sling 500.02 100.1 1 Favours injectable
 
 
Analysis 13.6.   Comparison 13 Traditional suburethral sling operation versus
injectables, Outcome 6 De novo detrusor overactivity (urodynamic diagnosis).
Study or subgroup Traditional Sling Minimally Invasive Sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
13.6.1 urodynamic stress incontinence (only)  
Maher 2005 1/21 0/22 3.14[0.13,72.96]
   
13.6.2 stress urinary incontinence (symptoms only)  
   
13.6.3 mixed urinary incontinence  
Favours traditional sling 10000.001 100.1 1 Favours injectable
 
 
Analysis 13.7.   Comparison 13 Traditional suburethral sling
operation versus injectables, Outcome 7 Urinary tract infection.
Study or subgroup Traditional Sling Injectable Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
13.7.1 urodynamic stress incontinence (only)  
Maher 2005 3/21 2/22 1.57[0.29,8.49]
   
Favours traditional sling 100.1 50.2 20.5 1 Favours injectable
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Study or subgroup Traditional Sling Injectable Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
13.7.2 stress urinary incontinence (symptoms only)  
   
13.7.3 mixed urinary incontinence  
Favours traditional sling 100.1 50.2 20.5 1 Favours injectable
 
 
Analysis 13.8.   Comparison 13 Traditional suburethral sling operation
versus injectables, Outcome 8 Repeat surgery for urinary incontinence.
Study or subgroup Traditional Sling Injectable Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
13.8.1 urodynamic stress incontinence (only)  
Maher 2005 1/21 2/22 0.52[0.05,5.36]
   
13.8.2 stress urinary incontinence (symptoms only)  
   
13.8.3 mixed urinary incontinence  
Favours traditional sling 5000.002 100.1 1 Favours injectable
 
 
Comparison 14.   Traditional suburethral sling operation versus bladder neck needle suspension (abdominal and
vaginal)





Statistical method Effect size
1 Number with incontinence
(worse, unchanged, or improved)
within first year (women's observa-
tions)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 urodynamic stress inconti-
nence (only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Number with incontinence
(worse, unchanged, or improved)
after first year (women's observa-
tions)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 urodynamic stress inconti-
nence (only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Statistical method Effect size
2.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 CURE: number of women cured
after first year (women's observa-
tions)
1   Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
3.1 urodynamic stress inconti-
nence (only)
1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 stress urinary incontinence
(symptoms only)
0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 mixed incontinence 0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Length of hospital stay (hours) 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.1 urodynamic stress inconti-
nence (only)
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 stress urinary incontinence
(symptoms only)
0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.3 mixed incontinence 0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Perioperative surgical complica-
tions
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
5.1 urodynamic stress inconti-
nence (only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Urge urinary symptoms, urgency
urinary incontinence
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
6.1 urodynamic stress inconti-
nence (only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Voiding dysfunction after 3
months
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
7.1 urodynamic stress inconti-
nence (only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Statistical method Effect size
7.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8 Detrusor overactivity (urodynam-
ic diagnosis)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
8.1 urodynamic stress inconti-
nence (only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 
 
Analysis 14.1.   Comparison 14 Traditional suburethral sling operation versus
bladder neck needle suspension (abdominal and vaginal), Outcome 1 Number with
incontinence (worse, unchanged, or improved) within first year (women's observations).
Study or subgroup sling needle suspension Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
14.1.1 urodynamic stress incontinence (only)  
Hilton 1989 1/10 2/10 0.5[0.05,4.67]
   
14.1.2 stress urinary incontinence (symptoms only)  
   
14.1.3 mixed incontinence  




Analysis 14.2.   Comparison 14 Traditional suburethral sling operation versus
bladder neck needle suspension (abdominal and vaginal), Outcome 2 Number with
incontinence (worse, unchanged, or improved) aOer first year (women's observations).
Study or subgroup Favours sling needle suspension Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
14.2.1 urodynamic stress incontinence (only)  
Hilton 1989 1/10 3/10 0.33[0.04,2.69]
   
14.2.2 stress urinary incontinence (symptoms only)  
   
14.2.3 mixed incontinence  
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Analysis 14.3.   Comparison 14 Traditional suburethral sling operation versus bladder neck needle suspension
(abdominal and vaginal), Outcome 3 CURE: number of women cured aOer first year (women's observations).
Study or subgroup sling needle suspension Odds Ratio Odds Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
14.3.1 urodynamic stress incontinence (only)  
Hilton 1989 9/10 7/10 3.86[0.33,45.57]
   
14.3.2 stress urinary incontinence (symptoms only)  
   
14.3.3 mixed incontinence  
Favours needle suspension 2000.005 100.1 1 Favours sling
 
 
Analysis 14.4.   Comparison 14 Traditional suburethral sling operation versus bladder neck
needle suspension (abdominal and vaginal), Outcome 4 Length of hospital stay (hours).
Study or subgroup sling needle suspension Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
14.4.1 urodynamic stress incontinence (only)  
Hilton 1989 10 20 (12.9) 10 7 (0.3) 13[5,21]
   
14.4.2 stress urinary incontinence (symptoms only)  
   
14.4.3 mixed incontinence  




Analysis 14.5.   Comparison 14 Traditional suburethral sling operation versus bladder neck
needle suspension (abdominal and vaginal), Outcome 5 Perioperative surgical complications.
Study or subgroup sling needle suspension Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
14.5.1 urodynamic stress incontinence (only)  
Hilton 1989 9/10 2/10 4.5[1.28,15.81]
   
14.5.2 stress urinary incontinence (symptoms only)  
   
14.5.3 mixed incontinence  




Analysis 14.6.   Comparison 14 Traditional suburethral sling operation versus bladder neck needle
suspension (abdominal and vaginal), Outcome 6 Urge urinary symptoms, urgency urinary incontinence.
Study or subgroup sling needle suspension Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
14.6.1 urodynamic stress incontinence (only)  
Hilton 1989 5/10 3/10 1.67[0.54,5.17]
   
Favours sling 50.2 20.5 1 Favours needle suspen-
sion
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Study or subgroup sling needle suspension Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
14.6.2 stress urinary incontinence (symptoms only)  
   
14.6.3 mixed incontinence  




Analysis 14.7.   Comparison 14 Traditional suburethral sling operation versus bladder neck
needle suspension (abdominal and vaginal), Outcome 7 Voiding dysfunction aOer 3 months.
Study or subgroup sling needle suspension Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
14.7.1 urodynamic stress incontinence (only)  
Hilton 1989 4/10 2/10 2[0.47,8.56]
   
14.7.2 stress urinary incontinence (symptoms only)  
   
14.7.3 mixed incontinence  




Analysis 14.8.   Comparison 14 Traditional suburethral sling operation versus bladder neck needle
suspension (abdominal and vaginal), Outcome 8 Detrusor overactivity (urodynamic diagnosis).
Study or subgroup sling needle suspension Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
14.8.1 urodynamic stress incontinence (only)  
Hilton 1989 2/10 1/10 2[0.21,18.69]
   
14.8.2 stress urinary incontinence (symptoms only)  
   
14.8.3 mixed incontinence  




Comparison 15.   Traditional suburethral sling operation versus open abdominal retropubic colposuspension





Statistical method Effect size
1 Number of women with urinary
incontinence (worse, unchanged,
or improved) within first year
(women's observations)
4 147 Risk Ratio (M-H, Fixed, 95% CI) 0.40 [0.11, 1.41]
1.1 urodynamic stress incontinence
(only)
4 147 Risk Ratio (M-H, Fixed, 95% CI) 0.40 [0.11, 1.41]
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1.2 stress urinary incontinence
(symptoms only)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 mixed incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Number not improved (worse
or unchanged) within first year
(women's observations)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.1 urodynamic stress incontinence
(only)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 stress urinary incontinence
(symptoms only)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 mixed incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Number of women with urinary in-
continence (worse, unchanged, or
improved) at 1 to 5 years (women's
observations)
4 687 Risk Ratio (M-H, Fixed, 95% CI) 0.73 [0.61, 0.89]
3.1 urodynamic stress incontinence
(only)
3 167 Risk Ratio (M-H, Fixed, 95% CI) 0.58 [0.22, 1.49]
3.2 stress urinary incontinence
(symptoms only)
1 520 Risk Ratio (M-H, Fixed, 95% CI) 0.75 [0.62, 0.91]
3.3 mixed incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Number not improved (worse
or unchanged) at 1 to 5 years
(women's observations)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.1 urodynamic stress incontinence
(only)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 stress urinary incontinence
(symptoms only)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.3 mixed incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Number of women with urinary in-
continence (worse, unchanged, or
improved) at > 5 years (women's ob-
servations)
2 481 Risk Ratio (M-H, Fixed, 95% CI) 0.85 [0.74, 0.98]
5.1 urodynamic stress incontinence
(only)
1 28 Risk Ratio (M-H, Fixed, 95% CI) 2.31 [0.24, 22.62]
5.2 stress urinary incontinence
(symptoms only)
1 453 Risk Ratio (M-H, Fixed, 95% CI) 0.84 [0.73, 0.97]
5.3 mixed incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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6 CURE: number of women cured at
> 1 year (women's observations)
3 515 Odds Ratio (M-H, Fixed, 95% CI) 1.56 [1.07, 2.28]
6.1 urodynamic stress incontinence
(only)
2 62 Odds Ratio (M-H, Fixed, 95% CI) 0.93 [0.18, 4.89]
6.2 stress urinary incontinence
(symptoms only)
1 453 Odds Ratio (M-H, Fixed, 95% CI) 1.61 [1.09, 2.37]
6.3 mixed incontinence 0 0 Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Number of women not satisfied at
> 5 years
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
7.1 urodynamic stress incontinence
(only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.2 stress urinary incontinence
(symptoms only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8 Incontinent episodes over 24
hours
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.1 urodynamic stress incontinence
(only)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.2 stress urinary incontinence
(symptoms only)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.3 mixed incontinence 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
9 Number of women with urinary
incontinence (clinician's observa-
tions) within first year
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.1 urodynamic stress incontinence
(only)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.2 stress urinary incontinence
(symptoms only)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.3 mixed incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
10 Number of women with urinary
incontinence (clinician's observa-
tions) at 1 to 5 years
2 592 Risk Ratio (M-H, Fixed, 95% CI) 0.90 [0.60, 1.34]
10.1 urodynamic stress inconti-
nence (only)
1 72 Risk Ratio (M-H, Fixed, 95% CI) 0.6 [0.15, 2.33]
10.2 stress urinary incontinence
(symptoms only)
1 520 Risk Ratio (M-H, Fixed, 95% CI) 0.94 [0.62, 1.42]
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Statistical method Effect size
10.3 mixed incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
11 Number of women with urinary
incontinence (clinician's observa-
tions) at > 5 years
2 461 Risk Ratio (M-H, Fixed, 95% CI) 0.90 [0.80, 1.01]
11.1 urodynamic stress inconti-
nence (only)
1 28 Risk Ratio (M-H, Fixed, 95% CI) 0.23 [0.01, 4.37]
11.2 stress urinary incontinence
(symptoms only)
1 433 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.81, 1.02]
11.3 mixed incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
12 Duration of operation (minutes) 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
12.1 urodynamic stress inconti-
nence (only)
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
12.2 stress urinary incontinence
(symptoms only)
0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
12.3 mixed incontinence 0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
13 Time to catheter removal (days) 2 108 Mean Difference (IV, Fixed, 95% CI) 8.01 [6.84, 9.18]
13.1 urodynamic stress inconti-
nence (only)
2 108 Mean Difference (IV, Fixed, 95% CI) 8.01 [6.84, 9.18]
13.2 stress urinary incontinence
(symptoms only)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
13.3 mixed incontinence 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
14 Length of hospital stay (days) 3   Mean Difference (IV, Fixed, 95% CI) Totals not selected
14.1 urodynamic stress inconti-
nence (only)
3   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
14.2 stress urinary incontinence
(symptoms only)
0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
14.3 mixed incontinence 0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
15 Time to return to normal activity
level
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
15.1 urodynamic stress inconti-
nence (only)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
15.2 stress urinary incontinence
(symptoms only)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
15.3 mixed incontinence 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
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16 Perioperative surgical complica-
tions
4 792 Risk Ratio (M-H, Fixed, 95% CI) 1.24 [0.83, 1.86]
16.1 urodynamic stress inconti-
nence (only)
3 137 Risk Ratio (M-H, Fixed, 95% CI) 0.85 [0.28, 2.52]
16.2 stress urinary incontinence
(symptoms only)
1 655 Risk Ratio (M-H, Fixed, 95% CI) 1.32 [0.86, 2.04]
16.3 mixed incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
17 Bladder perforation 1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
17.1 urodynamic stress inconti-
nence (only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
17.2 stress urinary incontinence
(symptoms only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
17.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
18 Urinary tract infection 1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
18.1 urodynamic stress inconti-
nence (only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.2 stress urinary incontinence
(symptoms only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19 Number of women with recurrent
UTIs at > 5 years
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
19.1 urodynamic stress inconti-
nence (only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19.2 stress urinary incontinence
(symptoms only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
20 Urge urinary symptoms, urgency
urinary incontinence
2 525 Risk Ratio (M-H, Fixed, 95% CI) 1.10 [0.74, 1.64]
20.1 urodynamic stress inconti-
nence (only)
1 72 Risk Ratio (M-H, Fixed, 95% CI) 2.0 [0.54, 7.39]
20.2 stress urinary incontinence
(symptoms only)
1 453 Risk Ratio (M-H, Fixed, 95% CI) 1.02 [0.67, 1.56]
20.3 mixed incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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21 Detrusor overactivity (urodynam-
ic diagnosis)
4 203 Risk Ratio (M-H, Fixed, 95% CI) 1.42 [0.52, 3.87]
21.1 urodynamic stress inconti-
nence (only)
4 203 Risk Ratio (M-H, Fixed, 95% CI) 1.42 [0.52, 3.87]
21.2 stress urinary incontinence
(symptoms only)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
21.3 mixed incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
22 Voiding dysfunction after 3
months
5 853 Risk Ratio (M-H, Fixed, 95% CI) 6.08 [3.10, 11.95]
22.1 urodynamic stress inconti-
nence (only)
4 198 Risk Ratio (M-H, Fixed, 95% CI) 4.48 [1.16, 17.36]
22.2 stress urinary incontinence
(symptoms only)
1 655 Risk Ratio (M-H, Fixed, 95% CI) 6.63 [3.04, 14.47]
22.3 mixed incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
23 Long-term voiding dysfunction >
5 years
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
23.1 urodynamic stress inconti-
nence (only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
23.2 stress urinary incontinence
(symptoms only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
23.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
24 Number of women requiring
treatment for pelvic organ prolapse
3 559 Risk Ratio (M-H, Fixed, 95% CI) 0.20 [0.05, 0.77]
24.1 urodynamic stress inconti-
nence (only)
2 106 Risk Ratio (M-H, Fixed, 95% CI) 0.2 [0.04, 1.11]
24.2 stress urinary incontinence
(symptoms only)
1 453 Risk Ratio (M-H, Fixed, 95% CI) 0.20 [0.02, 1.74]
24.3 mixed incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
25 Repeat surgery for urinary incon-
tinence
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
25.1 urodynamic stress inconti-
nence (only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
25.2 stress urinary incontinence
(symptoms only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
25.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Statistical method Effect size
26 Condition-specific measures to
assess quality of life
1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
26.1 Urinary Distress Index (UDI) 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
26.2 Incontinence Impact Question-
naire (IIQ)
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
 
 
Analysis 15.1.   Comparison 15 Traditional suburethral sling operation versus open
abdominal retropubic colposuspension, Outcome 1 Number of women with urinary
incontinence (worse, unchanged, or improved) within first year (women's observations).




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
15.1.1 urodynamic stress incontinence (only)  
Bai 2005 2/28 3/33 35.08% 0.79[0.14,4.37]
Fischer 2001 0/11 2/9 34.74% 0.17[0.01,3.08]
Henriksson 1978 0/15 0/15   Not estimable
Sand 2000 0/17 2/19 30.17% 0.22[0.01,4.33]
Subtotal (95% CI) 71 76 100% 0.4[0.11,1.41]
Total events: 2 (Traditional sling), 7 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=1.09, df=2(P=0.58); I2=0%  
Test for overall effect: Z=1.42(P=0.15)  
   
15.1.2 stress urinary incontinence (symptoms only)  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
15.1.3 mixed incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total (95% CI) 71 76 100% 0.4[0.11,1.41]
Total events: 2 (Traditional sling), 7 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=1.09, df=2(P=0.58); I2=0%  
Test for overall effect: Z=1.42(P=0.15)  
Test for subgroup differences: Chi2=0, df=1 (P<0.0001), I2=100%  
Favours sling 1000.01 100.1 1 Favours suspension
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Analysis 15.3.   Comparison 15 Traditional suburethral sling operation versus open
abdominal retropubic colposuspension, Outcome 3 Number of women with urinary
incontinence (worse, unchanged, or improved) at 1 to 5 years (women's observations).




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
15.3.1 urodynamic stress incontinence (only)  
Bai 2005 2/28 4/33 2.56% 0.59[0.12,2.98]
Demirci 2001 1/17 2/17 1.4% 0.5[0.05,5.01]
Enzelsberger 1996 3/36 5/36 3.49% 0.6[0.15,2.33]
Subtotal (95% CI) 81 86 7.45% 0.58[0.22,1.49]
Total events: 6 (Traditional sling), 11 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0.02, df=2(P=0.99); I2=0%  
Test for overall effect: Z=1.14(P=0.26)  
   
15.3.2 stress urinary incontinence (symptoms only)  
Albo 2007 101/265 130/255 92.55% 0.75[0.62,0.91]
Subtotal (95% CI) 265 255 92.55% 0.75[0.62,0.91]
Total events: 101 (Traditional sling), 130 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.92(P=0)  
   
15.3.3 mixed incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total (95% CI) 346 341 100% 0.73[0.61,0.89]
Total events: 107 (Traditional sling), 141 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0.29, df=3(P=0.96); I2=0%  
Test for overall effect: Z=3.14(P=0)  
Test for subgroup differences: Chi2=0.27, df=1 (P=0.6), I2=0%  
Favours sling 1000.01 100.1 1 Favours suspension
 
 
Analysis 15.5.   Comparison 15 Traditional suburethral sling operation versus open
abdominal retropubic colposuspension, Outcome 5 Number of women with urinary
incontinence (worse, unchanged, or improved) at > 5 years (women's observations).




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
15.5.1 urodynamic stress incontinence (only)  
Sand 2000 2/13 1/15 0.59% 2.31[0.24,22.62]
Subtotal (95% CI) 13 15 0.59% 2.31[0.24,22.62]
Total events: 2 (Traditional sling), 1 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.72(P=0.47)  
   
15.5.2 stress urinary incontinence (symptoms only)  
Albo 2007 130/224 158/229 99.41% 0.84[0.73,0.97]
Favours sling 500.02 100.1 1 Favours suspension
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Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Subtotal (95% CI) 224 229 99.41% 0.84[0.73,0.97]
Total events: 130 (Traditional sling), 158 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.4(P=0.02)  
   
15.5.3 mixed incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total (95% CI) 237 244 100% 0.85[0.74,0.98]
Total events: 132 (Traditional sling), 159 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0.76, df=1(P=0.38); I2=0%  
Test for overall effect: Z=2.26(P=0.02)  
Test for subgroup differences: Chi2=0.75, df=1 (P=0.39), I2=0%  
Favours sling 500.02 100.1 1 Favours suspension
 
 
Analysis 15.6.   Comparison 15 Traditional suburethral sling operation versus open abdominal retropubic
colposuspension, Outcome 6 CURE: number of women cured at > 1 year (women's observations).




Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
15.6.1 urodynamic stress incontinence (only)  
Demirci 2001 16/17 15/17 2.02% 2.13[0.17,26.03]
Sand 2000 11/13 14/15 4.58% 0.39[0.03,4.92]
Subtotal (95% CI) 30 32 6.61% 0.93[0.18,4.89]
Total events: 27 (Traditional sling), 29 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0.87, df=1(P=0.35); I2=0%  
Test for overall effect: Z=0.09(P=0.93)  
   
15.6.2 stress urinary incontinence (symptoms only)  
Albo 2007 94/224 71/229 93.39% 1.61[1.09,2.37]
Subtotal (95% CI) 224 229 93.39% 1.61[1.09,2.37]
Total events: 94 (Traditional sling), 71 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.42(P=0.02)  
   
15.6.3 mixed incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total (95% CI) 254 261 100% 1.56[1.07,2.28]
Total events: 121 (Traditional sling), 100 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=1.23, df=2(P=0.54); I2=0%  
Test for overall effect: Z=2.33(P=0.02)  
Favours suspension 500.02 100.1 1 Favours sling
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Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Test for subgroup differences: Chi2=0.4, df=1 (P=0.53), I2=0%  
Favours suspension 500.02 100.1 1 Favours sling
 
 
Analysis 15.7.   Comparison 15 Traditional suburethral sling operation versus open abdominal
retropubic colposuspension, Outcome 7 Number of women not satisfied at > 5 years.
Study or subgroup Traditional sling Colposuspension Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
15.7.1 urodynamic stress incontinence (only)  
   
15.7.2 stress urinary incontinence (symptoms only)  
Albo 2007 31/182 46/170 0.63[0.42,0.94]
   
15.7.3 mixed incontinence  




Analysis 15.10.   Comparison 15 Traditional suburethral sling operation versus open abdominal retropubic
colposuspension, Outcome 10 Number of women with urinary incontinence (clinician's observations) at 1 to 5 years.




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
15.10.1 urodynamic stress incontinence (only)  
Enzelsberger 1996 3/36 5/36 11.43% 0.6[0.15,2.33]
Subtotal (95% CI) 36 36 11.43% 0.6[0.15,2.33]
Total events: 3 (Traditional sling), 5 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.74(P=0.46)  
   
15.10.2 stress urinary incontinence (symptoms only)  
Albo 2007 37/265 38/255 88.57% 0.94[0.62,1.42]
Subtotal (95% CI) 265 255 88.57% 0.94[0.62,1.42]
Total events: 37 (Traditional sling), 38 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=0.3(P=0.76)  
   
15.10.3 mixed incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total (95% CI) 301 291 100% 0.9[0.6,1.34]
Total events: 40 (Traditional sling), 43 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0.38, df=1(P=0.54); I2=0%  
Test for overall effect: Z=0.53(P=0.6)  
Favours sling 1000.01 100.1 1 Favours suspension
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Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Test for subgroup differences: Chi2=0.38, df=1 (P=0.54), I2=0%  
Favours sling 1000.01 100.1 1 Favours suspension
 
 
Analysis 15.11.   Comparison 15 Traditional suburethral sling operation versus open abdominal retropubic
colposuspension, Outcome 11 Number of women with urinary incontinence (clinician's observations) at > 5 years.




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
15.11.1 urodynamic stress incontinence (only)  
Sand 2000 0/13 2/15 1.4% 0.23[0.01,4.37]
Subtotal (95% CI) 13 15 1.4% 0.23[0.01,4.37]
Total events: 0 (Traditional sling), 2 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.98(P=0.33)  
   
15.11.2 stress urinary incontinence (symptoms only)  
Albo 2007 153/221 161/212 98.6% 0.91[0.81,1.02]
Subtotal (95% CI) 221 212 98.6% 0.91[0.81,1.02]
Total events: 153 (Traditional sling), 161 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=1.56(P=0.12)  
   
15.11.3 mixed incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total (95% CI) 234 227 100% 0.9[0.8,1.01]
Total events: 153 (Traditional sling), 163 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0.86, df=1(P=0.35); I2=0%  
Test for overall effect: Z=1.73(P=0.08)  
Test for subgroup differences: Chi2=0.84, df=1 (P=0.36), I2=0%  
Favours sling 1000.01 100.1 1 Favours suspension
 
 
Analysis 15.12.   Comparison 15 Traditional suburethral sling operation versus open
abdominal retropubic colposuspension, Outcome 12 Duration of operation (minutes).
Study or subgroup Traditional sling Colposuspension Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
15.12.1 urodynamic stress incontinence (only)  
Demirci 2001 15 60.7 (8.6) 14 54.6 (9.3) 6.02[-0.52,12.56]
   
15.12.2 stress urinary incontinence (symptoms only)  
   
Favours sling 105-10 -5 0 Favours suspension
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Study or subgroup Traditional sling Colposuspension Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
15.12.3 mixed incontinence  
Favours sling 105-10 -5 0 Favours suspension
 
 
Analysis 15.13.   Comparison 15 Traditional suburethral sling operation versus open
abdominal retropubic colposuspension, Outcome 13 Time to catheter removal (days).
Study or subgroup Traditional sling Colposuspension Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
15.13.1 urodynamic stress incontinence (only)  
Enzelsberger 1996 36 15 (3) 36 7 (2) 99.27% 8[6.82,9.18]
Sand 2000 17 23.3 (24.4) 19 13.8 (16.5) 0.73% 9.5[-4.27,23.27]
Subtotal *** 53   55   100% 8.01[6.84,9.18]
Heterogeneity: Tau2=0; Chi2=0.05, df=1(P=0.83); I2=0%  
Test for overall effect: Z=13.38(P<0.0001)  
   
15.13.2 stress urinary incontinence (symptoms only)  
Subtotal *** 0   0   Not estimable
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
15.13.3 mixed incontinence  
Subtotal *** 0   0   Not estimable
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total *** 53   55   100% 8.01[6.84,9.18]
Heterogeneity: Tau2=0; Chi2=0.05, df=1(P=0.83); I2=0%  
Test for overall effect: Z=13.38(P<0.0001)  
Test for subgroup differences: Not applicable  
Favours sling 2010-20 -10 0 Favours suspension
 
 
Analysis 15.14.   Comparison 15 Traditional suburethral sling operation versus open
abdominal retropubic colposuspension, Outcome 14 Length of hospital stay (days).
Study or subgroup Traditional sling Colposuspension Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
15.14.1 urodynamic stress incontinence (only)  
Demirci 2001 15 5.9 (1.4) 14 5.4 (1.3) 0.51[-0.46,1.48]
Enzelsberger 1996 36 16 (3) 36 8 (2) 8[6.82,9.18]
Sand 2000 17 5.1 (1.2) 19 5 (1.4) 0.1[-0.75,0.95]
   
15.14.2 stress urinary incontinence (symptoms only)  
   
15.14.3 mixed incontinence  
Favours sling 105-10 -5 0 Favours suspension
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Analysis 15.16.   Comparison 15 Traditional suburethral sling operation versus open
abdominal retropubic colposuspension, Outcome 16 Perioperative surgical complications.




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
15.16.1 urodynamic stress incontinence (only)  
Demirci 2001 2/15 1/14 2.7% 1.87[0.19,18.38]
Enzelsberger 1996 3/36 4/36 10.44% 0.75[0.18,3.11]
Sand 2000 0/17 1/19 3.71% 0.37[0.02,8.53]
Subtotal (95% CI) 68 69 16.85% 0.85[0.28,2.52]
Total events: 5 (Traditional sling), 6 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0.75, df=2(P=0.69); I2=0%  
Test for overall effect: Z=0.3(P=0.76)  
   
15.16.2 stress urinary incontinence (symptoms only)  
Albo 2007 42/326 32/329 83.15% 1.32[0.86,2.04]
Subtotal (95% CI) 326 329 83.15% 1.32[0.86,2.04]
Total events: 42 (Traditional sling), 32 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.27(P=0.2)  
   
15.16.3 mixed incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total (95% CI) 394 398 100% 1.24[0.83,1.86]
Total events: 47 (Traditional sling), 38 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=1.26, df=3(P=0.74); I2=0%  
Test for overall effect: Z=1.06(P=0.29)  
Test for subgroup differences: Chi2=0.56, df=1 (P=0.45), I2=0%  
Favours sling 1000.01 100.1 1 Favours suspension
 
 
Analysis 15.17.   Comparison 15 Traditional suburethral sling operation versus
open abdominal retropubic colposuspension, Outcome 17 Bladder perforation.
Study or subgroup Traditional sling Colposuspension Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
15.17.1 urodynamic stress incontinence (only)  
   
15.17.2 stress urinary incontinence (symptoms only)  
Albo 2007 2/326 10/329 0.2[0.04,0.91]
   
15.17.3 mixed incontinence  
Favours sling 200.05 50.2 1 Favours suspension
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Analysis 15.18.   Comparison 15 Traditional suburethral sling operation versus
open abdominal retropubic colposuspension, Outcome 18 Urinary tract infection.
Study or subgroup Traditional sling Colposuspension Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
15.18.1 urodynamic stress incontinence (only)  
   
15.18.2 stress urinary incontinence (symptoms only)  
Albo 2007 247/326 166/329 1.5[1.33,1.7]
   
15.18.3 mixed incontinence  
Favours sling 20.5 1.50.7 1 Favours suspension
 
 
Analysis 15.19.   Comparison 15 Traditional suburethral sling operation versus open abdominal
retropubic colposuspension, Outcome 19 Number of women with recurrent UTIs at > 5 years.
Study or subgroup Traditional sling Colposuspension Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
15.19.1 urodynamic stress incontinence (only)  
   
15.19.2 stress urinary incontinence (symptoms only)  
Albo 2007 21/224 21/229 1.02[0.57,1.82]
   
15.19.3 mixed incontinence  
Favours sling 20.5 1.50.7 1 Favours suspension
 
 
Analysis 15.20.   Comparison 15 Traditional suburethral sling operation versus open abdominal
retropubic colposuspension, Outcome 20 Urge urinary symptoms, urgency urinary incontinence.




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
15.20.1 urodynamic stress incontinence (only)  
Enzelsberger 1996 6/36 3/36 7.77% 2[0.54,7.39]
Subtotal (95% CI) 36 36 7.77% 2[0.54,7.39]
Total events: 6 (Traditional sling), 3 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.04(P=0.3)  
   
15.20.2 stress urinary incontinence (symptoms only)  
Albo 2007 36/224 36/229 92.23% 1.02[0.67,1.56]
Subtotal (95% CI) 224 229 92.23% 1.02[0.67,1.56]
Total events: 36 (Traditional sling), 36 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.1(P=0.92)  
   
15.20.3 mixed incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Favours sling 200.05 50.2 1 Favours suspension
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Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total (95% CI) 260 265 100% 1.1[0.74,1.64]
Total events: 42 (Traditional sling), 39 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0.92, df=1(P=0.34); I2=0%  
Test for overall effect: Z=0.46(P=0.65)  
Test for subgroup differences: Chi2=0.92, df=1 (P=0.34), I2=0%  
Favours sling 200.05 50.2 1 Favours suspension
 
 
Analysis 15.21.   Comparison 15 Traditional suburethral sling operation versus open abdominal
retropubic colposuspension, Outcome 21 Detrusor overactivity (urodynamic diagnosis).




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
15.21.1 urodynamic stress incontinence (only)  
Bai 2005 0/28 3/33 52.25% 0.17[0.01,3.11]
Demirci 2001 1/17 1/17 16.22% 1[0.07,14.72]
Enzelsberger 1996 3/36 1/36 16.22% 3[0.33,27.5]
Sand 2000 4/17 1/19 15.32% 4.47[0.55,36.19]
Subtotal (95% CI) 98 105 100% 1.42[0.52,3.87]
Total events: 8 (Traditional sling), 6 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=3.71, df=3(P=0.29); I2=19.23%  
Test for overall effect: Z=0.69(P=0.49)  
   
15.21.2 stress urinary incontinence (symptoms only)  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
15.21.3 mixed incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total (95% CI) 98 105 100% 1.42[0.52,3.87]
Total events: 8 (Traditional sling), 6 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=3.71, df=3(P=0.29); I2=19.23%  
Test for overall effect: Z=0.69(P=0.49)  
Test for subgroup differences: Not applicable  
Favours sling 5000.002 100.1 1 Favours suspension
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Analysis 15.22.   Comparison 15 Traditional suburethral sling operation versus open
abdominal retropubic colposuspension, Outcome 22 Voiding dysfunction aOer 3 months.




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
15.22.1 urodynamic stress incontinence (only)  
Bai 2005 2/28 1/33 9.8% 2.36[0.23,24.64]
Demirci 2001 0/17 0/17   Not estimable
Enzelsberger 1996 5/36 1/36 10.67% 5[0.61,40.7]
Sand 2000 3/15 0/16 5.17% 7.44[0.42,132.95]
Subtotal (95% CI) 96 102 25.64% 4.48[1.16,17.36]
Total events: 10 (Traditional sling), 2 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0.42, df=2(P=0.81); I2=0%  
Test for overall effect: Z=2.17(P=0.03)  
   
15.22.2 stress urinary incontinence (symptoms only)  
Albo 2007 46/326 7/329 74.36% 6.63[3.04,14.47]
Subtotal (95% CI) 326 329 74.36% 6.63[3.04,14.47]
Total events: 46 (Traditional sling), 7 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=4.75(P<0.0001)  
   
15.22.3 mixed incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total (95% CI) 422 431 100% 6.08[3.1,11.95]
Total events: 56 (Traditional sling), 9 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0.73, df=3(P=0.87); I2=0%  
Test for overall effect: Z=5.24(P<0.0001)  
Test for subgroup differences: Chi2=0.24, df=1 (P=0.62), I2=0%  
Favours sling 10000.001 100.1 1 Favours suspension
 
 
Analysis 15.23.   Comparison 15 Traditional suburethral sling operation versus open
abdominal retropubic colposuspension, Outcome 23 Long-term voiding dysfunction > 5 years.
Study or subgroup Traditional sling Colposuspension Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
15.23.1 urodynamic stress incontinence (only)  
   
15.23.2 stress urinary incontinence (symptoms only)  
Albo 2007 7/224 1/229 7.16[0.89,57.69]
   
15.23.3 mixed incontinence  
Favours sling 1000.01 100.1 1 Favours suspension
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Analysis 15.24.   Comparison 15 Traditional suburethral sling operation versus open abdominal retropubic
colposuspension, Outcome 24 Number of women requiring treatment for pelvic organ prolapse.




Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
15.24.1 urodynamic stress incontinence (only)  
Demirci 2001 0/17 2/17 20.09% 0.2[0.01,3.88]
Enzelsberger 1996 1/36 5/36 40.18% 0.2[0.02,1.63]
Subtotal (95% CI) 53 53 60.27% 0.2[0.04,1.11]
Total events: 1 (Traditional sling), 7 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0, df=1(P=1); I2=0%  
Test for overall effect: Z=1.84(P=0.07)  
   
15.24.2 stress urinary incontinence (symptoms only)  
Albo 2007 1/224 5/229 39.73% 0.2[0.02,1.74]
Subtotal (95% CI) 224 229 39.73% 0.2[0.02,1.74]
Total events: 1 (Traditional sling), 5 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.45(P=0.15)  
   
15.24.3 mixed incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditional sling), 0 (Colposuspension)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total (95% CI) 277 282 100% 0.2[0.05,0.77]
Total events: 2 (Traditional sling), 12 (Colposuspension)  
Heterogeneity: Tau2=0; Chi2=0, df=2(P=1); I2=0%  
Test for overall effect: Z=2.35(P=0.02)  
Test for subgroup differences: Chi2=0, df=1 (P=0.99), I2=0%  
Favours sling 5000.002 100.1 1 Favours suspension
 
 
Analysis 15.25.   Comparison 15 Traditional suburethral sling operation versus open
abdominal retropubic colposuspension, Outcome 25 Repeat surgery for urinary incontinence.
Study or subgroup Traditional sling Colposuspension Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
15.25.1 urodynamic stress incontinence (only)  
   
15.25.2 stress urinary incontinence (symptoms only)  
Albo 2007 4/223 27/227 0.15[0.05,0.42]
   
15.25.3 mixed incontinence  
Favours sling 5000.002 100.1 1 Favours suspension
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Analysis 15.26.   Comparison 15 Traditional suburethral sling operation versus open abdominal
retropubic colposuspension, Outcome 26 Condition-specific measures to assess quality of life.
Study or subgroup Traditional sling Colposuspension Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
15.26.1 Urinary Distress Index (UDI)  
Albo 2007 224 40.2 (45.8) 229 50.2 (50.9) -10[-18.91,-1.09]
   
15.26.2 Incontinence Impact Questionnaire (IIQ)  
Albo 2007 224 44.8 (79.6) 229 43.1 (68.2) 1.7[-11.96,15.36]
Favours sling 4020-40 -20 0 Favours suspension
 
 
Comparison 16.   Traditional suburethral sling operation versus a mid-urethral sling or tape





Statistical method Effect size
1 Number of women with urinary
incontinence (worse, unchanged,
or improved) within first year
(women's observations)
11 841 Risk Ratio (M-H, Fixed, 95% CI) 1.04 [0.85, 1.28]
1.1 urodynamic stress incontinence
(only)
5 427 Risk Ratio (M-H, Fixed, 95% CI) 1.02 [0.77, 1.36]
1.2 stress urinary incontinence
(symptoms only)
1 53 Risk Ratio (M-H, Fixed, 95% CI) 1.12 [0.17, 7.37]
1.3 mixed urinary incontinence 5 361 Risk Ratio (M-H, Fixed, 95% CI) 1.06 [0.78, 1.42]
2 Number not improved (worse
or unchanged) within first year
(women's observations)
3 425 Risk Ratio (M-H, Fixed, 95% CI) 0.79 [0.49, 1.29]
2.1 urodynamic stress incontinence
(only)
2 286 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.40, 2.21]
2.2 stress urinary incontinence
(symptoms only)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 mixed urinary incontinence 1 139 Risk Ratio (M-H, Fixed, 95% CI) 0.72 [0.40, 1.29]
3 Number of women with urinary in-
continence (worse, unchanged, or
improved) at 1 to 5 years (women's
observations)
6 458 Risk Ratio (M-H, Fixed, 95% CI) 1.29 [0.98, 1.68]
3.1 urodynamic stress incontinence
(only)
4 364 Risk Ratio (M-H, Fixed, 95% CI) 1.18 [0.87, 1.59]
3.2 stress urinary incontinence
(symptoms only)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 mixed urinary incontinence 2 94 Risk Ratio (M-H, Fixed, 95% CI) 1.79 [0.96, 3.31]
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Statistical method Effect size
4 Number not improved (worse
or unchanged) after first year
(women's observations)
2 264 Risk Ratio (M-H, Fixed, 95% CI) 1.28 [0.56, 2.94]
4.1 urodynamic stress incontinence
(only)
2 264 Risk Ratio (M-H, Fixed, 95% CI) 1.28 [0.56, 2.94]
4.2 stress urinary incontinence
(symptoms only)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.3 mixed urinary incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Number of women with urinary in-
continence after 5 years (women's
observations)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
5.1 urodynamic stress incontinence
(only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.3 mixed urinary incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Number with incontinence not im-
proved after 5 years (women's ob-
servations)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
6.1 urodynamic stress incontinence
(only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 mixed urinary incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 CURE: number of women cured at
> 1 year (women's observations)
4 337 Odds Ratio (M-H, Fixed, 95% CI) 1.06 [0.65, 1.72]
7.1 urodynamic stress incontinence
(only)
3 293 Odds Ratio (M-H, Fixed, 95% CI) 1.21 [0.72, 2.03]
7.2 stress urinary incontinence
(symptoms only)
0 0 Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.3 mixed urinary incontinence 1 44 Odds Ratio (M-H, Fixed, 95% CI) 0.42 [0.10, 1.72]
8 Repeat surgery for urinary inconti-
nence
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
8.1 urodynamic stress incontinence
(only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Statistical method Effect size
8.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9 Number of women not satisfied 2   Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
9.1 urodynamic stress incontinence
(only)
2 163 Risk Ratio (M-H, Fixed, 95% CI) 0.82 [0.51, 1.32]
9.2 stress urinary incontinence
(symptoms only)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.3 mixed urinary incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
10 Pad test of quantified leakage
(mean weight of urine loss)
1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
10.1 urodynamic stress inconti-
nence (only)
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
10.2 stress urinary incontinence
(symptoms only)
0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
10.3 mixed urinary incontinence 0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
11 Number of women with urinary
incontinence (clinician's observa-
tions) within first year
2 105 Risk Ratio (M-H, Fixed, 95% CI) 1.29 [0.45, 3.71]
11.1 urodynamic stress inconti-
nence (only)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
11.2 stress urinary incontinence
(symptoms only)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
11.3 mixed urinary incontinence 2 105 Risk Ratio (M-H, Fixed, 95% CI) 1.29 [0.45, 3.71]
12 Number of women with urinary
incontinence (clinician's observa-
tions) after first year
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
12.1 urodynamic stress inconti-
nence (only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
12.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
12.3 mixed urinary incontinence 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
13 Duration of operation (minutes) 7 355 Mean Difference (IV, Fixed, 95% CI) 57.08 [54.67, 59.49]
13.1 urodynamic stress inconti-
nence (only)
2 61 Mean Difference (IV, Fixed, 95% CI) 46.91 [42.31, 51.52]
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Statistical method Effect size
13.2 stress urinary incontinence
(symptoms only)
1 53 Mean Difference (IV, Fixed, 95% CI) 20.0 [7.08, 32.92]
13.3 mixed urinary incontinence 4 241 Mean Difference (IV, Fixed, 95% CI) 62.96 [60.07, 65.86]
14 Length of hospital stay (days) 4 194 Mean Difference (IV, Fixed, 95% CI) 0.74 [0.55, 0.93]
14.1 urodynamic stress inconti-
nence (only)
1 20 Mean Difference (IV, Fixed, 95% CI) 0.65 [0.39, 0.91]
14.2 stress urinary incontinence
(symptoms only)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
14.3 mixed urinary incontinence 3 174 Mean Difference (IV, Fixed, 95% CI) 0.83 [0.56, 1.10]
15 Time to catheter removal (days) 2 113 Mean Difference (IV, Fixed, 95% CI) 0.11 [-0.07, 0.30]
15.1 urodynamic stress inconti-
nence (only)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
15.2 stress urinary incontinence
(symptoms only)
1 53 Mean Difference (IV, Fixed, 95% CI) 2.3 [0.01, 4.59]
15.3 mixed urinary incontinence 1 60 Mean Difference (IV, Fixed, 95% CI) 0.10 [-0.09, 0.29]
16 Perioperative surgical complica-
tions
4 293 Risk Ratio (M-H, Fixed, 95% CI) 1.74 [1.16, 2.60]
16.1 urodynamic stress inconti-
nence (only)
2 183 Risk Ratio (M-H, Fixed, 95% CI) 1.73 [1.01, 2.96]
16.2 stress urinary incontinence
(symptoms only)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
16.3 mixed urinary incontinence 2 110 Risk Ratio (M-H, Fixed, 95% CI) 1.74 [0.94, 3.21]
17 Bladder perforations 10 844 Risk Ratio (M-H, Fixed, 95% CI) 0.59 [0.34, 1.01]
17.1 urodynamic stress inconti-
nence (only)
3 334 Risk Ratio (M-H, Fixed, 95% CI) 0.74 [0.19, 2.86]
17.2 stress urinary incontinence
(symptoms only)
1 53 Risk Ratio (M-H, Fixed, 95% CI) 0.56 [0.05, 5.81]
17.3 mixed urinary incontinence 6 457 Risk Ratio (M-H, Fixed, 95% CI) 0.56 [0.30, 1.03]
18 Urethral injury 1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
18.1 urodynamic stress inconti-
nence (only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Statistical method Effect size
18.3 mixed urinary incontinence 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19 Vaginal bleeding 1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
19.1 urodynamic stress inconti-
nence (only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19.3 mixed urinary incontinence 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
20 Urinary tract infection 1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
20.1 urodynamic stress inconti-
nence (only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
20.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
20.3 mixed urinary incontinence 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
21 Voiding dysfunction 8 629 Risk Ratio (M-H, Fixed, 95% CI) 1.34 [0.85, 2.12]
21.1 urodynamic stress inconti-
nence (only)
3 325 Risk Ratio (M-H, Fixed, 95% CI) 1.22 [0.60, 2.46]
21.2 stress urinary incontinence
(symptoms only)
1 53 Risk Ratio (M-H, Fixed, 95% CI) 2.61 [0.76, 9.03]
21.3 mixed urinary incontinence 4 251 Risk Ratio (M-H, Fixed, 95% CI) 1.18 [0.58, 2.40]
22 De novo detrusor urgency or urge
symptoms
5 348 Risk Ratio (M-H, Fixed, 95% CI) 1.62 [0.66, 3.99]
22.1 urodynamic stress inconti-
nence (only)
1 124 Risk Ratio (M-H, Fixed, 95% CI) 0.34 [0.01, 8.29]
22.2 stress urinary incontinence
(symptoms only)
1 53 Risk Ratio (M-H, Fixed, 95% CI) 3.35 [0.14, 78.60]
22.3 mixed urinary incontinence 3 171 Risk Ratio (M-H, Fixed, 95% CI) 1.81 [0.65, 5.06]
23 De novo detrusor overactivity
(urodynamic diagnosis)
4 325 Risk Ratio (M-H, Fixed, 95% CI) 2.61 [1.17, 5.84]
23.1 urodynamic stress inconti-
nence (only)
1 59 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
23.2 stress urinary incontinence
(symptoms only)
1 47 Risk Ratio (M-H, Fixed, 95% CI) 3.13 [0.13, 73.01]
23.3 mixed urinary incontinence 2 219 Risk Ratio (M-H, Fixed, 95% CI) 2.57 [1.12, 5.92]
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Statistical method Effect size
24 Long-term adverse effects (re-
lease of sling required)
3 326 Risk Ratio (M-H, Fixed, 95% CI) 2.53 [0.87, 7.35]
24.1 urodynamic stress inconti-
nence (only)
2 266 Risk Ratio (M-H, Fixed, 95% CI) 1.68 [0.50, 5.66]
24.2 stress urinary incontinence
(symptoms only)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
24.3 mixed urinary incontinence 1 60 Risk Ratio (M-H, Fixed, 95% CI) 9.6 [0.54, 170.84]
25 Long-term adverse effects
(wound pain at 6 months)
3 257 Risk Ratio (M-H, Fixed, 95% CI) 6.40 [1.94, 21.12]
25.1 urodynamic stress inconti-
nence (only)
1 124 Risk Ratio (M-H, Fixed, 95% CI) 5.16 [0.25, 105.36]
25.2 stress urinary incontinence
(symptoms only)
1 53 Risk Ratio (M-H, Fixed, 95% CI) 3.92 [0.90, 17.15]
25.3 mixed urinary incontinence 1 80 Risk Ratio (M-H, Fixed, 95% CI) 17.0 [1.01, 284.96]
26 Long-term adverse effects (vagi-
nal mesh or graE exposure)
5 348 Risk Ratio (M-H, Fixed, 95% CI) 0.28 [0.05, 1.65]
26.1 urodynamic stress inconti-
nence (only)
2 165 Risk Ratio (M-H, Fixed, 95% CI) 0.35 [0.04, 3.24]
26.2 stress urinary incontinence
(symptoms only)
1 53 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
26.3 mixed urinary incontinence 2 130 Risk Ratio (M-H, Fixed, 95% CI) 0.2 [0.01, 3.97]
27 Condition-specific measures to
assess quality of life: UDI-6
1 63 Mean Difference (IV, Fixed, 95% CI) 7.30 [-2.00, 16.60]
27.1 urodynamic stress inconti-
nence (only)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
27.2 stress urinary incontinence
(symptoms only)
1 63 Mean Difference (IV, Fixed, 95% CI) 7.30 [-2.00, 16.60]
27.3 mixed urinary incontinence 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
28 Condition-specific measures to
assess quality of life: IIQ-7
1 63 Mean Difference (IV, Fixed, 95% CI) 0.60 [-10.17, 11.37]
28.1 urodynamic stress inconti-
nence (only)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
28.2 stress urinary incontinence
(symptoms only)
1 63 Mean Difference (IV, Fixed, 95% CI) 0.60 [-10.17, 11.37]
28.3 mixed urinary incontinence 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Analysis 16.1.   Comparison 16 Traditional suburethral sling operation versus a mid-
urethral sling or tape, Outcome 1 Number of women with urinary incontinence
(worse, unchanged, or improved) within first year (women's observations).
Study or subgroup Traditonal sling Mid-ure-
thral sling
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
16.1.1 urodynamic stress incontinence (only)  
Amaro 2007 9/21 6/20 5.71% 1.43[0.62,3.28]
Arunkalaivanan 2003 8/74 10/68 9.69% 0.74[0.31,1.75]
Bai 2005 2/28 2/31 1.76% 1.11[0.17,7.34]
Guerrero 2008 38/73 35/71 32.99% 1.06[0.76,1.46]
Tcherniakovsky 2009 1/20 2/21 1.81% 0.53[0.05,5.35]
Subtotal (95% CI) 216 211 51.97% 1.02[0.77,1.36]
Total events: 58 (Traditonal sling), 55 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=1.54, df=4(P=0.82); I2=0%  
Test for overall effect: Z=0.14(P=0.89)  
   
16.1.2 stress urinary incontinence (symptoms only)  
Wadie 2005 2/25 2/28 1.75% 1.12[0.17,7.37]
Subtotal (95% CI) 25 28 1.75% 1.12[0.17,7.37]
Total events: 2 (Traditonal sling), 2 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.12(P=0.91)  
   
16.1.3 mixed urinary incontinence  
Basok 2008 32/67 38/72 34.05% 0.9[0.65,1.26]
Kondo 2006 2/21 2/23 1.77% 1.1[0.17,7.1]
Sharifiaghdas 2008 6/36 3/25 3.29% 1.39[0.38,5.04]
Song 2004 1/19 3/48 1.58% 0.84[0.09,7.6]
Zargham 2013 11/25 6/25 5.58% 1.83[0.8,4.19]
Subtotal (95% CI) 168 193 46.28% 1.06[0.78,1.42]
Total events: 52 (Traditonal sling), 52 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=2.76, df=4(P=0.6); I2=0%  
Test for overall effect: Z=0.36(P=0.72)  
   
Total (95% CI) 409 432 100% 1.04[0.85,1.28]
Total events: 112 (Traditonal sling), 109 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=4.24, df=10(P=0.94); I2=0%  
Test for overall effect: Z=0.36(P=0.72)  
Test for subgroup differences: Chi2=0.03, df=1 (P=0.98), I2=0%  
favours traditional sling 500.02 100.1 1 favours MUS
 
 
Analysis 16.2.   Comparison 16 Traditional suburethral sling operation versus a mid-urethral sling or
tape, Outcome 2 Number not improved (worse or unchanged) within first year (women's observations).
Study or subgroup Traditonal sling Mid-ure-
thral sling
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
16.2.1 urodynamic stress incontinence (only)  
favours traditional sling 100.1 50.2 20.5 1 favours MUS
Traditional suburethral sling operations for urinary incontinence in women (Review)









Cochrane Database of Systematic Reviews
Study or subgroup Traditonal sling Mid-ure-
thral sling
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Arunkalaivanan 2003 6/74 4/68 13.67% 1.38[0.41,4.68]
Guerrero 2008 4/73 6/71 19.95% 0.65[0.19,2.2]
Subtotal (95% CI) 147 139 33.62% 0.95[0.4,2.21]
Total events: 10 (Traditonal sling), 10 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=0.73, df=1(P=0.39); I2=0%  
Test for overall effect: Z=0.13(P=0.9)  
   
16.2.2 stress urinary incontinence (symptoms only)  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditonal sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
16.2.3 mixed urinary incontinence  
Basok 2008 14/67 21/72 66.38% 0.72[0.4,1.29]
Subtotal (95% CI) 67 72 66.38% 0.72[0.4,1.29]
Total events: 14 (Traditonal sling), 21 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.11(P=0.27)  
   
Total (95% CI) 214 211 100% 0.79[0.49,1.29]
Total events: 24 (Traditonal sling), 31 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=1.01, df=2(P=0.6); I2=0%  
Test for overall effect: Z=0.94(P=0.35)  
Test for subgroup differences: Chi2=0.28, df=1 (P=0.6), I2=0%  
favours traditional sling 100.1 50.2 20.5 1 favours MUS
 
 
Analysis 16.3.   Comparison 16 Traditional suburethral sling operation versus a mid-
urethral sling or tape, Outcome 3 Number of women with urinary incontinence
(worse, unchanged, or improved) at 1 to 5 years (women's observations).
Study or subgroup Traditonal sling Mid-ure-
thral sling
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
16.3.1 urodynamic stress incontinence (only)  
Amaro 2007 9/21 7/20 12% 1.22[0.56,2.66]
Arunkalaivanan 2003 12/68 7/60 12.44% 1.51[0.64,3.59]
Bai 2005 2/28 4/31 6.35% 0.55[0.11,2.79]
Guerrero 2008 35/67 31/69 51.11% 1.16[0.82,1.65]
Subtotal (95% CI) 184 180 81.9% 1.18[0.87,1.59]
Total events: 58 (Traditonal sling), 49 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=1.17, df=3(P=0.76); I2=0%  
Test for overall effect: Z=1.07(P=0.28)  
   
16.3.2 stress urinary incontinence (symptoms only)  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditonal sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
favours traditional sling 200.05 50.2 1 favours MUS
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Study or subgroup Traditonal sling Mid-ure-
thral sling
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
   
16.3.3 mixed urinary incontinence  
Kondo 2006 7/21 4/23 6.39% 1.92[0.65,5.63]
Zargham 2013 12/25 7/25 11.71% 1.71[0.81,3.63]
Subtotal (95% CI) 46 48 18.1% 1.79[0.96,3.31]
Total events: 19 (Traditonal sling), 11 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=0.03, df=1(P=0.87); I2=0%  
Test for overall effect: Z=1.84(P=0.07)  
   
Total (95% CI) 230 228 100% 1.29[0.98,1.68]
Total events: 77 (Traditonal sling), 60 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=2.61, df=5(P=0.76); I2=0%  
Test for overall effect: Z=1.85(P=0.06)  
Test for subgroup differences: Chi2=1.42, df=1 (P=0.23), I2=29.37%  
favours traditional sling 200.05 50.2 1 favours MUS
 
 
Analysis 16.4.   Comparison 16 Traditional suburethral sling operation versus a mid-urethral sling or
tape, Outcome 4 Number not improved (worse or unchanged) aOer first year (women's observations).
Study or subgroup Traditonal sling Mid-ure-
thral sling
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
16.4.1 urodynamic stress incontinence (only)  
Arunkalaivanan 2003 5/68 4/60 46.31% 1.1[0.31,3.92]
Guerrero 2008 7/67 5/69 53.69% 1.44[0.48,4.32]
Subtotal (95% CI) 135 129 100% 1.28[0.56,2.94]
Total events: 12 (Traditonal sling), 9 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=0.1, df=1(P=0.75); I2=0%  
Test for overall effect: Z=0.59(P=0.55)  
   
16.4.2 stress urinary incontinence (symptoms only)  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditonal sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
16.4.3 mixed urinary incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditonal sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total (95% CI) 135 129 100% 1.28[0.56,2.94]
Total events: 12 (Traditonal sling), 9 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=0.1, df=1(P=0.75); I2=0%  
Test for overall effect: Z=0.59(P=0.55)  
Test for subgroup differences: Not applicable  
favours traditional sling 100.1 50.2 20.5 1 favours MUS
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Analysis 16.5.   Comparison 16 Traditional suburethral sling operation versus a mid-urethral sling or
tape, Outcome 5 Number of women with urinary incontinence aOer 5 years (women's observations).
Study or subgroup Traditonal sling Mid-urethral sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
16.5.1 urodynamic stress incontinence (only)  
Guerrero 2008 30/61 43/63 0.72[0.53,0.98]
   
16.5.2 stress urinary incontinence (symptoms only)  
   
16.5.3 mixed urinary incontinence  
favours traditional sling 200.05 50.2 1 favours MUS
 
 
Analysis 16.6.   Comparison 16 Traditional suburethral sling operation versus a mid-urethral sling
or tape, Outcome 6 Number with incontinence not improved aOer 5 years (women's observations).
Study or subgroup Traditonal sling Mid-urethral sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
16.6.1 urodynamic stress incontinence (only)  
Guerrero 2008 15/61 17/63 0.91[0.5,1.66]
   
16.6.2 stress urinary incontinence (symptoms only)  
   
16.6.3 mixed urinary incontinence  
favours traditional sling 200.05 50.2 1 favours MUS
 
 
Analysis 16.7.   Comparison 16 Traditional suburethral sling operation versus a mid-urethral
sling or tape, Outcome 7 CURE: number of women cured at > 1 year (women's observations).
Study or subgroup Traditonal sling Mid-ure-
thral sling
Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
16.7.1 urodynamic stress incontinence (only)  
Amaro 2007 12/21 14/20 19.32% 0.57[0.16,2.07]
Arunkalaivanan 2003 56/68 53/60 31.24% 0.62[0.23,1.68]
Guerrero 2008 31/61 20/63 30.43% 2.22[1.07,4.61]
Subtotal (95% CI) 150 143 80.99% 1.21[0.72,2.03]
Total events: 99 (Traditonal sling), 87 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=5.69, df=2(P=0.06); I2=64.86%  
Test for overall effect: Z=0.71(P=0.48)  
   
16.7.2 stress urinary incontinence (symptoms only)  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditonal sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
16.7.3 mixed urinary incontinence  
favours MUS 200.05 50.2 1 favours traditional sling
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Study or subgroup Traditonal sling Mid-ure-
thral sling
Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Kondo 2006 14/21 19/23 19.01% 0.42[0.1,1.72]
Subtotal (95% CI) 21 23 19.01% 0.42[0.1,1.72]
Total events: 14 (Traditonal sling), 19 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.2(P=0.23)  
   
Total (95% CI) 171 166 100% 1.06[0.65,1.72]
Total events: 113 (Traditonal sling), 106 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=7.59, df=3(P=0.06); I2=60.49%  
Test for overall effect: Z=0.23(P=0.82)  
Test for subgroup differences: Chi2=1.89, df=1 (P=0.17), I2=47.18%  
favours MUS 200.05 50.2 1 favours traditional sling
 
 
Analysis 16.8.   Comparison 16 Traditional suburethral sling operation versus a
mid-urethral sling or tape, Outcome 8 Repeat surgery for urinary incontinence.
Study or subgroup Traditonal sling Mid-urethral sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
16.8.1 urodynamic stress incontinence (only)  
Guerrero 2008 0/67 0/69 Not estimable
   
16.8.2 stress urinary incontinence (symptoms only)  
   
16.8.3 mixed incontinence  
favours traditional sling 200.05 50.2 1 favours MUS
 
 
Analysis 16.9.   Comparison 16 Traditional suburethral sling operation versus
a mid-urethral sling or tape, Outcome 9 Number of women not satisfied.
Study or subgroup Traditonal sling Mid-ure-
thral sling
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
16.9.1 urodynamic stress incontinence (only)  
Amaro 2007 4/20 8/19 30.5% 0.48[0.17,1.32]
Guerrero 2008 18/61 19/63 69.5% 0.98[0.57,1.68]
Subtotal (95% CI) 81 82 100% 0.82[0.51,1.32]
Total events: 22 (Traditonal sling), 27 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=1.5, df=1(P=0.22); I2=33.43%  
Test for overall effect: Z=0.8(P=0.42)  
   
16.9.2 stress urinary incontinence (symptoms only)  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditonal sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
favours traditional sling 2000.005 100.1 1 favours MUS
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Study or subgroup Traditonal sling Mid-ure-
thral sling
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
16.9.3 mixed urinary incontinence  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditonal sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
favours traditional sling 2000.005 100.1 1 favours MUS
 
 
Analysis 16.10.   Comparison 16 Traditional suburethral sling operation versus a mid-
urethral sling or tape, Outcome 10 Pad test of quantified leakage (mean weight of urine loss).
Study or subgroup Traditonal sling Mid-urethral sling Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
16.10.1 urodynamic stress incontinence (only)  
Silva Filho 2006 10 8.4 (16.4) 10 39.4 (39.5) -31[-57.53,-4.47]
   
16.10.2 stress urinary incontinence (symptoms only)  
   
16.10.3 mixed urinary incontinence  
favours traditional sling 5025-50 -25 0 favours MUS
 
 
Analysis 16.11.   Comparison 16 Traditional suburethral sling operation versus a mid-urethral sling or
tape, Outcome 11 Number of women with urinary incontinence (clinician's observations) within first year.
Study or subgroup Traditonal sling Mid-ure-
thral sling
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
16.11.1 urodynamic stress incontinence (only)  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditonal sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
16.11.2 stress urinary incontinence (symptoms only)  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditonal sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
16.11.3 mixed urinary incontinence  
Kondo 2006 2/21 2/23 35.03% 1.1[0.17,7.1]
Sharifiaghdas 2008 6/36 3/25 64.97% 1.39[0.38,5.04]
Subtotal (95% CI) 57 48 100% 1.29[0.45,3.71]
Total events: 8 (Traditonal sling), 5 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=0.04, df=1(P=0.84); I2=0%  
Test for overall effect: Z=0.47(P=0.64)  
   
favours traditional sling 100.1 50.2 20.5 1 favours MUS
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Study or subgroup Traditonal sling Mid-ure-
thral sling
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Total (95% CI) 57 48 100% 1.29[0.45,3.71]
Total events: 8 (Traditonal sling), 5 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=0.04, df=1(P=0.84); I2=0%  
Test for overall effect: Z=0.47(P=0.64)  
Test for subgroup differences: Not applicable  
favours traditional sling 100.1 50.2 20.5 1 favours MUS
 
 
Analysis 16.12.   Comparison 16 Traditional suburethral sling operation versus a mid-urethral sling or
tape, Outcome 12 Number of women with urinary incontinence (clinician's observations) aOer first year.
Study or subgroup Traditonal sling Mid-urethral sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
16.12.1 urodynamic stress incontinence (only)  
   
16.12.2 stress urinary incontinence (symptoms only)  
   
16.12.3 mixed urinary incontinence  
Kondo 2006 11/21 7/23 1.72[0.82,3.61]
favours traditional sling 100.1 50.2 20.5 1 favours MUS
 
 
Analysis 16.13.   Comparison 16 Traditional suburethral sling operation versus
a mid-urethral sling or tape, Outcome 13 Duration of operation (minutes).
Study or subgroup Traditonal sling Mid-urethral sling Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
16.13.1 urodynamic stress incontinence (only)  
Silva Filho 2006 10 69.5 (74.9) 10 21.1 (12) 0.26% 48.4[1.39,95.41]
Tcherniakovsky 2009 20 59.7 (10.3) 21 12.8 (2.4) 27.08% 46.9[42.27,51.53]
Subtotal *** 30   31   27.34% 46.91[42.31,51.52]
Heterogeneity: Tau2=0; Chi2=0, df=1(P=0.95); I2=0%  
Test for overall effect: Z=19.96(P<0.0001)  
   
16.13.2 stress urinary incontinence (symptoms only)  
Wadie 2005 25 68 (23) 28 48 (25) 3.47% 20[7.08,32.92]
Subtotal *** 25   28   3.47% 20[7.08,32.92]
Heterogeneity: Not applicable  
Test for overall effect: Z=3.03(P=0)  
   
16.13.3 mixed urinary incontinence  
Al-Azzawi 2014 40 80 (11.1) 40 20 (4.4) 42.22% 60[56.29,63.71]
Kondo 2006 21 87.1 (13.3) 23 43.9 (17.3) 7.05% 43.2[34.13,52.27]
Song 2004 19 125 (13) 48 27 (5) 16.05% 98[91.99,104.01]
Zargham 2013 25 42 (20) 25 56 (24) 3.87% -14[-26.25,-1.75]
Subtotal *** 105   136   69.18% 62.96[60.07,65.86]
Heterogeneity: Tau2=0; Chi2=302.78, df=3(P<0.0001); I2=99.01%  
Test for overall effect: Z=42.61(P<0.0001)  
favours traditional sling 10050-100 -50 0 favours MUS
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Study or subgroup Traditonal sling Mid-urethral sling Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
   
Total *** 160   195   100% 57.08[54.67,59.49]
Heterogeneity: Tau2=0; Chi2=368.95, df=6(P<0.0001); I2=98.37%  
Test for overall effect: Z=46.44(P<0.0001)  
Test for subgroup differences: Chi2=66.17, df=1 (P<0.0001), I2=96.98%  
favours traditional sling 10050-100 -50 0 favours MUS
 
 
Analysis 16.14.   Comparison 16 Traditional suburethral sling operation versus
a mid-urethral sling or tape, Outcome 14 Length of hospital stay (days).
Study or subgroup Traditonal sling Mid-urethral sling Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
16.14.1 urodynamic stress incontinence (only)  
Silva Filho 2006 10 1.9 (0.2) 10 1.2 (0.4) 51.03% 0.65[0.39,0.91]
Subtotal *** 10   10   51.03% 0.65[0.39,0.91]
Heterogeneity: Not applicable  
Test for overall effect: Z=4.84(P<0.0001)  
   
16.14.2 stress urinary incontinence (symptoms only)  
Subtotal *** 0   0   Not estimable
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
16.14.3 mixed urinary incontinence  
Al-Azzawi 2014 40 2.8 (1.3) 40 1.2 (0.4) 18.73% 1.6[1.17,2.03]
Kondo 2006 21 9.2 (0.9) 23 9.2 (0.6) 16.95% 0[-0.46,0.46]
Zargham 2013 25 2.9 (0.9) 25 2.1 (0.9) 13.28% 0.81[0.29,1.33]
Subtotal *** 86   88   48.97% 0.83[0.56,1.1]
Heterogeneity: Tau2=0; Chi2=24.79, df=2(P<0.0001); I2=91.93%  
Test for overall effect: Z=6.07(P<0.0001)  
   
Total *** 96   98   100% 0.74[0.55,0.93]
Heterogeneity: Tau2=0; Chi2=25.69, df=3(P<0.0001); I2=88.32%  
Test for overall effect: Z=7.71(P<0.0001)  
Test for subgroup differences: Chi2=0.9, df=1 (P=0.34), I2=0%  
favours traditional sling 21-2 -1 0 favours MUS
 
 
Analysis 16.15.   Comparison 16 Traditional suburethral sling operation versus
a mid-urethral sling or tape, Outcome 15 Time to catheter removal (days).
Study or subgroup Traditonal sling Mid-urethral sling Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
16.15.1 urodynamic stress incontinence (only)  
Subtotal *** 0   0   Not estimable
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
favours traditional sling 42-4 -2 0 favours MUS
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Study or subgroup Traditonal sling Mid-urethral sling Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
16.15.2 stress urinary incontinence (symptoms only)  
Wadie 2005 25 6.6 (5.3) 28 4.3 (2.6) 0.65% 2.3[0.01,4.59]
Subtotal *** 25   28   0.65% 2.3[0.01,4.59]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.97(P=0.05)  
   
16.15.3 mixed urinary incontinence  
Kondo 2006 29 1.4 (0.5) 31 1.3 (0.1) 99.35% 0.1[-0.09,0.29]
Subtotal *** 29   31   99.35% 0.1[-0.09,0.29]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.06(P=0.29)  
   
Total *** 54   59   100% 0.11[-0.07,0.3]
Heterogeneity: Tau2=0; Chi2=3.52, df=1(P=0.06); I2=71.61%  
Test for overall effect: Z=1.21(P=0.23)  
Test for subgroup differences: Chi2=3.52, df=1 (P=0.06), I2=71.61%  
favours traditional sling 42-4 -2 0 favours MUS
 
 
Analysis 16.16.   Comparison 16 Traditional suburethral sling operation versus
a mid-urethral sling or tape, Outcome 16 Perioperative surgical complications.
Study or subgroup Traditonal sling Mid-ure-
thral sling
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
16.16.1 urodynamic stress incontinence (only)  
Arunkalaivanan 2003 17/74 13/68 48.09% 1.2[0.63,2.29]
Tcherniakovsky 2009 12/20 3/21 10.39% 4.2[1.39,12.71]
Subtotal (95% CI) 94 89 58.48% 1.73[1.01,2.96]
Total events: 29 (Traditonal sling), 16 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=3.7, df=1(P=0.05); I2=73%  
Test for overall effect: Z=2.01(P=0.04)  
   
16.16.2 stress urinary incontinence (symptoms only)  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditonal sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
16.16.3 mixed urinary incontinence  
Kondo 2006 11/29 9/31 30.88% 1.31[0.64,2.69]
Zargham 2013 9/25 3/25 10.65% 3[0.92,9.79]
Subtotal (95% CI) 54 56 41.52% 1.74[0.94,3.21]
Total events: 20 (Traditonal sling), 12 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=1.42, df=1(P=0.23); I2=29.66%  
Test for overall effect: Z=1.78(P=0.08)  
   
Total (95% CI) 148 145 100% 1.74[1.16,2.6]
Total events: 49 (Traditonal sling), 28 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=5.12, df=3(P=0.16); I2=41.46%  
favours traditional sling 2000.005 100.1 1 favours MUS
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Study or subgroup Traditonal sling Mid-ure-
thral sling
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Test for overall effect: Z=2.68(P=0.01)  
Test for subgroup differences: Chi2=0, df=1 (P=0.99), I2=0%  
favours traditional sling 2000.005 100.1 1 favours MUS
 
 
Analysis 16.17.   Comparison 16 Traditional suburethral sling operation
versus a mid-urethral sling or tape, Outcome 17 Bladder perforations.
Study or subgroup Traditonal sling Mid-ure-
thral sling
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
16.17.1 urodynamic stress incontinence (only)  
Arunkalaivanan 2003 0/74 0/68   Not estimable
Guerrero 2008 2/79 4/72 13.51% 0.46[0.09,2.41]
Tcherniakovsky 2009 1/20 0/21 1.58% 3.14[0.14,72.92]
Subtotal (95% CI) 173 161 15.08% 0.74[0.19,2.86]
Total events: 3 (Traditonal sling), 4 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=1.14, df=1(P=0.29); I2=12.02%  
Test for overall effect: Z=0.44(P=0.66)  
   
16.17.2 stress urinary incontinence (symptoms only)  
Wadie 2005 1/25 2/28 6.09% 0.56[0.05,5.81]
Subtotal (95% CI) 25 28 6.09% 0.56[0.05,5.81]
Total events: 1 (Traditonal sling), 2 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.49(P=0.63)  
   
16.17.3 mixed urinary incontinence  
Al-Azzawi 2014 0/40 0/40   Not estimable
Basok 2008 3/67 8/72 24.89% 0.4[0.11,1.46]
Kondo 2006 7/29 7/31 21.83% 1.07[0.43,2.67]
Sharifiaghdas 2008 2/36 6/25 22.85% 0.23[0.05,1.05]
Song 2004 0/19 1/48 2.81% 0.82[0.03,19.21]
Zargham 2013 1/25 2/25 6.45% 0.5[0.05,5.17]
Subtotal (95% CI) 216 241 78.83% 0.56[0.3,1.03]
Total events: 13 (Traditonal sling), 24 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=3.53, df=4(P=0.47); I2=0%  
Test for overall effect: Z=1.86(P=0.06)  
   
Total (95% CI) 414 430 100% 0.59[0.34,1.01]
Total events: 17 (Traditonal sling), 30 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=4.66, df=7(P=0.7); I2=0%  
Test for overall effect: Z=1.93(P=0.05)  
Test for subgroup differences: Chi2=0.13, df=1 (P=0.94), I2=0%  
favours traditional sling 1000.01 100.1 1 favours MUS
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Analysis 16.18.   Comparison 16 Traditional suburethral sling operation
versus a mid-urethral sling or tape, Outcome 18 Urethral injury.
Study or subgroup Traditonal sling Mid-urethral sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
16.18.1 urodynamic stress incontinence (only)  
   
16.18.2 stress urinary incontinence (symptoms only)  
   
16.18.3 mixed urinary incontinence  
Kondo 2006 0/29 1/31 0.36[0.02,8.39]
favours traditional sling 5000.002 100.1 1 favours MUS
 
 
Analysis 16.19.   Comparison 16 Traditional suburethral sling operation
versus a mid-urethral sling or tape, Outcome 19 Vaginal bleeding.
Study or subgroup Traditonal sling Mid-urethral sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
16.19.1 urodynamic stress incontinence (only)  
   
16.19.2 stress urinary incontinence (symptoms only)  
   
16.19.3 mixed urinary incontinence  
Zargham 2013 5/25 3/25 1.67[0.45,6.24]
favours traditional sling 5000.002 100.1 1 favours MUS
 
 
Analysis 16.20.   Comparison 16 Traditional suburethral sling operation
versus a mid-urethral sling or tape, Outcome 20 Urinary tract infection.
Study or subgroup Traditonal sling Mid-urethral sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
16.20.1 urodynamic stress incontinence (only)  
   
16.20.2 stress urinary incontinence (symptoms only)  
   
16.20.3 mixed urinary incontinence  
Zargham 2013 3/25 3/25 1[0.22,4.49]
favours traditional sling 5000.002 100.1 1 favours MUS
 
 
Analysis 16.21.   Comparison 16 Traditional suburethral sling operation
versus a mid-urethral sling or tape, Outcome 21 Voiding dysfunction.
Study or subgroup Traditonal sling Mid-ure-
thral sling
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
16.21.1 urodynamic stress incontinence (only)  
Arunkalaivanan 2003 8/74 6/68 22.16% 1.23[0.45,3.35]
favours traditional sling 10000.001 100.1 1 favours MUS
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Study or subgroup Traditonal sling Mid-ure-
thral sling
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Bai 2005 2/28 4/31 13.45% 0.55[0.11,2.79]
Guerrero 2008 6/61 3/63 10.46% 2.07[0.54,7.89]
Subtotal (95% CI) 163 162 46.08% 1.22[0.6,2.46]
Total events: 16 (Traditonal sling), 13 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=1.51, df=2(P=0.47); I2=0%  
Test for overall effect: Z=0.55(P=0.58)  
   
16.21.2 stress urinary incontinence (symptoms only)  
Wadie 2005 7/25 3/28 10.03% 2.61[0.76,9.03]
Subtotal (95% CI) 25 28 10.03% 2.61[0.76,9.03]
Total events: 7 (Traditonal sling), 3 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.52(P=0.13)  
   
16.21.3 mixed urinary incontinence  
Al-Azzawi 2014 0/40 1/40 5.32% 0.33[0.01,7.95]
Kondo 2006 4/29 0/31 1.71% 9.6[0.54,170.84]
Sharifiaghdas 2008 11/36 5/25 20.91% 1.53[0.61,3.86]
Zargham 2013 0/25 4/25 15.95% 0.11[0.01,1.96]
Subtotal (95% CI) 130 121 43.89% 1.18[0.58,2.4]
Total events: 15 (Traditonal sling), 10 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=5.54, df=3(P=0.14); I2=45.9%  
Test for overall effect: Z=0.47(P=0.64)  
   
Total (95% CI) 318 311 100% 1.34[0.85,2.12]
Total events: 38 (Traditonal sling), 26 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=8.19, df=7(P=0.32); I2=14.53%  
Test for overall effect: Z=1.27(P=0.21)  
Test for subgroup differences: Chi2=1.3, df=1 (P=0.52), I2=0%  
favours traditional sling 10000.001 100.1 1 favours MUS
 
 
Analysis 16.22.   Comparison 16 Traditional suburethral sling operation versus a mid-
urethral sling or tape, Outcome 22 De novo detrusor urgency or urge symptoms.
Study or subgroup Traditonal sling Mid-ure-
thral sling
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
16.22.1 urodynamic stress incontinence (only)  
Guerrero 2008 0/61 1/63 19.52% 0.34[0.01,8.29]
Subtotal (95% CI) 61 63 19.52% 0.34[0.01,8.29]
Total events: 0 (Traditonal sling), 1 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.66(P=0.51)  
   
16.22.2 stress urinary incontinence (symptoms only)  
Wadie 2005 1/25 0/28 6.25% 3.35[0.14,78.6]
Subtotal (95% CI) 25 28 6.25% 3.35[0.14,78.6]
Total events: 1 (Traditonal sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
favours traditional sling 5000.002 100.1 1 favours MUS
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Study or subgroup Traditonal sling Mid-ure-
thral sling
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Test for overall effect: Z=0.75(P=0.45)  
   
16.22.3 mixed urinary incontinence  
Kondo 2006 3/29 2/31 25.56% 1.6[0.29,8.92]
Sharifiaghdas 2008 8/36 1/25 15.61% 5.56[0.74,41.68]
Zargham 2013 0/25 2/25 33.06% 0.2[0.01,3.97]
Subtotal (95% CI) 90 81 74.23% 1.81[0.65,5.06]
Total events: 11 (Traditonal sling), 5 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=3.3, df=2(P=0.19); I2=39.35%  
Test for overall effect: Z=1.13(P=0.26)  
   
Total (95% CI) 176 172 100% 1.62[0.66,3.99]
Total events: 12 (Traditonal sling), 6 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=4.43, df=4(P=0.35); I2=9.79%  
Test for overall effect: Z=1.05(P=0.29)  
Test for subgroup differences: Chi2=1.16, df=1 (P=0.56), I2=0%  
favours traditional sling 5000.002 100.1 1 favours MUS
 
 
Analysis 16.23.   Comparison 16 Traditional suburethral sling operation versus a mid-
urethral sling or tape, Outcome 23 De novo detrusor overactivity (urodynamic diagnosis).
Study or subgroup Traditonal sling Mid-ure-
thral sling
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
16.23.1 urodynamic stress incontinence (only)  
Bai 2005 0/28 0/31   Not estimable
Subtotal (95% CI) 28 31 Not estimable
Total events: 0 (Traditonal sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
16.23.2 stress urinary incontinence (symptoms only)  
Wadie 2005 1/23 0/24 6.7% 3.13[0.13,73.01]
Subtotal (95% CI) 23 24 6.7% 3.13[0.13,73.01]
Total events: 1 (Traditonal sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.71(P=0.48)  
   
16.23.3 mixed urinary incontinence  
Al-Azzawi 2014 2/40 2/40 27.36% 1[0.15,6.76]
Basok 2008 15/67 5/72 65.94% 3.22[1.24,8.39]
Subtotal (95% CI) 107 112 93.3% 2.57[1.12,5.92]
Total events: 17 (Traditonal sling), 7 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=1.15, df=1(P=0.28); I2=13.34%  
Test for overall effect: Z=2.22(P=0.03)  
   
Total (95% CI) 158 167 100% 2.61[1.17,5.84]
Total events: 18 (Traditonal sling), 7 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=1.17, df=2(P=0.56); I2=0%  
favours traditional sling 1000.01 100.1 1 favours MUS
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Study or subgroup Traditonal sling Mid-ure-
thral sling
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Test for overall effect: Z=2.33(P=0.02)  
Test for subgroup differences: Chi2=0.01, df=1 (P=0.91), I2=0%  
favours traditional sling 1000.01 100.1 1 favours MUS
 
 
Analysis 16.24.   Comparison 16 Traditional suburethral sling operation versus a mid-
urethral sling or tape, Outcome 24 Long-term adverse e@ects (release of sling required).
Study or subgroup Traditonal sling Mid-ure-
thral sling
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
16.24.1 urodynamic stress incontinence (only)  
Arunkalaivanan 2003 5/74 2/68 45.95% 2.3[0.46,11.45]
Guerrero 2008 2/61 2/63 43.38% 1.03[0.15,7.1]
Subtotal (95% CI) 135 131 89.33% 1.68[0.5,5.66]
Total events: 7 (Traditonal sling), 4 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=0.39, df=1(P=0.53); I2=0%  
Test for overall effect: Z=0.84(P=0.4)  
   
16.24.2 stress urinary incontinence (symptoms only)  
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Traditonal sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
16.24.3 mixed urinary incontinence  
Kondo 2006 4/29 0/31 10.67% 9.6[0.54,170.84]
Subtotal (95% CI) 29 31 10.67% 9.6[0.54,170.84]
Total events: 4 (Traditonal sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.54(P=0.12)  
   
Total (95% CI) 164 162 100% 2.53[0.87,7.35]
Total events: 11 (Traditonal sling), 4 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=1.67, df=2(P=0.43); I2=0%  
Test for overall effect: Z=1.7(P=0.09)  
Test for subgroup differences: Chi2=1.19, df=1 (P=0.27), I2=16.2%  
favours traditional sling 2000.005 100.1 1 favours MUS
 
 
Analysis 16.25.   Comparison 16 Traditional suburethral sling operation versus a mid-
urethral sling or tape, Outcome 25 Long-term adverse e@ects (wound pain at 6 months).
Study or subgroup Traditonal sling Mid-ure-
thral sling
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
16.25.1 urodynamic stress incontinence (only)  
Guerrero 2008 2/61 0/63 17.09% 5.16[0.25,105.36]
favours traditional sling 2000.005 100.1 1 favours MUS
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Study or subgroup Traditonal sling Mid-ure-
thral sling
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Subtotal (95% CI) 61 63 17.09% 5.16[0.25,105.36]
Total events: 2 (Traditonal sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.07(P=0.29)  
   
16.25.2 stress urinary incontinence (symptoms only)  
Wadie 2005 7/25 2/28 65.54% 3.92[0.9,17.15]
Subtotal (95% CI) 25 28 65.54% 3.92[0.9,17.15]
Total events: 7 (Traditonal sling), 2 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.81(P=0.07)  
   
16.25.3 mixed urinary incontinence  
Al-Azzawi 2014 8/40 0/40 17.37% 17[1.01,284.96]
Subtotal (95% CI) 40 40 17.37% 17[1.01,284.96]
Total events: 8 (Traditonal sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.97(P=0.05)  
   
Total (95% CI) 126 131 100% 6.4[1.94,21.12]
Total events: 17 (Traditonal sling), 2 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=0.91, df=2(P=0.64); I2=0%  
Test for overall effect: Z=3.05(P=0)  
Test for subgroup differences: Chi2=0.82, df=1 (P=0.66), I2=0%  
favours traditional sling 2000.005 100.1 1 favours MUS
 
 
Analysis 16.26.   Comparison 16 Traditional suburethral sling operation versus a mid-urethral
sling or tape, Outcome 26 Long-term adverse e@ects (vaginal mesh or graO exposure).
Study or subgroup Traditonal sling Mid-ure-
thral sling
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
16.26.1 urodynamic stress incontinence (only)  
Guerrero 2008 0/61 1/63 27.13% 0.34[0.01,8.29]
Tcherniakovsky 2009 0/20 1/21 26.93% 0.35[0.02,8.1]
Subtotal (95% CI) 81 84 54.06% 0.35[0.04,3.24]
Total events: 0 (Traditonal sling), 2 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=0, df=1(P=0.99); I2=0%  
Test for overall effect: Z=0.93(P=0.35)  
   
16.26.2 stress urinary incontinence (symptoms only)  
Wadie 2005 0/25 0/28   Not estimable
Subtotal (95% CI) 25 28 Not estimable
Total events: 0 (Traditonal sling), 0 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
16.26.3 mixed urinary incontinence  
Al-Azzawi 2014 0/40 0/40   Not estimable
favours traditional sling 5000.002 100.1 1 favours MUS
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Study or subgroup Traditonal sling Mid-ure-
thral sling
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Zargham 2013 0/25 2/25 45.94% 0.2[0.01,3.97]
Subtotal (95% CI) 65 65 45.94% 0.2[0.01,3.97]
Total events: 0 (Traditonal sling), 2 (Mid-urethral sling)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.06(P=0.29)  
   
Total (95% CI) 171 177 100% 0.28[0.05,1.65]
Total events: 0 (Traditonal sling), 4 (Mid-urethral sling)  
Heterogeneity: Tau2=0; Chi2=0.08, df=2(P=0.96); I2=0%  
Test for overall effect: Z=1.41(P=0.16)  
Test for subgroup differences: Chi2=0.08, df=1 (P=0.77), I2=0%  
favours traditional sling 5000.002 100.1 1 favours MUS
 
 
Analysis 16.27.   Comparison 16 Traditional suburethral sling operation versus a mid-
urethral sling or tape, Outcome 27 Condition-specific measures to assess quality of life: UDI-6.
Study or subgroup Traditonal sling Mid-urethral sling Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
16.27.1 urodynamic stress incontinence (only)  
Subtotal *** 0   0   Not estimable
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
16.27.2 stress urinary incontinence (symptoms only)  
Wadie 2005 39 31.7 (16.9) 24 24.4 (19.1) 100% 7.3[-2,16.6]
Subtotal *** 39   24   100% 7.3[-2,16.6]
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=1.54(P=0.12)  
   
16.27.3 mixed urinary incontinence  
Subtotal *** 0   0   Not estimable
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total *** 39   24   100% 7.3[-2,16.6]
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=1.54(P=0.12)  
Test for subgroup differences: Not applicable  
favours traditional sling 10050-100 -50 0 favours MUS
 
 
Analysis 16.28.   Comparison 16 Traditional suburethral sling operation versus a mid-
urethral sling or tape, Outcome 28 Condition-specific measures to assess quality of life: IIQ-7.
Study or subgroup Traditonal sling Mid-urethral sling Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
16.28.1 urodynamic stress incontinence (only)  
favours traditional sling 10050-100 -50 0 favours MUS
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Study or subgroup Traditonal sling Mid-urethral sling Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
Subtotal *** 0   0   Not estimable
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
16.28.2 stress urinary incontinence (symptoms only)  
Wadie 2005 39 24.4 (20.5) 24 23.8 (21.6) 100% 0.6[-10.17,11.37]
Subtotal *** 39   24   100% 0.6[-10.17,11.37]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.11(P=0.91)  
   
16.28.3 mixed urinary incontinence  
Subtotal *** 0   0   Not estimable
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
Total *** 39   24   100% 0.6[-10.17,11.37]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.11(P=0.91)  
Test for subgroup differences: Not applicable  
favours traditional sling 10050-100 -50 0 favours MUS
 
 
Comparison 17.   Traditional suburethral sling operation versus a single-incision sling (mini-sling)





Statistical method Effect size
1 Number of women with urinary
incontinence in the medium term
(1 to 5 years)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 urodynamic stress inconti-
nence (only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Number of women not satisfied
within first year
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 urodynamic stress inconti-
nence (only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Statistical method Effect size
3 Number of women with urinary
incontinence (clinician's observa-
tions) within first year
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3.1 urodynamic stress inconti-
nence (only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 CURE: number of women cured
at > 1 year (women's observations)
1   Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
4.1 urodynamic stress inconti-
nence (only)
1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 stress urinary incontinence
(symptoms only)
0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.3 mixed incontinence 0   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Bladder perforation 1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
5.1 urodynamic stress inconti-
nence (only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Urge urinary symptoms, urgency
urinary incontinence
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
6.1 urodynamic stress inconti-
nence (only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Pain with intercourse (dyspareu-
nia)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
7.1 urodynamic stress inconti-
nence (only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Statistical method Effect size
8 Long-term adverse effects (vagi-
nal mesh or graE exposure)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
8.1 urodynamic stress inconti-
nence (only)
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.2 stress urinary incontinence
(symptoms only)
0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.3 mixed incontinence 0   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9 Condition-specific measures to
assess quality of life: IIQ score
1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
9.1 urodynamic stress inconti-
nence (only)
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.2 stress urinary incontinence
(symptoms only)
0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.3 mixed urinary incontinence 0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
 
 
Analysis 17.1.   Comparison 17 Traditional suburethral sling operation versus a single-incision sling
(mini-sling), Outcome 1 Number of women with urinary incontinence in the medium term (1 to 5 years).
Study or subgroup Traditional sling Mini-sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
17.1.1 urodynamic stress incontinence (only)  
Sharifiaghdas 2015 4/35 4/35 1[0.27,3.69]
   
17.1.2 stress urinary incontinence (symptoms only)  
   
17.1.3 mixed incontinence  
favours traditional sling 10000.001 100.1 1 favours mini-sling
 
 
Analysis 17.2.   Comparison 17 Traditional suburethral sling operation versus a single-
incision sling (mini-sling), Outcome 2 Number of women not satisfied within first year.
Study or subgroup favours traditional sling Mini-sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
17.2.1 urodynamic stress incontinence (only)  
Sharifiaghdas 2015 10/35 7/35 1.43[0.61,3.32]
   
17.2.2 stress urinary incontinence (symptoms only)  
   
17.2.3 mixed incontinence  
favours traditional sling 10000.001 100.1 1 favours mini-sling
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Analysis 17.3.   Comparison 17 Traditional suburethral sling operation versus a single-incision sling (mini-
sling), Outcome 3 Number of women with urinary incontinence (clinician's observations) within first year.
Study or subgroup Traditional sling Mini-sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
17.3.1 urodynamic stress incontinence (only)  
Sharifiaghdas 2015 4/35 4/35 1[0.27,3.69]
   
17.3.2 stress urinary incontinence (symptoms only)  
   
17.3.3 mixed incontinence  
favours traditional sling 10000.001 100.1 1 favours mini-sling
 
 
Analysis 17.4.   Comparison 17 Traditional suburethral sling operation versus a single-incision
sling (mini-sling), Outcome 4 CURE: number of women cured at > 1 year (women's observations).
Study or subgroup Traditional sling Mini-sling Odds Ratio Odds Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
17.4.1 urodynamic stress incontinence (only)  
Sharifiaghdas 2015 31/35 31/35 1[0.23,4.36]
   
17.4.2 stress urinary incontinence (symptoms only)  
   
17.4.3 mixed incontinence  
favours mini-sling 1000.01 100.1 1 favours traditional sling
 
 
Analysis 17.5.   Comparison 17 Traditional suburethral sling operation
versus a single-incision sling (mini-sling), Outcome 5 Bladder perforation.
Study or subgroup Traditional sling Mini-sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
17.5.1 urodynamic stress incontinence (only)  
Sharifiaghdas 2015 1/35 0/35 3[0.13,71.22]
   
17.5.2 stress urinary incontinence (symptoms only)  
   
17.5.3 mixed incontinence  
favours traditional sling 10000.001 100.1 1 favours mini-sling
 
 
Analysis 17.6.   Comparison 17 Traditional suburethral sling operation versus a single-
incision sling (mini-sling), Outcome 6 Urge urinary symptoms, urgency urinary incontinence.
Study or subgroup Traditional sling Mini-sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
17.6.1 urodynamic stress incontinence (only)  
favours traditional sling 1000.01 100.1 1 favours mini-sling
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Study or subgroup Traditional sling Mini-sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
Sharifiaghdas 2015 5/35 1/35 5[0.62,40.64]
   
17.6.2 stress urinary incontinence (symptoms only)  
   
17.6.3 mixed incontinence  
favours traditional sling 1000.01 100.1 1 favours mini-sling
 
 
Analysis 17.7.   Comparison 17 Traditional suburethral sling operation versus a
single-incision sling (mini-sling), Outcome 7 Pain with intercourse (dyspareunia).
Study or subgroup Traditional sling Mini-sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
17.7.1 urodynamic stress incontinence (only)  
Sharifiaghdas 2015 3/35 4/35 0.75[0.18,3.11]
   
17.7.2 stress urinary incontinence (symptoms only)  
   
17.7.3 mixed incontinence  
favours traditional sling 10000.001 100.1 1 favours mini-sling
 
 
Analysis 17.8.   Comparison 17 Traditional suburethral sling operation versus a single-incision
sling (mini-sling), Outcome 8 Long-term adverse e@ects (vaginal mesh or graO exposure).
Study or subgroup Traditional sling Mini-sling Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
17.8.1 urodynamic stress incontinence (only)  
Sharifiaghdas 2015 1/35 2/35 0.5[0.05,5.27]
   
17.8.2 stress urinary incontinence (symptoms only)  
   
17.8.3 mixed incontinence  
favours traditional sling 10000.001 100.1 1 favours mini-sling
 
 
Analysis 17.9.   Comparison 17 Traditional suburethral sling operation versus a single-incision
sling (mini-sling), Outcome 9 Condition-specific measures to assess quality of life: IIQ score.
Study or subgroup Traditional sling Mini-sling Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
17.9.1 urodynamic stress incontinence (only)  
Sharifiaghdas 2015 35 50.2 (11.1) 35 42.7 (11.4) 7.5[2.23,12.77]
   
17.9.2 stress urinary incontinence (symptoms only)  
   
17.9.3 mixed urinary incontinence  
favours traditional sling 5025-50 -25 0 favours mini-sling
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Comparison 18.   One type of traditional sling operation versus another type of traditional sling operation





Statistical method Effect size
1 Number of women with urinary
incontinence (worse, unchanged,
or improved) within first year
(women's observations)
5   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
1.1 fascial sling vs Pelvicol sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 standard sling vs short sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 autologous fascial sling vs Forta-
perm sling
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.4 Vypro vs Ultrapro 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.5 Vypro vs Prolene light 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.6 Ultrapro vs Prolene light 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.7 fascial sling vs vaginal wall sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Number not improved (worse
or unchanged) within first year
(women's observations)
3   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
2.1 fascial sling vs Pelvicol sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 autologous fascial sling vs Forta-
perm sling
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 rectus fascia sling vs Goretex
sling
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Number of women with urinary in-
continence (worse, unchanged, or
improved) at 1 to 5 years (women's
observations)
7   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
3.1 fascial sling vs Pelvicol sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 standard sling vs short sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 autologous dermal graE patch vs
cadaveric fascia lata
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.4 rectus fascia sling vs Goretex
sling
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.5 Vypro vs Ultrapro 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.6 Vypro vs Prolene light 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Statistical method Effect size
3.7 Ultrapro vs Prolene light 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.8 anterior vaginal wall sling vs
biosynthetic mesh sling
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.9 anterior rectus sheath sling vs
Prolene strip
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.10 anterior rectus sheath sling vs
anterior vaginal wall patch
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.11 Prolene strip vs anterior vaginal
wall patch
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Number not improved (worse
or unchanged) after first year
(women's observations)
4   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
4.1 fascial sling vs Pelvicol sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 autologous dermal graE patch vs
cadaveric fascia lata
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.3 rectus fascia sling vs Goretex
sling
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.4 anterior rectus sheath sling vs
Prolene strip
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.5 anterior rectus sheath sling vs
anterior vaginal wall patch
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.6 Prolene strip vs anterior vaginal
wall patch
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Number of women with urinary in-
continence (worse, unchanged, or
improved) after 5 years (women's
observations)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
5.1 standard sling vs short sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 CURE: number of women with
urinary incontinence > 1 year
(women's observations)
3   Odds Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
6.1 fascial sling vs Pelvicol sling 1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 standard sling vs short sling 1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 autologous dermal graE patch vs
cadaveric fascia lata
1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Statistical method Effect size
7 Number of women not satisfied 3   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
7.1 fascial sling vs Pelvicol sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.2 Vypro vs Ultrapro 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.3 Vypro vs Prolene light 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.4 Ultrapro vs Prolene light 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.5 anterior vaginal wall sling vs
biosynthetic mesh sling
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8 Pad test of quantified leakage
(mean weight of urine loss) at 1 year
2   Mean Difference (IV, Fixed, 95% CI) Totals not select-
ed
8.1 standard sling vs short sling 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.2 Vypro vs Ultrapro 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.3 Vypro vs Prolene light 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.4 Ultrapro vs Prolene light 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
9 Pad test of quantified leakage
(mean weight of urine loss) at 1 to 5
years
1   Mean Difference (IV, Fixed, 95% CI) Totals not select-
ed
9.1 Vypro vs Ultrapro 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.2 Vypro vs Prolene light 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.3 Ultrapro vs Prolene light 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
10 Duration of operation (minutes) 2   Mean Difference (IV, Fixed, 95% CI) Totals not select-
ed
10.1 standard sling vs short sling 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
10.2 anterior rectus sheath sling vs
Prolene strip
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
10.3 anterior rectus sheath sling vs
anterior vaginal wall patch
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
10.4 Prolene strip vs anterior vaginal
wall patch
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
11 Blood loss (mL) 1   Mean Difference (IV, Fixed, 95% CI) Totals not select-
ed
11.1 anterior rectus sheath sling vs
Prolene strip
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
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11.2 anterior rectus sheath sling vs
anterior vaginal wall patch
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
11.3 Prolene strip vs anterior vaginal
wall patch
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
12 Length of hospital stay (days) 1   Mean Difference (IV, Fixed, 95% CI) Totals not select-
ed
12.1 anterior rectus sheath sling vs
Prolene strip
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
12.2 anterior rectus sheath sling vs
anterior vaginal wall patch
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
12.3 Prolene strip vs anterior vaginal
wall patch
1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
13 Perioperative surgical complica-
tions
3   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
13.1 standard sling vs short sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
13.2 rectus fascia sling vs Goretex
sling
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
13.3 fascial sling vs vaginal wall
sling
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
14 Bladder perforation 3   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
14.1 standard sling vs short sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
14.2 fascial sling vs Pelvicol sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
14.3 anterior rectus sheath sling vs
Prolene strip
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
14.4 anterior rectus sheath sling vs
anterior vaginal wall patch
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
14.5 Prolene strip vs anterior vaginal
wall patch
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
15 Urinary tract infection 2   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
15.1 standard sling vs short sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
15.2 anterior vaginal wall sling vs
biosynthetic mesh sling
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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16 Vaginal bleeding 1   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
16.1 anterior vaginal wall sling vs
biosynthetic mesh sling
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
17 Long-term adverse effects
(wound pain)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
17.1 fascial sling vs Pelvicol sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
18 Voiding dysfunction 6   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
18.1 fascial sling vs Pelvicol sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.2 standard sling vs short sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.3 Vypro vs Ultrapro 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.4 Vypro vs Prolene light 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.5 Ultrapro vs Prolene light 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.6 anterior vaginal wall sling vs
biosynthetic mesh sling
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.7 anterior rectus sheath sling vs
Prolene strip
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.8 anterior rectus sheath sling vs
anterior vaginal wall patch
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.9 Prolene strip vs anterior vaginal
wall patch
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.10 fascial sling vs vaginal wall
sling
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19 Long-term adverse effects (re-
lease of sling required)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
19.1 fascial sling vs Pelvicol sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
20 De novo detrusor urgency or urge
symptoms or detrusor overactivity
4   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
20.1 standard sling vs short sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
20.2 Vypro vs Ultrapro 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
20.3 Vypro vs Prolene light 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
20.4 Ultrapro vs Prolene light 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Statistical method Effect size
20.5 autologous dermal graE patch
vs cadaveric fascia lata
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
20.6 rectus fascia sling vs Goretex
sling
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
21 Repeat surgery for urinary incon-
tinence at first year
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
21.1 Fascial sling vs Pelvicol sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
22 Long-term adverse effects (vagi-
nal mesh or graE exposure)
3   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
22.1 fascial sling vs Pelvicol sling 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
22.2 Vypro vs Ultrapro 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
22.3 Vypro vs Prolene light 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
22.4 Ultrapro vs Prolene light 1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
22.5 anterior vaginal wall sling vs
biosynthetic mesh sling
1   Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
23 Condition-specific measures to
assess quality of life (ICI-Q short
form UI score at 1 year)
1   Mean Difference (IV, Fixed, 95% CI) Totals not select-
ed
23.1 Vypro vs Ultrapro 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
23.2 Vypro vs Prolene light 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
23.3 Ultrapro vs Prolene light 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
24 Condition-specific measures to
assess quality of life (ICI-Q short
form UI score at 1 to 5 years)
1   Mean Difference (IV, Fixed, 95% CI) Totals not select-
ed
24.1 Vypro vs Ultrapro 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
24.2 Vypro vs Prolene light 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
24.3 Ultrapro vs Prolene light 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Analysis 18.1.   Comparison 18 One type of traditional sling operation versus another
type of traditional sling operation, Outcome 1 Number of women with urinary
incontinence (worse, unchanged, or improved) within first year (women's observations).
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
18.1.1 fascial sling vs Pelvicol sling  
Guerrero 2008 38/73 25/45 0.94[0.67,1.32]
   
18.1.2 standard sling vs short sling  
Lucas 2000 14/72 16/72 0.88[0.46,1.66]
   
18.1.3 autologous fascial sling vs Fortaperm sling  
Pacetta 2005 1/10 5/24 0.48[0.06,3.61]
   
18.1.4 Vypro vs Ultrapro  
Okulu 2013 5/46 3/48 1.74[0.44,6.86]
   
18.1.5 Vypro vs Prolene light  
Okulu 2013 5/46 6/47 0.85[0.28,2.6]
   
18.1.6 Ultrapro vs Prolene light  
Okulu 2013 3/48 6/47 0.49[0.13,1.84]
   
18.1.7 fascial sling vs vaginal wall sling  
Viseshsindh 2003 1/15 0/11 2.25[0.1,50.54]
Favours sling A 500.02 100.1 1 Favours sling B
 
 
Analysis 18.2.   Comparison 18 One type of traditional sling operation versus another type of traditional sling
operation, Outcome 2 Number not improved (worse or unchanged) within first year (women's observations).
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
18.2.1 fascial sling vs Pelvicol sling  
Guerrero 2008 4/73 12/45 0.21[0.07,0.6]
   
18.2.2 autologous fascial sling vs Fortaperm sling  
Pacetta 2005 0/10 2/24 0.45[0.02,8.71]
   
18.2.3 rectus fascia sling vs Goretex sling  
Barbalias 1997 6/32 0/16 6.7[0.4,111.94]
Favours sling A 5000.002 100.1 1 Favours sling B
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Analysis 18.3.   Comparison 18 One type of traditional sling operation versus another
type of traditional sling operation, Outcome 3 Number of women with urinary
incontinence (worse, unchanged, or improved) at 1 to 5 years (women's observations).
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
18.3.1 fascial sling vs Pelvicol sling  
Guerrero 2008 35/67 36/46 0.67[0.51,0.88]
   
18.3.2 standard sling vs short sling  
Lucas 2000 35/75 30/70 1.09[0.76,1.57]
   
18.3.3 autologous dermal graO patch vs cadaveric fascia lata  
Shin 2001 8/33 5/24 1.16[0.43,3.12]
   
18.3.4 rectus fascia sling vs Goretex sling  
Barbalias 1997 11/32 2/16 2.75[0.69,10.95]
   
18.3.5 Vypro vs Ultrapro  
Okulu 2013 7/46 4/48 1.83[0.57,5.83]
   
18.3.6 Vypro vs Prolene light  
Okulu 2013 7/46 7/47 1.02[0.39,2.68]
   
18.3.7 Ultrapro vs Prolene light  
Okulu 2013 4/48 7/47 0.56[0.18,1.79]
   
18.3.8 anterior vaginal wall sling vs biosynthetic mesh sling  
Choe 2000 6/20 1/20 6[0.79,45.42]
   
18.3.9 anterior rectus sheath sling vs Prolene strip  
Teleb 2011 4/12 3/12 1.33[0.38,4.72]
   
18.3.10 anterior rectus sheath sling vs anterior vaginal wall patch  
Teleb 2011 4/12 2/8 1.33[0.32,5.64]
   
18.3.11 Prolene strip vs anterior vaginal wall patch  
Teleb 2011 3/12 2/8 1[0.21,4.71]
Favours sling A 500.02 100.1 1 Favours sling B
 
 
Analysis 18.4.   Comparison 18 One type of traditional sling operation versus another type of traditional sling
operation, Outcome 4 Number not improved (worse or unchanged) aOer first year (women's observations).
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
18.4.1 fascial sling vs Pelvicol sling  
Guerrero 2008 7/67 18/46 0.27[0.12,0.59]
   
18.4.2 autologous dermal graO patch vs cadaveric fascia lata  
Shin 2001 3/33 2/24 1.09[0.2,6.03]
   
18.4.3 rectus fascia sling vs Goretex sling  
Favours sling A 500.02 100.1 1 Favours sling B
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Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
Barbalias 1997 0/32 0/16 Not estimable
   
18.4.4 anterior rectus sheath sling vs Prolene strip  
Teleb 2011 1/12 1/12 1[0.07,14.21]
   
18.4.5 anterior rectus sheath sling vs anterior vaginal wall patch  
Teleb 2011 1/12 1/8 0.67[0.05,9.19]
   
18.4.6 Prolene strip vs anterior vaginal wall patch  
Teleb 2011 1/12 1/8 0.67[0.05,9.19]
Favours sling A 500.02 100.1 1 Favours sling B
 
 
Analysis 18.5.   Comparison 18 One type of traditional sling operation versus another
type of traditional sling operation, Outcome 5 Number of women with urinary
incontinence (worse, unchanged, or improved) aOer 5 years (women's observations).
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
18.5.1 standard sling vs short sling  
Lucas 2000 42/73 34/69 1.17[0.86,1.59]
Favours sling A 50.2 20.5 1 Favours sling B
 
 
Analysis 18.6.   Comparison 18 One type of traditional sling operation versus another type of traditional sling
operation, Outcome 6 CURE: number of women with urinary incontinence > 1 year (women's observations).
Study or subgroup Sling type A Sling type B Odds Ratio Odds Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
18.6.1 fascial sling vs Pelvicol sling  
Guerrero 2008 32/67 10/46 3.29[1.41,7.69]
   
18.6.2 standard sling vs short sling  
Lucas 2000 31/73 35/69 0.72[0.37,1.39]
   
18.6.3 autologous dermal graO patch vs cadaveric fascia lata  
Shin 2001 19/24 25/33 1.22[0.34,4.32]
Favours sling B 500.02 100.1 1 Favours sling A
 
 
Analysis 18.7.   Comparison 18 One type of traditional sling operation versus another
type of traditional sling operation, Outcome 7 Number of women not satisfied.
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
18.7.1 fascial sling vs Pelvicol sling  
Guerrero 2008 18/61 18/38 0.62[0.37,1.04]
Favours sling A 2000.005 100.1 1 Favours sling B
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Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
   
18.7.2 Vypro vs Ultrapro  
Okulu 2013 9/46 7/48 1.34[0.54,3.3]
   
18.7.3 Vypro vs Prolene light  
Okulu 2013 9/46 9/47 1.02[0.45,2.34]
   
18.7.4 Ultrapro vs Prolene light  
Okulu 2013 7/48 9/47 0.76[0.31,1.88]
   
18.7.5 anterior vaginal wall sling vs biosynthetic mesh sling  
Choe 2000 4/20 0/20 9[0.52,156.91]
Favours sling A 2000.005 100.1 1 Favours sling B
 
 
Analysis 18.8.   Comparison 18 One type of traditional sling operation versus another type of traditional
sling operation, Outcome 8 Pad test of quantified leakage (mean weight of urine loss) at 1 year.
Study or subgroup Sling type A Sling type B Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
18.8.1 standard sling vs short sling  
Lucas 2000 81 7.7 (34.1) 84 4.6 (34.1) 3.1[-7.3,13.5]
   
18.8.2 Vypro vs Ultrapro  
Okulu 2013 46 2.1 (1.4) 48 2 (1.1) 0.1[-0.41,0.61]
   
18.8.3 Vypro vs Prolene light  
Okulu 2013 46 2.1 (1.4) 47 2.4 (3.8) -0.3[-1.46,0.86]
   
18.8.4 Ultrapro vs Prolene light  
Okulu 2013 48 2 (1.1) 47 2.4 (3.8) -0.4[-1.53,0.73]
Favours sling A 2010-20 -10 0 Favours sling B
 
 
Analysis 18.9.   Comparison 18 One type of traditional sling operation versus another type of traditional
sling operation, Outcome 9 Pad test of quantified leakage (mean weight of urine loss) at 1 to 5 years.
Study or subgroup Sling type A Sling type B Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
18.9.1 Vypro vs Ultrapro  
Okulu 2013 46 0.7 (0.3) 48 0.2 (0.2) 0.45[0.35,0.55]
   
18.9.2 Vypro vs Prolene light  
Okulu 2013 46 0.7 (0.3) 47 0.8 (0.5) -0.18[-0.36,-0]
   
18.9.3 Ultrapro vs Prolene light  
Okulu 2013 48 0.2 (0.2) 47 0.8 (0.5) -0.63[-0.79,-0.47]
Favours sling A 21-2 -1 0 Favours sling B
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Analysis 18.10.   Comparison 18 One type of traditional sling operation versus another
type of traditional sling operation, Outcome 10 Duration of operation (minutes).
Study or subgroup Sling type A Sling type B Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
18.10.1 standard sling vs short sling  
Lucas 2000 81 62 (15.3) 84 54 (15.3) 8[3.32,12.68]
   
18.10.2 anterior rectus sheath sling vs Prolene strip  
Teleb 2011 12 52.1 (4.4) 12 35.7 (3.4) 16.4[13.25,19.55]
   
18.10.3 anterior rectus sheath sling vs anterior vaginal wall patch  
Teleb 2011 12 52.1 (4.4) 8 42.2 (4.5) 9.9[5.91,13.89]
   
18.10.4 Prolene strip vs anterior vaginal wall patch  
Teleb 2011 12 35.7 (3.4) 8 42.2 (4.5) -6.5[-10.16,-2.84]
Favours sling A 2010-20 -10 0 Favours sling B
 
 
Analysis 18.11.   Comparison 18 One type of traditional sling operation versus
another type of traditional sling operation, Outcome 11 Blood loss (mL).
Study or subgroup Sling type A Sling type B Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
18.11.1 anterior rectus sheath sling vs Prolene strip  
Teleb 2011 12 181 (33) 12 149 (29) 32[7.14,56.86]
   
18.11.2 anterior rectus sheath sling vs anterior vaginal wall patch  
Teleb 2011 12 181 (33) 8 201 (28) -20[-46.93,6.93]
   
18.11.3 Prolene strip vs anterior vaginal wall patch  
Teleb 2011 12 149 (29) 8 201 (28) -52[-77.41,-26.59]
Favours sling A 10050-100 -50 0 Favours sling B
 
 
Analysis 18.12.   Comparison 18 One type of traditional sling operation versus another
type of traditional sling operation, Outcome 12 Length of hospital stay (days).
Study or subgroup Sling type A Sling type B Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
18.12.1 anterior rectus sheath sling vs Prolene strip  
Teleb 2011 12 2.4 (0.5) 12 1.4 (0.4) 1.04[0.68,1.4]
   
18.12.2 anterior rectus sheath sling vs anterior vaginal wall patch  
Teleb 2011 12 2.4 (0.5) 8 1.5 (0.4) 0.92[0.53,1.31]
   
18.12.3 Prolene strip vs anterior vaginal wall patch  
Teleb 2011 12 1.4 (0.4) 8 1.5 (0.4) -0.12[-0.46,0.22]
Favours sling A 52.5-5 -2.5 0 Favours sling B
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Analysis 18.13.   Comparison 18 One type of traditional sling operation versus another
type of traditional sling operation, Outcome 13 Perioperative surgical complications.
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
18.13.1 standard sling vs short sling  
Lucas 2000 34/81 31/84 1.14[0.78,1.66]
   
18.13.2 rectus fascia sling vs Goretex sling  
Barbalias 1997 0/32 5/16 0.05[0,0.8]
   
18.13.3 fascial sling vs vaginal wall sling  
Viseshsindh 2003 0/15 0/11 Not estimable
Favours sling A 5000.002 100.1 1 Favours sling B
 
 
Analysis 18.14.   Comparison 18 One type of traditional sling operation versus
another type of traditional sling operation, Outcome 14 Bladder perforation.
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
18.14.1 standard sling vs short sling  
Lucas 2000 2/81 3/84 0.69[0.12,4.03]
   
18.14.2 fascial sling vs Pelvicol sling  
Guerrero 2008 2/79 1/50 1.27[0.12,13.6]
   
18.14.3 anterior rectus sheath sling vs Prolene strip  
Teleb 2011 0/12 1/12 0.33[0.01,7.45]
   
18.14.4 anterior rectus sheath sling vs anterior vaginal wall patch  
Teleb 2011 0/12 1/8 0.23[0.01,5.05]
   
18.14.5 Prolene strip vs anterior vaginal wall patch  
Teleb 2011 1/12 1/8 0.67[0.05,9.19]
Favours sling A 2000.005 100.1 1 Favours sling B
 
 
Analysis 18.15.   Comparison 18 One type of traditional sling operation versus
another type of traditional sling operation, Outcome 15 Urinary tract infection.
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
18.15.1 standard sling vs short sling  
Lucas 2000 10/81 6/84 1.73[0.66,4.54]
   
18.15.2 anterior vaginal wall sling vs biosynthetic mesh sling  
Choe 2000 0/20 1/20 0.33[0.01,7.72]
Favours sling A 1000.01 100.1 1 Favours sling B
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Analysis 18.16.   Comparison 18 One type of traditional sling operation versus
another type of traditional sling operation, Outcome 16 Vaginal bleeding.
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
18.16.1 anterior vaginal wall sling vs biosynthetic mesh sling  
Choe 2000 1/20 0/20 3[0.13,69.52]
Favours sling A 1000.01 100.1 1 Favours sling B
 
 
Analysis 18.17.   Comparison 18 One type of traditional sling operation versus another
type of traditional sling operation, Outcome 17 Long-term adverse e@ects (wound pain).
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
18.17.1 fascial sling vs Pelvicol sling  
Guerrero 2008 2/61 0/38 3.15[0.16,63.8]
Favours sling A 5000.002 100.1 1 Favours sling B
 
 
Analysis 18.18.   Comparison 18 One type of traditional sling operation versus
another type of traditional sling operation, Outcome 18 Voiding dysfunction.
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
18.18.1 fascial sling vs Pelvicol sling  
Guerrero 2008 4/61 0/38 5.66[0.31,102.29]
   
18.18.2 standard sling vs short sling  
Lucas 2000 19/81 17/84 1.16[0.65,2.07]
   
18.18.3 Vypro vs Ultrapro  
Okulu 2013 2/46 2/48 1.04[0.15,7.1]
   
18.18.4 Vypro vs Prolene light  
Okulu 2013 2/46 2/47 1.02[0.15,6.95]
   
18.18.5 Ultrapro vs Prolene light  
Okulu 2013 2/48 2/47 0.98[0.14,6.67]
   
18.18.6 anterior vaginal wall sling vs biosynthetic mesh sling  
Choe 2000 0/20 0/20 Not estimable
   
18.18.7 anterior rectus sheath sling vs Prolene strip  
Teleb 2011 0/12 1/12 0.33[0.01,7.45]
   
18.18.8 anterior rectus sheath sling vs anterior vaginal wall patch  
Teleb 2011 0/12 0/8 Not estimable
   
18.18.9 Prolene strip vs anterior vaginal wall patch  
Favours sling A 5000.002 100.1 1 Favours sling B
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Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
Teleb 2011 1/12 0/8 2.08[0.09,45.45]
   
18.18.10 fascial sling vs vaginal wall sling  
Viseshsindh 2003 0/15 0/11 Not estimable
Favours sling A 5000.002 100.1 1 Favours sling B
 
 
Analysis 18.19.   Comparison 18 One type of traditional sling operation versus another type of
traditional sling operation, Outcome 19 Long-term adverse e@ects (release of sling required).
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
18.19.1 fascial sling vs Pelvicol sling  
Guerrero 2008 2/61 1/38 1.25[0.12,13.28]
Favours sling A 10000.001 100.1 1 Favours sling B
 
 
Analysis 18.20.   Comparison 18 One type of traditional sling operation versus another type of traditional
sling operation, Outcome 20 De novo detrusor urgency or urge symptoms or detrusor overactivity.
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
18.20.1 standard sling vs short sling  
Lucas 2000 6/81 2/84 3.11[0.65,14.97]
   
18.20.2 Vypro vs Ultrapro  
Okulu 2013 5/46 2/48 2.61[0.53,12.78]
   
18.20.3 Vypro vs Prolene light  
Okulu 2013 5/46 4/47 1.28[0.37,4.46]
   
18.20.4 Ultrapro vs Prolene light  
Okulu 2013 2/48 4/47 0.49[0.09,2.55]
   
18.20.5 autologous dermal graO patch vs cadaveric fascia lata  
Shin 2001 4/33 5/20 0.48[0.15,1.6]
   
18.20.6 rectus fascia sling vs Goretex sling  
Barbalias 1997 4/32 3/16 0.67[0.17,2.63]
Favours sling A 100.1 50.2 20.5 1 Favours sling B
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Analysis 18.21.   Comparison 18 One type of traditional sling operation versus another type of
traditional sling operation, Outcome 21 Repeat surgery for urinary incontinence at first year.
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
18.21.1 Fascial sling vs Pelvicol sling  
Guerrero 2008 0/67 9/46 0.04[0,0.61]
Favours sling A 10000.001 100.1 1 Favours sling B
 
 
Analysis 18.22.   Comparison 18 One type of traditional sling operation versus another type of
traditional sling operation, Outcome 22 Long-term adverse e@ects (vaginal mesh or graO exposure).
Study or subgroup Sling type A Sling type B Risk Ratio Risk Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
18.22.1 fascial sling vs Pelvicol sling  
Guerrero 2008 0/61 0/38 Not estimable
   
18.22.2 Vypro vs Ultrapro  
Okulu 2013 2/46 1/48 2.09[0.2,22.24]
   
18.22.3 Vypro vs Prolene light  
Okulu 2013 2/46 2/47 1.02[0.15,6.95]
   
18.22.4 Ultrapro vs Prolene light  
Okulu 2013 1/48 2/47 0.49[0.05,5.22]
   
18.22.5 anterior vaginal wall sling vs biosynthetic mesh sling  
Choe 2000 0/20 0/20 Not estimable
Favours sling A 5000.002 100.1 1 Favours sling B
 
 
Analysis 18.23.   Comparison 18 One type of traditional sling operation versus another type of traditional sling
operation, Outcome 23 Condition-specific measures to assess quality of life (ICI-Q short form UI score at 1 year).
Study or subgroup Sling type A Sling type B Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
18.23.1 Vypro vs Ultrapro  
Okulu 2013 46 2 (0.7) 48 1.2 (0.6) 0.8[0.54,1.06]
   
18.23.2 Vypro vs Prolene light  
Okulu 2013 46 2 (0.7) 47 1.7 (0.4) 0.3[0.07,0.53]
   
18.23.3 Ultrapro vs Prolene light  
Okulu 2013 48 1.2 (0.6) 47 1.7 (0.4) -0.5[-0.7,-0.3]
Favours sling A 52.5-5 -2.5 0 Favours sling B
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Analysis 18.24.   Comparison 18 One type of traditional sling operation versus
another type of traditional sling operation, Outcome 24 Condition-specific
measures to assess quality of life (ICI-Q short form UI score at 1 to 5 years).
Study or subgroup Sling type A Sling type B Mean Difference Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI Fixed, 95% CI
18.24.1 Vypro vs Ultrapro  
Okulu 2013 46 2.1 (0.5) 48 0.8 (0.5) 1.3[1.1,1.5]
   
18.24.2 Vypro vs Prolene light  
Okulu 2013 46 2.1 (0.5) 47 1.5 (0.3) 0.6[0.43,0.77]
   
18.24.3 Ultrapro vs Prolene light  
Okulu 2013 48 0.8 (0.5) 47 1.5 (0.3) -0.7[-0.87,-0.53]
Favours sling A 52.5-5 -2.5 0 Favours sling B
 
 
A D D I T I O N A L   T A B L E S
 
Trial ID Definition of outcome Notes
WOMAN-REPORTED
Albo 2007 Overall success defined as no self-reported symptoms of UI, no incontinence on 3-day di-
ary, negative stress test, no re-treatment (combined outcome). Failure (self-reported UI)




Amaro 2007 Cure defined as complete dryness with no usage of pads (woman-reported)  
Arunkalaivanan
2003
Cure of incontinence defined as a quality of life (QoL) improvement of 90% and/or pa-
tient-determined continent status as dry (woman-reported)
Question-
naire-based
Demirci 2001 Dry (symptom-free) patients (woman-reported)  
Guerrero 2008 Assessment of cure not defined. Data abstracted from this trial therefore assumed to be
woman-reported
 
Hilton 1989 Cure stated as subjective (woman-reported) at 24 months' follow-up




Kondo 2006 Subjective cure consistent with complete dryness or a few drops of water with strong ex-




Lucas 2000 Success rate measured by recurrence of stress leakage as reported in patient question-
naire (woman-reported)
 





Table 1.   Definitions of cure and urinary incontinence used in included trials 
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Cure defined as of some degree of SUI at 1 year after surgery (woman-reported)  
Shin 2001 Success rate (dry) (method unspecified: assumed woman-reported)  
Song 2004 Cure rate (method unspecified: assumed woman-reported)  
Viseshsindh 2003 Stress urinary incontinence (method unspecified: assumed woman-reported)  
QUANTITATIVE
Basok 2008 Cure = dry pads, improvement = 1 wet pad, failure ≥ 1 wet pad per day (quantitative) Satisfaction sepa-
rately measured
by questionnaire
Fischer 2001 Subjective cure assessed via comparison between pre-operative and postoperative In-




Okulu 2013 Cure defined as no pad use (quantitative)  
Pacetta 2005 Subjective improvement only; subjective patient evaluations included QoL question-






Objective cure defined as 1-hour pad test ≤ 2 grams (quantitative) Also separate clin-
ician-reported
outcome
Silva Filho 2006 Women declared objectively cured when they had a postoperative pad test < 8 grams
(quantitative)
 
Zargham 2013 Objective assessment via 48-hour frequency volume chart, 48-hour pad test, and stan-
dardised stress test. Surgery was considered successful when there was no postoperative





Abouhashem 2014 No leakage of urine during stress test and urodynamic testing (clinician-reported)  
Barbalias 1997 Cure defined as complete freedom from SUI (clinician-reported)  
Choe 2000 Urine loss during cough-stress test defined as persistent stress incontinence (clinician-as-
sessed)
 





Hilton 1989 Cure stated as objective (urodynamic diagnosis, pad test (clinician-reported)) at 3 months Also woman-re-
ported outcome
at 24 months
Table 1.   Definitions of cure and urinary incontinence used in included trials  (Continued)
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Kondo 2006 Objective cure defined as complete absence of leakage during cough-stress test with 250




Maher 2005 Objective success: no leakage due to SUI on repeat urodynamic study (clinician-reported) Also separate
woman-reported
outcome









Objective cure defined as negative cough-induced stress test with full bladder (≥ 250 mL




Zargham 2013 Objective assessment via 48-hour frequency volume chart, 48-hour pad test, and stan-
dardised stress test. Surgery considered successful when stress test was negative (clini-




COMBINED WOMAN- AND CLINICIAN-REPORTED
Albo 2007 Overall success defined as no self-reported symptoms of UI, no incontinence on 3-day di-
ary, negative stress test, no re-treatment (combined outcome). Failure (self-reported UI)




Al-Azzawi 2014 Cure of SUI defined as significant dryness as perceived by the patient, no more use of
pads, negative stress test, and acceptable voiding stream (combined primary outcome)
However, no data
after first week, so
not useable
Bai 2005 Cure defined as absence of subjective complaints of leakage and absence of urinary leak-
age on stress test (combined outcome)
 
Enzelsberger 1996 Cure defined as dry, symptom-free without objective urine loss during stress with blad-
der filled to 300 mL or positive urethral-closure pressure during stress provocation (com-
bined outcome)
 
Helmy 2012 Continence defined as no urinary leakage on a 3-day voiding diary, no self-reported stress
incontinence symptoms, and no stress incontinence surgical treatment (combined out-
come)
 
Henriksson 1978 Cure defined as complete freedom from SUI (subjective and objective demonstrations)
(combined outcome)
 
Osman 2003 Patients evaluated by SEAPI score (subjective and objective) after urodynamic examina-




Cure defined as reported absence of SUI with no urinary loss during effort manoeuvres
(combined outcome)
 
Teleb 2011 Cure defined as no leakage reported by the patient or noticed at examination (combined
outcome)
 
Table 1.   Definitions of cure and urinary incontinence used in included trials  (Continued)
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Wadie 2005 Cure defined as complete dryness with no usage of pad and negative cough-stress test
(combined outcome)
 
Table 1.   Definitions of cure and urinary incontinence used in included trials  (Continued)
Trials that did not report cure rates.
□ Teixeira 2008: this trial did not address eIicacy because it was a trial of tissue (histological) reaction to diIerent sling materials.
□ Al-Azzawi 2014: this trial followed up women to one year and beyond but did not provide any outcome data aEer the first week.
 
 
Comparison 3. Traditional suburethral sling operation versus drugs
Osman 2003 Osman 2003 included 75 women with mixed urinary incontinence treated with surgery (either
Burch colposuspension (n = 24) or rectus fascia sling (n = 26)) or oxybutynin (an anticholinergic
drug treatment for urinary incontinence, overactive bladder, and detrusor overactivity - not for
stress incontinence; n = 25) (Osman 2003). The type of surgery was selected according to Valsal-
va leak point pressure (VLPP) - those with VLPP < 90 cm of water had rectus fascia sling, and those
with VLPP > 90 cm of water had Burch colposuspension)
Results for the surgically managed group were similar to those of the subgroup having slings. Due
to small sample sizes, data were too few to be reliable; we therefore compared only data from oxy-
butynin versus sling patients provided in tables
Primary outcomes
Number of continent (dry) women
Data suggest that, within the first year, women were significantly more likely to be continent af-
ter undergoing surgery with slings than after treatment with oxybutynin (20/24; 83% vs 0/21; OR
195.89, 95% CI 9.91 to 3871.03; n = 45; Analysis 3.1)
Number of women who have repeat continence surgery
Not reported
Secondary outcomes
Fewer women had persistent urgency urinary incontinence after traditional sling surgery (3/24;
13% vs 9/21; 43% with oxybutynin; RR 0.29, 95% CI 0.09 to 0.94; n = 45; Analysis 3.2)
Comparison 4. Traditional suburethral sling operation vs injectables
Maher 2005 Maher 2005 compared slings (21) vs injectable Macroplastique (22) in 45 women. Due to the small
size of the trial, the data were too few to be reliable
Primary outcomes
Number of continent (dry) women
Short-term: data from 1 small trial were too few to reliably identify evidence of a difference be-
tween traditional sling and injectables in the number of continent women within the first year (OR
2.79, 95% CI 0.48 to 16.33; n = 43; Maher 2005; Analysis 4.1)
Medium-term: Maher 2005 found no evidence of a difference between groups in the number of con-
tinent women after the first year (13/13; 100% continent with a traditional sling vs 10/14, 71% with
the injectable; OR 11.57, 95% CI 0.56 to 239.74; n = 27; very low-quality evidence; Analysis 4.2; Sum-
mary of findings 4)
Number of women who have repeat continence surgery
Table 2.   Results for data from comparisons with single trials 
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We found no evidence of a difference between groups in the numbers of women having repeat
surgery for urinary incontinence (1 after traditional sling vs 2 after injectable: RR 0.52, 95% CI 0.05
to 5.36; n = 43; very low-quality evidence; Maher 2005; Analysis 4.3; Summary of findings 4)
Secondary outcomes
Number of women cured at 1 year or later (women's observations)
The trial was too small to reliably identify evidence of a difference between groups in the number
of women cured after the first year (OR 11.57, 95% CI 0.56 to 239.74; n = 27; Analysis 4.4)
Number of women improved
Not reported
Number of women satisfied
Data from Maher 2005 were too few to identify a difference between groups in satisfaction rates at




Data suggest there were more women with incontinence (clinician-observed) within the first year
with injectables compared with the traditional sling: 4/21 vs 20/22 (RR 0.21, 95% 0.09 to 0.21; n =
43; Maher 2005; Analysis 4.6)
Surgical outcome measures
Injectables were quicker to perform, involved shorter hospital stay and time to catheter removal,
and led to quicker return to normal activity than after traditional sling surgery, but the data were









Maher 2005 reported no evidence of a difference between traditional slings and injectables in the
numbers of women with urinary tract infection (RR 1.57, 95% CI 0.29 to 8.49; very low-quality evi-
dence; Analysis 4.7; Summary of findings 4)
Urinary urgency symptoms, urgency urinary incontinence
Not reported
Detrusor overactivity (urodynamic overactivity)
Maher 2005 reported no evidence of a difference between traditional slings and injectables in the
numbers of women with de novo detrusor overactivity (RR 3.14, 95% CI 0.13 to 72.96; Analysis 4.8)
Voiding dysfunction (with or without urodynamic confirmation)
Table 2.   Results for data from comparisons with single trials  (Continued)
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Maher 2005 reported no evidence of a difference between traditional slings and injectables in the




Maher 2005 reported a significant reduction in Incontinence Impact Questionnaire (IIQ) scores
compared with baseline (P < 0.01) in both groups, although he provided no data
Comparison 6. Traditional suburethral sling operation vs bladder neck needle suspension (abdominal and vaginal)
Hilton 1989 Only 1 trial compared porcine dermis sling vs Stamey needle suspension (Hilton 1989). This was a
small trial with only 10 women in each arm. The women were unsuitable for abdominal colposus-
pension (the study author's preferred procedure) because they had vaginal narrowing secondary to
previous interventions or atrophic vaginitis. Thus they constitute a population of women with SUI
who are not typical of the majority. All women had urodynamic stress incontinence. Groups were
comparable for age, parity, previous interventions, and hormonal status. Follow-up was reported
at 3 months and 24 months. Due to the small size of the trial, the data were too few to be reliable
Primary outcomes
Number of continent (dry) women
Short-term: within the first year after surgery, 1 small trial reported 9/10 and 8/10 continent women
in the traditional sling and needle suspension groups, respectively (OR 2.25, 95% CI 0.17 to 29.77; n
= 20; Hilton 1989; Analysis 6.1)
Medium-term: very low-quality evidence from 1 trial comparing slings vs bladder neck needle sus-
pension suggested no evidence of a difference between groups in the likelihood of being continent
at 2 years after surgery (OR 3.86, 95% CI 0.33 to 45.57; n = 20; Hilton 1989; Analysis 6.2; Summary of
findings 6)
Long-term: not reported




Number of women cured at 1 year or later (women's observations)
Evidence from 1 small trial comparing slings vs bladder neck needle suspension suggests no dif-
ference between groups in cure rates at 2 years after surgery (OR 3.86, 95% CI 0.33 to 45.57; n = 20;
Hilton 1989)
Quantification of symptoms






Table 2.   Results for data from comparisons with single trials  (Continued)
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Length of hospital stay
Sling group needed an indwelling catheter for longer and more adjuvant therapy, resulting in a
longer stay in hospital than those with bladder neck needle suspension (MD 13 days longer, 95% CI
5 to 21; n = 20; Hilton 1989; Analysis 6.4)








Nine of the 10 women who had sling operations had complications, compared with 2/10 who had
needle suspension. These included pyrexia, blood loss, wound infection, and pulmonary embolus






Urinary urgency symptoms, urgency urinary incontinence
At 3 months: sling: 5/10, needle suspension: 3/10 (Hilton 1989; Analysis 6.6)
Detrusor overactivity (urodynamic overactivity)
At 3 months: sling: 2/10, needle suspension: 1/10 (Hilton 1989; Analysis 6.7)
Voiding dysfunction (with or without urodynamic confirmation)





Comparison 10. Traditional suburethral sling operation vs a single-incision sling (mini-sling)
Sharifiaghdas 2015 One small trial compared a rectus fascia pubovaginal traditional sling vs a single-incision sling (mi-
ni-sling; Ophira) and included women with urodynamically diagnosed stress urinary incontinence
(USI) (Sharifiaghdas 2015)
Due to the small size of the trial, the data were too few to be reliable
Primary outcomes
Number of continent (dry) women
Table 2.   Results for data from comparisons with single trials  (Continued)
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Short-term: not reported
Medium-term: exactly the same proportion of women were continent at 1 year after surgery (tradi-
tional sling: 31/35; mini-sling: 31/35; very low-quality evidence; Sharifiaghdas 2015; Analysis 10.1;
Summary of findings 10)
Long-term: not reported





For self-report of cure at 1 year after surgery, exactly the same proportion of women were cured
(traditional sling: 31/35; mini-sling: 31/35; Sharifiaghdas 2015; Analysis 10.2)
Number of women improved
Not reported
Number of women satisfied
10/35 women in the traditional sling group and 7/35 in the mini-sling group reported that they were





The clinician's report of observed stress incontinence concurred with that reported by women - 4 in









One woman (of 35) had a bladder perforation in the traditional sling group compared with none (of




Urinary urgency symptoms, urgency urinary incontinence
Table 2.   Results for data from comparisons with single trials  (Continued)
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More women in the traditional sling group reported urinary urgency incontinence (5/35) compared
with the mini-sling group (1/35) (RR 5.00, 95% CI 0.62 to 40.64; n = 70; Sharifiaghdas 2015; Analysis
10.6)
Detrusor overactivity (urodynamic overactivity)
Not reported
Voiding dysfunction (with or without urodynamic confirmation)
Not reported
Long-term adverse effects
Dyspareunia: 3/35 and 4/35 in traditional sling and mini-sling groups, respectively, reported pain
with intercourse (RR 0.75, 95% CI 0.18 to 3.11; n = 70; Sharifiaghdas 2008; Analysis 10.7)
Tape or mesh exposure: 1 woman in the traditional sling group and 2 in the mini-sling group were
found to have tape or mesh exposure (RR 0.50, 95% CI 0.05 to 5.27; n = 70; Sharifiaghdas 2008;
Analysis 10.8)
Quality of life
Based on mean IIQ score, quality of life was lower in the traditional sling group compared with the
mini-sling group (MD 7.50, 95% CI 2.23 to 12.77; very low-quality evidence; Analysis 10.9; Summary
of findings 10)
Table 2.   Results for data from comparisons with single trials  (Continued)
USI: urodynamically diagnosed stress urinary incontinence
VLPP: Valsalva leak point pressure
 
 
A P P E N D I C E S
Appendix 1. Search strategy for e@ectiveness studies - Cochrane Incontinence Specialised Register





({INTVENT.SURG.SLIN*} OR {INTVENT.SURG.SUBURETHRAL SLING.} OR {INTVENT.SURG.ABDO.SLING.})
(All searches were of the keyword field of EndNote 2018).
The date of the last fully incorporated search was: 27 February 2017. The date of the last search, which was not fully incorporated into the
review, was 23 January 2019.
Appendix 2. Details of extra literature searching performed for older versions of this review
For previous versions of this review (which covered all sling types) extra specific searches were performed by one of the review authors
(Carlos Bezerra). These are detailed below.
Systematic searches of electronic bibliographic databases:
• PubMed - years searched: January 1966 to January 2000, date searched: 30 January 2000; and
• UK National Research Register - 2001, Issue 1, date searched: May 2001.
Search term used: TVT.
Handsearching of conference proceedings: Brazilian Congress of Urology Annual Meeting: 1991 to 2003 inclusive.
Appendix 3. Search strategies for brief economic commentary
We performed additional searches for the brief economic commentary (BEC) in the following databases:
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• MEDLINE on OvidSP (1 January 1946 to week 5 July 2018) searched on 10 August 2018;
• Embase on OvidSP (1 January 1980 to week 32 2018) searched on 10 August 2018; and
• NHS Economic Evaluation Database (NHS EED) on OvidSP (1st Quarter 2016) searched on 6 April 2017 (this database is no longer updated
by the producer).
We used one search strategy in NHS EED (OvidSP) and two diIerent search strategies on MEDLINE and Embase (OvidSP). Details of the
searches run and the search terms used can be found below. The economic evaluation search filters used for MEDLINE and Embase are
those developed by and available on the Centre for Reviews and Dissemination web pages.
MEDLINE on OvidSP (1 January 1946 to week 5 July 2018) and Embase on OvidSP (1 January 1980 to week 32 2018) searched on
10 August 2018
We used two diIerent search strategies in MEDLINE and Embase (OvidSP) - these are given below.
Search strategy 1:
1. Economics, Pharmaceutical/ or Economics, Medical/ or Economics/ or Economics, Hospital/ or economics.mp. or Economics, Nursing/
2. exp "costs and cost analysis"/
3. "Value of Life"/




8. (economic* or pharmaco?economic*).ti.
9. (price* or pricing*).ti,ab.
10. (cost* adj2 (eIective* or utilit* or benefit* or minimi* or unit* or estimat* or variable*)).ab.
11. (financ* or fee or fees).ti,ab.
12. (value adj2 (money or monetary)).ti,ab.
13. ((energy or oxygen) adj cost).ti,ab.
14. (metabolic adj cost).ti,ab.
15. ((energy or oxygen) adj expenditure).ti,ab.
16. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15
17. exp Urinary Incontinence/
18. ((stress* or mix* or urg* or urin*) adj3 incontinen*).tw.
19. Urodynamics/ or Urinary Incontinence, Stress/ or Urinary Incontinence/ or Suburethral Slings/ or mixed incontinence.mp. or Urinary
Bladder/ or Urinary Incontinence, Urge/
20. 17 or 18 or 19
21. anterior vaginal repair*.tw.
22. 16 and 20 and 21
23. anterior colporrhaphy*.tw.
24. 21 or 23
25. 16 and 20 and 23
26. bladder neck needle suspension$.tw.
27. 16 and 20
28. 26 and 27
29. open abdominal retropubic colposuspension*.tw.
30. retropubic colposuspension*.tw.
31. burch colposuspension*.tw.
32. 29 or 30 or 31
33. 27 and 32
34. laparoscopic retropubic colposuspension*.tw.
35. laparoscopic colposuspension*.tw.
36. 34 or 35
37. 27 and 36
38. traditional suburethral retropubic sling procedure$*.tw.
39. traditional sling procedure$*.tw.
40. suburethral retropubic sling procedure$*.tw.
41. retropubic sling procedure$*.tw.
42. traditional suburethral sling*.tw.
43. Suburethral Slings/ or Urinary Incontinence, Stress/ or Urologic Surgical Procedures/
44. 27 and 43
45. 21 or 23 or 26 or 32 or 36 or 38 or 39 or 40 or 41 or 42
46. suburethral slings/
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47. urological surgical procedures/
48. 45 or 46 or 47
49. 48 and 27
50. remove duplicates from 49
Search strategy 2:
1. economics.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
2. value of life.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
3. exp "costs and cost analysis"/
4. exp economics, hospital/
5. exp economics, medical/
6. economics, nursing.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
7. economics, pharmaceutical.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]




12. (economic* or pharmaco?economic*).ti.
13. (price* or pricing*).ti,ab.
14. (cost* adj2 (eIective* or utilit* or benefit* or minimi* or unit* or estimat* or variable*)).ab.
15. (financ* or fee or fees).ti,ab.
16. (value adj2 (money or monetary)).ti,ab.
17. or/1-16
18. economics.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
19. value of life.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
20. exp "costs and cost analysis"/
21. exp economics, hospital/
22. exp economics, medical/23. economics, nursing.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
24. economics, pharmaceutical.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]




29. (economic* or pharmaco?economic*).ti.
30. (price* or pricing*).ti,ab.
31. (cost* adj2 (eIective* or utilit* or benefit* or minimi* or unit* or estimat* or variable*)).ab.
32. (financ* or fee or fees).ti,ab.
33. (value adj2 (money or monetary)).ti,ab.
34. 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33
35. ((energy or oxygen) adj cost).ti,ab.
36. (metabolic adj cost).ti,ab.
37. ((energy or oxygen) adj expenditure).ti,ab.
38. 34 or 35 or 36 or 37
39. urinary incontinence.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
40. ((stress$ or mix$ or urg$ or urin$) adj3 incontinen$).tw.
41. Urinary incontinence, stress.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
42. stress urinary incontinence*.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
43. 39 or 40 or 41 or 42
44. intervention surgery*.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
45. colporrhaphy.tw.
46. Bologna procedure*.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
47. Kelly-Kennedy.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
48. Marion Kelly.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
49. Diaphragmplasty.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
50. Vaginal urethrocystopexy.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
51. Cystocele repair.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
52. Kelly plication.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
53. anterior vaginal repair$.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
54. anterior colporrhaphy.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
55. 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54
56. 38 and 43 and 55
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57. remove duplicates from 56
58. Bladder neck needle suspension$.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
59. 38 and 43 and 58
60. burch colposuspension.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
61. open abdominal retropubic colposuspension.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
62. Paravaginal defect repair.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
63. Marshall-Marchetti-Krantz.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
64. abdominal burch.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
65. abdominal colposuspension.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
66. endopelvic Fascia Plication.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
67. 60 or 61 or 62 or 63 or 64 or 65 or 66
68. 38 and 43
69. 67 and 68
70. laparoscopic retropubic colposuspension.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
71. laparoscopic colposuspension.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
72. retropubic colposuspension.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
73. 70 or 71 or 72
74. 68 and 73
75. remove duplicates from 74
76. suburethral sling.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
77. abdominal sling.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
78. traditional sling procedure$*.tw.
79. suburethral sling procedure.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
80. 76 or 77 or 78 or 79
81. 68 and 80
82. remove duplicates from 81
83. mid$urethral sling.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
84. retropubic sling procedure$*.tw.
85. transobturator sling procedure$.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
86. 83 or 84 or 85
87. remove duplicates from 86
88. 68 and 87
89. TVT-Secur.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
90. mini-arc.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
91. ajust.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
92. needleless.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
93. solyx.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
94. single$incision sling$.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
95. miniarc.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
96. mini$sling.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
97. Ophira.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
98. Tissue Fixation System.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
99. 89 or 90 or 91 or 92 or 93 or 94 or 95 or 96 or 97 or 98
100. 68 and 99
101. remove duplicates from 100
102. ((urethra$ or periurethra$ or transurethra$) adj3 (agent$ or bulk$ or injection$ or injectable$)).tw.
103. injection therapy.tw.
104. injectable$.tw.
105. (injectable$ adj2 agent$).tw.
106. (bulk$ adj3 agent$).tw.
107. Peri$urethral injection$.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
108. Autologous fat.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
109. Macroplastique.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
110. Calcium hydroxylapatite.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
111. Hyaluronic acid with dextranomer.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
112. Porcine dermal implant.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
113. Ethylene vinyl alcohol copolymer.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
114. Silicon particles.mp. [mp=ti, ab, ot, nm, hw, fx, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, dq]
115. 102 or 103 or 104 or 105 or 106 or 107 or 108 or 109 or 110 or 111 or 112 or 113 or 114
116. 102 or 103 or 104 or 105 or 106 or 107 or 108 or 109 or 110 or 111 or 112 or 113 or 114
117. 68 and 115
118. 55 or 58 or 67 or 73 or 80 or 86 or 99 or 115
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119. 118 and 38 and 43
120. remove duplicates from 119
NHS EED (Ovid) (1st Quarter 2016)
NHS Economic Evaluation Database (NHS EED) on OvidSP (1st Quarter 2016) searched on 6 April 2017. As this database is no longer updated
by the producer, we did not perform further updates of this search as no new records would have been added.
We searched NHS EED using the following search strategy.
1. Urinary incontinence/
2. Urinary incontinence, stress/





8. Bladder neck needle suspension$.tw.
9. Anterior vaginal repair$ .tw.
10. Or/1-9
W H A T ' S   N E W
 
Date Event Description
21 January 2020 New citation required but conclusions
have not changed
Updated. Conclusions not changed.
21 January 2020 New search has been performed For this update, published in 2020, the following changes were
made.
1. The search was updated to February 2017 and 8 trials were
newly included (Abouhashem 2014; Al-Azzawi 2014; Choe
2000; Helmy 2012; Okulu 2013; Sharifiaghdas 2015; Teleb 2011;
Zargham 2013). A further search was conducted on 23 January
2019; as a result, several additional reports of studies are await-
ing classification.
2. Additional reports for the following trials were identified: Al-
bo 2007; Amaro 2007; Guerrero 2008; Wadie 2005, and extra data
were added where appropriate.
3. The methods were substantially updated in line with current
Cochrane standards. This includes assessment of risk of bias in
included trials and assessment of the quality of the body of evi-
dence via the GRADE approach.
4. The primary outcome was changed from 'Number of women
with urinary incontinence' to 'Number of continent (dry)
women', and a further outcome, 'Number of women cured', was
added.
 
H I S T O R Y
Protocol first published: Issue 3, 1999
Review first published: Issue 3, 2000
 
Date Event Description
8 December 2010 New citation required but conclusions
have not changed
A total of 13 new studies have been added.
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Date Event Description
30 July 2010 New search has been performed This is the second update of the review of traditional slings. 13
new RCTs have been added (Albo 2007; Amaro 2007; Bai 2005;
Basok 2008; Guerrero 2008; Maher 2005; Pacetta 2005; Sharifi-
aghdas 2008; Silva Filho 2006; Song 2004; Tcherniakovsky 2009;
Teixeira 2008; Wadie 2005), and 3 have been updated (Arunk-
alaivanan 2003; Kondo 2006; Lucas 2000).
13 October 2008 Amended Review was converted to new review format.
25 May 2005 New citation required and conclusions
have changed
Substantive amendments were made. The review was divided in-
to 2 separate reviews: 1 on traditional suburethral sling opera-
tions (current review, updated) and another on suburethral self-
fixing sling operations (to include the new TVT and SPARC pro-
cedures) to be prepared. The trials on TVT vs procedures other
than traditional suburethral sling operations (4) were moved to
the excluded trials list and will be included in the new review.
Five new trials were included.
13 February 2003 New search has been performed Minor updates were made; 5 studies were added.
17 May 2001 New citation required and conclusions
have changed
This is the first update.
 
C O N T R I B U T I O N S   O F   A U T H O R S
LS and CG updated the protocol and conducted the update of the review including screening, data abstraction, and updating of results
and discussion. MO analysed and interpreted the results, assessed the quality of evidence (with LS), wrote the first draE of the abstract and
plain language summary, and critically revised other sections of the review. HR updated a previous version of the review and contributed
to this update by screening abstracts and commenting on the results, with assistance provided by JDC. PA conducted the brief economic
commentary. All review authors contributed to writing the review.







S O U R C E S   O F   S U P P O R T
Internal sources
• No sources of support supplied
External sources
• The National Institute for Health Research (NIHR), UK.
This project was supported by the National Institute for Health Research, via Cochrane Infrastructure, Cochrane Programme Grant, or
Cochrane Incentive funding to Cochrane Incontinence. The views and opinions expressed therein are those of the authors and do not
necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS, or the Department of Health. The NIHR is the single largest
funder of Cochrane Incontinence.
D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W
For this update, published in 2020, the following changes were made.
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• New comparison was added: traditional suburethral sling operation versus a single-incision sling (mini-sling). The mini-sling is a new
procedure for surgical treatment of women with SUI, which diIers significantly from the mid-urethral sling technique and is considered
to be less invasive.
• Two new subgroup analyses were specified: primary versus recurrent SUI, and presence or absence of prolapse. These factors might
be expected to aIect the outcome and choice of surgery. We wished to explore whether diIerent interventions had diIerential eIects
among women with these diIerent clinical characteristics.
• Outcome measures were re-defined: primary outcomes were re-defined as numbers of continent (dry) women using any definition of
urinary incontinence and the need for repeat continence surgery. An additional outcome of 'cure' as reported by women was added.
• We adopted the GRADE method for assessing the quality of evidence for those outcomes included in the 'Summary of findings' tables.
• A brief economic commentary was added.
I N D E X   T E R M S
Medical Subject Headings (MeSH)
*Suburethral Slings  [adverse eIects]  [economics];  Polytetrafluoroethylene  [therapeutic use];  Randomized Controlled Trials as Topic; 
Treatment Outcome;  Urinary Incontinence  [drug therapy]  [surgery];  Urinary Incontinence, Stress  [drug therapy]  [*surgery]
MeSH check words
Adult; Female; Humans
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